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Abstract 
RNA silencing pathways control the expression of genes and other DNA loci by 
the action of small RNA molecules and are found in many eukaryotes. In plants 
there are a number of RNA silencing pathways, of which RNA-directed DNA 
methylation (RdDM) is one. In this pathway the small RNA molecules direct DNA 
methylation, resulting in the down regulation of expression of the target locus. In 
terms of the mechanism of the pathway it is mostly well characterised but 
several gaps exist in our knowledge. These relate to its initiation, where it is not 
known how RdDM targets the correct locus; methylation, where it is unclear how 
the action of small RNAs triggers methylation; and chromatin modification, 
where it is unclear how methylated DNA is converted into higher order 
chromatin modification. These gaps in the pathway raised the possibility of the 
involvement of novel proteins and so this project aimed to identify and 
characterise mutants in these proteins. 
Screening of a library of putative RdDM mutants in Arabidopsis thaliana 
identified three alleles in MORC6, which encodes a GHKL ATPase containing 
protein associated with RdDM that is thought to form higher order chromatin in 
response to DNA methylation. Analysis of the three alleles revealed that morc6 
mutants have no effect on siRNA production but at certain loci do have an effect 
on DNA methylation and so would suggest that MORC6 is also involved in the 
DNA methylation process in RdDM at specific loci. It was also shown that 
silencing by RdDM can still occur in morc6 mutants in a limited capacity and that 
this silencing is stochastic and cell autonomous in nature. These findings point to 
MORC6 also having further roles in RdDM other than higher order chromatin 
modification and so increase our understanding of the mechanism of RdDM. 
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1.1 RNA silencing in plants 
1.1.1 Overview 
RNA silencing is a term that refers to eukaryotic gene regulatory pathways that 
are directed by small RNA molecules. There are a number of such pathways in 
plants of which one of them, RNA-directed DNA methylation (RdDM), regulates 
gene expression by DNA methylation and it is this pathway that is the focus of 
this study (Wassenegger et al. 1994, Xie et al. 2004). Before discussing the 
mechanism of RdDM in detail, it is important to understand the basic structure 
of RNA silencing pathways and therefore this will be explained as well as a brief 
outline of the other pathways found in plants. The process through which RdDM 
represses genes, DNA methylation, will also be introduced in order to 
understand how the RdDM pathway functions. This will also introduce other 
pathways involved in methylation and the process by which these repressive 
marks are removed. The introduction will then move onto the RdDM pathway 
itself in terms of its mechanism and function. Finally this chapter will discuss the 
aims of this study and the rational for why it was undertaken. 
1.1.2 Discovery of RNA silencing 
In 1928 a study by Wingard noted that when Tobacco plants were infected with 
the tobacco ring spot virus, younger leaves further up the plant were 
asymptomatic and that the plants were resistant to further ring spot infections 
(Wingard 1928). At the time it was not known how the plants gained this 
immunity to the virus but it is now known to be due to an RNA silencing pathway 
acting in viral defence (Ratcliff et al. 1999). The actual discovery of RNA silencing 
occurred in the 1990s and came about as a result of research to identify the 
cause of unusual experimental findings from transgenic lines in Petunia (Napoli 
et al. 1990, van der Krol et al. 1990a, van der Krol et al. 1990b). The Petunia lines 
contained a transgenic copy of the endogenous Chalcone synthase (CHS) gene, 
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which is part of the floral pigment biosynthesis pathway, and the aim was to 
determine if the action of this enzyme was the rate limiting step of biosynthesis 
by increasing the level of CHS in petals. The introduction of the transgene was 
expected to either increase the purple flower pigmentation or have no effect, 
but instead the studies found that a significant percentage of transformant lines 
either totally or partially lacked pigmentation. Further investigation showed 
where there was no pigmentation both the transgenic and endogenous CHS 
genes had reduced expression and this affect was named co-suppression as a 
result of this dual repression. Co-suppression was later shown to be post 
transcriptional in nature as levels of RNA polymerase transcription were 
unaffected in silenced Petunia lines and instead the resulting mRNA transcripts 
were degraded (Van Blokland et al. 1994). Co-suppression was renamed post 
transcriptional gene silencing (PTGS) after studies in Arabidopsis thaliana and 
Nicotiana tabacum where a single transgene that was unrelated to any 
endogenous gene, also caused a post-transcriptional reduction in gene 
expression (Dehio and Schell 1994, Ingelbrecht et al. 1994, Elmayan and 
Vaucheret 1996). PTGS was initially thought to be a plant phenomenon until 
similar silencing mechanisms were identified in Fungi and Metazoan species 
which were termed quelling and RNA interference (RNAi), respectively (Cogoni et 
al. 1996, Fire et al. 1998, Kennerdell and Carthew 1998, Lohmann et al. 1999, 
Sánchez Alvarado and Newmark 1999, Wianny and Zernicka-Goetz 2000). 
Investigation of the mechanism behind PTGS suggested that it involved double 
stranded RNA (dsRNA) as RNA corresponding to the antisense sequence of the 
CHS gene could be detected in silenced Petunia lines (Van Blokland et al. 1994). 
This was confirmed when it was shown that co-expression of two transgenes that 
produced sense and antisense mRNAs could successfully trigger RNA silencing as 
could the expression of an inverted repeat transgene (Hamilton et al. 1998, 
Waterhouse et al. 1998). These two studies showed that inverted repeats and 
antisense strand expression were both sources of dsRNA for PTGS. It was also 
suggested that another source of dsRNA was viral replication as several groups 
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showed that viral infection could trigger silencing of either an endogenous gene 
or transgene if the virus contained part of the target genes sequence (Lindbo et 
al. 1993, Kumagai et al. 1995, Ruiz et al. 1998). Later studies also found that 
dsRNA can be produced by RNA-dependent RNA polymerases (RDRs) that 
convert single stranded RNA (ssRNA) into dsRNA (Cogoni and Macino 1999, 
Dalmay et al. 2000b, Mourrain et al. 2000, Tang et al. 2003).  
The next development in the investigation of the mechanism of PTGS was the 
identification, in four different PTGS systems, of small 25 nucleotide RNA 
molecules corresponding to the antisense sequence of the target gene (Hamilton 
and Baulcombe 1999). These small RNAs were subsequently shown to be created 
by cleavage of dsRNA by proteins with RNase III activity, known as Dicers in 
animals and Dicer-like (DCL) in plants, into short dsRNAs (Bernstein et al. 2001, 
Elbashir et al. 2001, Tang et al. 2003). These small RNA molecules were termed 
small interfering RNAs (siRNA) and were shown predominantly to be between 
twenty one to twenty four nucleotides in length in plants (Hamilton et al. 2002, 
Llave et al. 2002, Tang et al. 2003). It was discovered that the larger sizes of 
siRNA were involved in transcriptional gene silencing (TGS) rather than PTGS and 
so the term RNA silencing began to be used to refer to both PTGS and TGS that 
involved these siRNA molecules (Hamilton et al. 2002, Xie et al. 2004). The 
discovery of these siRNA molecules explained what happened to the dsRNA but 
raised the question of how silencing of targets is achieved.  
In 2000 it was shown that in Drosophila cells primed with dsRNA, cellular extracts 
contained a protein complex termed the RNA induced silencing complex (RISC) 
that had endonuclease activity specific to the dsRNA target sequence and that its 
function was dependent on siRNAs produced from the dsRNA (Hammond et al. 
2000, Zamore et al. 2000, Nykänen et al. 2001). It was assumed that the siRNA 
provides the RISC with target specificity through Watson and Crick base pairing 
but this requires the siRNA to be single stranded and further investigation 
revealed that one of the strands is removed in a ATP dependent manner after 
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association with the RISC complex (Nykänen et al. 2001). Analysis of RISC 
revealed one of the components to be an ARGONAUTE (AGO) protein that was 
later shown to be responsible for both the endonuclease and siRNA binding 
activities of RISC (Hammond et al. 2001, Liu et al. 2004, Ma et al. 2005, Rivas et 
al. 2005, Wang et al. 2008, Wang et al. 2009). AGO proteins were first identified 
in plants and the plant AGO1 protein has been shown to be required for PTGS, 
indicating that plant AGOs are also likely to function in RISCs (Bohmert et al. 
1998, Fagard et al. 2000). With the identification of the RISC complex this 
completed the basic outline of RNA silencing pathways, which consists of the 
production of dsRNA by a variety of sources, cleavage of the dsRNA by a DCL 
enzyme into siRNAs and loading of one of the siRNA strands into an AGO protein 
to form a RISC (Figure 1.1). 
 
Figure 1.1: Basic outline of RNA silencing pathways 
Diagram shows the key steps of RNA silencing pathways with RNA strands shown in red 
with bases in orange. A Dicer-like (DCL) RNase III enzyme is shown in blue and a AGO 
protein, which forms part of the RISC, is shown in yellow. 
1.1.3 Divergence of RNA silencing pathways in plants 
There are five distinct RNA silencing pathways in plants and although their basic 
structure (Figure 1.1) is the same there are key differences between them, 
namely how dsRNA is produced, the size of the small RNAs produced; and 
whether RISC silences post-transcriptionally or transcriptionally. The divergence 
of RNA silencing pathways in plants can be seen by the large number of silencing 
components in Arabidopsis as there are a total of six RDR genes, four DCL genes; 
and ten AGO genes (Finnegan et al. 2003, Yu et al. 2003, Havecker et al. 2010). 
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The five RNA silencing pathways are the: micro RNA (miRNA), trans-acting siRNA 
(tasiRNA), natural antisense siRNA (nat siRNA), viral defence siRNA and RNA-
directed DNA methylation (RdDM) pathways (Mourrain et al. 2000, Hamilton et 
al. 2002, Park et al. 2002, Reinhart et al. 2002, Yu et al. 2003, Peragine et al. 
2004, Vazquez et al. 2004, Xie et al. 2004, Wang et al. 2005, Yoshikawa et al. 
2005, Axtell et al. 2006, Henz et al. 2007, Jin et al. 2008). This section will briefly 
explain how each pathway functions and highlight the differences between the 
pathways, which are also summarised in Table 1.1. 
Pathway dsRNA production DCL 
Main siRNA 
size (bp) 
AGO 
Mode of 
action 
miRNA Secondary structure 1 21 1 PTGS 
tasiRNA 
miRNA cleavage 
followed by RDR6 
4 21 1 and 7 PTGS 
nat siRNA RDR6 1 and 2 21 and 24 ? PTGS 
viral siRNA RDR1 and RDR6 2 and 4 21 and 22 1 and 7 PTGS 
RdDM RDR2 3 and 4 24 4,6 and 9 TGS 
Table 1.1: Differences between the five main RNA silencing pathways in plants 
Summary of the key differences between RNA silencing pathways in plants including: 
how dsRNA is produced, which DCL is required, the size of the siRNAs produced, which 
AGO is required and whether the pathway acts post-transcriptionally (PTGS) or 
transcriptionally (TGS) 
The miRNA pathway is a PTGS pathway where dsRNA is produced by the 
formation of a stem loop secondary structure by an RNA transcript and so does 
not require the activity of an RDR to produce dsRNA (Figure 1.2 A) (Park et al. 
2002, Reinhart et al. 2002). The stem does not show full complementarity in 
terms of sequence resulting in bulges and it is this lack of complementarity that 
is the major difference between miRNAs and siRNAs as siRNAs are produced 
from full complementary dsRNA (Figure 1.2 A and B). The stem loops are known 
as pri-miRNA transcript and are cleaved by DCL1 to produce the mature miRNA 
from the stem, which are typically 21 nt in length, although some such as those 
associated with tasiRNAs (22 nt) are longer (Park et al. 2002, Chen et al. 2010, 
Cuperus et al. 2010). miRNAs are then loaded into the AGO1 protein and act in 
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trans to down regulate the level of its target mRNA (Rhoades et al. 2002). This 
down regulation can occur either through cleavage and resulting degradation of 
the target mRNA or by repression of ribosomal translation from this mRNA, 
however cleavage is the most common process through which miRNAs operate 
in plants (Aukerman and Sakai 2003). 
 
Figure 1.2: Differences in production of dsRNA by RNA silencing pathways 
Diagram shows how dsRNA is produced for miRNAs (A), siRNA pathways including RdDM 
and viral defence (B) and tasiRNAs (C). miRNAs and pri miRNA transcript are shown in 
blue while siRNAs and associated dsRNA are shown in red. A RDR is shown in green 
while an AGO is shown in yellow and a nuclease is shown in purple. RNA nucleotides are 
shown as a red and orange T shape. The blue arrows show the direction of RDR 
transcription. 
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The tasiRNAs are produced from four non-coding RNA genes in Arabidopsis that 
are known as TAS1-TAS4, although there may be further as yet unidentified TAS 
genes (Allen and Howell 2010). siRNA production from these transcripts requires 
the cleavage of the transcript by a miRNA, which in the case of TAS1, 2 and 3 is 
miR173 and for TAS3 is miR390, and this miRNA-dependent initiation is one of 
the major difference between the tasiRNA pathway and other siRNA pathways 
(Yoshikawa et al. 2005, Axtell et al. 2006). The cleavage by these two miRNAs on 
their respective targets results in two cleaved transcripts of which the one to the 
3’ side of the cleavage site is turned into dsRNA by the action of RDR6 while the 
other transcript is either degraded or also turned into dsRNA, but at a far lower 
efficiency (Figure 1.2 C) (Peragine et al. 2004, Vazquez et al. 2004, Yoshikawa et 
al. 2005). The dsRNA is then cleaved by DCL4 into 21 nt siRNAs before being 
loaded into an AGO, possibly either AGO1 or AGO7 as both result in a reduction 
in tasiRNA silencing, although this may be down purely to the miRNAs involved in 
tasiRNA synthesis being loaded into these AGOs (Peragine et al. 2004, Vazquez et 
al. 2004, Adenot et al. 2006). The resulting complex then acts in trans to cleave 
target mRNA so is another PTGS pathway. 
The nat siRNA pathway involves the silencing of a target gene by the production 
in cis of a corresponding antisense transcript and the resulting production of 
siRNAs from this transcript (Wang et al. 2005, Henz et al. 2007, Jin et al. 2008). 
Similarly to tasiRNAs, nat siRNAs are produced in a two-step process whereby 
initially 24 nt siRNAs are produced that direct cleavage of the sense gene’s mRNA 
and the resulting cleaved RNA transcripts are used to produce 21 nt siRNAs that 
go on to cleave further mRNA transcripts of the target gene thereby amplifying 
the pathway (Borsani et al. 2005, Katiyar-Agarwal et al. 2006). The initial 
antisense transcript is transcribed by RNA polymerase IV (PolIV) and forms 
dsRNA by annealing to the sense transcript transcribed by RNA Polymerase II 
(PolII), which is then cleaved by DCL2 into 24 nt siRNAs. These 24 nt siRNAs 
cleave the sense transcripts, which are then themselves turned into dsRNA by 
RDR6 and 21 nt siRNAs are produced by DCL1 cleavage. The identity of the AGO 
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or AGOs involved in this pathway is unknown. Since the nat siRNAs result in 
cleavage of the sense mRNA target the pathway acts post-transcriptionally.  
The viral defence pathway is a siRNA pathway that defends the plant against RNA 
virus infection through degradation of the viral RNA. In theory viral replication 
should create dsRNA that could be processed into siRNAs, however anti-viral 
defence often requires RDR1 and RDR6 thus suggesting that dsRNA can be 
produced by the action of these enzymes (Mourrain et al. 2000, Xie et al. 2001, 
Yu et al. 2003, Xie et al. 2004). The dsRNA is then processed into 21 and 22 nt 
siRNAs by DCL4 and DCL2 respectively. These are then loaded into AGO1 and 
AGO7 and go on to cleave the viral RNA resulting in its degradation (Xie et al. 
2004, Deleris et al. 2006, Qu et al. 2008).  
The final pathway is the RNA-directed DNA methylation (RdDM) pathway in 
which siRNAs direct TGS of targets through DNA methylation (Hamilton et al. 
2002, Xie et al. 2004). The pathway acts in cis as initially the target DNA is 
transcribed by RNA polymerase IV and the resulting transcript is turned into 
dsRNA by RDR2 (Xie et al. 2004, Herr et al. 2005, Kanno et al. 2005, Onodera et 
al. 2005). The dsRNA is then processed by DCL3 and DCL4 into 24 nt siRNAs that 
are loaded into AGO4, 6 or 9 and directs DNA methylation of the target DNA 
(Hamilton et al. 2002, Park et al. 2002, Schauer et al. 2002, Finnegan et al. 2003, 
Xie et al. 2004, Havecker et al. 2010, Pélissier et al. 2011). RdDM is the only 
pathway of the five mentioned here that involves a transcriptional rather than 
post-transcriptional form of gene silencing. It is also the focus of this study and 
so will be discussed in further detail later on in this chapter, but before RdDM is 
discussed, the mechanism by which RdDM causes silencing, DNA methylation, 
must be first introduced. For this reason the next section will discuss DNA 
methylation in plants. 
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1.2 DNA methylation in plants  
1.2.1 Types of DNA methylation found in plants 
DNA methylation involves the modification of the base of a nucleic acid by the 
addition of a methyl group, but of the four DNA bases only adenine and cytosine 
have a functional significance in cells (Johnson and Coghill 1925, Wyatt 1951, 
Dunn and Smith 1958, Doskočil and Šormová 1965, Ehrlich et al. 1985). Cytosine 
can be modified at either the carbon atom at position five or the nitrogen side 
group of the carbon at position four, referred to as 5-methylcytosine and N4-
methylcytosine, respectively (Figure 1.3 A). Adenine can only be modified at the 
nitrogen side group of the carbon atom at position six and is referred to as N6-
methyladenine. The majority of DNA methylation in plants is comprised of 5-
methylcytosine but low levels of N6-methyladenine have been detected in the 
plant genome and from experiments using transgenes with adenine methylation 
it appears that this DNA modification acts as a repressive mark in plants and may 
have functional significance (Gruenbaum et al. 1981, Pintor-Toro 1987, Rogers 
and Rogers 1995, Van Blokland et al. 1998, Ashapkin et al. 2002, Sugimoto et al. 
2003). By comparison to adenine methylation in plants, 5-methylcytosine 
methylation is considerably better understood and as it is this methylation mark 
that this study will concentrate on any future reference to DNA methylation 
refers to 5-methylcytosone only. Closer analysis of the sequence context of 
methylated cytosines reveals that in plants there are three sequence contexts in 
which methylated cytosines appear, these being CG, CHG and CHH, where H 
represent C, A or T with the majority of methylated cytosines being in the CG 
context (Figure 1.3 B) (Gruenbaum et al. 1981, Ingelbrecht et al. 1994, Meyer et 
al. 1994, Jacobsen and Meyerowitz 1997, Cokus et al. 2008, Lister et al. 2008). By 
comparison to plants, the majority of methylation in animals is in the CG 
sequence context with around 0.02% of methylation being non-CG in 
differentiated cells, although in stem cells this rises to around a quarter 
suggesting a difference in methylation mechanism between stem cells and 
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differentiated cells (Ramsahoye et al. 2000, Lister et al. 2009). The fact that non-
CG methylation is more prevalent in plants than animals makes it a defining 
feature of plant DNA methylation. The nature of CG and CHG methylation means 
that there will also be a cytosine on the opposite strand that can be methylated 
and it has been found that if one cytosine is methylated the other tends to be as 
well, which has a relevance to how the methylation at these cytosines is 
maintained (Figure 1.3 B) (Cokus et al. 2008, Lister et al. 2008). 
 
Figure 1.3: The different methylated bases found in plants and the cytosine 
sequence context that can be methylated 
A: Chemical structures of the three types of DNA methylation found in eukaryotes and 
prokaryotes. Single lines represent single bonds while double lines represent double 
bonds. N is nitrogen while O is oxygen and H is hydrogen, and any junction between 
lines without a N or O is carbon. The CH3 in red is the methyl group added to the 
respective base. The numbers inside the rings for each schematic show the position of 
each carbon and nitrogen in the rings. B: Shows the three sequence contexts for 5-
methylcytosine methylation in plants. The methyl groups are shown as white Ms in a 
black circle. CG methylation is in red, CHG methylation in blue; and CHH methylation in 
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green. H represents cytosine (C), adenine (A) or thymine (T) and D represents guanine 
(G), adenine or thymine. 
1.2.2 DNA methyltransferases in plants 
The addition of methyl groups to DNA is catalysed by the methyltransferase 
enzymes, of which there are three families in plants: the Methyltransferase 
(MET) family, the Chromomethylase (CMT) family and the Domains rearranged 
methyltransferase (DRM) family (Finnegan and Dennis 1993, Henikoff and Comai 
1998, Rose et al. 1998, Genger et al. 1999, Cao et al. 2000, McCallum et al. 2000, 
Henderson et al. 2010). Within these three families MET1, CMT3 and DRM2 are 
the principle methyltransferase enzymes from their respective families. MET1 
and CMT3 are maintenance methyltransferases whereas DRM2 is required for de 
novo methylation, although for some loci CMT3 can also act as a de novo 
methyltransferase (Finnegan et al. 1996, Lindroth et al. 2001, Cao and Jacobsen 
2002a, Cao and Jacobsen 2002b, Aufsatz et al. 2004). Interestingly in a transgene 
system mutation of either of the three principle methyltransferases resulted in a 
reduction in methylation in all cytosine contexts and so suggests a more complex 
relationship between the three methyltransferases at some loci (Singh et al. 
2008). Only CG and CHG methylation can be maintained by maintenance 
methyltransferases whereas CHH requires continuous de novo methylation in 
order to be maintained (Finnegan et al. 1996, Lindroth et al. 2001, Cao and 
Jacobsen 2002a, Cao and Jacobsen 2002b, Aufsatz et al. 2004). The reason for 
this is that, for CG and CHG methylation, after DNA replication during S-phase 
the unmethylated daughter strand can be methylated using the parent strand 
methylation as a template since both CG and CHG are palindromic (Figure 1.4). 
Only one of the parental strands is methylated for CHH methylation, meaning 
that to methylate the other DNA helix de novo methylation must occur as there 
is no template to indicate where methylation should occur. The next three 
sections will discuss how each of these three methyltransferase enzymes 
functions. 
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Figure 1.4: Effect on DNA replication on DNA methylation 
Diagram showing what happens to CG, CHG and CHH methylation after replication has 
occurred. The parental strands are shown in blue while the daughter strands are shown 
in purple. DNA methylation is shown as a white M in a red circle. 
1.2.3 MET1 methylation 
MET1 is part of a family of four genes in Arabidopsis which also include MET2a, 
MET2b and MET3 (Genger et al. 1999). MET3 is a truncated protein so is unlikely 
to be functional and MET2a and MET2b are both expressed at lower levels 
compared to MET1, hence it can be considered that MET1 is the major 
methyltransferase in this family. This is supported by the fact that met1 mutants 
have a near total loss of CG methylation, with some reduction in global levels of 
CHG and CHH methylation and would suggest that MET1 targets CG sites 
preferentially but may also influence the methylation of other sequence contexts 
(Finnegan et al. 1996, Ronemus et al. 1996, Kankel et al. 2003, Cokus et al. 2008, 
Lister et al. 2008). This loss of CG methylation in met1 mutants is associated with 
the alteration of expression of a large number of genes and intergenic non-
coding loci as well as pleiotropic developmental defects and so would suggest 
that MET1 and hence CG methylation is functionally important in plants 
(Finnegan et al. 1996, Ronemus et al. 1996, Kankel et al. 2003). MET1’s primary 
function is to maintain CG methylation while de novo methylation is the 
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responsibility of DRM2 (Jones et al. 2001, Cao and Jacobsen 2002a, Cao and 
Jacobsen 2002b, Cao et al. 2003, Kankel et al. 2003). However, some loci may 
require MET1 for de novo methylation of CG sites as a study showed that a met1 
mutant was unable to establish de novo CG methylation of a transgene system 
(Aufsatz et al. 2004). Another study has also shown that reintroduction of MET1 
into a met1 mutant resulted in partial restoration of gene body CG methylation 
again suggesting de novo methylation activity (Zubko et al. 2012). In Nicotiana 
tabacum the de novo methyltransferase NtDRM1 was able to methylate CHG and 
CHH sites in vitro but was not as proficient at methylating CG sites, suggesting 
that NtDRM1 may not be the main CG de novo methyltransferase and so would 
support the idea that MET1 or in this case its N. tabacum homolog may carry out 
CG de novo methylation (Wada et al. 2003).  
Due to their homology, the process of MET1 methylation is thought to be similar 
to that of the mammalian DNMT1 methyltransferase. MET1 recognises 
hemimethylated CG sites, where one of the cytosines is unmethylated and 
methylates this cytosine using S-adenosyl methionine (SAM) as a methyl donor 
(Figure 1.5) (Gruenbaum et al. 1982, Smith et al. 1992). The chromatin modifier 
DDM1 is required for MET1 function and is a SWI/SNF2 ATPase-containing 
protein that can translocate nucleosomes along DNA in an ATP-dependent 
manner (Jeddeloh et al. 1999, Brzeski and Jerzmanowski 2003). DDM1 may be 
required for MET1 to be able to access the DNA to methylate and similar to met1 
mutants, ddm1 mutants result in a large reduction in CG methylation and also a 
reduction in CHG and CHH methylation at some specific loci (Vongs et al. 1993, 
Teixeira et al. 2009). This suggests that both MET1 and DDM1 may function in 
non-CG methylation in a locus specific manner. The activity of MET1 and DDM1 
also results in the modification of histone three lysine 9 (H3K9) and histone four 
lysine 16 (H4K16) with the former being methylated and latter deacetylated 
(Soppe et al. 2002, Tariq et al. 2003). How DNA methylation results in histone 
modification is likely to be mediated by the methyl binding domain (MBD) 
proteins MBD6 and MBD7 which bind to methylated CG dinucleotides and also 
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associate with histone deacetylases (Zemach and Grafi 2003, Zemach et al. 
2005). Both met1 and ddm1 mutants perturb the localisation of MBD6 and MBD7 
thus suggesting that MBD and MET1 activities are indeed interlinked. The most 
likely candidate for the histone deacetylase is HDA6 as mutants in this protein 
result in a decrease in CG methylation (Aufsatz et al. 2002b, Aufsatz et al. 2004). 
The protein responsible for the methylation of the H3K9 residue is unknown but 
again could be directed by an MBD protein or alternatively a SRA-SET containing 
protein such as SUVH4/KRYPTONITE which is responsible for H3K9 methylation in 
relation to CMT3 methylation (Jackson et al. 2002, Malagnac et al. 2002, Zemach 
et al. 2005, Johnson et al. 2007). 
 
Figure 1.5: MET1 methylation and resulting histone modification 
Diagram showing the linkage between CG methylation by MET1 and the resulting 
histone deacetylation that is mediated by MBD proteins. The DNA double helix is shown 
in black with grey lines representing base pairing. Methyl groups are shown as white Ms 
in a red circle. A: MET1 (purple) in conjunction with DDM1 (blue) recognises and 
methylates hemi-methylated CG sites using SAM (red) as a methyl group donor. B: The 
methylated cytosine binding proteins MBD6 and MBD7 (green and yellow respectively) 
bind to the methylated CG sites. C: The MBD proteins interact with HDA6 (red), which 
removes acetyle groups from the nucleosome component Histone 3. A single 
nucleosome is shown in blue and is labelled, including four of the eight histone subunits. 
Histone acetyl groups are shown as black As in yellow circles and histone methylation is 
shown as black Ms in green circles. 
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1.2.4 CMT3 methylation 
There are three members of the CMT methyltransferase family in Arabidopsis, of 
which CMT1 function is non-essential as several ecotypes have a retrotransposon 
insertion in the CMT1 gene that inactivates it (Henikoff and Comai 1998, Rose et 
al. 1998, McCallum et al. 2000). Of the other two family members, only CMT3 
has so far been identified in mutant screens for DNA methylation mutants, so the 
exact function of CMT2 remains unknown (Bartee et al. 2001, Lindroth et al. 
2001). In cmt3 mutants there is a large scale decrease in CHG methylation 
throughout the genome suggesting that this protein is involved in CHG 
methylation maintenance since many of the loci tested only undergo 
maintenance methylation (Bartee et al. 2001, Lindroth et al. 2001, Tompa et al. 
2002, Cao and Jacobsen 2002a). CMT3 has little effect on CG methylation but is 
involved in CHH methylation at some loci, thus it may also have de novo 
methyltransferase activity since CHH methylation only occurs by de novo 
methylation. CMT3 is also not the only methyltransferase involved in CHG 
methylation as at certain loci, DRM2 mutants have a greater effect on 
methylation than CMT3 (Cao et al. 2003). The fact that there is some level of 
redundancy between DRM2 and CMT3 in terms of CHG and CHH methylation 
means that CHG and CHH methylation is only totally lost in triple mutants of 
cmt3, drm1 and drm2 and these mutants exhibit developmental defects that are 
not observed in cmt3 or drm2 single mutants (Cao and Jacobsen 2002a, Cao et al. 
2003, Chan et al. 2006, Lister et al. 2008). 
The mechanism by which CMT3 methylation occurs is similar to MET1 in that 
CMT3 recognises hemimethylated DNA and methylates the cytosines on the 
daughter strand using the methylated cytosine on the parental strand as a 
template (Figure 1.6) (Cao and Jacobsen 2002a). CMT3 methylation does not 
require a nucleosome modifying enzyme such as DDM1, but does require LHP1, a 
protein that binds to di-methylated H3K9 and H3K27 residues, which are both 
repressive marks associated with heterochromatic regions (Jackson et al. 2002, 
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Exner et al. 2009). LHP1 may therefore target CMT3 to regions with H3K9 and 
H3K27 di-methylation and so would indicate that CHG methylation is controlled 
by histone methylation. CMT3 itself has also been shown to interact directly with 
the H3 histone but only when both H3K9 and H3K27 are methylated and so also 
supports the idea that histone methylation directs CHG methylation (Lindroth et 
al. 2004). There are a number of proteins that can perform H3K27 methylation 
but none of them have an effect on CHG methylation when mutated so the exact 
protein or proteins responsible for methylation of this residue in the CMT3 
pathway is currently unknown. The protein responsible for H3K9 methylation is 
known and is the SRA and SET domain containing protein SUVH4, also known as 
KRYPTONITE (KYP) (Jackson et al. 2002, Malagnac et al. 2002). The SRA domain 
recognises and binds to methylated cytosine, with a preference for CHG and 
CHH, and mutations in this domain results in a loss of function of SUVH4 
(Johnson et al. 2007). The fact that CHG DNA methylation requires histone 
modification to occur and vice versa means that methylation is cyclic and self-
reinforcing in nature, whereby DNA methylation triggers histone methylation 
that triggers further DNA methylation and so on. This dual requirement for DNA 
and histone methylation explains the fact that only CHG methylation is affected 
in a partial mutant in S-adenosylhomocysteine hydrolase (SAH), which is 
responsible for the production of the SAM molecule that is the methyl group 
donor during methylation of both DNA and histones (Mull et al. 2006). There is 
also periodicity in CHG methylation with the average distance between 
methylated sites being around 167 base pairs (bp), which is similar to that of the 
length of DNA around a nucleosome(175-185 bp), and so CMT3 may be limited in 
terms of its access to site due to the presence of nucleosomes (Cokus et al. 2008, 
Lister et al. 2008). The reason for the disparity in sizes is believed to be due to 
the tight packing of nucleosomes. 
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Figure 1.6: CMT3 DNA methylation and SUVH4 H3K9 di-methylation 
Diagram showing the linkage between CHG methylation by CMT3 and H3K9 di-
methylation by SUVH4. DNA methylation is shown as white Ms in a red circle while 
histone methylation is shown as black Ms in green circles. A: CMT3 (blue) is directed 
hemimethylated CHG sites by LHP1 (purple), which recognises histone H3K9 di-
methylation. CMT3 then methylates the CHG site using SAM (red) as a methyl group 
donor. B: The H3K27 di-methylation occurs in response to CHG methylation, although 
the protein (yellow) or proteins involved are unknown. C: The SUVH2 protein (green) 
recognises CHG methylation and then di-methylates the H3K9 residue.  
1.2.5 DRM2 methylation 
The final group of methyltransferases in plants is the de novo methyltransferase 
DRM family comprising three proteins (Cao et al. 2000, Henderson et al. 2010). 
Of these three proteins, DRM2 is the main protein responsible for de novo 
methylation as drm2 mutants are unable to carry out this function whereas 
DRM1 expression levels are low and drm1 mutants do not affect methylation 
levels; and DRM3 lacks several of the ten conserved motifs that are important for 
methyltransferase function (Cao and Jacobsen 2002b, Henderson et al. 2010, 
Naumann et al. 2011).However, although unlikely to catalyse DNA methylation 
itself, DRM3 is still required for de novo DNA methylation and so may act as a co-
factor for DRM2. It is not known if there is any role for DRM1 in DNA methylation 
either as a methyltransferase or as a co-factor to DRM2, but most studies have 
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used double mutants of drm1 and drm2 to investigate the role of de novo 
methyltransferases. The drm1 drm2 double mutant results in a large decrease in 
CHH methylation and a more limited decrease in CHG methylation but does not 
affect CG methylation (Cao and Jacobsen 2002a, Cao and Jacobsen 2002b, Cao et 
al. 2003). As mentioned previously CHH and CHG methylation is only completely 
removed in triple mutants of drm1, drm2 and cmt3 and would suggest that CMT3 
is required for de novo methylation at some loci but that DRM2 is the 
predominant methyltransferase involved (Cao and Jacobsen 2002a, Cao et al. 
2003, Lister et al. 2008). The mechanism which triggers and controls DRM2 is the 
RdDM pathway and will be discussed in detail in section 1.3 so will not be 
covered here (page 39).  
1.2.6 Location of DNA methylation within genome  
In principle any cytosines can be methylated, however there does appear to be a 
preference as to which cytosines are methylated in terms of the surrounding 
sequence (Cokus et al. 2008, Lister et al. 2008). Certain sequences favour 
methylation with cytosines in all configurations more likely to be methylated if 
preceded by the sequence CN, with N being any nucleotide. Other sequences 
discourage methylation and for CG sites this is where the CG is directly preceded 
by an A and followed by a T, while for both CHG and CHH sites it is if the middle 
H is a cytosine. The likelihood of CHG and CHH methylation occurring also 
increases if a upstream CG site is methylated and in the case of CHH also if a 
upstream CHG site is methylated. The exact reason for this sequence preference 
is currently not known and neither is it known whether the methyltransferases 
themselves or a co-factor is responsible for this sequence recognition. 
Methylation levels are not uniform throughout the Arabidopsis genome with the 
majority of methylation located within the centromeric and pericentromeric 
regions which have a large concentration of repetitive sequences and 
transposable elements (Lippman et al. 2003, May et al. 2005, Zhang et al. 2006, 
Zilberman et al. 2007, Cokus et al. 2008, Lister et al. 2008). This methylation is 
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required for heterochromatin formation and silencing of these regions, which is 
important for genome stability in terms of preventing transposable element 
movement and centromere stability. Another characteristic of DNA methylation 
is that it overlaps with areas of the genome that have associated siRNAs and is to 
be expected considering that the RdDM pathway is responsible for de novo 
methylation (Chan et al. 2006, Cokus et al. 2008, Lister et al. 2008). Perhaps the 
most surprising finding is that CG but not CHG or CHH methylation is found 
within the gene bodies including those of vital plant genes and it has been 
suggested that this methylation is functionally significant in terms of correct 
expression or splicing, although its exact role has yet to be determined (Cokus et 
al. 2008, Lister et al. 2008, Takuno and Gaut 2011, Dalakouras et al. 2012, Zubko 
et al. 2012). It has also been shown that CHG gene body methylation also occurs 
but that this is subsequently removed by IBM1 (Miura et al. 2009, Rigal et al. 
2012) 
1.2.7 Demethylation 
DNA methylation is a dynamic modification and can be removed either passively, 
through a lack of maintenance of the methylated cytosines after DNA replication, 
or actively by demethylation enzymes (Agius et al. 2006). One of these enzymes 
is ROS1, which has both DNA glycosylase and apurinic/apyrimidinic lyase activity 
and is specific to 5-methylcytosines (Gong et al. 2002, Agius et al. 2006, Morales-
Ruiz et al. 2006). ROS1 functions by first removing the methylated cytosine base 
from the DNA backbone through DNA glycosylase activity, leaving an abasic site. 
Subsequently the DNA lyase domain removes the deoxyribose sugar from the 
backbone leaving a gap in the strand that can be repaired by the base excision 
repair pathway. ROS1 operates in a pathway with ROS3, which is an RNA binding 
protein that can interact with siRNAs, and so demethylation by ROS1 may be 
directed to specific targets by siRNAs (Zheng et al. 2008). ROS1 targets are also 
associated with 24 nt siRNAs from the RdDM pathway so it is possible that ROS3 
interacts with siRNAs and mediates ROS1 demethylation (Penterman et al. 2007). 
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This would also suggest contradictory roles for siRNAs in that they may be 
required for both methylation and demethylation and so raises the question of if 
siRNAs are targeting the demethylation machinery to targets how it only affects 
a subset of loci with 24 nt siRNAs whereas methylation occurs at the others. One 
possibility could be the differences in the amount of siRNAs sequestered into the 
two pathways; however this requires further investigation. Another protein has 
also been shown to be required for ROS1 activity, IDM1, which is a histone 
acetyltransferase enzyme that acetylates the H3 histone of nucleosomes with 
repressive marks such as H3K9 di-methylation but not ones with H3K4 di-
methylation, which are  transcriptionally active marks (Qian et al. 2012). Since 
IDM1 targets nucleosomes with repressive marks and is required for ROS1 
demethylation, it would suggest that IDM1 may modify nucleosomes in a 
transcriptionally inactive state in such a manner that allows ROS1 to demethylate 
the locus. 
A second enzyme, DEMETER (DME), that is part of the same family of DNA 
glycosylases as ROS1 has also been shown to directly remove methylated 
cytosines (Choi et al. 2002, Gehring et al. 2006, Morales-Ruiz et al. 2006). 
Similarly to ROS1, DME also has both DNA glycosylase and apurinic/apyrimidinic 
lyase activity so is considered to function in a similar manner, although it is not 
known if DME also interacts with ROS3 and may not be directed to targets by 
siRNAs. DME activity is facilitated by the action of SSRP1, which is part of the 
FACT complex that modifies nucleosomes in order to allow transcription 
initiation and so may also similarity modify nucleosomes to allow DME 
demethylation activity (Ikeda et al. 2011). There are a further two proteins in the 
DME family in Arabidopsis, DML2 and DML3, which have also been shown to be 
required for DNA demethylation and again probably function in a similar manner 
to ROS1 (Ortega-Galisteo et al. 2008). DML2 and DML3 have also been shown to 
function in the same pathway as ROS1 and IDM1 but may target different 
subsets of loci as a triple mutant of dml2, dml3 and ros1 resulted in a larger 
number of loci with increased DNA methylation than a ros1 single mutant (Qian 
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et al. 2012). Mutation of ROS1, DML1 and DML2 resulted in hypermethylation of 
loci that were previously unmethylated or had low levels of DNA methylation in 
wild-type plants, however single mutants of ros1, dml1 and dml2 and a triple 
mutant of these genes resulted in a loss of DNA methylation at loci with high 
levels of methylation in wild-type plants (Ortega-Galisteo et al. 2008, Qian et al. 
2012). This would suggest a more complex relationship between DNA 
methylation and demethylation than merely an antagonistic one in which 
demethylation counteracts methylation and instead suggests that at specific loci 
that are highly methylated, demethylation is required in order to achieve these 
high levels. However, this finding could also be caused by down-regulation of 
DNA methylation genes in response to the loss of demethylation. Equally RdDM 
appears to be required for demethylation as in rdr2 and drm2 mutants, there 
was CG hypermethylation as a result of ROS1 down regulation (Penterman et al. 
2007). 
1.3 RNA-directed DNA methylation pathway 
1.3.1 Discovery of RNA-directed DNA methylation pathway 
The elucidation of the mechanism of the RdDM pathway has occurred over the 
past decade although the idea of an RNA silencing pathway carrying out 
transcriptional gene silencing through DNA methylation first appeared in the 
1990s (Wassenegger et al. 1994). Previously to this suggestion of a role for RNA 
in DNA methylation the exact mechanism by which methylation occurred was 
not well understood and the only suggestion of a role for RNA in this process was 
a study that indicated that RNA inhibited methylation (Bolden et al. 1984). This 
changed after a study in 1994 showed that DNA methylation could occur as a 
result of RNA (Wassenegger et al. 1994). In this study it was shown that a T-DNA 
insertion in the genome of Tobacco plants that contained viroid cDNA sequence 
could be methylated upon infection with the viroid RNA and that methylation 
was localised to the viroid cDNA and persisted after the viroid infection had 
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abated. The authors therefore suggested that the viroid RNA guided Tobacco 
DNA methyltransferase enzymes to methylate the viroid cDNA and described the 
phenomenon as RNA-directed methylation. At this point it was still not known 
how the RNA caused DNA methylation and whether it was direct action of the 
viroid RNA or occurred through an intermediate as the viroid used in that study 
replicated in the nucleus. Another study showed that an intermediate was 
required by using an RNA virus to induce DNA methylation of a transgene 
containing part of the viral sequence (Jones et al. 1998). This RNA virus 
replicated in the cytoplasm thus the viral RNA molecule could not trigger DNA 
methylation directly but instead a signal must be transmitted from the cytoplasm 
to the nucleus. This raised the question as to the nature of the signal and it was  
hypothesised that it was small RNA molecules produced from aberrant RNA in 
the cytoplasm, although this had not been tested experimentally (Wassenegger 
and Pélissier 1998). 
The identity of this signal was not identified until the early 2000s. Small RNA 
molecules had been shown to be associated with post transcriptional gene 
silencing in 1999 and a study in 2000 demonstrated that DNA methylation was 
also associated with small RNA molecules (Hamilton and Baulcombe 1999, Mette 
et al. 2000). In the study by Mette DNA methylation of a NOS transgene 
promoter was shown to occur upon introduction of a dsRNA molecule 
comprising of an inverted repeat of the NOS promoter and that the dsRNA was 
processed into 23-25 nucleotide (nt) RNA molecules. These small RNA molecules 
were suspected to be the signal that results in DNA methylation, however this 
needed to be proved experimentally. A later study identified two classes of small 
RNA molecules, now termed small interfering RNAs (siRNAs), a short class 
between 21-22 nt in length and a longer class between 24-26 nt in length 
(Hamilton et al. 2002). The study showed that the longer class of siRNAs were 
required for DNA methylation of both the GFP transgene used in the study and 
the AtSN1 retrotransposon and so would support the idea that small RNAs are 
the signal for DNA methylation. The study also found that the sde4 mutant 
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resulted in a loss in both AtSN1 siRNAs and DNA methylation and as such was the 
first component of the RdDM pathway to be identified, although it was not until 
later that the identity of the mutant gene was discovered to be the large subunit 
of the Arabidopsis RNA polymerase IV (Hamilton et al. 2002, Herr et al. 2005). 
There is variation in the size of siRNAs associated with DNA methylation between 
studies, which was due to difficulties in obtaining an exact size from the northern 
blots used to identify the siRNAs. A later study was however able to produce an 
exact size of siRNAs associated with RdDM and that was 24 nt (Xie et al. 2004).  
During this period as well as identifying 24 nt siRNAs as being required for RdDM 
several mutants defective in the RdDM pathway were also identified. As 
mentioned in a previous section Arabidopsis has multiple paralogs of key RNA 
silencing proteins including the six RDRs, four DCLs and ten AGOs and 
assessment of the phenotype of mutants in these proteins revealed RDR2, DCL3 
and AGO4 to be required for RdDM (Zilberman et al. 2003, Xie et al. 2004). From 
this point onwards a large number of other proteins have been shown to be part 
of the RdDM pathway which have advanced our understanding of the pathway’s 
mechanism. In the next sections I will describe the pathway itself in detail 
beginning with siRNA production 
1.3.2 RdDM siRNA biogenesis 
During the initial stages of RdDM, 24 nt siRNAs are produced. Early research into 
RdDM identified the largest and second largest subunits of a novel plant RNA 
Polymerase IV (PolIV), described as NRPD1 and NRPD2 respectively, as RdDM 
components (Herr et al. 2005, Kanno et al. 2005, Onodera et al. 2005). Further 
studies have also identified the fourth subunit of PolIV, NRPD4, as being required 
for RdDM (He et al. 2009a, Greenberg et al. 2011). No other subunits of PolIV 
have been identified in forward genetic screens for RdDM mutants. The reason 
for this may be that PolIV has evolved from RNA polymerase II (PolII) early in 
plant evolution, before the divergence of algae, and as such, of the twelve PolIV 
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subunits, eight are shared with PolII. These subunits are unlikely to appear in 
RdDM mutant screens as mutations in these subunits may be lethal due to the 
loss of PolII function (Luo and Hall 2007, Ream et al. 2009). It is not known why 
the fourth subunit that is specific to PolIV, NRPD7, has not to date been 
identified in an RdDM mutant screen. The subunits that differ between PolIV and 
PolII are located at the points of DNA template entry and RNA transcript exit and 
so would be expected to alter the function of PolIV (Figure 1.7) (Ream et al. 
2009).  
 
Figure 1.7: Subunit structure of RNA polymerases II, IV and V 
Diagram shows the positions within the polymerase complex of the twelve 
subunits found in PolII, PolIV and PolV. Each subunit is labelled numerically with 
the 1 being the 1st subunit of the three polymerases etc. The black lines 
represent DNA while the red line is the RNA transcript. The entry point of the 
DNA template strand is found at the junction between the 1st, 2nd, 5th and 9th 
subunits. The point at which the RNA transcript exits the polymerase is found 
between the 1st, 8th and 4th subunit. The subunit sizes are not to scale and their 
positions are not exact in relation to other subunits. This diagram is adapted 
from Ream 2009. 
In terms of the function of PolIV in RdDM, mutants in its subunits show loss of 
both DNA methylation and siRNA accumulation and so would suggest that PolIV 
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is required for siRNA production (Herr et al. 2005, Kanno et al. 2005, Onodera et 
al. 2005, He et al. 2009a, Greenberg et al. 2011). It was therefore concluded that 
PolIV most likely transcribes the target DNA and its transcript would then be 
used for siRNA biogenesis (Figure 1.8 B). However, no study to date has shown 
PolIV to have transcription activity in vivo or in vitro and PolIV transcripts have 
not been detected. Several groups have proposed that due to a lack of evidence 
for transcription of DNA, PolIV may actually transcribe RNA rather than DNA 
(Vaughn and Martienssen 2005, Pontes et al. 2006). However, this seems unlikely 
as both PolII and PolV use DNA as a template and PolIV is closely related to both 
(Luo and Hall 2007, Marcussen et al. 2010). Another possible explanation for the 
lack of detectable PolIV transcripts is the close association of PolIV with RDR2 
(Law et al. 2011). RDR2 is a RNA-dependent RNA polymerase required for RdDM 
and as such is expected to convert single stranded RNA templates into double 
stranded RNA (dsRNA) (Dalmay et al. 2000b, Xie et al. 2004). RDR2 interacts 
strongly with the NRPD1 PolIV subunit, most likely at the point where the RNA 
transcript exits the polymerase and so it is possible that RDR2 converts the PolIV 
transcript immediately into dsRNA (Figure 1.8 B) (Law et al. 2011). This would 
explain the lack of a PolIV transcript as the dsRNA could be quickly targeted for 
processing into siRNAs. Whether this hypothesis is correct could be tested by 
searching for PolIV transcripts in rdr2 mutants, which should in theory not 
produce dsRNA from these transcripts.  
As with PolII transcription PolIV, also requires transcription factors and 
chromatin modifiers in order to function. The first such factor to be identified 
was CLASSY1 (CLSY1) a SNF2 protein which displayed a reduction in siRNA 
accumulation and DNA methylation and was believed to be involved in siRNA 
production (Smith et al. 2007, Greenberg et al. 2011). SNF2 proteins were first 
discovered in S. cerevisiae and modify chromatin in an ATP dependent manner 
through the translocation of nucleosomes, achieved by the disassociation of DNA 
from the histones and alterations to the histone octamers conformation 
(Hirschhorn et al. 1992, Whitehouse et al. 1999, Bruno et al. 2003, Kassabov et 
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al. 2003). These changes allow RNA polymerase complexes access to the DNA 
sequence and so in this case it was assumed that CLSY1 facilitates PolIV 
transcription (Figure 1.8 A). In support of this idea, it was recently shown that 
CLSY1 directly interacts with the largest subunit of PolIV, probably around the 
DNA template entry point, as the NRPD1 subunit spans both the DNA template 
entry point and RNA transcript exit point in the polymerase complex (Ream et al. 
2009, Law et al. 2011). There are also three homologs of CLSY1 in Arabidopsis 
and these have been named CLSY2-4. These have also been shown to interact 
with the NRPD1 PolIV subunit, although it is not known whether the CLSY 
proteins act redundantly to each or are required for RdDM at different loci. 
Two transcription factors have also been shown to be required for PolIV 
transcription, SHH1 and RDM4 (He et al. 2009b, Kanno et al. 2009, Law et al. 
2011, Liu et al. 2011). RDM4, also referred to as DMS4, is a conserved IWR1-like 
transcription factor found in eukaryotes that associates with PolII, PolIV and PolV 
(Krogan et al. 2006, Collins et al. 2007, He et al. 2009b, Kanno et al. 2009). IWR1 
transcription factors are normally associated with PolII so the association with 
PolIV and PolV is likely due to the close homology between the three 
polymerases (Luo and Hall 2007, Marcussen et al. 2010). Mutations in RDM4 
result in a loss of siRNAs and DNA methylation but also a reduction of expression 
at a number of PolII transcribed genes resulting in a pleiotropic developmental 
phenotype. RDM4 has also been shown to interact directly with the NRPD1 
subunit and so is likely to target PolIV to RdDM targets, however like CLSY1, it is 
not known whether RDM4 is required for all RdDM targets or whether it is only 
required for a subset of these targets. The other transcription factor is SHH1, also 
known as DTF1, and is a member of the SAWADEE homeobox transcription factor 
family found in plants (Mukherjee et al. 2009, Law et al. 2011, Liu et al. 2011). 
SHH1 interacts directly with PolIV through the NRPD1 subunit and mutation of 
SHH1 results in loss of siRNAs and DNA methylation at some RdDM target loci 
but not others. This would suggest that SHH1 is required for PolIV transcription 
at specific loci.  
1. General Introduction 
45 
 
In terms of how these six proteins function in order to facilitate PolIV 
transcription, since they all interact with PolIV it could be considered that they 
form a complex that precedes PolIV (Figure 1.8 A). In this scenario SHH1 and 
RDM4 would bind to specific DNA sequence motifs and so bring in CLSY1 or one 
its homologs and PolIV, with the CLSY then allowing transcription to occur by 
removing nucleosomes from the site of transcription. The transcription factors 
would then disassociate upon transcription initiation. These proteins may also be 
target specific, such as different CLSYs being required for specific loci but not 
others. Whether these proteins function in such a complex is not known and 
would require further investigation to determine if this is the case. The six 
proteins so far identified that are required for PolIV transcription also highlight 
one of several gaps in the knowledge of the RdDM pathway and that is how PolIV 
is targeted to the correct locus. It is likely that combinations of CLSY1-4, SHH1 
and RDM4 will facilitate PolIV transcription at different loci, however these six 
proteins cannot account for the myriad number of targets of RdDM in the 
genome that PolIV must be targeted to or provide enough scope for finer control 
of RdDM. This would suggest that there may be other transcription factors and 
chromatin modifiers involved in PolIV transcription.  
Once PolIV transcription has occurred and the RNA transcript turned into dsRNA 
through the action of RDR2, the dsRNA is then targeted by Dicer-like 3(DCL3) and 
DCL4 (Figure 1.8 C)(Xie et al. 2004, Pélissier et al. 2011). DCL3 and DCL4 are two 
of the four plant homologs of the Dicer enzyme which cleave dsRNA into small 
RNA molecules between 21-24 nt in length. Both DCL enzymes specifically 
cleaves dsRNA in the RdDM pathway into 24 nt long segments (Hamilton et al. 
2002, Park et al. 2002, Schauer et al. 2002, Finnegan et al. 2003, Xie et al. 2004, 
Pélissier et al. 2011). The two DCLs probably act redundantly in RdDM as the 
reduction in siRNA levels in single mutants of dcl3 and dcl4 are modest 
(Greenberg et al. 2011, Pélissier et al. 2011, Ausin et al. 2012a). A recent study 
has shown that the spliceosome component SR45 is an RdDM component and 
due to the reduction in both DNA methylation and siRNA levels in sr45 mutants it 
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was concluded it was involved in siRNA production (Ausin et al. 2012a). In terms 
of SR45’s role in siRNA production it was found that the sr45 phenotype was 
enhanced in a double mutant with dcl3, which may suggest that SR45 facilitates 
both DCL3 and DCL4 function and so a sr45 dcl3 double mutant that lacks DCL3 
siRNA processing may also disrupt DCL4 activity through SR45. Splicing 
machinery has previously been implicated in the plant miRNA pathway as it was 
found that three proteins involved in the nuclear cap-binding complex, are 
required, along with DCL1, for the processing of long pri-miRNA transcripts into 
mature miRNAs (Laubinger et al. 2008). However, the exact function of SR45 in 
RdDM is not known and as no other spliceosome components tested in the study 
were found to result in reduction in DNA methylation or siRNA levels, the 
function may be different to its role in splicing. The double stranded RNA binding 
protein DRB2 is also involved in siRNA production but has an antagonistic role to 
DCL3 as in drb2 mutants levels of 24 nt siRNAs are enhanced (Pélissier et al. 
2011). This suggests that DRB2 is involved in the regulation of siRNA levels and 
prevents over accumulation. How DRB2 achieves this is unknown, although it is 
not through reduction in the levels of DCL3 itself, and could be either through 
sequestration of the dsRNA produced by RDR2 thus blocking access by DCL3 or 
DRB2 triggering degradation of the dsRNA. There is also a second DRB protein, 
DRB4, involved in RdDM, however it has an antagonistic role to DRB2 as in drb4 
mutants there is a reduction in siRNA levels, therefore suggesting that DRB4 
either promotes or is directly involved in siRNA production. DRB4’s function is 
likely to be in conjunction with DCL4 as DRB4 interacts directly with DCL4 but not 
DCL3; and in this case DRB4 through binding to the dsRNA would facilitate DCL4 
cleavage of the RNA.  
The dsRNA molecules created by DCL3 and DCL4 have a two nucleotide overhang 
at the 3’ ends, which can be degraded by endonucleases. In order to protect 
these ends from ribonuclease attack the 3’ ends of both strands are modified by 
HEN1 by the addition of methyl groups to the end base (Figure 1.8 D) (Xie et al. 
2004, Yu et al. 2005). However, only certain siRNAs require this modification as 
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in hen1 mutants some siRNAs are reduced in abundance whereas levels of other 
siRNAs are unaffected. In the cases where HEN1 is not required for siRNA 
production it is not known how the dsRNA segments produced by DCL3 or DCL4 
avoid degradation. 
 
 
Figure 1.8: RdDM siRNA production 
A: Transcription factors and nucleosome modifiers facilitate PolIV transcription. B: The 
RNA transcript produced by PolIV is turned into dsRNA by RDR2. C: DCL3 and DCL4 
cleave the dsRNA into 24 nt segments. D: HEN1 methylates the 5’ ends of the 24 nt 
dsRNA molecules. E: The 24 nt dsRNA molecules are then exported from the nucleus. 
The nuclear envelope is depicted as a yellow line with protein channels within this 
membrane shown as pairs of purple ovals. Areas with a white background are within the 
nucleus and areas in pale yellow are in the cytoplasm. RNA strands are shown as red 
lines with orange bars representing base pairing between strands. Methylation at the 3’ 
end of siRNAs is shown by CH3 labels and RNA nucleotides are shown as red and orange 
T shapes. DNA strands are shown as black lines with grey bars representing base pairing 
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between strands. All proteins in the pathway have been labelled except some PolIV 
subunits as these have not yet been shown to be required for RdDM.  
1.3.3 Loading of siRNAs into AGO proteins in RdDM 
After the dsRNAs are produced by DCL3 or DCL4, one of the strands is then 
loaded into ARGONAUTE (AGO) 4, 6 or 9 while the other is then likely degraded 
by ribonuclease activity (Zilberman et al. 2003, Xie et al. 2004, Zilberman et al. 
2004, Qi et al. 2006). The strand that is loaded into AGO4 is known as the siRNA 
strand whereas the other strand is termed the passenger strand. As well as AGO4 
there are also two other AGOs (AGO6 and AGO9) that have been shown to be 
involved in RdDM (Zheng et al. 2007, Havecker et al. 2010, Eun et al. 2011, 
Greenberg et al. 2011). These three AGO are closely related and with AGO8 form 
a separate clade from the other six Arabidopsis AGO proteins. Whether AGO8 is 
involved in RdDM is unknown but it lacks the PIWI catalytic domain and so could 
either have a divergent function or be a pseudogene (Takeda et al. 2008). The 
presence of two other AGOs in the RdDM pathway explains why ago4 mutants 
have locus specific reductions in siRNA and DNA methylation levels and indeed 
AGO6 and AGO9 target different loci to AGO4, but AGO4 appears to be the 
predominant AGO in RdDM as it targets the majority of loci (Zilberman et al. 
2003, Zilberman et al. 2004, Qi et al. 2006, Havecker et al. 2010). The target 
specificity is partly due to expression patterns between the AGOs as expressing 
AGO6 and AGO9 using a AGO4 promoter in a ago4 mutant background resulted 
in rescue of the mutant phenotype at some loci. However, this did not occur at 
all loci and so suggested that factors other than expression pattern affect the 
specificity of the three AGOs. 
AGO proteins are characterised by four domains: the N-terminus, PAZ, Mid and 
PIWI domains, of which the function of the PAZ, Mid and PIWI domains have 
been determined but that of the N-terminus domain is still unknown (Hutvagner 
and Simard 2008, Parker 2010). Of the three known domains, the PAZ and Mid 
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domains are important for siRNA strand loading whereas the PIWI domain is 
important in catalytic activity. The function of the PAZ domain is in the binding of 
the 3’ end of the siRNA strand via the creation of a binding pocket in which the 3’ 
end resides upon loading (Lingel et al. 2004, Ma et al. 2005). The Mid domain is 
also involved in siRNA binding and forms a pocket at the point where it borders 
the PIWI domain in which the 5’ end of the siRNA strand binds. These two 
domains therefore are responsible for siRNA loading and hold the siRNA strand 
in place (Figure 1.9). The three AGOs involved in RdDM show a preference as to 
which of the strands from the dsRNA is loaded. This preference depends on the 
thermo-stability of the base pairing at the 5’ end of each strand, with the strand 
with the least stable 5’ end being preferentially loaded (Khvorova et al. 2003, 
Schwarz et al. 2003, Gyorgy 2005). The reason why the less stable 5’ end is 
selected is thought to be that the base pairing will be inherently weaker and so is 
more likely to become single stranded and enter the Mid binding pocket. The 
AGOs also have a preference in terms of which base is at the 5’ end, with 
adenosine being the preferred base (Mi et al. 2008, Havecker et al. 2010). In this 
case the preference is again likely to be caused by the Mid domain 5’ binding 
pocket. 
 
Figure 1.9: AGO protein domain structure 
Schematic of the basic domain structure of AGO proteins and how it binds to a siRNA 
strand. The four domains are labelled and also shown in different colours. The N-
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terminal domain also contains a nuclear localisation signal (NLS) shown in red. The PAZ 
domain is linked to the rest of the AGO protein by the grey linker region shown in the 
diagram. The siRNA strand is in red while the target transcript is in dark blue, with base 
pairing between the strands shown in orange. The orientation of the siRNA strand is 
given by the 5’ and 3’ labels and the black circle highlights the 13th and 14th bases from 
the 3’ end of the siRNA, which is the point at which PIWI cleaves the target transcript. 
Diagram is adapted from Song 2004. 
The loading of AGO proteins was initially believed to occur in cajal bodies within 
the nucleus (Li et al. 2006, Pontes et al. 2006, Pikaard et al. 2008). Cajal bodies 
are dense clusters of proteins and DNA that are associated with the nucleolus. 
These studies found that in isolated nuclei DCL3, RDR2, AGO4 and NRPE1 all 
localised strongly to the cajal bodies, although were present in the rest of the 
nucleus, and so it was concluded that due to the presence of these proteins that 
AGO4 loading must occur here. However, a recent study has contradicted this 
assumption and instead suggests the AGO loading occurs in the cytoplasm (Ye et 
al. 2012). This study found that the 24 nt siRNAs associated with RdDM were 
most prevalent in the cytoplasm rather than the nucleus and also found that 
although AGO4 was most predominant in the nucleus, it could also be detected 
in the cytoplasm. They showed that AGO4 proteins bind to the dsRNAs produced 
by DCL3 or DCL4 in the cytoplasm and require the PIWI domain for removal of 
the passenger strand. The PIWI domain catalyses the cleavage of RNA strands 
that are bound to the siRNA strand through the DDH motif, comprising two 
aspartic acid residues and histidine residues (Figure 1.9) (Liu et al. 2004, Rivas et 
al. 2005, Wang et al. 2008, Wang et al. 2009). This cleavage of the RNA strand 
bound to the siRNA occurs specifically between the 11th and 12th base from the 
3’ end of the siRNA and in this case it would appear that the passenger strand is 
cleaved in this manner, resulting in its release. Indeed mutants that lack the PIWI 
catalytic activity are shown to bind to siRNA duplex but are apparently unable to 
remove the passenger strand. 
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The binding of an siRNA with an AGO protein results in a conformational change 
whereby the PAZ domain is swung out from the main body of the protein so that 
it sits above the PIWI domain (Figure 1.9) (Song et al. 2004). There is also another 
conformational difference between when the siRNA is bound or unbound and 
this occurs when the passenger strand is released by AGO4 (Ye et al. 2012). This 
change exposes a nuclear localisation signal (NLS) in the N-terminal domain and 
it is thought that this results in the AGO4-siRNA complex being transported back 
into the nucleus (Figure 1.10 C and D). Mutants that lacked the NLS did not move 
back into the nucleus and mutants in the PIWI domain also were unable to move 
back into the nucleus as they were unable to remove the passenger strand. It 
should be noted that the mechanism by which dsRNAs and siRNA bound AGOs 
are exported and imported from the nucleus is not known and would raise the 
possibility of other proteins involvement in the pathway. The process of AGO4 
loading with the siRNA strand has however been shown to require the HSP90 
protein, which is a chaperone protein and its function in RdDM is ATP dependent 
(Figure 1.10 B). HSP90 has also been shown to be required for AGO loading for 
plant AGO1 and in Metazoan species suggesting that the requirement for HSP90 
in AGO loading is universal (Iki et al. 2010, Iwasaki et al. 2010). It was therefore 
suggested that HSP90 binds to AGO4 proteins and facilitates the conformational 
change required for AGO4 to bind to the dsRNA molecules in a ATP dependent 
manner (Figure 1.10 E). The cleavage and resulting degradation of the passenger 
strand results in the release of HSP90. The removal of the passenger strand 
causes the NLS to be exposed and the AGO4 protein is then imported back into 
the nucleus. The study by Ye did not show if AGO6 and AGO9 were also loaded 
with siRNAs in the cytoplasm, although their close homology to each other would 
support the idea that they do (Ye et al. 2012). The fact that the rest of the 
pathway occurs within the nucleus also raises the question of why AGO4 loading 
occurs in the cytoplasm. One possible explanation is that as the prevalence of 24 
nt siRNAs is higher in the cytoplasm than the nucleus that this process acts as a 
rate limiting step for RdDM and so prevents hypermethylation occurring.  
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Figure 1.10: Loading of siRNAs into AGO proteins in RdDM 
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A: 24 nt dsRNA molecules are exported from the nucleus. B: dsRNA molecules are loaded into AGO4, 6 or 9 and the process is facilitated by HSP90. C: The 
passenger strand is cleaved by the AGO resulting in HSP90 releasing the AGO protein and the nuclear localisation signal (in red) becoming exposed. D: The siRNA 
loaded into a AGO protein is imported back into the nucleus. E: The HSP90 binds to a new AGO protein and facilitates a conformational change in the AGO protein 
that allows it to bind to a 24 nt dsRNA molecule. The nuclear envelope is depicted as a yellow line with protein channels within this membrane shown as pairs of 
purple ovals or silver ovals for exporters from or importers into the nucleus respectively. Areas with a white background are within the nucleus and areas in pale 
yellow are in the cytoplasm. RNA strands are shown as red lines with orange bars representing base pairing between strands. Methylation at the 3’ end of siRNAs 
is shown by CH3 labels and RNA nucleotides are shown as red and orange T shapes. 
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1.3.4 DNA methylation in RdDM 
After the loading of the AGO proteins with 24 nt siRNAs, the next stage of the 
pathway is the methylation of the DNA target and this requires another plant 
specific RNA polymerase, PolV, which evolved from PolIV after the divergence of 
ferns from other land plants but before flowering plants diverged (Kanno et al. 
2005, Pontier et al. 2005, Huettel et al. 2007, Luo and Hall 2007). Of the twelve 
PolV subunits, NRPE1, NRPE5 and NRPE7 are specific to PolV with NRPE2 and 
NRPE4 being shared with PolIV and the remaining seven subunits shared by PolV, 
PolIV and PolII (Ream et al. 2009). These PolV-specific subunits are located at the 
DNA template entry and RNA transcript exit points of the polymerase, which 
would suggest that the divergence in function between PolIV and PolV is due to 
changes at these two points (Figure 1.7). Of the subunits that are PolV specific or 
shared with only PolIV, mutants have been identified in NRPE1, NRPE2, NRPE4 
and NRPE5, which means that only NRPE7 has yet to be shown to be required for 
RdDM (Kanno et al. 2005, Pontier et al. 2005, Huettel et al. 2007, Eamens et al. 
2008, He et al. 2009a, Huang et al. 2009, Lahmy et al. 2009, Greenberg et al. 
2011). The remaining seven subunits are unlikely to appear in RdDM mutant 
screens as they are also PolII subunits and so mutants in these subunits may have 
severe phenotypes due to loss of PolII function. NRPE9 has been identified in a 
mutant screen, however the reason for this may be that there are actually two 
versions of this PolII subunit and it is the second version (b) that is required for 
PolV activity in RdDM (Tan et al. 2012).  
In terms of PolV’s role in RdDM, it is believed to be responsible for producing 
transcripts from the target DNA locus that AGO proteins loaded with siRNAs then 
bind to. PolV transcriptional activity has not yet been demonstrated in vitro, 
however transcripts have been detected in vivo that are PolV-dependent which 
would suggest that PolV is transcriptionally active (Wierzbicki et al. 2008, Lee et 
al. 2012, Wierzbicki et al. 2012). This transcriptional activity does not require the 
presence of siRNAs and in PolV mutants the levels of the majority of siRNAs are 
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unaffected, however for some loci there is a reduction in siRNA levels and the 
exact reason for this is unknown, although it could be due to DNA methylation 
acting as a trigger for further siRNA production and so maintains RdDM at this 
locus (Kanno et al. 2005, Pontier et al. 2005, Wierzbicki et al. 2008, Rowley et al. 
2011). PolV transcription has been shown to originate from outside the region 
targeted by 24 nt siRNAs and therefore produces transcripts that span across the 
target regions to which siRNA loaded AGOs bind (Wierzbicki et al. 2008, 
Wierzbicki et al. 2009). Further investigation of PolV transcription showed that 
61% of the PolV transcription sites corresponded to sites with both methylation 
and 24 nt siRNAs, with a further 12% corresponding to sites with either 24 nt 
siRNAs or methylation. These sites included a high percentage of transposable 
elements. However, 27% of PolV transcription sites lacked both siRNAs and 
methylation and it was found that the majority of these sites corresponded to 
genes (Douet et al. 2009, Wierzbicki et al. 2012). This would suggest that PolV 
may have other roles outside of its role in RdDM. Such a role for PolV was found 
in higher order heterochromatin formation, as a mutant in the 1st PolV subunit, 
nrpe1, results in decondensation of the pericentromeric heterochromatin 
regions but this was shown not to occur in a PolIV mutant, nrpd1 (Pontes et al. 
2009). In the same way that PolV’s role in plants appears to be not just restricted 
to RdDM, PolV is not the only polymerase involved in this stage of the pathway. 
PolII has also been shown to perform an identical role to PolV at a subset of 
RdDM loci where PolIV but not PolV is required (Pontier et al. 2005, Huettel et al. 
2006, Zheng et al. 2009). These loci that are targeted by PolII tend to be 
intergenic or low copy number loci, whereas PolV targets are usually 
transposable elements, but the reason why PolII is used instead of PolV at certain 
loci is unknown (Zheng et al. 2009). The PolII-dependent RdDM pathway is likely 
to be similar to that of the PolV-dependent pathway as both create transcripts to 
which siRNA-loaded AGOs bind, however whether there are any differences 
between the pathways apart from the polymerases involved is currently 
unknown. Work into the RdDM mechanism has focused on the PolV-dependent 
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RdDM pathway so for this reason the rest of this section will refer only to the 
PolV-dependent pathway. 
There is uncertainty about PolV transcription initiation as, similar to PolIV, it is 
not clear how PolV is targeted to the correct RdDM targets. The most likely 
explanation is through the action of transcription factors and so far PolV has 
been shown to require the RDM4 transcription factor to carry out transcription 
at a subset of loci (He et al. 2009b, Kanno et al. 2009, Greenberg et al. 2011). To 
date RDM4 is the only transcription factor known to be required for PolV 
transcription so does not explain how it is targeted to all RdDM target loci. This 
therefore raises the possibility of other undiscovered transcription factors being 
involved in PolV transcription. It has been shown, however that PolV 
transcription requires the DDR complex which comprises of RDM1, DRD1 and 
DMS3 and that this complex would appear to interact with the NRPE1 and NRPE2 
subunits of PolV (Figure 1.11 B) (Law et al. 2010). DMS3 contains two coiled coil 
domains and a hinge domain, of which the hinge domain provides the protein 
with the flexibility to change its 3D structure and the coiled coil domains 
facilitate interactions with other proteins that also contain these domains (Kanno 
et al. 2008, Ausin et al. 2009, Greenberg et al. 2011). In this case it is thought 
that DMS3 forms homodimers that bind to DNA strands as a previous study has 
shown that a protein containing hinge and coiled coil domains was able to bind 
to DNA as a homodimer (Chiu et al. 2004, Kanno et al. 2008). The role in the DDR 
complex may therefore be to bind to the DNA strands and provide a platform for 
DRD1 and RDM1. DRD1 belongs to a plant-specific subfamily of SWI2/SNF2-like 
proteins that are defined by the SWI2/SNF2 ATPase domain (Kanno et al. 2004, 
Flaus et al. 2006, Chan et al. 2006, Greenberg et al. 2011). This is the same family 
as CLSY1 and would therefore suggest that DRD1 performs a similar function to 
CLSY1 in that it is responsible for nucleosome displacement in an ATP dependent 
manner, but is associated with PolV rather than PolIV (Hirschhorn et al. 1992, 
Whitehouse et al. 1999, Bruno et al. 2003, Kassabov et al. 2003). The final 
component of the DDR complex, RDM1, is a small protein that appears to bind to 
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single stranded DNA with a preference for methylated DNA, which suggests that 
it may target the DDR complex to RdDM targets that have already been 
methylated and so allow for maintenance of methylation of these sites by 
triggering further methylation (Gao et al. 2010). RDM1 binding to DNA is likely to 
occur at the transcription fork of PolV as RDM1 only binds to single stranded 
DNA and may also help localise the DDR complex to PolV. 
Comparisons between the largest subunits of PolIV and PolV, NRPD1 and NRPE1, 
showed that the biggest difference between the two proteins is the presence of 
ten GW/WG motifs within the carboxy-terminal domain (CTD) of NRPE1 (Pontier 
et al. 2005, El-Shami et al. 2007). These motifs were shown to be required for 
PolV function as complementation of a nrpe1 mutant with a NRPE1 protein that 
lacked these motifs was unable to restore DNA methylation (El-Shami et al. 
2007). The GW/WG motifs allow proteins to interact and bind to other GW/WG 
containing proteins and previous studies in other eukaryotic species have shown 
that several AGO proteins have these repeats and bind to other proteins through 
them, hence the motifs are also known as an AGO hook (Behm-Ansmant et al. 
2006, Ding and Han 2007, Partridge et al. 2007, Eulalio et al. 2008). This means 
that the function of the GW/WG repeat in the NRPE1 subunit could be to interact 
with AGO proteins and indeed it was shown that AGO4 has GW/WG repeats and 
interacts with NRPE1 (El-Shami et al. 2007). The study did not show if AGO6 and 
AGO9 can interact with NRPE1 in this way but due to their close homology to 
AGO4 and similar function in RdDM it is likely that they also do. The GW/WG 
repeats may therefore allow siRNA loaded AGO proteins to interact directly with 
PolV and so position them near the RNA transcript exit point of the polymerase 
thus making it easier for the siRNA loaded into the AGO to bind to the PolV 
transcript. AGO4 and NRPE1 are however not the only GW/WG repeat containing 
proteins in Arabidopsis and one of these, KTF1/SPT5-like, has been shown to be a 
RdDM component (El-Shami et al. 2007, Bies-Etheve et al. 2009, He et al. 2009c). 
This protein is a member of the SPT5 family of transcription elongation factors 
that are part of the DSIF complex which prevents PolII pausing or prematurely 
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terminating transcription (Sims et al. 2004, Bies-Etheve et al. 2009, He et al. 
2009c). The main difference between KTF1/SPT5-like and the SPT5 Arabidopsis 
ortholog is the presence of forty GW/WG repeats at the C-terminal end of KTF1 
that allows it to interact directly with AGO4 (Bies-Etheve et al. 2009). KTF1 has 
also been shown to interact directly with RNA, most likely the transcript 
produced by PolV, and these results would suggest that KTF1 acts as an 
elongation factor for PolV by binding to both PolV and the RNA transcript in 
order to stabilise the polymerase thus preventing transcription arrest or 
premature termination (Figure 1.11 C) (Parker 2010, He et al. 2009c). KTF1 may 
also have another function in RdDM, as a recent study has shown that although 
localisation of KTF1 to RdDM target sites is unaffected in ago4 mutants, AGO4 
localisation to targets is reduced in ktf1 mutants (Rowley et al. 2011). This result 
and the fact that KTF1 can bind to AGO4 would suggest that KTF1, rather than 
NRPE1, may provide a platform for AGO binding via the GW/WG motifs and so 
allowing the siRNA loaded into the AGO to bind to the PolV transcript (Figure 
1.11 C) (Bies-Etheve et al. 2009, He et al. 2009c). It should be noted that ktf1 
mutants lose DNA methylation at most RdDM targets so far tested, but some 
show no change in DNA methylation or AGO4 binding, which could therefore 
suggest that KTF1 is not required at certain target loci and that other 
transcription elongation factors may be involved, however this has yet to be 
proven (Bies-Etheve et al. 2009, He et al. 2009c, Rowley et al. 2011).  
The function of KTF1 and AGO proteins has been further elucidated in a recent 
study. The study found that in ago4, there was an increase in the levels of PolV 
and KTF1 associated with some RdDM loci and suggests that AGO4 reduces the 
number of PolV-KTF1 complexes at these loci (Rowley et al. 2011). Mutation of 
ktf1 also results in increased levels of PolV at some loci. Since KTF1 is a 
transcription elongation factor and so is responsible for preventing polymerase 
transcriptional arrest or premature termination, this would suggest that the 
reason for the increase in PolV complexes in ktf1 and ago4 mutants could be an 
increase in arrest of PolV transcription. Assuming that KTF1 behaves similarly to 
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SPT5, it would be associated with PolV after initiation of transcription and then 
throughout transcription elongation, however the binding of AGO is likely to be 
transient otherwise when the siRNA loaded in the AGO protein binds to the PolV 
transcript this would tether PolV preventing further transcription (Sims et al. 
2004). For AGO binding to be transient it must be released from the complex 
with KTF1 and PolV and this could be triggered by the siRNA binding to the PolV 
transcript, since during siRNA loading the AGO undergoes conformational 
changes in response to the siRNA becoming single stranded, the opposite could 
occur when dsRNA is formed by the siRNA binding (Ye et al. 2012). The release of 
the AGO from PolV and KTF1 could then allow a second AGO protein to bind and 
stabilise PolV (Figure 1.11 C).This would result in multiple siRNA loaded AGO 
proteins being bound to the PolV transcript, however this hypothesis would need 
to be confirmed experimentally. 
The next stage of the pathway, after the binding of siRNA loaded AGO proteins to 
the PolV transcript, is DNA methylation itself. Until recently it was unclear how 
the binding of siRNAs triggered this event. However, recent studies have 
identified the IDN2 protein and its homologs as RdDM components and these 
may provide the link between siRNA binding and DNA methylation (Ausin et al. 
2009, Zheng et al. 2010, Ausin et al. 2012b, Xie et al. 2012, Zhang et al. 2012). 
The first of these components to be identified was IDN2, also known as RDM12, 
which was shown to be a homolog of SGS3, a component of the post-
transcriptional gene silencing RNA silencing pathway that binds to dsRNA with a 
5’ overhang (Mourrain et al. 2000, Ausin et al. 2009, Zheng et al. 2010). Both 
SGS3 and IDN2 are characterised by XS, XH and zinc finger domains, of which it is 
the RNA recognition motif of the XS domain that binds dsRNA with 5’ overhangs 
(Bateman 2002, Ausin et al. 2009, Zheng et al. 2010). There is some dispute as to 
whether IDN2 just binds to dsRNA with a 5’ overhang or whether it can bind to 
dsRNA lacking an overhang as two studies show in vitro binding to only dsRNA 
with 5’ overhangs whereas another study found it could also bind to dsRNA with 
blunt ends (Ausin et al. 2009, Ausin et al. 2012b, Zhang et al. 2012). In all three 
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cases binding was shown in vitro using different dsRNA constructs thus 
investigation of the in vivo binding properties of IDN2 may resolve this issue. 
Mutants in idn2 show a reduction in DNA methylation but only a minor reduction 
in siRNA accumulation, which is characteristic of RdDM components acting 
downstream of siRNA production. Thus it was concluded that IDN2 may bind to 
the dsRNA formed when 24 nt siRNAs base pair with PolV transcript. Assuming 
that IDN2 can only bind to dsRNA with 5’ overhangs, the overhangs in this case 
would be created by the fact that the PolV transcript is longer than the siRNA 
and the 5’ end of the siRNA is held in the Mid domain binding pocket of the AGO 
protein it is loaded into (Lingel et al. 2004, Ma et al. 2005). 
IDN2 and SGS3 have twelve homologs that also contain the XS, XH and zinc finger 
domain. Two homologs, IDNL1 and IDNL2 (which are also known as IDP1 and 
FDM1 in the case of IDNL1 and IDP2 and FDM2 in the case of IDNL2) have been 
shown to form heterodimers with IDN2 (Ausin et al. 2012b, Xie et al. 2012, Zhang 
et al. 2012). One of the studies that identified IDNL1 and IDNL2 also showed that 
three other homologs of IDN2, FDM3, FDM4 and FDM5, also function in RdDM, 
however they only exhibited a reduction in methylation in double mutants with 
INDL1, suggesting that they are redundant with IDNL1 (Xie et al. 2012). By 
comparison IDNL1 and IDNL2 are not redundant with each other as mutants in 
either both show a reduction in DNA methylation, although IDNL1 has a greater 
reduction than IDNL2, and this is increased in idnl1 idnl2 double mutants (Ausin 
et al. 2012b, Zhang et al. 2012). It should also be noted that this double mutant 
has a similar decrease in methylation as the idn2 mutants but the triple mutant 
of idn2, idnl1 and idnl2 showed no further decrease in DNA methylation. Yeast-2-
hybrid data also shows that the strongest interactions amongst IDNL1, INDL2 and 
IDN2 occurred between IDNL1 and IDN2; and IDNL2 and IDN2.This would suggest 
that IDN2 is a constitutive part of the heterodimer whereas the dimer can 
contain either IDNL1 or IDNL2 and the composition of the heterodimer may vary 
between RdDM targets. The XH domain has been shown to be required for the 
formation of these heterodimers and mutation of this domain disrupts RdDM 
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function, suggesting that the formation of these dimers is a requirement for 
RdDM (Zhang et al. 2012). As with the binding affinity of IDN2 to dsRNA, there is 
also disagreement about the dsRNA binding of the XS domains of IDNL1 and 
IDNL2. One study found that neither the IDNL1 nor IDNL2 XS domains could bind 
any form of dsRNA, whereas another study showed that IDNL1 could bind dsRNA 
with 5’ overhangs and interacts with AGO4, although IDNL2 was not tested (Xie 
et al. 2012, Zhang et al. 2012). This would require further investigation, 
preferably in vivo to determine whether or not IDNL1 and IDNL2 can bind to 
dsRNA and what their exact function in the complex is. In terms of what the 
heterodimers function is during RdDM, assuming that they do have dsRNA 
binding activity it was suggested that IDN2 and IDNL1 or IDNL2 bind to separate 
siRNA-PolV transcript duplexes and form a platform from which the zinc finger 
motifs of both proteins in the heterodimer can interact with the DNA of the 
RdDM target (Figure 1.11 D) (Ausin et al. 2012b). The interaction of the zinc 
finger domains may be the trigger for DRM2 to methylate the target DNA. 
As previously discussed, the DRM2 methyltransferase is the main enzyme 
responsible for de novo methylation in plants, although CMT3 is also required at 
some loci and total loss of CHH methylation occurs only in drm1 drm2 cmt3 triple 
mutants (Cao and Jacobsen 2002a, Cao and Jacobsen 2002b, Cao et al. 2003, 
Chan et al. 2006). For this reason it was concluded that DRM2 was the main 
methyltransferase of the RdDM pathway and that CMT3 may also have a minor 
role in this pathway at some loci. Whether DRM1 has a function in RdDM is 
unclear as most studies that used drm1 mutants did so as drm1 drm2 double 
mutants, however one study did test the drm1 single mutant and found no 
change in DNA methylation levels in the transgene system used in the study (Cao 
and Jacobsen 2002b). This coupled with the fact that DRM1 expression is lower 
than that of DRM2 may suggest that DRM1 does not have a significant role in 
RdDM and requires further investigation to determine whether it has any 
involvement. A role has however been shown for DRM3, which although 
homologous to DRM2, lacks key functional residues in the methyltransferase 
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domain including the proline-cysteine residues of motif IV that are directly 
responsible for the methylation of the cytosine residue (Henderson et al. 2010). 
It should be noted that although DRM3 is not expected to have 
methyltransferase activity this was not directly tested. DRM3 is required for 
methylation of RdDM targets and so may either facilitate methylation by DRM2 
or has redundancy with DRM2 depending on its catalytic activity.  
DRM2 methylation shows a 10 bp periodicity in methylation of CHH sites 
although the reasons for why this occurs are currently unknown (Cokus et al. 
2008, Lister et al. 2008). A recent study has shown that DRM2 activity does not 
require a functional RdDM pathway in order to carry out DNA methylation, 
however in this case methylation tends to be off target (Wierzbicki et al. 2012). It 
was found that in both nrpd1 and nrpe1 mutants, although there was no change 
in global CHH methylation, there was a 50-60% reduction in CHH methylation at 
RdDM targets and that methylation instead occurred at pericentromeric regions. 
There was also miss targeting of CHG methylation in nrpd1 and nrpe1 mutants, 
but not to the same extent as CHH methylation and there was no change in CG 
methylation. Why DRM2 would methylate pericentromeric regions in RdDM 
mutants is unclear but could be related to the presence of other chromatin 
modification responsible for the formation of heterochromatin at these regions.
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Figure 1.11: PolV transcription and DNA methylation in RdDM 
A: siRNA loaded AGOs are imported into the nucleus. B: The DDR complex allows PolV transcription to occur. C: The siRNA loaded AGO binds to the 
PolV transcript and this binding is facilitated by KTF1. D: The duplex between the bound siRNA and PolV transcript is recognised by a IDN2 
heterodimer and this triggers DRM2 to methylate the DNA. The nuclear envelope is depicted as a yellow line with protein channels within this 
membrane shown as pairs of silver ovals. Areas with a white background are within the nucleus and areas in pale yellow are in the cytoplasm. RNA 
strands are shown in red and DNA strands are shown in black. RNA nucleotides are shown as red and orange T shapes. All proteins have been labelled 
except some of the PolV subunits that have yet to be shown to be required for RdDM. DNA methylation is shown as a white M in a red circle on the 
DNA strands. 
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1.3.5 Reinforcement of DNA methylation by histone 
modification in RdDM 
The next stage of RdDM is reinforcement of DNA methylation by histone 
modification. DNA methylation can disrupt the binding of transcription factors 
and other DNA binding proteins due to the presence of the methyl groups on the 
cytosine residues, however DNA methylation itself is not always sufficient to fully 
silence a DNA target and instead requires chromatin modifications, such as 
histone modification, in order to achieve full silencing (Buschhausen et al. 1987, 
Kass et al. 1993, Eden and Cedar 1994, Kass et al. 1997). DNA methylation can act 
as a signal for this histone modification and this was shown to be the case for the 
removal of acetyl groups from histone four (H4), which is a mark found at 
transcriptionally active sites (Hendrich and Bird 1998, Ballestar and Wolffe 2001, 
Berg et al. 2003, Zemach and Grafi 2003). The mechanism for this process 
involves the methyl binding domain (MBD) protein family, found in both plants 
and animals. These proteins recognise and bind to DNA methylation and then 
interact with histone deacetylases, triggering these enzymes to deacetylate the 
nucleosomes within that region thus changing it from transcriptionally active to 
inactive. In Arabidopsis the MBD6 and MBD10 proteins have been shown to have 
an involvement in RdDM silencing of rRNA loci (Figure 1.12 A), although it is not 
known if they are involved in silencing at other RdDM target sites or if any of the 
other eight Arabidopsis MBD proteins are also connected to RdDM silencing 
(Berg et al. 2003, Zemach and Grafi 2003, Preuss et al. 2008). MBD6 recognises 
CG methylation at the 5S rDNA locus but the preference of MBD10 is not known 
and the histone deacetylase responsible for the resulting histone deacetylation is 
thought to be HDA6 as it has also been shown to have a role in rRNA loci 
silencing (Aufsatz et al. 2002b, Preuss et al. 2008). HDA6 has also been 
implicated in RdDM and is responsible for the conversion of nucleosomes from a 
transcriptionally active state to an inactive state through the removal of acetyl 
groups from H4 (Figure 1.12 B) (Aufsatz et al. 2002b, Probst et al. 2004, Elmayan 
et al. 2005, He et al. 2009a). Mutation of hda6 results in a reduction in DNA 
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methylation at several loci, with CG and CHG methylation being particularly 
affected and may be the result of a reinforcement loop between DNA 
methylation and HDA6 whereby DNA methylation recruits HDA6 activity which 
leads to further DNA methylation. The fact that hda6 mutants cause a greater 
loss in CG and CHG methylation than CHH methylation may be related to the fact 
that the MBD proteins that trigger HDA activity have so far only been shown to 
bind to CG methylation (Preuss et al. 2008). 
There is a second family of methylated cytosine binding proteins with an 
involvement in RdDM silencing. These are the SUVH family, of which there are 
nine in Arabidopsis, and are characterised by the SRA domain that binds to 
methylated DNA and the SET domain that has histone methyltransferase activity 
(Johnson et al. 2008). Of these proteins so far only SUVH2 and SUNVH9 have 
been implicated in RdDM and act redundantly in the pathway, with mutants in 
these two genes resulting in a reduction in DNA methylation at several RdDM 
target loci as well as minor reduction in siRNA levels. This could again be due to 
the loss of a reinforcement loop between DNA methylation and histone 
methylation whereby DNA methylation triggers SUVH methylation of histone 
residues which itself leads to further DNA methylation (Johnson et al. 2007). This 
has been shown to be the case for SUVH4 which is required for both CHG DNA 
methylation and di-methylation of the histone three lysine nine (H3K9) residue at 
sites targeted by CMT3 (Jackson et al. 2002, Malagnac et al. 2002, Lindroth et al. 
2004, Johnson et al. 2007). Although both SUVH2 and SUVH9 are largely 
redundant to each other at most loci, there are some loci where SUVH2 but not 
SUVH9 is required. It was also shown that the binding preference of the two 
proteins is different, with SUVH2 preferentially binding to CG methylation 
whereas SUVH9 preferentially binding to CHH methylation (Figure 1.12 C) 
(Johnson et al. 2008). Biochemical analysis of SUVH2 and SUVH9 activity also 
raises questions as to the function of their SET domain as there is conflicting 
evidence as to whether this domain is capable of di-methylating the H3K9 
residue (Ebbs and Bender 2006, Naumann et al. 2005, Johnson et al. 2008). This 
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raises the possibility that the SET domains of SUVH2 and SUVH9 may have a 
different function to that of histone modification, however this analysis was 
carried out in vitro, so it is possible that the SET domain of these proteins 
requires a co-factor in order to function that was missing in these in vitro studies. 
SUP32 (also known as UBP36) is another histone modifier that’s function is 
related to H3K9 di-methylation. It is a deubiquitination enzyme responsible for 
the removal of ubiquitin groups from the lysine 123 residue of histone 2B 
(H2BK123) (Figure 1.12 D) (Sridhar et al. 2007). Ubiquitin groups are found at 
transcriptionally active sites and so their removal results in a shift to an inactive 
state and it has been shown that their presence inhibits the di-methylation of 
H3K9 (Ng et al. 2002, Sun and Allis 2002, Sridhar et al. 2007). This means that 
SUP32 may interact with SUVH2 and SUVH9 in order to remove ubiquitin H4 
marks and add H3K9 di-methylation marks in response to DNA methylation in 
RdDM, however no study has looked at an interaction between SUP32 and these 
proteins so would require further investigation to determine if this is indeed the 
case. The final histone modifier that has been associated with RdDM is JMJ14, 
which is also known as LSD1 and, like HDA6 and SUP32, removes histone 
modifications that are associated with transcriptionally active sites (Deleris et al. 
2010, Searle et al. 2010). In this case the mark is the di-methylation of the lysine 
four residue of H3 (H3K4) (Figure 1.12 D). jmj14 mutants result in an increase in 
di-methylation of H3K4 and a decrease in DNA methylation, with a minor 
decrease in siRNA levels. This would again suggest a feedback mechanism 
between DNA methylation and the activity of the JMJ14 protein, however it is 
not known if JM14 recognises DNA methylation itself or is activated by the action 
of another as yet undiscovered protein. 
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Figure 1.12: Histone modification in response to DNA methylation in RdDM 
A: MBD6 and MBD10 bind to methylated cytosine residues. B: MBD binding triggers 
HDA6 to deacteylate nucleosomes. C: SUVH2 and SUVH9 also recognise and bind to 
methylated cytosines. D: SUP32 and JMJ14 remove the ubiquitin groups from H2BK123 
residues and di-methylation from the H4K4 residues of nucleosomes respectively. E: 
MOM1 forms a homodimer when functioning in RdDM. DNA strands are shown as black 
lines with grey bars representing base pairing between strands. A nucleosome is 
depicted in blue with four of the eight histones shown. DNA methylation is shown as a 
white M in a red circle on the DNA strands while histone methylation is depicted as a 
black M in a green circle. Histone ubiquitination is shown as a white U in a blue circle 
and histone actelyation is shown as a black A in a yellow circle. 
Another protein that is considered to function downstream of DNA methylation 
is MOM1. This protein was first identified as a being required for transcriptional 
silencing at a number of loci but mutants in MOM1 did not result in a reduction 
in either DNA methylation or histone modification (Amedeo et al. 2000, Habu et 
al. 2006, Vaillant et al. 2006). Interestingly these loci targeted by MOM1 have an 
unusual intermediate chromatin state between that of hetero- an euchromatin 
and are characterised by the presence of both repressive state H3K9 di-
methylation and active state H3K4 di-methylation (Habu et al. 2006). The exact 
reason for having intermediate chromatin at these loci is unknown but it is 
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suggested that it allows for the rapid change between active and repressed 
states in response to environmental factors. A screen for enhancers of loss of 
silencing in mom1 mutants identified mutants in PolV and other RdDM 
components and therefore indicated that MOM1 and RdDM are linked 
(Yokthongwattana et al. 2010) Further analysis showed that this was loci 
dependent with some being silenced by both MOM1 and RdDM, others requiring 
only MOM1 or RdDM and some where MOM1 counteracted RdDM and 
therefore suggested a complex relationship between RdDM and MOM1. For loci 
that are targeted by both MOM1 and RdDM there is a modest decrease in H3K9 
di-methylation, although not to the same extent as a drm2 cmt3 double mutants, 
but no change in DNA methylation or siRNA levels (Numa et al. 2010). This 
decrease is not observed in loci that are targeted only by MOM1 and it was 
therefore suggested that MOM1 facilitates histone modification in response to 
RdDM and therefore works downstream of DNA methylation in the pathway. A 
study of the domain structure of MOM1 found that its activity requires only a 
nuclear localisation signal and the novel conserved MOM1 Motif 2 (CMM2) 
domain (Čaikovski et al. 2008). Subsequent biochemical analysis revealed that 
the CMM2 domain formed a hendecad-based coiled coil that could form 
homodimers (Nishimura et al. 2012). This domain is sufficient to maintain 
silencing at loci where MOM1 and RdDM are required, however the entire 
MOM1 protein is needed for loci that are silenced by MOM1 only. As no other 
MOM1 domain is required at RdDM targets it was suggested that the homodimer 
forms a binding platform for other proteins to bind but currently the identity of 
such proteins is unknown (Figure 1.12 E). These results would indicated that 
MOM1 has as yet unspecified role in RdDM during histone modification but only 
at specific loci and that this function requires dimerization. 
1.3.6 Maintenance of DNA methylation by RdDM 
Once DNA methylation and histone modification has occurred the target locus is 
fully silenced but these repressive marks must be maintained. This maintenance 
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is likely to involve in re-initiation of the entire RdDM pathway and is supported 
by the fact that 24 nt siRNAs are present in adult plant tissue for loci where 
initiation of silencing would be expected to occur in the ovule and pollen (Kanno 
et al. 2005, Brosnan et al. 2007, Mosher et al. 2009, Slotkin et al. 2009). There is 
also the evidence that one of the DDR complex’s components, RDM1, binds 
preferentially to methylated single stranded DNA and so may target PolV to 
RdDM targets that have already been methylated (Gao et al. 2010). It is also 
likely that the maintenance DNA methyltransferase enzymes, MET1 and CMT3 
are involved since both enzymes are able to maintain CG and CHG methylation, 
respectively, independently of RdDM (Jones et al. 2001, Lindroth et al. 2001, Cao 
and Jacobsen 2002a, Kankel et al. 2003, Aufsatz et al. 2004). CMT3 can also 
maintain CHH methylation at some loci but others require DRM2 and the RdDM 
pathway for maintenance (Cao and Jacobsen 2002a). Maintenance of histone 
modifications may occur through a cycle of reinforcement with DNA methylation 
whereby histone modification as a result of DNA methylation results in re-
initiation of RdDM and further histone modification, such as occurs with CMT3 
(Jackson et al. 2002, Malagnac et al. 2002, Lindroth et al. 2004, Johnson et al. 
2007).  
1.3.7 Summary of the RdDM pathway 
The previous sections of the introduction have given a detailed account of the 
mechanism of the RdDM pathway and this section will now briefly summarise 
the aforementioned mechanism (Figure 1.13). The pathway is initiated by PolIV 
transcription that requires the nucleosome modifier, CLSY1, or its homologs and 
transcription factors such as SHH1 and RDM4 (Herr et al. 2005, Kanno et al. 2005, 
Onodera et al. 2005, Smith et al. 2007, He et al. 2009b, Kanno et al. 2009, Law et 
al. 2011, Liu et al. 2011) (Figure 1.13 A). The PolIV transcript is then converted by 
RDR2 into dsRNA (Figure 1.13 B) before being processed by DCL3 or DCL4 into 24 
nt dsRNA segments (Xie et al. 2004) (Figure 1.13 C). These are then methylated 
at the 3’ end of both strands by HEN1 to protect them from degradation before 
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being transported out of the nucleus (Xie et al. 2004, Ye et al. 2012) (Figure 1.13C 
and D). In the cytoplasm they are loaded into either AGO4, 6 or 9 and this is 
facilitated by HSP90 (Havecker et al. 2010, Ye et al. 2012) (Figure 1.13 D). 
Cleavage and subsequent removal of one of the two strands leaving just the 
siRNA strand results in a conformational change in the AGO protein that makes a 
nuclear localisation signal accessible (Ye et al. 2012) (Figure 1.13 E). This allows 
the siRNA loaded AGO to enter the nucleus and once in the nucleus it binds to a 
PolV transcript and this is facilitated by KTF1 (Bies-Etheve et al. 2009, He et al. 
2009c, Rowley et al. 2011) (Figure 1.13 H). PolV transcription requires the DDR 
complex, consisting of DMS3, DRD1 and RDM1 as well as transcription factors 
such as RDM4 (He et al. 2009b, Kanno et al. 2009, Law et al. 2010) (Figure 1.13 
G). The duplex created by the siRNA and PolV transcript upon siRNA loaded AGO 
binding is recognised and bound by a heterodimer of IDN2 and one of its five 
homologs (Ausin et al. 2009, Zheng et al. 2010, Ausin et al. 2012b, Xie et al. 2012, 
Zhang et al. 2012) (Figure 1.13 H). The resulting complex allows IDN2 and its 
homologs to interact with the target DNA through their zinc finger motifs and 
this is thought to trigger the methylation of the DNA by DRM2 and its non-
catalytic co-factor DRM3 (Cao and Jacobsen 2002a, Cao and Jacobsen 2002b, Cao 
et al. 2003, Chan et al. 2006, Henderson et al. 2010, Ausin et al. 2012b, Xie et al. 
2012, Zhang et al. 2012) (Figure 1.13 I). DNA methylation is then reinforced by 
histone modifiers and the methylated DNA is first recognised by MDB6 and 10; 
and SUVH2 and 9 (Figure 1.13 J). MDB6 and 10 binding results in HDA6 removing 
the acetyl groups from H4 while SUVH2 and 9 di-methylate the H3K9 residue 
(Aufsatz et al. 2002b, Johnson et al. 2008, Preuss et al. 2008) (Figure 1.13 K). This 
di-methylation is facilitated by the MOM1 protein and requires that SUP32 must 
first deubiquitinates the H2BK123 residue (Sridhar et al. 2007, Numa et al. 2010). 
JMJ14 also removes di-methylation of the H3K4 residue in response to DNA 
methylation (Deleris et al. 2010, Searle et al. 2010). The DNA methylation and 
histone modification is then maintained by re-initiation of the pathway and the 
action of the maintenance methyltransferases MET1 and CMT3 (Jones et al. 
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2001, Lindroth et al. 2001, Cao and Jacobsen 2002a, Kankel et al. 2003, Aufsatz 
et al. 2004).  
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Figure 1.13: The RdDM pathway 
A: Transcription factors and nucleosome modifiers allow PolIV to transcribe the target DNA locus. B: The PolIV transcript is turned into dsRNA by RDR2. C: The 
dsRNA is then cleaved into 24 nt segments by DCL3 and DCL4 and the 5’ ends are then methylated by HEN1. D: The 24 nt dsRNA molecules are then exported from 
the nucleus and loaded into AGO4, 6 or 9. E: The passenger is cleaved by the AGO and is then degraded leaving the siRNA loaded into the AGO. This results in the 
release of the AGO from HSP90 and the exposure of the nuclear localisation signal (in red) that triggers the siRNA loaded AGO to be imported into the nucleus. F: 
The HSP90 binds to a new AGO and causes conformation changes in the AGO protein that allows it to bind to a 24 nt dsRNA molecule. G: The DDR complex 
facilitates PolV transcription of the target locus. H: The siRNA loaded AGO binds to the PolV transcript and this is aided by KTF1. The duplex formed between the 
siRNA and PolV transcript is recognised by a IDN2 heterodimer. I: The IDN2 heterodimer triggers DRM2 and its cofactor DRM3 to methylate the target DNA locus. 
J: The methylated DNA is recognised and bound to be DNA-binding proteins. K: These DNA binding proteins trigger the modification of histones with repressive 
marks. The nuclear envelope is depicted as a yellow line with protein channels within this membrane shown as pairs of purple ovals if they are exporters and silver 
ovals if they are importers. Areas with a white background are within the nucleus and areas in pale yellow are in the cytoplasm. RNA strands are shown in read and 
DNA strands in black. Methylation at the 3’ end of siRNAs is shown by CH3 labels and RNA nucleotides are shown as red and orange T shapes. The twelve subunits 
of RNA polymerase IV have been depicted in red, yellow and orange, but only subunits with a proven role in RdDM have been labelled and the twelve subunits of 
RNA polymerase V have been depicted in blue, green and purple, but only subunits with a proven role in RdDM have been labelled. DNA methylation is shown as a 
white M in a red circle on the DNA strands while histone methylation is depicted as a black M in a green circle. Histone ubiquitination is shown as a white U in a 
blue circle and histone actelyation is shown as a black A in a yellow circle. 
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1.3.8 Other RNA directed transcriptional gene silencing 
pathways in plants 
There is some evidence for other plant RNA silencing pathways that silence 
targets by DNA methylation. miRNAs are usually considered to function purely in 
PTGS but miRNAs have also been shown to be capable of directing DNA 
methylation. In Arabidopsis it was shown that two genes, PHABULOSA (PHB) and 
PHAVOLUTA (PHV), encoding transcription factors involved in early leaf 
development, are regulated by the miRNAs miR165 and miR166 and that this is 
associated with DNA methylation corresponding to the sequence downstream of 
the mRNA cleavage site of miR165 and miR166 (Bao et al. 2004). This 
methylation is lost in phb and phv mutants lacking the miRNA cleavage sites and 
is reduced in undifferentiated tissue where miRNA repression of these two genes 
does not occur, therefore suggesting that the DNA methylation is associated with 
silencing. However, it was not shown whether this methylation is the cause of 
the silencing or if it occurs as a consequence of PTGS by the miRNA; neither is 
the mechanism for how the miRNAs trigger methylation known and may still 
feature RdDM. miRNA-directed DNA methylation was however shown in the 
moss Physcomitrella patens where in dcl1b mutants that can still produce mature 
miRNAs but are unable to cleave target mRNA, a build-up of miRNA-target RNA 
duplexes resulting in DNA methylation of the target locus (Khraiwesh et al. 
2010). DNA methylation of the promoter of a miRNA target gene, which is down 
regulated by abscisic acid signalling, occurred in wild-type P. patens upon 
treatment with the hormone, thus suggesting that DNA methylation by miRNA 
can occur naturally in this species. The ratio of miRNA and target RNA is believed 
to be important for whether silencing occurs through DNA methylation or PTGS. 
These two studies showed a possible role in DNA methylation for 21 nt miRNAs, 
which is the most prevalent length of miRNA, but it has also recently been shown 
that there are 24 nt miRNAs which are processed by DCL3 in Arabidopsis; but are 
at a considerably lower abundance to their 21 nt counterparts (Dunoyer et al. 
2004, Vazquez et al. 2008). These 24 nt miRNAs are also found in Oryza sativa 
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and a study in this species showed that these miRNAs are loaded into the O. 
sativa AGO4 homolog and direct DNA methylation (Wu et al. 2010). It was 
suggested that this pathway may be similar to that RdDM, except, due to the 
nature of miRNA production, that it is not dependent on RDR2 and PolIV and its 
transcriptional co-factors, of which RDR2 was indeed shown not to be required 
for miRNA-directed DNA methylation. The 24 nt miRNAs are produced from the 
same transcript as 21 nt miRNAs for the same target, with the 21 nt and 24 nt 
miRNAs being encoded at different point on the transcript or overlapping each 
other, resulting in DCL1 and DCL3 competing to produce either a 21 or 24 nt 
miRNA respectively. This suggests that for the targets of these miRNA, genes are 
targeted for both PTGS and TGS and it is possible that these two systems are 
interlinked, although this has not so far been tested. A 24 nt miRNA has also 
been shown to be involved in DNA methylation of the SP11 male self-
incompatibility gene in Brassica rapa, indicating that the role of 24 nt miRNAs in 
DNA methylation is not just specific to O. sativa, although it has so far not been 
shown whether any of the Arabidopsis 24 nt miRNAs mediate DNA methylation 
(Tarutani et al. 2010, Finnegan et al. 2011). These four examples point to miRNAs 
being able to direct DNA methylation at specific loci, although the mechanism for 
this process is incomplete. 
Two recent studies have also demonstrated that RNA silencing components that 
are traditionally associated with PTGS are required for DNA methylation but only 
at specific loci (Garcia et al. 2012, Pontier et al. 2012). The loci were originally 
identified as losing DNA methylation in a mutant for a novel chromatin modifier, 
NERD, which was shown to bind to unmethylated H3K4 residues that are found 
at transcriptionally inactive sites and that this methylation loss was associated 
with siRNA loss (Pontier et al. 2012). Analysis of these loci to determine which 
RDR is required for DNA methylation showed that RDR1 and RDR6 were required 
rather than RDR2. Interestinly neither rdr1 nor rdr6 mutants resulted in a 
decrease in siRNA levels associated with these loci whereas rdr2 mutants did and 
so raises questions as to the exact function of RDR1 and RDR6 as they appear not 
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to produce dsRNA for siRNA production but are still required for DNA 
methylation. The DCL requirement of these loci is also unusual as for most loci 
single mutants in dcl2, dcl3 or dcl 4 were sufficient to lead to a reduction in DNA 
methylation but at one locus only a line with all four DCL genes mutated caused 
a reduction in DNA methylation and so this would suggest redundancy in DCL 
requirement at these loci. In terms of AGO requirement, neither AGO4 nor AGO6 
were required for DNA methylation and instead AGO2 or its homolog AGO3 were 
required. The study by Garcia also demonstrated that for at least one of the loci 
the PTGS components SGS3 (a homolog of IDN2), SDE3 (a RNA helicase) and 
SDE5 were also required for DNA methylation (Garcia et al. 2012). These findings 
raise the possibility that PTGS components are involved in DNA methylation, 
however it remains to be determined as to whether they form an entirely novel 
pathway for DNA methylation or are a locus specific adaption of RdDM pathway. 
The fact that PolIV and PolV have also been showed to be required for DNA 
methylation at these loci as well as DCL3 and DCL4 may suggest RdDM or at least 
an RdDM like pathway is responsible (Xie et al. 2004, Pélissier et al. 2011, Garcia 
et al. 2012, Pontier et al. 2012).  
1.3.9 RNA directed TGS silencing in other eukaryotes 
RdDM is plant specific RNA silencing pathway as many of the key components, 
particularly RNA PolIV and V, are unique to plants and more specifically to higher 
plants as Pol V is only present in plant species that evolved after the divergence 
of ferns from other land plants (Luo and Hall 2007, Marcussen et al. 2010). This 
means that the pathway described in the previous sections applies only to higher 
plant species, while the mechanism in lower plant species is currently unknown 
but may be similar to the one described as PolIV is present in these species. 
Despite RdDM being plant specific there are RNAi pathways in other eukaryotic 
organisms that are involved in TGS. The RNAi pathway in fission yeast 
responsible for TGS is similar to RdDM in that it also involves the action of an 
RNA Polymerase, in this case PolII, and that siRNAs are produced from the PolII 
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transcript by the actions of an RDR and Dicer (Volpe et al. 2002, Verdel et al. 
2004, Sugiyama et al. 2005, Irvine et al. 2006). There is also similarity between 
the two pathways in that once the siRNA is loaded into an AGO it triggers 
transcriptional silencing by binding to a PolII transcript, however unlike RdDM 
where binding to a PolV transcript triggers DNA methylation, the binding to PolII 
transcripts in fission yeast results in di-methylation of the H3K9 residue. Unlike 
the fission yeast pathway, the Drosophila and Mus musculus TGS RNAi pathways 
are highly dissimilar to RdDM. The RNAi pathway in these organisms responsible 
for TGS is mediated by PIWI RNAs (piRNA) that are between 25-30 nt in length 
and are produced by a mechanism that is different to that of RdDM (Aravin et al. 
2001, Vagin et al. 2006, Aravin et al. 2007, Brennecke et al. 2007, Carmell et al. 
2007, Gunawardane et al. 2007). This mechanism is described as “ping pong” and 
involves the PIWI proteins, a subset of AGO proteins and unlike RdDM does not 
feature RDR or Dicer enzymes. The mechanism involves the initial production of 
piRNAs from an antisense transcript, which are then loaded into a PIWI protein 
(PIWI in Drosophila and MIWI2 in M. musculus) that directs cleavage of a sense 
transcript, creating sense piRNAs which are then loaded into another PIWI 
protein (AGO3 in Drosophila and MILI in M. musculus) that then cleave an 
antisense transcript and create further antisense piRNAs. Another difference 
between piRNAs and RdDM is that piRNAs are specific to germ cells where they 
trigger histone modification or DNA methylation in Drosophila and M. musculus 
respectively, whereas RdDM is found in somatic cells as well as germ cells (Pal-
Bhadra et al. 2004, Aravin et al. 2008, Aravin and Bourc’his 2008, Kuramochi-
Miyagawa et al. 2008). Although the mechanism of piRNA production is different 
to RdDM, both silence transposable elements in order to prevent the deleterious 
movement of these elements and so could be considered to have similar roles 
(Huettel et al. 2006, Carmell et al. 2007, Kuramochi-Miyagawa et al. 2008, Slotkin 
et al. 2009). 
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1.4 RdDM function 
1.4.1 Silencing of transposable elements and repetitive 
sequences 
There are several proposed functions for RdDM including: silencing of 
transposable elements and repeat elements, control of development, stress 
responses and hybrid vigor. The best understood of these is the role in silencing 
transposable elements and repetitive sequences. It has been found that RdDM 
targets these genetic elements in areas of constitutive heterochromatin, such as 
the pericentromeric region, presumably to help maintain the heterochromatic 
state of the DNA and to prevent the proliferation of transposable elements in the 
genome which could have deleterious effects on the plant (Kato et al. 2003, Herr 
et al. 2005, Kanno et al. 2005, Onodera et al. 2005, Pontier et al. 2005, Lisch 
2009, Lisch and Bennetzen 2011). In support of this, in RdDM mutants the 
expression level of transposable elements that are targeted is up regulated (He 
et al. 2009c, Pontes et al. 2009). However, with the exception of nrpe1 mutants, 
no other RdDM mutant results in heterochromatin decondensation suggesting 
that the pathway is actually dispensable for heterochromatin maintenance and 
could suggest redundancy with other pathways (Pontes et al. 2009). This lack of 
an effect in RdDM mutants is also seen at telomeres where the pathway is 
responsible for CHH methylation of the CCCTAAA repeats that form the telomere 
(Cokus et al. 2008, Vrbsky et al. 2010). RdDM was therefore thought to have a 
role in maintaining the telomere heterochromatin and yet in an rdr2 mutant 
where methylation and siRNA levels were reduced, the heterochromatin 
structure of the telomeres was unaffected. This would again suggest other 
epigenetic pathways involvement in telomere maintenance and so to 
demonstrate a role for RdDM in heterochromatin maintenance other pathways 
may also need to be inactivated.  
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RdDM also targets transposable element and repetitive sequences in 
euchromatic genome regions, particularly small transposable elements and this 
is again likely to be to prevent their movement within the genome (Tran et al. 
2005, Zilberman et al. 2007). Another role for RdDM in targeting these 
euchromatin features is in controlling gene expression. A study looking at long 
terminal repeats (LTR) of retrotransposons found that, of those targeted by 
RdDM, only those in euchromatic regions were up regulated in mutants of the 
pathway whereas ones in heterochromatic regions were not (Huettel et al. 
2006). This would suggest that unlike in heterochromatic regions, RdDM is the 
chief pathway responsible for silencing transposable elements and repetitive loci 
in euchromatic regions and so has a more significant role in the maintenance of 
repressive marks within euchromatin than heterochromatin. Further 
investigation also showed that these LTR regions also seemed to affect 
transcription from nearby genes as in one example a Solo LTR on chromosome 
five that was reactivated in RdDM mutants, triggered up regulation of two 
nearby genes (Huettel et al. 2006). The Solo LTR was shown to possess enhancer 
elements that were activated in RdDM mutants. This could suggest that RdDM 
and demethylation pathways may potentially be able to alter gene expression 
levels by alteration of the methylation status of such elements. This idea will be 
taken further in the section on stress response and RdDM.  
The role of RdDM in control of transposable elements has particular relevance 
during gametogenesis. During pollen development each pollen grain produces 
two sperm cells and a vegetative nucleus, of which only the sperm cells go on 
fertilise the egg and central cell in the ovule resulting in the embryo and 
endosperm, respectively (Huh et al. 2008). Investigation into transposable 
element activity in pollen revealed that they were expressed and active in the 
vegetative nucleus but not the sperm cells and that 21 nt siRNAs associated with 
such elements were produced in the vegetative nucleus and then transported 
into the sperm cells (Slotkin et al. 2009). This would suggest that these siRNAs 
protect the sperm cells from transposable element activation and thus prevents 
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the deleterious effects of uncontrolled transposition being transferred to the 
plant’s progeny. The reason why this is required is that during gametogenesis 
DNA methylation is reset and so methylation of transposable elements and 
repetitive loci must be re-established. In support of this, it was shown that DNA 
methylation of these elements had indeed occurred in mature sperm cells. Since 
RdDM is responsible for de novo methylation it is assumed that it is responsible 
for this methylation, although this has not been proven, particularly as 21 nt 
siRNAs are not normally associated with RdDM. There is stronger evidence of a 
function for RdDM in the endosperm. The endosperm is produced by the 
fertilisation of the central cell by a sperm cell and it was found that extensive 
demethylation by DME occurred in the endosperm tissue (Gehring et al. 2009, 
Hsieh et al. 2009). This demethylation of the endosperm correlates with changes 
in the embryo whereby hypermethylation of transposable elements and 
imprinted genes occurs and so it was suggested that the demethylation process 
in the endosperm triggers methylation in the embryo. This was supported by the 
discovery that 24 nt siRNAs expression is up regulated during female 
gametogenesis and in the endosperm and so these siRNAs, like those in pollen, 
could be transported from the endosperm to the embryo where they direct 
epigenetic reprogramming of the genome (Mosher et al. 2009). The up 
regulation during female gametogenesis could be a similar process to that in 
pollen. However, the exact mechanism by which this up regulation occurs is 
unknown as demethylation mutants did not affect siRNA levels and neither did 
mutations in other chromatin modifiers such as the histone deacetylases 
(Mosher et al. 2011). Another study looking at the effects of genome dosage on 
seed development in Arabidopsis found that if a tetraploid male was crossed 
with a diploid female the seed were larger than normal due to a delay in normal 
endosperm development whereas the reciprocal cross results in smaller seeds 
(Lu et al. 2012). In these crosses there is a decrease in 24 nt siRNA levels in the 
male tetraploid to female diploid cross indicating that RdDM may be responsible 
for the larger seed size. It was then shown that when a wild-type male diploid 
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plant is crossed with a nrdp1 female diploid plant, this resulted in a similar seed 
size as when a male tetraploid is crossed with a female diploid and that the 
increased size was associated with up regulation of the endosperm specific 
AGAMOUS-LIKE transcription factor due to a reduction in 24 nt siRNAs targeting 
this gene. This supports the idea that RdDM is involved in gene imprinting in the 
endosperm as only the maternal copy of the AGAMOUS-LIKE gene is expressed. 
Taken together the studies appear to show that RdDM is involved in gene 
imprinting and reprogramming the epigenome in the embryo and endosperm, 
although apart from an increase in seed size RdDM mutants do not display any 
defects in seed development, meaning that further investigation is required to 
determine the significance of its role in these processes. 
1.4.2 RdDM role in development 
One of the biggest mysteries associated with RdDM is that mutants in the 
pathway do not show any strong phenotype apart from the up regulation of 
transposable elements as mentioned in the last section. This is exemplified by 
the contrasting met1 mutant phenotype which shows severe pleotropic 
developmental defects whereas drm2 mutants do not (Finnegan et al. 1996, 
Ronemus et al. 1996, Cao and Jacobsen 2002a, Cao and Jacobsen 2002b, Cao et 
al. 2003). As previously suggested this is likely down to redundancy with other 
epigenetic pathways and in support of this triple mutants in cmt3, drm1 and 
drm2 have developmental defects such as later flowering time, twisted leaves 
and dwarf stature that are not seen in the respective single mutants (Cao et al. 
2003, Chan et al. 2006). This has also shown to be the case in double mutants of 
cmt3 and other RdDM mutants such as either nrpd1 or drd1. Arabidopsis dcl3, 
nrpd1 and nrpe1 mutants also show late flowering that is most obvious in short 
day growth conditions (8 hours) suggesting that components of the pathway 
have a role in the regulation of flowering time (Pontier et al. 2005, Greenberg et 
al. 2011). This effect on flowering is thought to be due to changes in the 
regulation of the FLC locus and will be discussed in more detail in the 
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introduction of chapter five (page 293) (Swiezewski et al. 2007). These results 
could suggest that RdDM is of low importance to plant growth and development 
due to the limited phenotype in single mutants in the pathway. However in 
maize, mutants in the homolog of NRPD1 do show developmental defects in leaf 
and inflorescence tissue and would suggest that RdDM is biologically relevant in 
maize (Parkinson et al. 2007, Erhard Jr. et al. 2009). No Arabidopsis single mutant 
of NRPD1 or NRPD2 has shown such effects and so raises the question of why 
they are seen in maize but not Arabidopsis. One possibility is that there is a 
difference in function in RdDM between the two species and another is the fact 
that all investigations of RdDM mutants have so far only looked at mutants in 
ideal growth conditions so a RdDM phenotype may only appear in more natural 
conditions where the plants are subject to changes in growth conditions and 
resulting stresses. Investigation of RdDM Arabidopsis mutants under different 
conditions and over multiple generations may reveal both developmental and 
stress response defects. 
1.4.3 RdDM role in stress response 
The involvement of DNA methylation in stress response is well known but the 
evidence for the role of the RdDM pathway in stress responses is more limited. 
Microarray analysis of gene expression in response to stress found several genes 
involved in the RdDM pathway were up-regulated and although circumstantial, 
may suggest that RdDM is more active during stress conditions (Chinnusamy and 
Zhu 2009). Stronger evidence for a role in RdDM came from a study that looked 
at promoters of both biotic and abiotic stress response genes and whether these 
promoters were associated with 24 nt siRNAs, DNA methylation or transposable 
elements (Baev et al. 2010). They found that around 13 % of biotic stress 
response genes and 18 % of abiotic stress response genes were associated with 
24 nt siRNAs and so could potentially be regulated by RdDM. Amongst these a 
subset also had associated DNA methylation and transposable elements within 
the promoter region and analysis of three of these promoters showed that two 
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lost DNA methylation in nrpd1 and nrpe1 mutants. This suggests that RdDM 
represses these stress response genes in normal conditions and that methylation 
could be removed by demethylation during stress conditions allowing gene 
expression to occurs. The reason that the study looked at promoters with 
transposable elements is that, as described previously, it has been shown that 
transposable elements that are silenced by RdDM can influence the expression 
of nearby genes, thus providing a route through which RdDM can control gene 
expression (Huettel et al. 2006). The findings of the study by Baev were validated 
by a recent study which analysed expression of ONSEN retrotransposons, which 
are targeted by RdDM for suppression and are found to be upregulated in nrpd1 
and nrpe1 mutants, during heat stress (Ito et al. 2011). The study found that 
expression of ONSEN was upregulated during and immediately after heat stress 
before gradually decreasing back to pre-stress levels and that this up regulation 
of ONSEN is associated with the increased expression of nearby genes, two of 
which are stress response genes. The heat dependent release of ONSEN 
therefore provides an example of RdDM functioning in the control of stress 
response genes through the control of a transposable element.  
Two studies have also provided evidence that RdDM is involved in the regulation 
of genes relevant to stress response, although in both cases they did not show 
RdDM altering expression levels in response to stress. One of these studies 
identified mutants in a enhancer element of HKT1 that increased resistance to 
salt stress (Baek et al. 2011). HKT1 is responsible for the importation of Na+ ions 
into cells and so down regulation results in a decrease in the number of ions 
entering the cell, which increases the plants resistance to salt stress. The 
mutants in the enhancer element reduced expression of HKT1 and it was also 
shown that this element was likely controlled by RdDM as rdr2 mutants lost 
methylation of the enhancer and resulted in up regulation of HKT1 expression. 
Methylation of this enhancer differed between roots and leaves suggesting that 
RdDM is involved in tissue specific regulation, however it was not shown 
whether RdDM actually regulates HKT1 expression in response to stress. Another 
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study found that dcl3 mutants resulted in an increase in stress tolerance to the 
mutagenic agent methyl methane sulfonate, implicating a loss of RdDM control 
of certain loci was the cause of this tolerance (Yao et al. 2010). However, the 
genes involved were not identified and therefore it is also not known if RdDM 
regulation of these genes is altered in response to this mutagen in wild-type 
plants. 
1.4.4 RdDM and hybrid vigor 
Recent discoveries have suggested a role for RdDM in hybrid vigor, also known as 
heterosis, which is the phenomenon whereby the progeny of parents from 
different species, ecotypes, varieties or strains, display an improvement or 
increase in certain traits compared to its parents (Meyer et al. 2004, Chen 2010). 
For example crossing the Columbia and C24 Arabidopsis ecotypes produces 
progeny with significantly larger rosette size than either parent. A study 
investigating the differences between wild-type plants from the C24 and 
Landsberg erecta (Ler) ecotypes and hybrids of the two ecotypes revealed a 
decrease in 24 nt siRNAs in the progeny compared to the parental lines and that 
these changes correlated to regions of the Arabidopsis genome where the two 
ecotypes had differences in 24 nt siRNA levels (Groszmann et al. 2011). Further 
investigation showed that a majority of these loci correlated to genes or nearby 
intergenic loci and that the changes in siRNA levels were associated with DNA 
methylation changes. This would seem to indicate that the changes in siRNA 
levels for these genes and intergenic regions may account for some of the 
differences between parents and hybrids and indeed similar results showing a 
decrease in 24 nt siRNAs in hybrids has also been described in maize (Barber et 
al. 2012).  
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1.5 Project aims 
1.5.1 Prospects of identifying novel RdDM mutants in a 
forward genetic screen 
The RdDM pathway has been well characterised and large numbers of proteins 
have been shown to be involved, however gaps in our knowledge still remain. 
For instance there is uncertainty about how DNA methylation results in the 
formation of silenced chromatin. As mentioned previously DNA methylation may 
not be sufficient to achieve a fully silenced state and so chromatin modification is 
also required (Buschhausen et al. 1987, Kass et al. 1993, Eden and Cedar 1994, 
Kass et al. 1997). This includes the formation of higher order heterochromatin by 
the tight packing of nucleosomes into a coiled structure similar to a solenoid and 
the formation of loops of these coils, both of which will result in a fully silenced 
state. It is thought that such changes occur in response to RdDM, however no 
proteins have yet been identified in the RdDM pathway that cause these higher 
order chromatin. There are currently a total of eight proteins that are involved in 
histone modification in response to DNA methylation have so far been identified 
but there is still scope for other histone modifiers being involved. For example 
there several protein families, namely MBD, HDA and SUVH, which have 
members that are known to be a part of the RdDM pathway. Not all of the other 
genes in these families have been tested and so could also potentially be 
involved in the pathway as well.  
Another gap in the mechanism of RdDM is how DNA methylation by DRM2 is 
triggered. Previous studies have shown that 24 nt siRNAs loaded into AGO4 bind 
to the PolV transcript and that it is this binding that triggers DRM2 to methylate 
the target DNA locus (El-Shami et al. 2007, Bies-Etheve et al. 2009, He et al. 
2009c, Wang and Dennis 2009, Rowley et al. 2011). Recent studies have shown 
that IDN2 and its homologs recognise and bind to the siRNA and PolV transcript 
duplex and then interact with the target DNA through their zinc finger motif 
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(Ausin et al. 2009, Ausin et al. 2012b, Xie et al. 2012, Zhang et al. 2012). This was 
suggested to signal to DRM2 to methylate the DNA target, however no 
interaction between DRM2 and IDN2 and its homolog, nor any other RdDM 
protein associated with PolV or AGO4 has been demonstrated. Thus it is still 
unknown how the RdDM pathway signals DRM2 to methylate the target DNA 
locus and is therefore possible that other, as yet undiscovered, RdDM proteins 
may exist that sequester DRM2 to the correct target locus and trigger 
methylation.  
Another aspect of the pathway where there is uncertainty is that PolIV is thought 
to transcribe the target DNA locus and this transcript is then turned into 24 nt 
siRNAs through the action of RDR2 and DCL3, however how PolIV is recruited to 
the correct DNA loci is unknown (Herr et al. 2005, Kanno et al. 2005, Onodera et 
al. 2005, Vaucheret 2005). There are several transcription factors and chromatin 
modifiers that interact with PolIV including RDM4, SHH1 and CLSY1, 2, 3 and 4, 
and these may guide PolIV to specific target sites, however no study has yet 
demonstrated that this is the case (Smith et al. 2007, He et al. 2009b, Kanno et 
al. 2009, Law et al. 2011, Liu et al. 2011). This modest number of transcription 
factors and chromatin modifiers would seem unlikely to be able to account for 
the targeting of PolIV to the myriad number of loci that RdDM is active at and 
would therefore raise the possibility that there are other proteins that interact 
with and guide PolIV. This problem of the targeting of PolIV also occurs with 
PolV, which has been shown to require RDM4 and the DDR complex, comprising 
of RDM1, DRD1 and DMS3, for transcription but no study has yet shown how 
PolV is recruited to the correct locus (Kanno et al. 2004, Huettel et al. 2007, 
Kanno et al. 2005, Kanno et al. 2008, Ausin et al. 2009, He et al. 2009b, Kanno et 
al. 2009, Gao et al. 2010, Law et al. 2010). There are an estimated to be between 
1400 to 2000 transcription factors in Arabidopsis, most of which will only interact 
with PolII, but others may interact with PolIV or PolV, or as with RDM4, interact 
with PolII, PolIV and PolV (Davuluri et al. 2003, Guo et al. 2005, Iida et al. 2005, 
Riano-Pachon et al. 2007, He et al. 2009b, Kanno et al. 2009). It is also worth 
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mentioning that a large number of the proteins involved in the pathway have 
been discovered since this project began in 2008. Of the areas highlighted in this 
section where there is uncertainty in the mechanism this study will focus on 
chromatin modification and DNA methylation.  
1.5.2 Strategy for the identification of novel mutants 
The aim of this study was to identify novel RdDM components and investigate 
their function in the pathway. This was achieved using a forward genetic screen 
of an Arabidopsis ethyl ester methane sulfonic acid (EMS) mutant library for 
RdDM mutants. Screening mutants for a loss of RdDM silencing of endogenous 
targets would be time consuming, thus a transgene system that allows for easy 
and rapid RdDM mutant identification was used. The transgene system and how 
it works is described in the introduction of chapter three (page 124). Mutants 
that lost RdDM silencing of the transgene could then be characterised in terms of 
their effect on DNA methylation and siRNA production in order to sort them into 
phenotypic groups. Allelism tests between known mutants with a similar 
phenotype to the mutants would then be performed to identify any mutants that 
have already been identified. For those that were presumed to be novel the 
causal mutation would be identified by a dual mapping and sequencing strategy. 
If the mutant was indeed novel the phenotype would be fully characterised in 
order to determine a possible function in the RdDM pathway. 
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2.1 Equipment and chemicals 
2.1.1 List of chemicals  
Below is a list of chemicals used to make solutions mentioned in the following 
sections. The abbreviation and manufacturer of each chemical are given. Distilled 
water dH2O was obtained from a Purelab Ultra water purifier (ELGA).  
Chemical Abbreviation Manufacturer 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide EDC Sigma-Aldrich 
1-methylimidazole   Sigma-Aldrich 
2-(N-morpholino)ethanesulfonic acid  MES Sigma-Aldrich 
3-(N-morpholino)propanesulfonic acid MOPS Sigma-Aldrich 
30 % Acrylamide   National Diagnostics 
Agar   Sigma-Aldrich 
Agarose   Melford 
Ammonium persulfate APS Sigma-Aldrich 
Bacto agar   Sigma-Aldrich 
Boric acid   Fisher 
Bovine serum albumin BSA Sigma-Aldrich 
Bromophenol blue   Fisons indicator 
Calcium di-chloride CaCl2 Sigma-Aldrich 
Carbenicillin   Sigma-Aldrich 
Cetyltrimethylammonium bromide CTAB Sigma-Aldrich 
Chloroform: isomyl alcohol 24: 1    Sigma-Aldrich 
Di-sodium hydrogen phosphate Na2HPO4 Fisher 
DL-phosphinothricin   Melford 
Ethanol   Fisher 
Ethidium bromide EtBr Sigma-Aldrich 
Ethylenediaminetetraacetic acid EDTA Fisher 
Formamide   Sigma-Aldrich 
Glycerol   Fisher 
Hydrochloric acid HCl Fisher 
Isopropanol   Fisher 
Kanamycin   Sigma-Aldrich 
Mannitol   Sigma-Aldrich 
Polyethylene glycol 8000 PEG (8000) Fisher 
Polyvinylpyrrolidone 40 PVP 40 Sigma-Aldrich 
Potassium chloride KCl Sigma-Aldrich 
Sodium acetate NaAc Fisher 
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Chemical Abbreviation Manufacturer 
Sodium chloride NaCl VWR 
Sodium di-hydrogen phosphate NaH2PO4 Fisher 
Sodium dodecyl sulfate SDS Sigma-Aldrich 
Sodium hydroxide NaOH Fisher 
Tetramethylethylenediamine TEMED Bio Rad 
Tris   Invitrogen 
Tri-sodium citrate Na3CIT Fisher 
Tryptone   Oxoid 
Urea   Fisher 
Xylene cyanol FF   BDH 
Yeast extract   Oxoid 
β-mercaptoethanol   Sigma-Aldrich 
Table 2.1: Chemicals used in this study 
 
2.1.2 Centrifuges 
For samples in microcentrifuge tubes (Sarstedt) a S41SP microcentrifuge 
(Eppendorf) was used for centrifugation or if the samples needed to the 
centrifuged at 4 °C a 4515 R microcentrifuge (Eppendorf) was used. For samples 
in centrifuge tubes (15 ml or 50 ml) (Sarstedt) a CR312 centrifuge (Jouan) was 
used. For 96 well DNA extractions a 4K15C 96 well plate centrifuge (Sigma-
Aldrich) was used. 
2.1.3 Pipettes 
A set of Gilson pipettes (P2, P10, P100, P200 and P1000) were used for all 
volumes smaller than 1 ml and a Pipetboy (Integra) and 10 ml or 25 ml pipettes 
(Sarstedt) were used for volumes up to 30 ml. For higher volumes measuring 
cylinders were used. 
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2.2 Chemical solutions 
2.2.1 1X CTAB 
To produce 200 ml of 1 X CTAB DNA extraction buffer, 4 g CTAB, 20 ml 1 M Tris 
pH 8, 0.25 M EDTA pH 8, 16.4 g NaCl and 4 g PVP 40 were added to 150 ml dH2O 
and then the volume was brought up to 200 ml by the addition of dH2O. 
2.2.2 5 X TBE 
1 l of 5 X tris-boric acid-EDTA buffer was made by the addition of 54 g tris, 27.5 g 
boric acid and 20 ml of 0.5 M EDTA pH8 to 980 ml dH2O. 
2.2.3 6 X Loading dye 
To produce 30 ml of 6 X loading dye, 9 ml of glycerol, 75 µg bromophenol blue, 
75 µg of xylene cyanol FF and 300 µl 0.5M EDTA pH8 was added to 15 ml dH2O. 
The pH of the solution was then changed to pH7 by the addition of 10 M NaOH 
and the volume was then adjusted to 30 ml by the addition of dH2O. 
2.2.4 Southern denaturing solution 
To produce 1 l of Southern denaturing solution, 87.6 g NaCl and 20 g NaOH were 
added to 800 ml dH2O and the volume was then brought up to 1 l using dH2O. 
2.2.5 Southern neutralisation solution 
To produce 1 l of Southern denaturing solution, 175.3 g NaCl and 60.6 g Tris were 
added to 800 ml dH2O. The pH of the solution was then altered to pH 6.5 by the 
addition of concentrated HCl and the volume was then brought up to 1 l using 
dH2O. 
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2.2.6 20 X SSC 
To produce 1 l of saline sodium citrate, 174.5 g NaCl and 88.2 g Na3CIT were 
added to 800 ml dH2O and the volume was then brought up to 1 l using dH2O. 
2.2.7 1 M Sodium phosphate buffer 
To produce approximately 450 ml of 1 M sodium phosphate buffer NaH2PO4 was 
added to 300 ml of Na2HPO4 until the pH was 7.2 (approximately 150 ml). 
2.2.8 Hybridisation buffer 
To produce 50 ml of hybridisation buffer 12.5 ml of 1 M sodium phosphate 
buffer and 17.5 ml 20 % SDS was added to 20 ml dH2O and heated to 65 °C. 
2.2.9 2 X SSC 0.1 % SDS 
200 ml of 2 X SSC 0.1 % SDS solution was produced by adding 20 ml of 20 X SSC 
and 1 ml of 20 % SDS to 179 ml of dH2O. 
2.2.10 0.1 X SSC 0.1% SDS 
200 ml of 0.1 X SSC 0.1 % SDS solution was produced by adding 1 ml of 20 X SSC 
and 1 ml of 20 % SDS to 198 ml of dH2O. 
2.2.11 Northern blot crosslinking solution 
To produce 24 ml of northern blot crosslinking solution, 245 µl of 12.5 M 1-
methylimidazole was added to 9 ml of dH2O and the pH adjusted to pH 8 using 
concentrated HCl. 0.753 g of EDC was then added to the solution and the volume 
increased to 24 ml using dH2O. 
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2.2.12 Plasmolysis solution 
To produce 50 ml of plasmolysis solution, 2.5 ml of 100 mM MES pH 5.7, 50 µl of 
1 M CaCl2 and 9.95 ml dH2O were added to 37.5 ml of 1 M mannitol. The solution 
was then filter sterilised using a Corning 0.2 µm syringe filter (Corning) and a 20 
ml syringe (BD). 
2.2.13 Protoplast enzyme solution 
15 ml of protoplast enzyme solution was produced by adding 0.225 g Cellulase 
RS (Yakult), 0.114 g Macerozyme (Yakult) and 2. 98 ml dH2O to 9 ml of 1M 
mannitol. The solution was then incubated for 10 minutes at 55 °C to inactive 
proteases and then cooled to room temperature. 15 µl of CaCl2, 1.5 ml of 
10mg/ml BSA and 5.85 µl of β-mercaptoethanol were then added to the solution 
before it was then filter sterilised using a Corning 0.2 µm syringe filter (Corning) 
and a 20 ml syringe (BD). 
2.2.14 Protoplast re-suspension solution 
50 ml of protoplast re-suspension solution was produced by adding 2 ml of 100 
mM MES pH 5.7, 2 ml of 100 mM KCl, 150 µl of 1 M CaCl2 and 15.85 ml of dH2O 
to 30 ml of 1 M mannitol The solution was then filter sterilised using a Corning 
0.2 µm syringe filter (Corning) and a 20 ml syringe (BD). 
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2.3 Arabidopsis thaliana lines 
Below are listed all plant lines used during this study along with the ecotype, transgenes, mutated loci and associated reference for each 
line. The ecotypes are C24, Landsberg erecta (Ler) and Columbia (Col). 
Line Ecotype Transgene Mutation Reference 
C24 WT C24 None Wild-type (WT) 
 
Ler WT Ler  WT  
142 C24 35S:GFP construct WT (Dalmay et al. 2000a) 
142S C24 
NOS: 35S IR silencer construct and a 35S:GFp reporter 
construct 
WT (Eamens et al. 2008) 
M1 (morc6-5) C24 Same as 142S parent EMS in At1G19100 
 
M2-M8 C24 Same as 142S parent EMS in unknown locus 
 
M9 (morc6-6) C24 Same as 142S parent EMS in At1G19100 
 
M10-M24 C24 Same as 142S parent EMS in unknown locus 
 
rmd1 (nrpe1) 
 
Same as 142S parent EMS in At2G40030 (Eamens et al. 2008) 
rmd3 (nrpd1) C24 Same as 142S parent EMS in At1G63020 (Eamens et al. 2008) 
SALK_059661 (rdr2-1) C24 T-DNA insert from pROK2 T-DNA in At1G14790 (Alonso et al. 2003) 
SALK_128428 (nrpd1-2) Col T-DNA insert from pROK2 T-DNA in At1G63020 (Alonso et al. 2003) 
GABI-Kat 599B06 
(morc6-3) 
Col T-DNA insert from pAC161 T-DNA 
(Kleinboelting et al. 
2012) 
T5 Col 
35S:NOS silencer construct and a NOS: NPTII reporter 
construct 
WT (Aufsatz et al. 2002a) 
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Line Ecotype Transgene Mutation Reference 
hda6-1 Col 
Same as T5 parent and also MAS: PAT-OT used as a T-
DNA insertion 
T-DNA in hda6 (Aufsatz et al. 2002b) 
SAIL_610_G01 (mom1-2) Col T-DNA insert from either pCSA110 or pDAP101 T-DNA in mom1 (McElver et al. 2001) 
Table 2.2: Plant lines 
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2.4 Propagation and manipulation of plants 
2.4.1 Plant growth media 
Murashige and Skoog (MS) medium was used to grow plants on plates. MS media 
was made by dissolving MS powder (Phytotechnology laboratories) in the 
appropriate volume of dH2O and then adding 1 g of agar per 100 ml of media. 
This was then autoclaved before being poured into plates. If the media was to be 
used for the selection of lines containing the transgenes used in this study then 
kanamycin and DL-phosphinothricin were added to the media, at 50 µg/ml and 
10 µg/ml respectively, before the media was poured into plates. 
2.4.2 Surface sterilisation of seeds 
Arabidopsis seeds were sterilised by chlorine gas. Seeds in open microcentrifuge 
tubes, or petri dishes if sterilising more than 400 µl of seed, were placed inside a 
sealable box. 5 ml of concentrated HCl was added to 100 ml of Haychlor bleach 
(Brenntag) in a beaker and this was placed inside the box, which was then sealed. 
The seeds were left to sterilise for 3 hours. Once completed seeds could then 
either be imbibed or stored. 
2.4.3 Planting seeds 
Plants grown on soil were either individually planted using a tooth pick or were 
loosely scattered over the soil, depending on what the plants would be used for. 
For plants grown on plates the seeds were first imbibed for 4 hours at room 
temperature or overnight at 4 °C in 0.1% agar. The seeds were then spread onto 
the plates by first suspending them in the agar through vortexing and then 
pipetted onto the plates. 
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2.4.4 Growth conditions 
Both plants grown on soil and plates were first stratified for between three to 
seven days in a cold room before being placed in growth rooms or a greenhouse. 
For those placed in growth rooms they were placed in either a short day or long 
day growth room. Two long day growth rooms were used that operated a 16 
hour day from 5 am to 9 pm. One of the growth rooms (L247) had a relative 
humidity of between 36-66% and day temperature for between 18.90-21.90 °C 
with the night temperature being between 19.20-20.07 °C. Light intensity was 
between 65-132 µmol photons m-2 s-1. For the other growth room (L248) the 
relative humidity was between 40-70% and day temperature between 19.10- 
21.50 °C with the night temperature being between 18.30-20.9 °C. Light intensity 
was between 50-101 µmol photons m-2 s-1. The short day growth room operated 
on an 8 hour day from 8 am to 4 pm and had a day temperature between 19.30- 
21.80 °C and a night temperature between 18.70-21.30 °C. The relative humidity 
was between 33-64% and the light intensity was between 52-82 µmol photons 
m-2 s-1. For plants grown on plates the plates were placed horizontally in growth 
rooms, except for the root silencing experiment where the plates were near 
vertical in racks. 
2.4.5 Crossing plant lines 
Arabidopsis lines were crossed by using tweezers to remove the petals, sepals 
and stamen of flowers from the plant that would be the female parent. The 
flower was then pollinated by gently rubbing the anthers of a mature flower 
from the male parental line against the stigma. The pollinated flowers were then 
left to elongate and form mature siliques, from which the seeds were collected 
when the siliques turned yellow. 
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2.5 Plasmids 
The only plasmid used in this study was the pGEM T-easy (Promega) vector that 
contains an ampicillin resistance gene and a β-galactosidase gene (Promega 
2012). The cloning site for this vector is within the β-galactosidase gene so 
transformants that contain an insert can be selected for by blue/white screening. 
2.6 Bacteria 
2.6.1 Bacterial media and growth conditions 
Luria broth (LB) was used for both bacterial liquid and solid media. 1 l LB medium 
was produced by adding: 10 g of tryptone, 5 g yeast extract and 10 g NaCl to 800 
ml dH2O. The pH was then adjusted to 7.5 using 10 M NaOH and dH2O was added 
to get a final volume of 1 L. For solid medium 1 g of bacto-agar was added per 
100 ml of media. The medium was then autoclaved.  
If the media was to be used to select for bacteria containing the pGEM plasmid 
the antibiotic carbenicillin was added to the media to produce a concentration of 
100 µg/ml. For liquid bacterial cultures a pipette tip was used to take a sample of 
a bacterial colony or glycerol stock and this was added to 5 ml of liquid LB media. 
These cultures were then incubated overnight at 37 °C in a shaker set at 250 
rpm. When making LB plates the solid media was first melted in a 100 °C water 
bath and carbenicillin was added to the media before 25 ml of the media was 
added to each plate in a flow hood. If the plates were to be used for blue/white 
screening, 50 µl of 50 mg/ml X-Gal solution (Promega) was spread over each 
plate. When growing bacteria on plates the plates were placed in a 37 °C 
incubator overnight. All bacterial work was conducted under sterile conditions. 
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2.6.2 Bacterial strains 
All cloning was carried out using either the Library Efficient DH5α (Invitrogen) or 
One Shot MAX Efficiency DH5α (Invitrogen) competent E. coli strains. The Library 
Efficient cells were used for the cloning of probes while the One Shot cells were 
used for bisulfite sequencing, bar the 21 dpg sequencing which used the Library 
Efficient cells. 
2.6.3 Transformation 
For bacterial transformation 50 µl of competent E. coli cells were mixed with 6 µl 
of plasmid in a microcentrifuge tube and incubated on ice for 30 minutes. The 
cells were then heat shocked for 45 s in a 42 °C water bath before being placed 
back on ice for 10 minutes. 500 µl of SOB media (Invitrogen) was added and the 
culture was then incubated for 30 minutes in a 37 °C incubator. The cultures 
were then spread onto plates containing a selective antibiotic, with 100 µl of 
culture added to each plate. 
2.7 DNA purification 
2.7.1 Plasmid extraction 
The isolation of plasmids from E. coli was carried out using a QIAprep spin 
miniprep kit (QIAGEN) and was carried out according to manufacturer’s 
instructions. 
2.7.2 CTAB genomic DNA extraction 
DNA was extracted from plant protoplasts using the CTAB extraction method. 
The protoplast samples, in 15 ml centrifuge tubes, were initially snap frozen in 
liquid nitrogen and then 1 ml of 1 X CTAB extraction buffer was added to each 
tube. The tubes were then incubated at 37 °C for 3 hours in a water bath. 1 ml of 
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phenol: chloroform: isomyl alcohol 25: 24: 1 (Sigma-Aldrich) was added and the 
solution was mixed by inversion before being centrifuged at room temperature 
and 1000 rcf for 30 minutes. The upper aqueous layer was transferred into a new 
15 ml centrifuge tube and 1 ml of isopropanol was then added. The tubes were 
mixed by inversion before being centrifuged at room temperature and 1000 rcf 
for 30 minutes. The supernatant was removed and 1 ml 70% ethanol was then 
added. The tubes were centrifuged at room temperature and 1000 rcf for 20 
minutes. The ethanol was removed and the pellet allowed to air dried for 
approximately 10 minutes. The pellet was then resuspended in 50 µl of dH2O. 
The DNA samples were then treated with 1 µl of 10 mg/ml RNase A (QIAGEN) for 
half an hour to remove RNA in the sample. 
2.7.3 Genomic DNA extraction using kits 
The QIAGEN DNeasy 96 plant kit (QIAGEN) was used to extract DNA for CAPS and 
SSLP mapping and for all other DNA samples the DNeasy plant maxi kit (QIAGEN) 
was used. Both kits were used according to manufacturer’s instructions.  
2.7.4 Precipitation of DNA by sodium acetate 
For precipitation of DNA using NaAc, 1/ 10 of the volume of 3 M NaAc pH 5.2 and 
2 volumes of 100 % ethanol were added to a DNA solution in a microcentrifuge 
tube and left to precipitate overnight. The DNA was then pelleted by 
centrifugation at room temperature and 16100 x g for 20 minutes and the 
supernatant removed. 1 ml of 70% ethanol was then added and the tube was 
centrifuged at room temperature and 16100 x g for 10 minutes. The ethanol was 
then removed and the pellet allowed to air dry for 10 minutes before being re-
suspended in the required volume of dH2O. 
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2.7.5 Purification of DNA by phenol chloroform 
For purification of DNA using phenol chloroform, initially 500 µl of phenol: 
chloroform: isomyl alcohol 25: 24: 1 (Sigma-Aldrich) were added to the DNA 
solution in a microcentrifuge tube and were then mixed by inversion before 
being centrifuged at room temperature and 16100 x g for 10 minutes. The upper 
aqueous layer was transferred into a new microcentrifuge tube and 500 µl of 
chloroform: isomyl alcohol 24: 1 (Sigma-Aldrich) was added and the solution was 
then mixed by inversion before being centrifuged at room temperature and 
16100 x g for 10 minutes. The upper aqueous layer was transferred into a new 
microcentrifuge tube and 500 µl of isopropanol was then added. The tubes were 
mixed by inversion before being centrifuged at room temperature and 16100 x g 
for 20 minutes. The supernatant was removed and 1 ml 70% ethanol was then 
added. The tubes were centrifuged at room temperature and 16100 x g for 20 
minutes. The ethanol was removed and the pellet was air dried for 
approximately 10 minutes before being re-suspended in the required volume of 
dH2O. 
2.7.6 Extraction of DNA from a electrophoresis gel 
DNA bands were extracted and purified from gels using a QIAQuick gel extraction 
kit (QIAGEN) according to the manufacturer’s instructions. 
2.8 RNA purification 
2.8.1 RNA extraction 
Approximately one gram of plant leaf tissue was snap frozen in liquid nitrogen 
and ground into a power using a pestle and mortar before being transferred into 
a 15 ml centrifuge tube. 5 ml of TRIzol (Invitrogen) was then added to the tubes 
and the tubes were inverted before being incubated at room temperature for 10 
minutes. 2 ml of chloroform: isomyl alcohol 24: 1 (Sigma-Aldrich) was added to 
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each tube and was mixed by inversion before being incubated at room 
temperature for 10 minutes. The tubes were then centrifuged at 4 °C and 1000 
rcf for 30 minutes and the upper aqueous layer was transferred to a new 15 ml 
centrifuge tube. 5 ml of isopropanol was then added to each tube and then 
mixed by inversion, before being incubated for 10 minutes at room temperature. 
The tubes were then centrifuged at 4 °C and 1000 rcf for 30 minutes. The 
supernatant was then removed and the pellet washed with 2 ml of 70% ethanol 
before being centrifuged at 4°C and 1000 rcf for 20 minutes. The ethanol was 
then removed and the pellet air dried for 10 minutes. The RNA pellet was then 
resuspend in 200 µl of dH2O. 
2.8.2 Enrichment for small RNAs 
RNA samples were enriched for small RNAs by PEG precipitation described 
previously by Lu (Lu et al. 2007). 50 % PEG and 5 M NaCl were added to the RNA 
sample to produce a final concentration of 5 % and 0.5 M respectively and was 
incubated on ice for 30 minutes. The samples were then centrifuged at 4 °C and 
16100 x g for 10 minutes and the supernatant transferred to a new 
microcentrifuge tube. 2.5 volumes of 100 % ethanol was added to the sample 
and this was incubated at -20 °C overnight. The samples were then centrifuged at 
4 °C and 16100 x g for 30 minutes and the supernatant removed. The pellets 
were then washed with 80 % ethanol and then allowed to air dry before being 
re-suspended in either dH20 or 50 % formamide, if the RNA was to be used for 
northern blotting. 
2.9 Quantification of nucleic acids 
2.9.1 Non-denaturing agarose gel electrophoresis 
Gel electrophoresis using agarose gels was used to visually assess the quantity 
and purity of DNA and RNA samples as well as for gel extraction purification of 
DNA. A 100 ml agarose gel was produced by the addition of 1g agarose and 10 µl 
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of 10 mg/ml ethidium bromide to 100 ml 0.5 X TBE buffer and these volumes 
could be scaled up of down depending on the size of the gel required. For gels 
that required separation of nucleic acids of similar sizes a higher percentage of 
agarose was used to a maximum of 3%. If the gel was to be used for extraction 
purification 10 µl of 10000 X SYBR safe (Invitrogen) was used instead of ethidium 
bromide. Before being run on the gel DNA samples were mixed with 6 X loading 
dye in a 5 DNA: 1 loading dye ratio. The 1 Kb plus DNA ladder (Invitrogen) was 
used as a molecular size marker. The gels were run in 0.5 X TBE buffer at 
between 50 V-150 V until a sufficient level of separation was achieved. The gels 
were then imaged on a UV light box for ethidium bromide or a blue light box 
(Invitrogen) for SYBR safe using the GENESnap camera and software (Syngene). 
2.9.2 Denaturing acrylamide gel electrophoresis 
Gel electrophoresis using a denaturing acrylamide gel was used for northern 
blotting to detect small RNAs. A single 24 % polyacrylamide gel was produced by 
adding 25.2 g urea, 6 ml 10 X MOPS and 1 ml dH2O to 34 ml of 30 % acrylamide 
(National Diagnostics) and then heating this at 65 °C until it had melted. The gel 
mould apparatus was set up and the gel was left to cool to near room 
temperature. 30 µl of TEMED was then added and the gel was then mixed by 
inversion. 120 µl of 25 % APS was then added and again the gel was mixed by 
inversion. The gel was then poured and allowed to polymerize for 1 hour. Once 
polymerized the gel was placed in a gel tank filled with 1 X MOPS solution and 
the gel’s wells were washed with 1 X MOPS using a 5 ml syringe (BD) and 25 G 
0.5 x 1.6 mm needle (BD). The gel was then pre-run at 150 V for 1 hour and the 
RNA samples to be run on the gel were prepared by adding 2 µl of 6 X loading 
dye to 24 µl of RNA in 50 % formamide and heating to 80 °C for 3 minutes before 
being stored on ice. The wells were then washed again with 1 X MOPS and the 
RNA samples were loaded. For the first 30 minutes the gel was run at 250 V and 
then at 70 V overnight. Once the gel had been run it was removed from the gel 
apparatus and stained in 500 ml 1 X MOPS and 30 µl ethidium bromide for 10 
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minutes, before being imaged on a UV light box using the GENESnap camera and 
software (Syngene). 
2.9.3 Spectrophotometer analysis 
Nucleic acid quantification and purity was also assessed using a Nanodrop 
ND8000 8 sample spectrophotometer (Thermo scientific). The analysis was 
conducted as per the Nanodrop manufacturer’s instructions and the 
concentrations and Absorbance (Ab) 260/230 and Ab 260/280 ratios, which are a 
measure of nucleic acid purity, were recorded. 
2.10 PCR 
2.10.1 Primers 
Primers were produced by the Eurofins MWG and Sigm-Aldrich custom primer 
ordering services. The primers used in this study are listed in the tables below 
and the sequence, annealing temperature and product size is given for each 
primer. The annealing temperature was obtained by primer optimisation using 
the primer melting temperature (Tm) given by the primer manufacturer. The 
primers are arranged in terms of their use and this includes: mapping primers, 
sequencing primers, oligonucleotide probes and probe production primers. 
Name Primer Sequence Target 
AtREP2 
GCGGGACGGGTTTGGCA
GGACGTTACTTAAT 
Oligonucloetide probe for the AtREP2 tranposon 
miR167 
TAGATCATGCTGGCAGCT
TCA 
Oligonucloetide probe for micrc RNA miR167 that 
is used as a loading control 
tRNAmet 
TCGAACTCTCGACCTCAG
GAT 
Oligonucloetide probe for RNAmet that is used as a 
loading control 
Table 2.3: Oligonucleotide probes 
Primers used as oligonucleotide probes for northern blotting. 
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Name Primer Sequence Annealling Temperature (°C) Product size (bp) Target 
PVV45' GTTTGAAAGTGTAGATGTAAC 56 1000 PVV4 Chromosome 1 CAPS marker 
PVV4 3' GGTTGTGTTTTGCTAGCATC 56 1000 PVV4 Chromosome 1 CAPS marker 
21M1F TTACTTTTTGCCTCTTGTCATTG 56 200 NF21M12 Chromosome 1 SSLP marker 
21M1R GGCTTTCTCGAAATCTGTCC 56 200 NF21M12 Chromosome 1 SSLP marker  
M59F GTGCATGATATTGATGTACGC 56 800 M59 Chromosome 1 CAPS marker  
M59R GAATGACATGAACACTTACACC 56 800 M59 Chromosome 1 CAPS marker  
CAT3 5' CGGTGGTGCTCCAGTCTCCAA 56 900 CAT3 Chromosome 1 CAPS marker 
CAT3 3' CAGATGCAATGGCATCGTGGA 56 900 CAT3 Chromosome 1 CAPS marker 
GAPB 5' GGCACTATGTTCAGTGCTG 55 1400 GAPB Chromosome 1 CAPS marker 
GAPB 3' TCTGATCAGTTGCAGCTATG 55 1400 GAPB Chromosome 1 CAPS marker 
G4026 5' GGGGTCACTTACATTACTAGC 51 800 G4026 Chromosome 1 CAPS marker 
G4026 3' GTACGGTTCTTCTTCCCTTA 51 800 G4026 Chromosome 1 CAPS marker 
ADH 5' GCGTGACCATCAAGACTAAT 61 1200 ADH Chromosome 1 CAPS marker 
ADH 3' AAAAATGGCAACACTTTGAC 61 1200 ADH Chromosome 1 CAPS marker 
GPA1 5' GGGATTTGATGAAGGAGAAC 61 1600 GPA1 Chromosome 2 CAPS marker  
GPA1 3' ATTCCTTGGTCTCCATCATC 61 1600 GPA1 Chromosome 2 CAPS marker  
M249 5' TGGTAACATGTTGGCTCTATAATTG 59 300 M429 Chromosome 2 CAPS marker 
M249 3' GGCAGTTATTAGAATGTCTGCATG 59 300 M429 Chromosome 2 CAPS marker 
17D8LE 5' CTCCTTTGTCATCTCCCGAATC 59 2000 17D8LE Chromosome 3 CAPS marker 
17D8LE 3' CCAACAACATGCATGATAGTTCA 59 2000 17D8LE Chromosome 3 CAPS marker 
GL1 5' ATATTGAGTACTGCCTTTAG 52 550 GL1 Chromosome 3 CAPS marker 
GL1 3' CCATGATCCGAAGAGACTAT 52 550 GL1 Chromosome 3 CAPS marker 
F3H 5' TACTCCTCCGTCACTTTCAC 55 900 F3H Chromosome 3 CAPS marker 
F3H 3' ATTTTCTCCACAGACCACAAG 55 900 F3H Chromosome 3 CAPS marker 
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Name Primer Sequence Annealling Temperature (°C) Product size (bp) Target 
GA1 5' CCGGAGAATCGTACGGTAC 59 1200 GA1 Chromosome 4 CAPS marker 
GA1 3' AAGCTTCGAACTCAAGGTTC 59 1200 GA1 Chromosome 4 CAPS marker 
AG 5' CAAACACCATTTAATCTTGACA 59 1300 AG Chromosome 4 CAPS marker 
AG 3' CAACAGGTTTCTTCTTCTTCTC 59 1300 AG Chromosome 4 CAPS marker 
CAT2 5' GACCAGTAAGAGATCCAGATACTGCG 54 900 CAT2 Chromosome 4 CAPS marker 
CAT2 3' CACAGTCATGCGACTCAAGACTTG 54 900 CAT2 Chromosome 4 CAPS marker 
HAE1 5' GAGTCGAGGGGGATGTATTCG 54 2000 HAE1 Chromosome 4 CAPS marker 
HAE1 3' GTGGTTTGCCATTCTTAACTTC 54 2000 HAE1 Chromosome 4 CAPS marker 
NIT4 5' CAACTCCACATCCGTCGGCG 65 3000 NIT4 Chromosome 5 CAPS marker 
NIT4 3' CGTTTCTTGTTGCATGGACATGAGAG 65 3000 NIT4 Chromosome 5 CAPS marker 
DFR 5' AGATCCTGAGGTGAGTTTTTC 55 1100 DFR Chromosome 5 CAPS marker 
DFR 3' TGTTACATGGCTTCATACCA 55 1100 DFR Chromosome 5 CAPS marker 
10A10 5' GCCTTATGGATTTTCTGGAGAAAG 61 2200 10A10 Chromosome 5 CAPS marker 
10A10 3' GGTCACAGGATCAAGATGTGG 61 2200 10A10 Chromosome 5 CAPS marker 
Table 2.4: Mapping primers 
Primers used for CAPS and SSLP mapping. The product sizes are estimated from an agarose gel 
Name Primer Sequence Annealling Temperature (°C) Product size (bp) Target 
191001F AGCTTTGCATGAGCCTGATT 52 955 Sequencing the At1G19100 candidate gene 
191001R TTGCAGTAATGAACAAGCAGGT 52 955 Sequencing the At1G19100 candidate gene 
191002F TGCTCTGCATCTTCATCACC 52 984 Sequencing the At1G19100 candidate gene 
191002R AAAATGGGTTGCATGGAGAA 52 984 Sequencing the At1G19100 candidate gene 
191003F GCCCCTACATGTTGGTCAAT 52 1121 Sequencing the At1G19100 candidate gene 
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Name Primer Sequence Annealling Temperature (°C) Product size (bp) Target 
191003R GCCAGGTTCAGTGTAGAGAGG 52 1121 Sequencing the At1G19100 candidate gene 
191004F TCATTTGCTTTGCTCTTTTCA 51 833 Sequencing the At1G19100 candidate gene 
191004R TGGACCAATCCAGGTCAGA 51 833 Sequencing the At1G19100 candidate gene 
191005F TTTCCCCGAACTCTCTCTGA 52 1149 Sequencing the At1G19100 candidate gene 
191005R TTCCGAGACAGCCCATAAAC 52 1149 Sequencing the At1G19100 candidate gene 
M13 For GTAAAACGACGGCCAGT 55 300 For primer for pGEM sequencing 
M13 Rev GGAAACAGCTATGACCATG 55 300 Rev primer for pGEM sequencing 
SR451F TCGTTGCATCTAATGAGGAGA 52 1114 Sequencing the SR45 candidate gene 
SR451R TCTCCAATCCGTAGGCGTAG 52 1114 Sequencing the SR45 candidate gene 
SR452F GGGGTGAGATGGAACTTGAA 51 1153 Sequencing the SR45 candidate gene 
SR452R ATGTCGAAATTGCGATGGAT 51 1153 Sequencing the SR45 candidate gene 
SR453F GGAAAGAGACATACACCATCCA 52 1139 Sequencing the SR45 candidate gene 
SR453R CCTGCCACGTATCATCTTCG 52 1139 Sequencing the SR45 candidate gene 
Table 2.5: Sequencing primers 
Primers used for sequencing of candidate genes or inserts in the pGEM plasmid. 
Name Primer Sequence 
Annealling 
Temperature 
(°C) 
Product size 
(bp) 
Target 
35SsiRNAF GTCTCAGAAGACCAAAGGGCTA 57 328 
Amplifies part of the 35S promoter targeted by the 35S IR 
transgene 
35SsiRNAR GGTCTTGCGAAGGATAGTGG 57 328 
Amplifies part of the 35S promoter targeted by the 35S IR 
transgene 
5SF GGATGCGATCATACCAG 45 628 Amplifies 5S rDNA probe 
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Name Primer Sequence 
Annealling 
Temperature 
(°C) 
Product size 
(bp) 
Target 
5SR GAGGGATGCAMCACSAG 45 628 Amplifies 5S rDNA probe 
AtACTIN 5' CATGGTTGGGATGAACCAGAAGGA 61 591 Amplifies the Actin2 gene 
AtACTIN 3' GTCTCTTACAATTTCCCGCTCTGC 61 591 Amplifies the Actin2 gene 
AtMU1F GTGGATATACCAAAAACACAA 50 565 Amplifies the AtMu1 transposon 
AtMU1R CTTAGCCTTCTTTTCAATCTCA 50 565 Amplifies the AtMu1 transposon 
AtSN1F 
ACCAACGTGCTGTTGGCCCAGTGGT
AAATC 
65 170 Amplifies the AtSN1 retrotransposon 
AtSN1R 
TTTTTTTTTTTGAATATCTGGAAGTTC
AAG 
65 170 Amplifies the AtSN1 retrotransposon 
BS14 CACACTTRTCTACTCCAAAAATATC 50 492 
Amplifies the 35S promoter of the 35S:GFP transgene for 
bisulfite sequencing 
BS22 GAGGATAATGATAGGAGAAGTG 50 492 
Amplifies the 35S promoter of the 35S:GFP transgene for 
bisulfite sequencing 
GFP1 CAAGGAGATATAACAATGAAG 50 813 Amplifies the GFP transgene 
GFP8 CATGACGAACTCTAAGAGCTA 50 813 Amplifies the GFP transgene 
MEA-ISRF 
AAACCTTTCGTAAGCTACAGCCACTT
TGTT 
64 1091 Amplifies the MEA-ISR intergenic repeat element 
MEA-ISRR 
TCGGATTGGTTCTTCCTACCTCTTTAC
CTT 
64 1091 Amplifies the MEA-ISR intergenic repeat element 
SoloLTRF AATGCATTACAAAAACCTTCTGA 51 446 Amplifies the Solo LTR long terminal repeat 
SoloLTRR GGATTCACGATTAGAGAACGTAGA 51 446 Amplifies the Solo LTR long terminal repeat 
Table 2.6: Probe primers 
Primers used to produce probes for Southern and northern blotting
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2.10.2 PCR machine 
All PCRs were carried out using a DNA engine DYAD (MJ Research) PCR machine. 
2.10.3 Taq PCR 
Taq based PCR was used for amplification of sequences which would not be used 
for sequencing. PCR reactions that used the Taq thermo polymerase (New 
England Biolabs) to amplify DNA sequences were set up using the following 
volumes for a 20 µl reaction: 
 X µl dH2O (depending on DNA volume used) 
 2 µl 10 X Taq buffer 
 1 µl 10 µM Forward primer 
 1 µl 10 µM Reverse primer 
 0.4 µl 10mM dNTPs 
 0.2 µl Taq (1 Unit) 
 X µl DNA 
This reaction could be scaled up in order to produce more PCR product. The 
dNTPs consist of 10 mM ATP, 10 mM TTP, 10 mM CTP and 10 mM GTP 
(Fermentas). The basic PCR program used for Taq PCRs was: 
1. 94°C for 2 minute 
2. 94 °C for 30 s 
3. X °C for 30 s  
4. 72 °C for X minutes  
5. Repeats steps 2 to 4 34 times 
6. 72 °C for 10 minutes 
7. 4 °C hold 
The annealing temperature (3) and elongation time (4) varied between PCRs. The 
annealing temperature depends on the primers and the elongation time depends 
on the size of the insert; Taq amplifies 1 Kb of DNA a minute. 
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2.10.4 Colony PCR 
Colony PCRs were used for screening bacterial colonies for plasmid inserts and 
used similar reaction volumes and conditions as normal Taq PCR. The differences 
were that instead of DNA a sample of a colony was added to the PCR reaction 
and that the initial denaturing step was extended to 4 minutes in order to lyse 
the bacteria to allow access to the DNA. 
2.10.5 Pfu PCR 
PfuUltra IIF Fusion (Strategene) was to amplify DNA sequences that would be 
sequenced. For a 20 µl reaction the following volumes were used: 
 X µl dH2O (depending on DNA volume used) 
 2 µl 10 X PfuUltra II Fusion buffer 
 1 µl 10 µM Forward primer 
 1 µl 10 µM Reverse primer 
 0.4 µl 10 mM dNTPs 
 0.2 µl Pfu 
 X µl DNA 
The reaction volumes could be scaled up in order to produce more PCR product. 
The reaction conditions were similar to that of a normal Taq PCR except that the 
amplifaction time is reduced as Taq amplifies 1 kb a minute whereas PfuUltra 
amplifies 4 Kb a minute 
2.10.6 Bisulfite PCR 
For bisulfite sequencing Epimark Hot Start Taq polymerase (New England 
Biolabs) was used as it is more effective than Taq at amplifying bisulfite treated 
DNA. The reaction volumes for a 20 µl PCR reaction are as follows: 
 X µl dH2O (depending on DNA volume used) 
 4 µl 5X Epimark buffer 
 1 µl 10 µM Forward primer 
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 1 µl 10 µM Reverse primer 
 0.4 µl 10 mM dNTPs 
 0.2 µl Epimark Hot Start Taq 
 X µl Bisulfite treated DNA 
The reaction conditions were similar to that of a normal Taq PCR except that 40 
amplification cycles were used and a hot start was performed. Hot start means 
that the PCR reactions were only placed in the PCR machine once it had reached 
the denaturing temperature (94 °C). 
2.10.7 Reverse transcriptase PCR 
For the detection of RNA levels reverse transcriptase (RT) PCR was used. 
Approximately 0.5 µg of RNA was used for each reaction and a no RT control was 
also carried out for each reaction. dH2O was added to bring the volume of the 
RNA up to 10 µl and the RNA sample was then incubated at 75 °C for 10 minutes 
and 4 °C for 5 minutes. The following were then added to the reaction: 
 4 µl 5 x Superscript II  RT buffer (invitrogen) 
 2 µl 10 mM dNTP (Fermentas) 
 1 µl Oligo dT (Invitrogen) 
 1 µl Superscript II Reverse Transcriptase(Invitrogen) 
For the no Superscript II RT was added for the non RT control. The samples were 
then incubated for 1 hour at 37 °C and then the RT was inactivated by heating at 
95 °C for 5 minutes. A normal Taq PCR using primers specific to the RNA 
transcript was then performed on the resulting cDNA to determine the relative 
levels of the transcript. 
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2.11 Manipulation of nucleic acids 
2.11.1 Plasmid ligation 
The pGEM T-easy (Promega) vector and ligation kit was used for all plasmid 
ligations and was used as per manufacturer’s instruction. 
2.11.2 Restriction enzyme digestion 
DNA was digested using restriction enzymes (New England Biolabs and Promega) 
overnight at 37 °C. Below are listed the volumes required for a 20 µl restriction 
enzyme reaction but this can be scaled up if a larger reaction is required: 
 X µl DNA 
 2 µl Manufacturer’s Buffer 
 0.1 µl 10 mg/ml BSA 
 0.2 µl Restriction enzyme 
 X µl dH2O (depending on DNA volume used) 
2.11.3 Bisulfite conversion of DNA 
Bisulfite conversion of DNA was achieved using an EpiTect Bisulfite Kit (QIAGEN) 
that was used as per the manufacturer’s instructions. 
2.11.4 Global methylation analysis 
Global DNA methylation was analysed using an Epigentek Methyl Flash kit 
(Epigentek) as per the manufacturer’s instructions. 
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2.12 Blotting and detection of nucleic acids  
2.12.1 Southern blotting 
DNA samples that were to be analysed by Southern blotting were first digested 
using restriction enzymes and then run on an agarose gel. The DNA on the gel 
was first denatured in Southern denaturing solution for 20 minutes on a shaker 
set at 80 rpm. The denaturing solution was then replaced with Southern 
neutralisation solution and returned to the shaker for another 15 minutes. The 
neutralisation solution was replaced by fresh neutralisation solution and left on 
the shaker for a further 15 minutes. After this was completed the DNA was 
transferred overnight to a Hybond-NX (GE healthcare) or Hybond N+ membrane 
(GE healthcare) by capillary action of 20X SSC solution. The DNA was then 
crosslinked to the membrane by UV radiation in a UV Stratalinker 1800 
(Stratagene). 
2.12.2 Northern blotting (mRNA) 
RNA samples that were to be analysed for levels of mRNA were first mixed with 
glyoxal loading dye (Ambion) in a ratio of 5 µl of DNA to 1 µl of glyoxal. This RNA 
was then run on an agarose gel before being blotted to a Hybond N+ membrane 
(GE healthcare) by capillary action of 20X SSC solution. The DNA was then 
crosslinked to the membrane by UV radiation in a UV Stratalinker 1800 
(Stratagene). 
2.12.3 Northern blotting (siRNA) 
For the detection of small RNAs the RNA samples were run on polyacrylamide 
gel. The gel was then placed into the electroblotting apparatus with Hybond NX 
membrane (GE Healthcare) and placed in the blotting tank filled with 1 X MOPS. 
The gel was then electroblotted for two and a half hours at 5000 mA. The 
blotting apparatus was then disassembled and the RNA was chemically 
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crosslinked to the membrane by placing a piece of 3 mm blotting paper 
(Whatman) soaked in northern blot crosslinking solution underneath the 
membrane and wrapping this in cling film. This was then incubated at 60 °C for 2 
hours and then the membrane was washed with dH2O and allowed to dry. 
2.12.4 Probes  
Below are listed the probes used in this project along with whether they are an 
oligonucleotide or a DNA/RNA fragment. 
Probe Type of probe 
5S rDNA DNA fragment 
AtMu1 DNA fragment 
MEA-ISR DNA fragment 
Solo LTR DNA fragment/RNA fragment 
GFP DNA fragment 
35S RNA fragment 
At REP2 Oligo 
miR167 Oligo 
tRNAmet Oligo 
Table 2.7: Probes used in this study 
 
2.12.5 Radio-labelling probes by random primer based 
amplification 
For DNA probes a Prime-It II Random Primer Labelling kit (Agilent) was used to 
label the probe with the radioactive α P32-CTP nucleotide (Perkin Elmer). The kit 
was used according to manufacturer’s instructions. The α P32-CTP had an activity 
of 370 MBq/ml. 
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2.12.6 Radio-labelling probes by end labelling  
Oligonucleotide probes were end labelled with γ P32-ATP (Perkin Elmer) using T4 
polynucleotide kinase (New England Biolabs). The γ P32-ATP had an activity of 
370 MBq/ml. To probe a single blot a 16 µl reaction was set up consisting of:  
 10 µl dH2O  
 2 µl 10 X T4 buffer 
 0.4 µl 10 µM oligonucleotide probe 
 5 µl γ P32 ATP 
 1 µl T4 polynucleotide kinase 
The reaction is then incubated at 37 °C for 1 hour.  
2.12.7 Radio-labelling probes by in vitro transcription 
RNA probes were produced by in vitro transcription using the MAXIscripts kit 
(Ambion) and were used to detect siRNAs. The kit was used according to 
manufacturer’s instructions and used the α P32 labelled UTP nucleotide (Perkin 
Elmer), which has an activity of 370 MBq/ml/ 
2.11.8 Hybridisation of blots with radio-labelled probe 
Blots were placed in a Techne hybridisation bottle (Techne) with 20 ml of 
hybridisation buffer or Perfecthyb Plus Hybridisation Buffer (Sigma-Aldrich). The 
bottles were then placed in a Techne Hybridiser HB-1D hybridisation oven 
(Techne) set at 62 °C for Southern blots or 42 °C for northern blots for one hour 
to pre-hybridise. The P32-labelled probe was then added to the bottle and the 
blot was left to hybridise overnight.  
2.12.9 Washing blots to remove unbound probe 
After hybridisation was complete the hybridisation buffer was then removed and 
replaced with 20 ml of either 2 X SSC 0.1 % SDS, for Southern blots, or 0.1 X SSC 
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0.1 % SDS, for northern blots, and returned to the hybridisation oven for a 
further 20 minutes. The solutions were then removed and replaced twice, except 
for Southern blots, the second wash was with 0.1 X SSC 0.1 % SDS. The 
radioactivity of the final wash was checked with a Geiger counter and if still high 
the blots were washed again.  
2.12.10 Imaging blots using a phosphor screen 
Blots that had been probed were wrapped in cling film and placed on a Kodak 
phosphor screen (GE Healthcare) and left to develop at room temperature for 
between 2 hours to 2 days, depending on the strength of the signal of the bound 
probe. The Quantity One (Bio rad) software and FX Molecular imager (Bio rad) 
machine were used to image the phosphor screen. 
2.12.11 Imaging blots using a autoradiography film 
Blots that had been probed were wrapped in cling film and placed with a 
Hyperfilm autoradiography MP 5 × 7" film (GE Healthcare) in an exposure 
cassette. The cassette was then placed in a -81 °C freezer to develop for 1 day to 
1 month, depending on the strength of the signal of the bounds probe. The film 
was then developed using a Compact X4 xograph (Xograph Imaging Systems). 
2.12.12 Stripping blots of radio-labelled probes 
Blots were stripped of bound probe by incubation at 80 °C in 0.1 % SDS for 20 
minutes in a hybridisation oven (Techne). The SDS solution was then removed 
and the blot checked with a Geiger counter and if there was still a detectable 
signal the blot was washed again in 0.1 % SDS. Once the probe had been 
removed the blot was placed on a phosphor screen (GE Healthcare) or in an 
exposure cassette with autoradiography film (GE Healthcare) and the screen or 
film was then developed to check that the probe had been removed totally. 
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2.13 Sequencing 
2.13.1 Sanger sequencing 
Sanger sequencing of plasmids and PCR products was carried out by the 
University of York Biology Department and Eurofins MWG sequencing services.  
2.13.2 Next generation sequencing 
Next generation sequencing was carried out by the Exeter University sequencing 
service. 
2.14 Imaging 
2.14.1 UV lamp 
Images of plants under UV light were taken by Phil Roberts from University of 
York Biology Graphics department using a DSLR camera with a UV filter. The UV 
lamp used was a Blak Ray (UVP). 
2.14.2 Fluorescence microscopy 
Images of plants were taken under a Leica MZFLIII UV fluorescence microscope 
(Leica) using a CoolSNAP camera and imaging software (RS Photometrics). The 
GFP1 filter set up was used on this microscope, which consists of a: 395-455 nm 
excitation filter, 470 nm dichroic mirror and 480 nm barrier filter. 
2.14.3 Confocal microscopy  
Images of whole plant leaves and leaf cross-sections were taken using a 510 Zeiss 
confocal microscope. Whole leaves were mounted in 10 % glycerol between two 
1.5 22 x 22 mm cover slips (SLS) using nail varnish (Boots) to allow for both sides 
of the leaf to be imaged and was then placed on 1.0-1.2 mm thick 76 x 26 mm 
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glass slide (Fisherbrand) for imaging. Cross-sections were mounted in 10 % 
glycerol between a 1 .0-1.2 mm thick 76 x 26 mm glass slide (Fisherbrand) and a 
1.5 22 x 22 mm cover slip (SLS). All images were taken using a 20 X 0.5 objective 
and used an Argon laser emitting at 488 nm and a Helium-Neon laser that emits 
at 543 nm, which excite GFP and propidium iodide/chlorophyll respectively. The 
Argon laser was used at 16 % capacity while the Helium-Neon laser was used at 
40 % capacity. For the whole leaf samples two channels were set up for GFP and 
propidium iodide using the following filter set: Main dichromatic beam splitter: 
HFT 488/453 nm, Dichromatic beam splitter 1: Mirror; and Dichromatic beam 
splitter 2: NFT 545 nm. A 505-530 nm band pass filter was also used for the 
propidium iodide channel. The only parameter altered between images was the 
master gain in order to account for differences in fluorescence levels between 
the samples. For the sectioning work a third channel was used, ChD, that detects 
the laser light that passed through the sample and so provides a bright field view 
of the object being imaged. 
2.14.4 Propidium iodide staining 
Leaves were stained with propidium iodide before being imaged under the 
confocal microscope. The leaves were placed in a microcentrifuge tube with 200 
µl of 20 mg/ml propidium iodide (Sigma-Aldrich) and left on a roller for half an 
hour to two hours, depending on the size of the leaves. The leaves were then 
removed from the propidium iodide and washed in d H2O for 10 minutes before 
being mounted in 10 % glycerol.  
2.14.5 Leaf sectioning 
Leaves were sectioned using a vibratome. The leaves were first set in blocks of 
10 % porcine gelatine (Sigma-Aldrich) these were then fixed to the sectioning 
platform of a Leica VT1000S vibratome (Leica) so that the leaf tip was vertical 
and the abaxial side of the leaf was facing the vibratome’s blade. The blade 
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vibration frequency was set at 90 Hz and the movement of the blade was set at 
0.5 mm/s and the thickness of each section was set to 200 µm. The end point of 
each cut by the vibratome was set so that it did not go all the way through the 
gelatin block allowing for the sections to be kept in sequence. Once sectioning 
was completed the gelatin spine left by the vibratome could be remove using a 
scalpel and the desired section selected using tweezers and mounted on a slide 
for confocal microscopy. 
2.15 Protoplasts 
2.15.1 Production of mesophyll protoplasts 
For the production of mesophyll protoplasts 30 adult rosette leaves between 1-2 
cm in length were collected from 5 week old plants and placed in plasmolysis 
solution. A razor blade was used to cut 1 mm wide strips along the centrolateral 
leaf axis. The plasmolysis buffer was removed and the leaf strips were washed 
with fresh plasmolysis buffer. The buffer was again removed and replaced with 
protoplast enzyme solution and this was vacuum infiltrated into the leaf strips 
for 1 to 2 minutes and these were then incubated at 28 °C for two hours. The 
strips were then swirled gently to release the protoplasts and filtered through a 
40 µm nylon mesh. The flow through was centrifuged at room temperature and 
100 rcf for 5 minutes. The supernatant was then removed and the protoplasts re-
suspended in protoplast re-suspension solution and kept at room temperature in 
the dark. 
2.15.2 Cell sorting 
Cell sorting was carried out by the University of York Imaging and Cytometry 
laboratory. 
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2.16 Bioinformatics 
2.16.1 Sequence analysis 
Wild-type DNA and protein sequences from the Arabidopsis Columbia ecotype 
were obtained from The Arabidopsis Information Resource (TAIR). For sequences 
that were produced by Sanger sequencing, the Sequence Scanner (ABI) and 
Lasergene EditSeq (DNAStar) programs were used to view and manipulate 
sequences. The NCBI BLAST (NCBI) and TAIR sequence viewer (TAIR) online tools 
were used to identify sequences and align them with known sequences. Clustal 
W (EMBL EBI) and Jalview were used to produce alignments of multiple 
sequences for presentation as figures and analysis of sequence homology 
(Waterhouse et al. 2009). For the analysis of bisulfite sequencing, the sequences 
were first aligned using Clustal W (EMBL EBI) and then cytosine methylation was 
determined using the CyMate online tool (Hetzl et al. 2007). Analysis of next 
generation sequencing was carried out by Zhesi He using the SHOREmap 
software (Schneeberger et al. 2009). The location in the Arabidopsis genome of 
single nucleotide polymorphisms (SNPs) identified from the SHOREmap analysis 
was found using the TAIR sequence viewer online tool (TAIR). TAIR was then used 
to determine whether the SNP was within a gene or in a intergenic region and 
whether the SNP resulted in a change in protein sequence. 
2.16.2 Identification of protein orthologs 
Orthologs of Arabidopsis proteins were identified using the Arabidopsis protein 
sequence in a BLAST (NCBI) search of protein sequences from specific Plantae, 
Metazoan and Bacteria species. Sequences with a 40 % homology to the 
Arabidopsis sequence were selected. 
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2.16.3 Domain identification and 3D domain structure 
Protein domains were identified by searching for domains using the Pfam and 
SMART protein databases (Letunic et al. 2012, Punta et al. 2012). The 3D 
structure of domains were produced using the Phyre 2 3D structure prediction 
online tool (Kelley and Sternberg 2009). 
2.16.3 Production of phylogenetic trees 
Phylogenetic trees were produced from an alignment of protein sequences by 
Clustal W. The program used to produce the tree and bootstrap the tree was 
Clustal X2 and Dendroscope was used to view the tree and edit it for a figure 
(Huson et al. 2007, Larkin et al. 2007). 
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3.1 Introduction 
3.1.1 Dual transgene silencing system 
The forward genetic screen carried out in this work used a dual transgene system 
to enable the identification of mutants in the RdDM pathway. The system 
consists of a 35S promoter-driven GFP gene (35Sp:GFP) and a nopaline synthase 
(NOS) promoter driven inverted repeat of part of the 35S promoter (NOSp:35S 
IR). The full sequence of both transgenes is given in Appendix 1.1 (page 346). The 
35S promoter provides near ubiquitous expression of GFP in the majority of plant 
tissue (Fang et al. 1989, Slater et al. 2003).The GFP protein in this case is targeted 
to the endoplasmic reticulum (ER) (Haseloff et al. 1997). The NOS promoter is 
expected to give constitutive expression of the 35S IR transgene, although 
expression may be highest in roots (An et al. 1988, Aufsatz et al. 2004). The 
inverted repeats of the 35S promoter are separated by an intron of the Petunia 
Chalcone Synthase A (CHSa) gene, which stabilises the inverted repeat during 
transcription (Kerschen et al. 2004, Eamens et al. 2008). The wild-type (WT) line 
that contains both transgenes is referred to as 142S throughout this work. 142S 
was produced from a WT transgenic plant line in the C24 ecotype. This line, GFP 
142, contains the 35Sp:GFP transgene (Dalmay et al. 2000a). GFP 142 is referred 
to as 142 hereafter. The NOSp:35S IR transgene was introduced into 142 to 
produce the 142S line (Eamens et al. 2008). Both transgenes have been shown to 
be single loci insertions through 3:1 Mendelian segregation.  
In the dual transgene system the 35Sp:GFP transgene acts as a reporter and the 
NOSp:35S IR acts as a silencer (Figure 3.1). The mRNA transcript of the 35S IR 
transgene is expected to be produced by RNA polymerase II, although it is 
dependent upon PolIV for siRNA production (Figure 3.1 A) (Eamens et al. 2008). 
The transcript forms dsRNA via sequence complementarity (Figure 3.1 B). This 
acts as a trigger for the RdDM pathway, which produces 24nt siRNAs from this 
transcript. These siRNAs have homology to both the 35S IR and the 35S promoter 
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of the GFP transgene. These are then loaded into a AGO protein, likely to be 
AGO4, which then facilitate the methylation of the 35S promoter of the GFP 
transgene (Figure 3.1 C and D). This represses transcription of GFP, thus resulting 
in a loss of GFP fluorescence in 142S, which contains both transgenes (Figure 3.1 
E). In 142, which lacks the 35S IR transgene, GFP is not silenced and therefore 
GFP fluorescence is detectable.  
 
Figure 3.1: How the dual transgene silencing system functions 
A: An RNA polymerase transcribes the NOS: 35S IR transgene. B: The 35S IR repeats form 
dsRNA through self-complementation and this is then cleaved by DCL3 into 24 nt siRNAs. 
C: PolV transcribes the corresponding sequence of the 35S promoter of the GFP 
transgene and 35S siRNAs loaded into AGOs bind to the transcript. D: The binding of 
AGO loaded with siRNAs triggers DRM2 to methylate the 35S promoter. E: The 
methylation prevents transcription of GFP. Promoters are shown as arrows with NOS in 
black and the 35S in red and purple. The red section of the 35S promoter is the region 
targeted by the 35S IR transgene. Rectangles represent the CDS of each transgene with 
GFP being in green and the 35S IR in red. There is an intron between the two inverted 
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repeats in the35S IR and this is represented as DNA double helix. The transcription 
activity of both transgenes is shown by the black line at the start of each transgene with 
an arrow meaning that is transcribed whereas a cross means that it is not. 
An ethyl ester methane sulfonic acid (EMS) mutagenesis of the 142S line was 
completed by A. Eamens (Eamens et al. 2008). Progeny from this mutagenesis 
were then self-fertilized and M2 plants screened for defects in RdDM by 
visualising GFP fluorescence under UV-light. The M2 generation is the first 
generation which would contain homozygous EMS mutations. The initial study 
identified mutants in nrpd1 and nrpe1 (Eamens et al. 2008). Characterisation of 
these mutants revealed that as well as their established role in TGS both NRPD1 
and NRPE1 are important for maintenance of PTGS. This was unexpected as both 
PolIV and PolV were thought to act exclusively in TGS pathways. 
3.1.2 Aims of chapter 
The aim of this chapter was to screen an EMS mutated Arabidopsis population 
for putative novel RdDM mutants and to identify the mutated gene. 
Bioinformatic tools would then be used to assess the gene’s expression pattern, 
evolutionary history and protein structure. This was achieved by: 
A) Identification of putative novel RdDM mutants. The library was screened for 
GFP fluorescence and putative mutants were characterised and sorted into 
phenotypic groups according to their patterns of DNA methylation and siRNA 
accumulation. Complementation assays were then used to identify alleles in the 
same gene and assess if the mutants are in a known RdDM gene. 
B) Identify mutant locus in novel RdDM mutants. A rough map position for the 
mutant was obtained using cleaved amplified polymorphic sequences (CAPS) and 
simple sequence length polymorphisms (SSLP) mapping and then genome 
sequencing was done to find the candidate RdDM gene. This was confirmed by 
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sequencing other alleles of the RdDM mutant and complementation assays with 
known mutants in that gene. 
C) Characterise the RdDM gene using bioinformatics. The gene expression 
pattern, phylogenetic tree and protein structure of the RdDM gene was assessed 
using bioinformatic tools.  
3.2 Chapter-specific methods 
3.2.1 Mutation identification strategy 
The two most common strategies for the production of mutants for forward 
genetic screens in Arabidopsis thaliana are mutagenesis using a mutagen, usually 
EMS, or T-DNA insertion (Krysan et al. 1999, Greene et al. 2003). Whereas T-DNA 
insertion mutations can be easily identified by sequencing out from the T-DNA 
insertion into the genome, EMS mutations are harder to identify. Before the 
advent of next generation sequencing technology, EMS mutants were identified 
by mapping the mutant locus to a specific region of the genome and sequencing 
candidate genes within this region. However, with modern sequencing 
technology it is now possible to use re-sequencing of the entire genome and 
identify candidate single nucleotide polymorphisms (SNPs) from this sequence 
(Ossowski et al. 2008, Schneeberger et al. 2009, Schneeberger and Weigel 2011). 
Both strategies can also be used in conjunction with each other, with mapping 
first identifying the region of the genome where the mutation resides and this 
can be used to direct the choice of candidate SNPs in the re-sequencing. Initially 
a purely mapping based strategy was used but it was realised that it would be 
more cost effective to instead use re-sequencing to identify mutants and so for 
this reason a dual strategy that has been used for this study. Although 
unintentional this strategy should provide the added benefit of a dual strategy 
described previously.  
3. Identification of M1 and M9 as morc6 mutants 
 
128 
 
3.2.2 Mapping of RdDM mutant gene locus using CAPS and 
SSLP markers 
To identify the region of the genome where the mutant locus was located 
mapping was employed for this purpose. Mapping relies upon the principle that 
two features on a chromosome are more likely to segregate together if they are 
close to one another than if they are further apart (Morgan 1911a, Morgan 
1911b). Features that segregate together are said to be linked and it was shown 
that the frequency of co-segregation did not only provide a measure of linkage 
between the two features, but that it also is a direct measure of the distance 
between the two features (Sturtevant 1913). This frequency of segregation and 
hence distance can be calculated for the EMS mutation and markers. As the 
location of the on the chromosome is known this can therefore provide an 
indication of the location of the EMS mutation. However, for this to work there 
must be at least two alleles of each marker and in Arabidopsis researchers have 
taken advantage of the fact that genetic variation between different ecotypes of 
Arabidopsis results in several loci that vary between ecotypes and therefore can 
be used as markers. Two of these marker types have been used in this study and 
they are cleaved amplified polymorphic sequences (CAPS) and simple sequence 
length polymorphisms (SSLP). CAPS markers are sections of genomic DNA that 
when amplified by PCR and cleaved with a restriction enzyme, produce products 
of specific sizes (Konieczny and Ausubel 1993). These products are ecotype 
specific so different ecotypes produce products of different sizes. SSLP markers 
are microsatellites that are of a specific length in each ecotype, but vary in length 
between ecotypes (Bell and Ecker 1994). 
3.2.3 Producing pooled DNA samples for Illumina 
sequencing 
In RdDM mutant lines produced using EMS mutagenesis, identifying a causal 
mutation is difficult due to the presence of a large number of other mutations 
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carried in that particular line. In order to reduce the number of EMS mutations 
backcrossing and sample pooling was employed. Initially the mutant line was 
backcrossed twice to the parental 142S line and plants that were homozygous for 
the RdDM mutation were selected in the following F2 generation using GFP 
fluorescence (Figure 3.2 A). In the F1 generation’s germline recombination will 
occur between the RdDM mutant and 142S parental line chromosomes, 
producing chromosomes with sections from each line (Figure 3.2 B). Due to the 
selection for homozygote mutants in the RdDM locus in the F2 generation both 
the RdDM locus and surrounding sequence must come from the RdDM mutant. 
However, there is no selection on any other section of the genome, meaning that 
they can originate from either the mutant or 142S line. In the F2 generation each 
plant should have undergone a different set of recombination events so will also 
carry a different set of EMS mutations, except for the causal mutation that has 
been selected for and those that are closely linked. To take advantage of this 
variation between individuals the DNA sample from the RdDM mutant was 
produced from plant tissue collected from one hundred of the F2 GFP 
fluorescent plants from the 2nd backcross. Only the young rosette leaves, 
typically around 5 mm long, were collected. The reference sample of 142S did 
not require pooling so adult rosette leaves were collected from five 142S plants. 
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Figure 3.2: Removal by backcrossing of unlinked mutations segregating with the causal mutation 
Diagrams showing how back crossing a mutant line (M) to 142S can reduce the number of non-causative mutations in the mutant line. A: Diagram 
showing how the back crossing and selection process works. Plants that are coloured green are GFP fluorescent and therefore a mutant (M) while 
plants that are red are not and are wild-type (142S). The generation number is shown to the left of the figure, with the M and 142S lines designated 
the F0 generation. B: Diagram showing the same process as A but shows the chromosomal pair, on which the causal M mutation resides, at each 
stage. The M chromosomes are coloured green while the 142S chromosomes are coloured red. The numbers (1-5) on the M chromosome show 
homozygous mutations carried by the M line that are not causative of the RdDM phenotype. The causative mutation is represented by a white M in a 
black circle. 
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3.3 Results 
3.3.1 Identification of M1 and M9 as alleles in a potentially 
novel RdDM mutant 
To identify mutants in the RdDM pathway the dual transgene system, as 
described in the introduction, was used. The 142S line carries both transgenes 
whereas line 142 carries only the 35S:GFP transgene. An EMS mutagenesis of 
142S was performed during a previous study to identify RdDM mutants and the 
M2 generation were screened for GFP fluorescence as these are likely to be a 
mutation in the RdDM pathway (Eamens et al. 2008). From this initial screen 
there were twenty four uncharacterised mutants that were GFP fluorescent, 
these were numbered M1 to M24.  
The mutants were then separated into two phenotypic groups through 
assessment of 5S rDNA methylation, those being mutants with no change from 
WT in DNA methylation and those with reduced DNA methylation. The 5S rDNA 
repeats are an endogenous target of RdDM and are commonly used to 
characterise RdDM mutants (Aufsatz et al. 2002b, Vaillant et al. 2007, Ausin et al. 
2009). DNA methylation was assessed using methylation sensitive Southern 
blotting whereby the DNA is digested with a methylation sensitive restriction 
enzyme that creates a banding pattern, which is altered by presence or absence 
of DNA methylation. Cytosine methylation was assessed in the CG, CHG and CHH 
sequence contexts, where H represents A, T or C, using the restriction enzymes: 
HpaII which is sensitive to CG methylation and HaeIII which is sensitive to CHG 
and CHH methylation. When DNA methylation is present the restriction enzymes 
will not cleave the DNA and higher molecular weight (HMW) bands are formed, 
which is seen in the WT lines 142 and 142 (Figure 3.3). There were four lines with 
a banding pattern similar to WT, indicating no loss in methylation, which 
comprised M1, M6, M9 and M19. The remaining twenty lines all showed an 
increase in lower molecular weight (LMW) bands compared to WT indicating a 
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loss in DNA methylation in these lines. In the initial blots differences in the 
amount of DNA loaded for 142S (Figure 3.3 A) and 142 (Figure 3.3 C) meant that 
the banding pattern for these samples was similar to that of the lines that lost 
DNA methylation. For this reason the blots were repeated for the group of 
mutants that retained methylation and are shown in Figure 3.3 B and D; and in 
chapter five (page 298). These repeats again show that the mutants retain DNA 
methylation. This study concentrated on the group of mutants that did not lose 
DNA methylation due to the fact that at the time the only known RdDM mutant 
that did not show a change is MOM1 and therefore would suggest that these 
mutants are also involved downstream of DNA methylation either in histone 
modification or higher order heterochromatin modification (Amedeo et al. 2000, 
Habu et al. 2006, Vaillant et al. 2006, Numa et al. 2010). This is one of the areas 
of the RdDM pathway where there are gaps in our knowledge and so there was 
the potential for the involvement of novel components. Re-assessment of GFP 
fluorescence revealed that M19 had been wrongly identified as fluorescent, 
indicating that it was not an RdDM mutant and so was discarded. M6 was shown 
to be a mutant in the 35S IR transgene, therefore only M1 and M9 have been 
studied in detail. Both M1 and M9 are GFP fluorescent, however not to the same 
extent as 142, indicating that silencing must still occur in the mutants but at 
reduced levels (Figure 3.4). 
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Figure 3.3: Screening EMS mutants for loss of 5S rDNA methylation 
Images of Southern blots used to assess the methylation status of the 5S rDNA repeats 
in all twenty four EMS mutant lines (A and C), with mutants that maintain methylation 
highlighted by an asterisk, and three mutants (M1, M6 and M9) that show no decrease 
in DNA methylation (B and D). Mutants were tested for CG methylation (A and B) and 
CHG and CHH methylation (C and D). For B and D line M10 was used to show the 
banding pattern of an RdDM mutant that loses DNA methylation, although the mutant 
gene in M10 is unknown. The restriction enzyme used to digest the DNA is shown at the 
bottom of each blot while the cytosine configurations that the restriction enzymes are 
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sensitive to are shown above each blot. The order of samples is shown above each lane, 
with 142 and 142S being the WT samples. 
 
Figure 3.4: Differing levels of GFP fluorescence between 142, 142S, M1 and M9  
Images of lines 142 (A), 142S (B), M1 (C) and M9 (D) taken under UV light at 32 dpg. 
Images are representative for each lines. The autofluorescence on the top-middle leaf of 
142S is due to necrosis and has no relevance to the silencing phenotypes. The area of 
fluroscence on the right hand leaf of M1 is soil on top of the leaf that fluoresces. 
Allelism testing showed that M1 and M9 were allelic as they failed to 
complement each other and therefore were alleles in the same RdDM mutant 
locus (Figure 3.5). The phenotype of M1/M9, discussed in detail in the next two 
chapters, was similar to another mutant named rmd6, identified in the previous 
screen of the EMS mutant library by A. Eamens, but whose causative mutation 
had not been identified. Allelism testing revealed that rmd6 was also an allele in 
the same gene as M1 and M9 (Figure 3.5 G and H). All characterisation in this 
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study, apart from sequencing, has only been carried out on M1 and M9 but not 
rmd6. The reason for this is that rmd6 has a stunted growth phenotype that is 
most likely unrelated to the RdDM mutation but has not yet been removed by 
back crossing and may interfere with phenotypic analysis. Allelism tests were 
then performed between M1 and M9 and a previously identified mom1 mutant 
to determine if they were mutant alleles of MOM1 (Amedeo et al. 2000). The 
mutants were also tested against a hda6 mutant as at the point when these tests 
were being carried out MOM1 and HDA6 were the only two proteins known to 
act downstream of DNA methylation (Amedeo et al. 2000, Aufsatz et al. 2002b). 
However, hda6 mutants cause a reduction in DNA methylation so unless M1 and 
M9 were partial loss of function mutants in HDA6 they were unlikely to be 
mutants in this gene (Aufsatz et al. 2002b). The allelism tests between M1 and 
M9; and the known RdDM mutants showed complementation, thus indicating 
that that the mutant locus in M1 and M9 is neither hda6 or mom1 (Appendix 1.2 
page 352). Since the allelism testing showed no complementation this suggested 
that M1 and M9 are alleles in a novel RdDM mutant, however the M1/M9 locus 
needed to be identified in order to determine whether this is the case or not. To 
achieve this, mapping and genome re-sequencing were employed. 
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Figure 3.5: Allelism tests identifying M1, M9 and rmd6 as allelic 
Images taken under UV light of parents and crosses at 46 dpg. The parental lines shown 
are 142, 142S, M1, M9 and rmd6. For all crosses the names of the parents are given, the 
first name is the male and the second is the female. The bright fluorescence seen on the 
older leaves of lines shown are due to necrosis and are not linked to the silencing 
phenotypes. Images are representative for each line. 
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3.3.2 Obtaining a rough map position for the M1/M9 locus 
In order to identify the location of the M1/M9 locus within the genome, mapping 
with SSLP and CAPS markers was used. The distance between these markers and 
the M1/M9 locus can be determined using linkage analysis and this principle is 
explained further in the methods section of this chapter (page 128). However, 
for the markers to work they require the M1 and M9 mutants to be in a mixed 
ecotype background so that there are two segregating ecotype specific alleles for 
each marker. Both M1 and M9 mutants are in the C24 ecotype background so 
were crossed with WT Landsberg erecta (Ler) and the M1/M9 mutants identified 
in the F2 generation by GFP fluorescence. As Ler lacks the two transgenes not all 
F2 plants will have both transgenes, therefore in order to correctly identify M1 
and M9 the two transgenes must also be selected for. The GFP transgene 
insertion includes a kanamycin resistance gene and the 35S IR transgene 
insertion includes a DL-phosphinothricin resistance gene, therefore to select for 
only the plants with both transgenes the F2 generation was germinated on MS 
plates containing kanamycin and DL-phosphinothricin. The plants that were 
resistant to both compounds were then screened for GFP fluorescence and those 
that were fluorescent were transferred to soil as these will be the M1/M9 
mutants. A number of plants that were not fluorescent were also transferred to 
soil as these will act as controls for the mutant plants.  
The F2 progeny will have undergone crossing over events between C24 and Ler 
chromosomes resulting in heterogeneous chromosomes with sections from both 
ecotypes, however as the M1 and M9 mutation have been selected for, the 
origin of markers close to the M1/M9 locus should be mostly from C24 rather 
than Ler. The proportion of markers that only come from C24 should decrease as 
the distance from the M1/M9 locus increases. One problem with this technique 
is that as well as the M1/M9 locus the two transgenes will also be selected for so 
the plants will also be either homozygous or heterozygous for the two transgene 
loci. If by chance a large number of plants that are homozygous for the 
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transgenes are selected this will results in there being three loci with strong 
selection for C24. This will not be a problem if the transgenes and M1/M9 locus 
are not linked to each other as three distinct areas of linkage to C24 will be 
detected. However, if the M1/M9 mutant is linked to either transgene this will 
mean that the area to which the mutant can be mapped to is increased as there 
is selection for a larger area of the C24 chromosome due to the presence of both 
the M1/M9 locus and one of the transgenes. This would consequently make 
identifying candidate genes from genome re-sequencing more difficult due to 
the larger area in which the locus could reside. 
In order to produce a mapping position for the loci, the map distance of the 
mutant loci from each marker needed to be calculated. This is also known as the 
recombination frequency. The map distance is the maximum distance either side 
of the marker for the mutant locus’ location and the locus can be found 
anywhere between these two points. To narrow down the location further 
multiple markers and their respective map distances to the mutant locus are 
compared and the region where these map distances overlap will be the location 
of the mutant locus. To calculate a map distance the parental status of markers 
are tested in a large number of DNA samples, each sample coming from a single 
plant that will have different crossover events and the markers are scored for 
being:  homozygous for C24; homozygous for Ler; or a heterozygous. The number 
of DNA samples that are heterozygous and homozygous for Ler are 
recombination events and can be used to calculate the map distance using the 
formula shown in Equation 1.   
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Equation 1: Mapping distance equation 
Equation to calculate the mapping distance between a marker and the linked locus of 
interest. It is measured by the total number of recombinant chromosomes divided by 
the total number of chromosomes. The number of recombinant chromosomes is the 
sum of all chromosomes in plants that are homozygous for Ler (L) and one of the 
chromosomes for each heterozygous (H) plant. N is the total number of DNA 
samples/plants screened, so is doubled to get the total chromosome number. 
Initially CAPS and SSLP markers had to be identified that showed a difference 
between C24 and Ler. Seventeen CAPS markers with such a difference had 
previously been identified and these covered all five chromosomes (Table 3.1). 
Screening of the M1 and M9 DNA samples with these markers showed linkage 
with markers on the left arm of chromosome one. Linkage was not observed for 
the control DNA samples, suggesting that the markers were linked to the M1/M9 
locus rather than the GFP or 35S IR transgene (Table 3.2 and Figure 3.6). The 
markers on the left arm of chromosome one are PVV4 and CAT3. This gave a 
rough map position for the M1/M9 locus, however to produce a finer map 
position for the locus, more markers on the left arm of chromosome one were 
required. Using the TAIR marker database search tool NF21M12 and M59 were 
identified for this purpose and showed a difference between C24 and Ler (Table 
3.1). These two markers also showed linkage to the M1/M9 locus (Table 3.2 and 
Figure 3.6). 
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Marker Type Chromosome 
Position of 
chromosome (bp) 
Restriction 
enzyme 
Bands in C24 
homozygote (bp) 
Bands in Ler homozygote 9bp) 
PVV4 CAPS 1 174459 AflIII 650 and 280 280 and 250 
NF21M12 SSLP 1 3212189 NA 200 180 
M59 CAPS 1 5855075 BstuI 520, 130 and 110 520 and 240 
CAT3 CAPS 1 7144251 HincII 970 790 and 180 
GAPB CAPS 1 16127765 DdeI 605, 284, 225 and 174 284, 255, 225 and 174 
G4026 CAPS 1 22276033 RsaI 650 800 
ADH CAPS 1 28975141 HaeII 1200 1400 
GPA1 CAPS 2 11196996 AflIII 705, 680 and 209 1385 and 209 
M249 CAPS 2 14454000 HpaII 250 and 100 350 and 100 
17D8LE CAPS 3 589969 HincII 13000, 1500 and 600 1500, 1000, 650 and 600 
GL1 CAPS 3 10360633 RsaI 400 and 110 220, 160 and 110 
F3H CAPS 3 19025417 BclI 1200 700 and 350 
GA1 CAPS 4 1242594 BfaI 1200 3000, 1200, 900, 700, 500 and 200 
AG CAPS 4 10384141 DdeI 700, 230 and 220 700, 600, 230 and 220 
CAT2 CAPS 4 16701115 DdeI 420, 260, 160 and 150 420, 280 and 260 
HAE1 CAPS 5 980447 HaeIII 850, 600 and 350 850, 620 and 350 
NIT4 CAPS 5 7377397 HaeIII 1750 and 650 1000 and 850 
DFR CAPS 5 17164364 BsaAI 609 and 534 609, 318 and 216 
10A10 CAPS 5 24572772 HphI 1300, 310, 290 and 100 800, 500, 310, 290 and 100 
Table 3.1: CAPS and SSLP markers that can be used differentiate between C24 and Ler 
Table of all CAPS and SSLP markers used for mapping of the M1/M9 locus and their location on the chromosomes. The restriction enzyme used for 
each CAPS marker is also given and the size of all bands produced from each marker is also given. 
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Name Chromosome 
Position of 
chromosome (bp) 
Genetic map 
position (cM) 
Number C24 
Number 
Ler 
Number 
Heterozygote 
Map distance 
(cM) 
PVV4 1 174459 0.77 62 (89.86%) 0 (0.00%) 7 (10.14%) 5.07 
NF21M12 1 3212189 14.24 83 (69.75%) 1 (0.84%) 35 (29.41%) 15.55 
M59 1 5855075 25.99 131 (93.57%) 1 (0.72%) 8 (5.71%) 3.57 
CAT3 1 7144251 31.69 150 (88.76%) 3 (1.77%) 16 (9.47%) 6.51 
Table 3.2: Markers linked to the M1/M9 locus and their respective distances from the locus 
CAPS and SSLP markers that are linked to the M1/M9 gene on chromosome one and their physical and genetic map positions. The combined number 
of M1 and M9 plants that were either C24 homozygotes, Ler homozygotes or heterozygotes are shown for each marker and the percentage of the 
total is given in brackets for each catergory. The map distance for each maker is given, this is the distance of the M1/M9 gene from the marker in 
centiMorgran (cM) map units. 
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Figure 3.6: Examples of banding pattern of the linked CAPS and SSLP markers 
A: Example images of gels of the PVV4, NF21M12, M59 and CAT3 markers in control 
DNA samples. The marker being tested for each gel is shown above the image. The 
status of the marker in each DNA samples is given below each image; with C being 
homozygous for C24, L being homozygous for Landsberg erecta and H being 
heterozygous. For PVV4, NF21M12 and M59 the gels show at least one DNA sample in 
each category, but CAT3 lacks a sample that is homozygous for Landsberg erecta. Lanes 
on the gel marked with N denote those where the marker failed to amplify. B: Diagrams 
showing the banding pattern for each marker when it is homozygous for C24 (C), 
homozygous for Landsberg (L) or heterozygous (H). The black lines represent the bands 
on the gels and the numbers above give their approximate size in base pairs (bp). The 
bands position are not to scale. 
Having identified four markers on the left arm of chromosome one that showed 
linkage to the M1/M9 locus, the map distance of the markers to the locus were 
compared. The marker M59 showed the strongest linkage with 93.57% of plants 
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tested being a homozygote for the C24 variant of that marker, thus suggesting 
that the M1/M9 locus is closest to this marker. The second most strongly linked 
marker is PVV4 with 89.86% of plants tested being homozygous for the C24 
variant. However, PVV4 and M59 are far apart from each other with PVV4 being 
at the end of the chromosome whereas M59 is nearly half way along the 
chromosome arm and so the mapping distances from these two markers do not 
overlap. It should also be noted that the NF21M12 marker, which is in between 
these two markers, has lower linkage than either PVV4 or M59. Both PVV4 and 
M59 do not show linkage in the control DNA samples, which would suggest that 
linkage to the one of the transgenes is not the cause of this discrepancy. One 
possible explanation is that double crossover events can cause stronger linkage 
and consequently a shorter distance between a marker and gene than there is in 
reality. Crossover events interfere with other nearby crossover events thus 
making it less likely that double crossover events will occur, however this 
interference decreases with distance, therefore the distance between PVV4 and 
M59 may allow for two crossover events to occur (Foss et al. 1993). Another 
possibility is that the markers for some DNA samples were mis-scored, for 
example if there was poor separation of the 280 bp and 250 bp bands when 
testing the PVV4 marker, thus leading to an incorrect mapping distance.  
The map distance for three of the four markers overlapped with each other and 
so it was assumed that these markers were correct and the PVV4 marker was 
ignored when the region of interest (ROI) for the M1/M9 locus was determined. 
The region where the map distances of the NF21M12, M59 and CAT3 markers 
overlap defines the ROI for the M1/M9 locus and is located between 25.18 cM 
(5.68 Mb) and 29.56 cM (6.66 Mb), spanning 0.98 Mb (Figure 3.7). However, due 
to the comparatively low number of plants tested for each marker the M1/M9 
locus could fall outside this region, so during sequencing mutants that are within 
1 Mb of this region were also considered.
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Figure 3.7: Location of the region of interest for the M1/M9 locus on chromosome one 
Schematic showing the ROI for the M1/M9 locus on chromosome one both in terms of its relative position on the chromosome and its position in 
relation to CAPS and SSLP markers. The red lines represent the chromosome with the black oval being the centromere and the blue lines indicating 
the region of interest (ROI) of the M1/M9 locus. On the enlargement of a section of chromosome one, CAPS and SSLP marker locations are shown 
below the red line. The name of each marker is given along with its position (middle) and the maximum distance away from that marker that the 
M1/M9 locus is (bottom). A scale bar (black line) is given for both the whole chromosome and enlargement. In all cases positions are given in 
centiMorgans (cM) and Megabases (Mb).
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3.3.3 Identification of candidate genes using Illumina 
sequencing of M1 
Having identified a region of interest where the M1/M9 locus is located, Illumina 
genome re-sequencing of the M1 and 142S genome was then used to identify 
candidate genes for this locus. The M1 sequence was compared against the 
parental line sequence in order to identify the EMS mutations in M1. EMS 
mutagenesis predominantly produces G to A and C to T transitions, with >99% of 
all mutations being of this type, however G/C to C/G; G/C to T/A; and A/T to G/C 
can also occur at low frequency (Krieg 1963, Greene et al. 2003). This means that 
the differences between M1 and 142S should predominantly be G/C to A/T 
changes with other base substitutions being the result of either EMS 
mutagenesis or the natural rate of mutation between generations. However, the 
M1 sample is likely to carry a large number of EMS mutations other than the 
causal mutation, making its identification difficult. The mutation rate for EMS is 
between 10-6 to 10-7 events per base pair, which over the entire Arabidopsis 
genome equates to between 12.5 to 125 base changes in each mutant line 
(Kovalchuk et al. 2000). For this reason, steps were taken to reduce the number 
of EMS mutations carried in M1 by backcrossing and producing a pooled DNA 
sample, the strategy and principle behind this is explained in the methods 
section of this chapter (page 128). This process will not however, remove all 
other mutations, particularly those mutations that are closely linked to the 
causative mutation. This means that several candidate genes may be identified, 
although this number will be greatly reduced compared to that of an M1 sample 
that has not undergone the backcrossing and pooling process. 
The 142S and M1 DNA samples were sequenced using a Illumina HiSeq 2000 
platform. The M1 and 142S DNA samples were run in separate columns on a 
Illumina flowcell and this produced a total of 129,533,529 reads for M1 and 
66,098,454 reads for 142S, which provides an approximate 100 times coverage 
of the genome for M1 and 51 times coverage of the genome for 142S. However, 
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for 142S this number of reads was lower than the 100 million reads per column 
that the HiSeq 2000 was expected to produce. A second sequencing run was 
therefore completed this time using an older platform, the Genome Analyser IIx, 
which produced at total of 187,244,483 read for M1 and 85,214,126 reads for 
142S. When combined this gave a total of 316,778,012 reads for M1 with a 244 
times coverage of the genome and a total of 151,312,580 reads for 142S with a 
116 time coverage of the genome and so the combined data set was used for 
sequence analysis to compensate for the reduced number of reads in the first 
sequencing run. 
To identify and map the mutation sites in M1 compared to 142S, the SHORE 
mapping and analysis pipeline was used. SHORE is a sequencing analysis tool that 
can both assemble a genome from a reference genome and identify single 
nucleotide polymorphism (SNPs) differences between the reference genome and 
the data set being tested (Ossowski et al. 2008, Schneeberger et al. 2009). The 
SHORE analysis was carried out by Xhesi He at the University of York. To analyse 
the sequence data a SHORE-specific predefined directory structure was created 
to store raw data and alignment results. Initially the C24 reference genome, 
obtained from the 1001 genomes website, was preprossed into a SHORE format 
for mapping the sequencing data to it (Cao et al. 2011, Schneeberger et al. 2011). 
The sequence data from the Illumina sequencing was in the FastQ format so was 
first converted into a SHORE flat file format. For 142S the reads from the first and 
second sequencing runs were mapped to the C24 reference genome separately 
before being merged together and the same process was carried out for M1. 
Consensus analysis was then performed between 142S and M1 to identify SNPs, 
indels and CNVs (Copy number variation). In this analysis, as the C24 reference 
genome is not complete, the results are expected to be less informative than 
comparing to a complete genome because of the incontinuity and lack of definite 
location on the chromosomes. This indeed was the case as for example, no 
insertions were detected, but SNP differences between M1 and 142S could be 
identified. SHORE identifies all SNP differences between the reference, 142S and 
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M1 so the SNPs had to be filtered to select for homozygous SNPs and ones that 
are present in M1 but not in 142S. To provide further information, such as indels 
or CNVs, the analysis was repeated with the Columbia genome as the reference 
genome, as this is fully annotated. However, this resulted in a dramatic increase 
in the number of homozygous SNPs identified from one hundred and seventy 
nine using C24 to eighteen thousand nine hundred and fifty nine using Columbia. 
This discordance, although unexpected, between the two SHORE analyses is due 
to the difference between C24 and Columbia and therefore only the analysis 
using C24 was used. 
Analysis of the sequencing data using SHOREmap identified one hundred and 
seventy nine SNPs where there was a difference between M1 and the parental 
142S line and the change was homozygous, of which sixty nine are located on the 
left arm of chromosome one. A table of all one hundred and seventy nine SNPs is 
shown in Appendix 1.3 (page 353). For the majority of the SNPs identified on the 
left arm of chromosome one the base change from 142S to M1 is either C to T or 
G to A, which is the predominant mutation caused by EMS mutagenesis, 
however for SNPs identified on other chromosomes or the right arm of 
chromosome one, C to T and G to A changes were not the predominant 
mutation. This shows that homozygous EMS-induced SNPs were enriched within 
or near the region of interest. As to the nature of the SNPs not on chromosome 
one’s left arm, some will also be the result of EMS mutagenesis and others could 
either be due to the natural mutation rate between generations or artefacts of 
the sequencing analysis. The natural mutation rate for Arabidopsis is 7 x 10-9 
base substitutions per generation, equating to a change of around 0.88 bp per 
generation, so some of these SNPs identified will be due to the natural mutation 
rate (Ossowski et al. 2010).  
From the mapping analysis the causal mutation was expected to be amongst the 
sixty nine SNPs on the left arm of chromosome one. Therefore in order to 
identify the mutation, the location of each SNP and whether it is within a gene or 
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intergenic region was determined for those SNPs on the left arm of chromosome 
one. The C24 genome has not been fully annotated and is in sections called 
scaffolds. Although a rough position for each scaffold is known, where each 
scaffold corresponds to on the fully annotated Columbia genome is not known. 
This means that despite knowing the exact location of each SNP on the scaffolds, 
it was not known if these locations correspond to a gene or intergenic region nor 
where on the left arm they are located. To identify the exact location of each 
SNP in the genome the upstream and downstream sequence for each SNP was 
identified from the C24 genome and this sequence was then used in a BLAST 
search of the Columbia genome. This gave the exact location of the SNP on the 
left arm and whether it was in genic or intergenic sequence. For those SNPs that 
were within genes, the function of the gene was recorded, as well as whether 
the SNP was in a UTR, exon or intron and, if it was within an exon, whether the 
mutation caused an amino acid change or not. For intergenic mutations the 
distance to the nearest gene and the function of the gene were recorded. There 
were a total of nineteen intergenic SNPs, ten intronic SNPs, seven located in 
UTRs and thirty three exonic SNPs. A table showing the location and nature of all 
chromosome one left arm SNPs is shown in Appendix 1.4 (page 358). Of the 
thirty three exon SNPs, seventeen caused a change in amino acid sequence 
(Table 3.3). Further analysis concentrated on the exon mutations that caused an 
amino acid change as, although other mutations may also impact on gene 
function, amino acid changes were the most likely to cause loss of function. 
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SNP 
position 
(bp) 
TAIR ID 
Gene 
name 
Exon Codon 
Base 
change 
Amino acid change 
Proportion of 
concordance in M1 
272314 AT1G01740 AT1G01740 10 417 G to A Glutamine (CAA) to Stop codon (UAA) 0.87 (111) 
448847 AT1G02280 TOC33 6 264 C to T Glycine (GGA) to Arginine (AGA) 0.86 (127) 
613895 AT1G02810 AT1G02810 1 38 C to T Serine (UCC) to Phenylalanine (UUC) 0.85 (113) 
989786 AT1G03890 AT1G03890 2 145 C to T Phenylalanine (UUC) to Leucine (UUA) 0.89 (89) 
1893527 AT1G06190 AT1G06190 1 49 C to T Glycine (GGG) to Glutamic acid (GAG) 0.87 (109) 
2543135 AT1G08130 LIG1 16 756 C to T GAA (Glutamic acid) to Lysine (AAA) 0.90 (96) 
3753966 AT1G11200 AT1G11200 2 24 C to T Serine (UCG) to Stop codon (UAG) 0.91 (125) 
3816744 AT1G11340 AT1G11340 1 226 C to T Glycine (GGA) to Glutamic acid (GAA) 0.93 (132) 
4798406 AT1G14000 VIK 3 146 C to T Proline (CCA) to Serine (UCA) 0.95 (120) 
5326847 AT1G15500 NTT2 1 142 C to T Alanine (GCU) to Valine (GUU) 0.96 (127) 
5419895 AT1G15750 TPL 4 98 C to T Valine (GUG) to Methionine (AUG) 0.98 (106) 
5677535 AT1G16610 SR45 6 195 C to T Aspartic acid (GAU) to Asparagine (AAU) 0.96 (103) 
6595680 AT1G19100 AT1G19100 2 41 C to T Glutamine (CAA) to Stop codon (UAA) 0.97 (109) 
6651377 AT1G19250 FMO1 4 360 C to T Glycine (GGG) to Glutamic acid (GAG) 0.96 (126) 
7280563 AT1G20910 AT1G20910 2 25 C to T Glutamic acid (GAA) to Lysine (AAA) 0.98 (106) 
7445662 AT1G21270 WAK2 1 222 C to T Proline (CCU) to Serine (UCU) 0.93 (124) 
13085698 AT1G3552 ARF15 2 19 T to C Arginine (AGA) to Glycine (AGA) 0.81 (189) 
Table 3.3: SNPs on the left arm of chromosome one that result in an amino acid change in M1 
Table of SNPs found within exons that cause a change in the amino acid sequence. The position of each SNP in the genome is given, as is the TAIR ID 
and gene name of the gene it is located in. For each SNP the exon and codon it is located in is given as is the base change and amino acid change. The 
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proportion of concordance in M1 is also given, this is the proportion of reads that contain this mutation, the exact number of reads that have this 
base change is shown in brackets in each case.
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Of the seventeen SNPs with amino acid changes, there are three SNPs that 
resulted in a premature stop codon, which are likely to lead to a loss of function 
of that gene and they are At1G01740, At1G11200 and At1G19100 (Table 3.3). 
These were therefore good candidates for the M1/M9 locus. However, two of 
these, At1G01740 and At1G11200, are over 1.5 Mb away from the region of 
interest (ROI) so may not be the causal mutation, although At1G01740 is close to 
the marker PVV4 so cannot be discounted. The other gene with a premature stop 
codon, At1G19100, is within the ROI so was a strong candidate. The function of 
all sixteen genes was also ascertained and this identified SR45, which has a 
aspartic acid to asparagine amino acid change, as another strong candidate for 
the M1/M9 RdDM mutant. This is because it has been previously identified as a 
RdDM mutant, is within the ROI, and the amino acid change is not conservative 
as it is a change from an acidic amino acid to a non-acidic amino acid (Table 3.4) 
(Ausin et al. 2012a).  
Gene name Function 
AT1G01740 Protein kinase containing tetratricopeptide repeat domain 
TOC33 GTPase involved in chloroplast importation machinary 
AT1G02810 
Plant inverstase/pectin methyltransferase inhibitor, inhibits cell wall 
modification 
AT1G03890 RmlC-like cupins superfamily protein, involved in metabolism 
AT1G06190 Rho termination factor, involved in transciption termination 
LIG1 DNA ligase involved in DNA replication and base excision repair 
AT1G11200 Unknown function 
AT1G11340 S-locus protein kinase, involved in pollen recognition 
VIK MAP Kinase involved in auxin signalling 
TPL 
Transcription factor involved in repressing root development in aerial 
tissues 
SR45 Involved in RdDM and spliceosome 
AT1G19100 MORC1 homolog, GHKL ATPase  
FMO1 Response to viral infection, promotes cell death 
AT1G20910 DNA binding proteins which contains ARID/BRIGHT domains 
WAK2 Serine/threonine protein kinase involved in cell expansion  
ARF15 Auxin response transcription factor 
Table 3.4: Function of genes with an amino acid change 
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Table of gene function for genes that have an amino acid change in M1 on chromosome 
one. Each gene function was determined from the TAIR annotation of each gene. 
As well as SR45 and At1G19100 there are five other genes with mutations that 
are either within the ROI or are 1 Mb either side (between 4.59 Mb to 7.71 Mb) 
(Table 3.5). Although, SR45 and At1G19100 were tested first, the other five 
mutations were also good candidates for the causal mutation due to their 
location in the genome, so would be tested next if neither SR45 nor At1G19100 
were the causal mutant. During the completion of this work At1G19100 was also 
identified as a RdDM mutant and was shown to be a ATPase that is involved in 
both DNA methylation and higher order chromatin modification in the RdDM 
pathway (Lorković et al. 2012, Moissiard et al. 2012). Due to the nature of the 
mutation in M1 and the fact that At1G19100 is a RdDM component this made 
At1G19100 the top candidate for the causal mutation in M1 and M9. The two 
studies also showed that At1G19100 is a ortholog of Mircorchidia 1 (MmMORC1) 
in Mus musculus so was named AtMORC6 or MORC6 and will be referred to as 
such from henceforth in this work. The reason it is called MORC6 is that it is the 
sixth of seven paralogs in Arabidopsis to MmMORC1. 
SNP 
position 
(bp) 
Gene 
name 
Exon Codon 
Base 
change 
Amino acid change 
4798406 VIK 3 146 C to T Proline to Serine 
5419895 TPL 4 98 C to T Valine to Methionine 
5677535 SR45 6 195 C to T Aspartic acid to Asparagine 
6595680 At1G19100 2 41 C to T Glutamine to Stop codon  
6651377 FMO1 4 360 C to T Glycine to Glutamic acid  
7280563 At1G20910 2 25 C to T Glutamic acid to Lysine 
7445662 WAK2 1 222 C to T Proline to Serine  
Table 3.5: Mutations in M1 that are within the ROI for the M1/M9 locus 
Table of mutations within or 1 Mb either side of the ROI in M1. The position of each 
mutant in the genome is given. The gene, exon and codon the SNP is located in is also 
given, as is the base and amino acid change for that SNP. 
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3.3.4 Sequencing of M9 and rmd6 to identify MORC6 as the 
mutated gene 
To determine which of the candidate genes is the causal mutation the candidates 
were sequenced by Sanger sequencing in the other two alleles, M9 and rmd6. 
The RdDM gene is expected to have a mutation in all three lines whereas it is 
unlikely that a gene that has no effect on the silencing phenotype will be 
mutated in all three lines. The top two candidate genes from SHOREmap analysis 
were SR45 and MORC6 so these two were initially sequenced. No exon or intron 
mutations were detected in M9 for SR45, but premature stop codon mutations 
were detected in MORC6 for both M9 and rmd6 (Figure 3.8).  
The MORC6 gene is 6.43 Kb in length and is predicted to encode a protein 663 
amino acids in length (Figure 3.8 and Figure 3.10). The coding sequence (CDS) of 
MORC6 is split between nineteen exons and the 1st exon is non-coding, as it is 
part of the 5’UTR (Figure 3.8 A). A full genomic sequence for MORC6 can be 
found in Appendix 1.5 (page 366) and this also shows ecotype specific 
differences between the Columbia and C24 ecotypes, most of which are in 
introns and the 5’UTR. There is however one exon SNP found in MORC6, but this 
does not cause an alteration in amino acid sequence as it is a change from the 
Leucine codon CTC to the Leucine codon CTT and can therefore not affect 
MORC6 function. 
The premature stop codon in M9 is in codon 267 in the 9th exon and is a change 
from the glutamine CAA codon to the stop codon TAA, whereas rmd6 has a 
premature stop codon in codon 392 in the 12th exon and is a change from the 
glutamine CAG codon to the stop codon TAG (Figure 3.8 B). The mutation in M1 
is a mutation of the 41st codon in exon two from a CAA glutamine codon to the 
TAA stop codon. The premature stop codons will either lead to the production of 
a truncated MORC6 protein or will trigger nonsense mediated decay and 
therefore no protein will be produced from MORC6. Preliminary results indicate 
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that a transcript is produced in all three lines and would therefore produce a 
truncated form of the MORC6 protein (Jones, L. personal communication). The 
presence of a premature stop codon in all three cases means it is therefore likely 
that the mutations in MORC6 are indeed the causative mutations. However, to 
conclusively show this an allelism test between M1 and a GABI-KAT line that has 
a T-DNA insertion in the MORC6 gene, morc6-3, was carried out. The T-DNA 
insertion was previously characterised in the study by Moissiard that identified 
MORC6 as an RdDM component and was shown to lack expression of MORC6 
(Moissiard et al. 2012). M1 and wilditype (WT) Columbia were also crossed with 
each other to show that the 35S IR transgene could silence the GFP transgene 
when both are in a heterozygous state, which is indeed the case (Figure 3.9 A). 
The progeny of the cross between morc6-3 and M1 showed a lack of 
complementation, seen by GFP fluorescence, which confirms that MORC6 is the 
causative mutation in M1, M9 and rmd6 (Figure 3.9 A).  
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Figure 3.8: The location within the MORC6 gene of the mutations in M1, M9 and rmd6 
Schematic showing the structure of the At1G19100 (MORC6) gene and the location of the mutations in M1, M9 and rmd6. A: Is a scale diagram of the 
structure of the MORC6 gene and its position in relation to the upstream and downstream genes. The yellow lines represent intergenic DNA and the 
upstream and downstream genes of At1G19100 are shown in black, with the direction of transcription shown by the black arrow above each gene. 
The UTRs of At1G19100 are shown in red, with exons in black and introns in blue. The exon number is given above each exon and purple lines below 
the gene highlight where the M1, M9 and rmd6 mutations are located. A scale bar is given in the bottom right. B: Shows the location of each mutation 
in terms of exon and codon and gives the sequence for each mutation. The right hand purple box shows the sequence of the area highlighted to the 
left of the diagram. For each box the top sequence is the C24 WT sequence with the change in the respective mutant line shown below, with the 
substituted base highlighted in black. The codons are represented by a black line above the sequences and the codon number for each one is also 
given. For the mutated codon the original amino acid encoded is given above the sequence. The position within the MORC6 sequence for the start 
and end of each sequence shown is given at the beginning and end of each sequence.
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Figure 3.9: Allelism test demonstrating M1 is a morc6 mutant 
Images of the progeny of crosses between WT Columbia and M1 (A), morc6-3 and 142 
(B), and morc6-3 with M1 (C) under UV light. In each case the first name is the male and 
the second is the female. The images were taken at 18 dpg and are representative for 
each line. 
3.3.5 Truncation of the MORC6 protein in the mutants 
If MORC6 is expressed in M1, M9 and rmd6 it will result in truncated forms of the 
MORC6 protein that are 40, 266 and 391 amino acids long respectively (Figure 
3.10). To predict what affect truncation of MORC6 may have, the protein 
domains of MORC6 first needed to be identified using the protein databases 
Pfam and SMART, both of which can identify putative protein domains (Letunic 
et al. 2012, Punta et al. 2012). This analysis identified two functional domains in 
MORC6, these being a GHKL ATPase domain and a coiled coil domain (Figure 
3.10).  
The GHKL domain contains four conserved sequence motifs responsible for ATP 
binding, the sequences for which are shown in Table 3.6, and all four could be 
identified in MORC6 (Figure 3.10) (Bergerat et al. 1997, Mushegian et al. 1997, 
3. Identification of M1 and M9 as morc6 mutants 
 
159 
 
Ban and Yang 1998, Lorković et al. 2012). There is however sequence divergence 
of the conserved motifs in MORC6, for example in motif I the highly conserved 
alanine residue at the end of the motif is instead a glutamic acid residue in 
MORC6, which is a change from a small hydrophobic amino acid to a larger acidic 
amino acid (Table 3.6). Of the motifs, motif III shows the greatest difference 
between the consensus sequence and MORC6 sequence as there has been an 
addition of four amino acids to the motif and a conversion of two highly 
conserved threonine residues to serine residues (Table 3.6). However, the 
substitution of threonine for serine is a relatively conservative change as both 
are hydrophilic and differ by a single methyl group. It should be noted that motif 
IV is outside of the ATPase domain defined by both Pfam and SMART so the 
ATPase domain will extend beyond the area identified by these two databases 
and the previous study by Lorković suggests the domain extends to the 500th 
amino acid (Figure 3.10) (Lorković et al. 2012). The reason why this was not 
identified is that motif IV contains only three conserved residues and these can 
be separated by any number of random amino acids, hence the failure of the 
databases to identify this as part of the ATPase domain.  
  Consensus Sequence MORC6 Sequence 
Motif I (N box) uubEuuaNouDA ouoEuuaNouDE 
Motif II (G1 box) uxuxDNGxGuxbaauxxuu uxuxDDGxGuxuxxuxxuu 
Motif III (G2 box) uGxxGxouxSxxxuoxbuTuxT uGxxGuouxxSxxxuoxauuuuSuxS 
Motif IV (G3 box) TxnGT TxnGT 
Table 3.6: Conserved sequence motifs in GHKL ATPases 
Table showing the consensus sequence and MORC6 sequence for the four conserved 
sequence motifs of GHKL ATPases. The amino acids in capitals are specific highly 
conserved amino acid residues whereas the lower case can be any amino acid with a 
particular set of properties, those being: u are amino acids which have a bulky side 
group and are hydrophobic; b are amino acids that are basic; a are amino acids that are 
acidic; o are amino acids with small side chains; and x can be any amino acids. For motif 
IV the xn can be any number of amino acids. 
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The coiled coil domain was identified by the SMART database and is found at the 
C terminal end of the protein (Figure 3.10). This coiled coil domain allows for 
binding and interaction with other proteins and MORC6 has been shown to 
interact with DMS3 through this domain (Crick 1952, Mason and Arndt 2004, 
Lorković et al. 2012). DMS3 is a RdDM component and has a hinge domain found 
in structural maintenance of chromosome (SMC) proteins, but lacks the ATPase 
domains of SMC proteins; MORC6, through its interaction with DMS3, therefore 
provides the missing ATPase domain (Hirano 2005, Kanno et al. 2008, Ausin et al. 
2009, Lorković et al. 2012). It is therefore likely that MORC6 and DMS3 function 
together in the RdDM pathway as a SMC protein, although MORC6 functioning 
separately to DMS3 cannot be discounted. 
Having identified the protein domains in MORC6, the three mutants were then 
analysed to determine what affect they would have on the domains. The M1 
MORC6 protein lacks all functional domains identified and therefore can be 
assumed to totally disrupt MORC6 function. The M9 protein still has the majority 
of the ATPase domain identified by Pfam and SMART, however it lacks the fourth 
motif of the GHKL ATPase and is also lacking the coiled coil domain. This means 
that it should not be able to interact with DMS3 so any function in RdDM that 
requires both proteins interaction should be inhibited. The ATPase domain in M9 
will be disrupted to some extent as the fourth motif is missing so the protein will 
not fold in the same way as the WT protein; whether this would affect RdDM 
function is unknown. rmd6 produces the most complete MORC6 protein and 
contains all four conserved GHKL ATPase motifs. As with M9 it lacks the coiled 
coil domain so interaction with DMS3 should again be prohibited. It should also 
be noted that the study by Lorković suggests the ATPase domain extends to the 
500th amino acid and therefore rmd6 would lack 109 amino acids of the ATPase 
domain, this would again affect protein folding. 
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Figure 3.10: Truncation of the MORC6 protein in the three morc6 mutants compared to WT 
Alignment of the M1, M9 and rmd6 protein sequences against the WT MORC6 protein sequence, the sequence named MORC6 being the WT 
sequence. The domains of MORC6 have been highlighted; the GHKL ATPase domain is highlighted in red while the coiled coil domain is highlighted in 
green. The conserved sequence motifs of the GHKL domain are highlighted: motif I is in light blue; motif II is in light purple; motif III is in dark blue; 
and motif IV is in turquoise. The highly conserved residues within these motifs are highlighted in black.
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Although M1 clearly lacks all identified functional domains of MORC6, both M9 
and rmd6 contain at least part of the GHKL ATPase domain. In order to 
determine whether this affects protein folding Phyre 2 was used to predict the 
3D structure of the WT MORC6, M9 MORC6 and rmd6 MORC6 GHKL ATPase 
domains (Figure 3.11). Phyre 2 identifies 3D structure through homology with 
other proteins whose 3D structure is known and then uses this known structure 
to predict that of the protein being tested (Kelley and Sternberg 2009). All 
predicted 3D structures show the strongest homology to the HSP90 GHKL ATPase 
domain and start near the beginning of the predicted ATPase domain but end at 
different points (Figure 3.10 and Table 3.7). The M9 3D structure ends at amino 
acid 226, this being the last amino acid in the M9 MORC6 protein, whereas for 
rmd6 the structure ends at amino acid 285, which is not at the end of the rmd6 
protein. In both cases, although both proteins form a cleft where ATP binding 
and hydrolysis occurs, they lack the larger extraneous structure of WT MORC6 
(Figure 3.11). In WT MORC6 the cleft is deeper and partly enclosed and this 
larger structure may be required for the correct function of the GHKL ATPase 
domain, therefore both M9 and rmd6 would not function normally as the 3D 
structure of the GHKL ATPase domain is disrupted. However, it cannot be 
concluded that they are a null mutants, like M1, as both the M9 and rmd6 
proteins have at least part of the ATPase domain and therefore could possess 
some residual function. 
MORC6 Predicted 3D structure between amino acids Strongest homology  
WT 132-490 HSP90 Chain A 
M9 129-226 HSP90 ATPase domain 
rmd6 129-285 HSP90 Chain A 
Table 3.7: Size of the predicted structure of the WT, M9 and rmd6 MORC6 
GHKL ATPase domain 
Table showing the amino acids where a predicted 3D structure has been found for each 
protein tested and which protein with a known 3D structure it is most homologous to. 
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Figure 3.11: Differences in the predicted 3D structures of the GHKL ATPase 
domain between the WT, M9 and rmd6 MORC6 proteins 
3D structures of the MORC6 GHKL ATPase domain for the WT protein (A) M9 protein (B) 
and rmd6 protein (C). For each protein a ribbon and space fill model of the protein is 
given. For the ribbon model α helices are shown as spirals; β sheets are flat sections and 
unstructured section are thin strands. The colour represents where in the sequence 
each section is located, with the N terminus of the structure being red and then going 
through the spectrum to dark blue at the C terminus. The catalytic domain and cleft 
where ATP binding and hydrolysis occurs is highlighted in each case by a white arrow 
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3.3.6 Arabidopsis MORC protein family 
BLAST searches of the MORC6 DNA and protein sequence revealed that MORC6 
is one of a family of seven MORC genes in Arabidopsis thaliana that are found on 
chromosomes one, four and five. A list of the seven MORCs and their location in 
the genome can be found in Appendix 1.6 (page 372). Three of the MORC genes, 
MORC1, MORC2 and MORC3, are located next to each other and could therefore 
be the consequence of recent gene duplication events. Gene size, exon number 
and protein length are similar amongst the MORC gene family with most MORC 
genes being around 4 to 4.5 Kb long containing eighteen exons and producing a 
protein around 600-700 amino acids in length. There are exceptions to this, for 
instance MORC6 is 1.49 Kb larger than the next largest MORC gene although it 
produces a protein 663 amino acids long. As well as MORC6, MORC1 has also 
been shown to be involved in RdDM, however whether any of the other MORC 
proteins are involved in RdDM is unknown (Moissiard et al. 2012). As well as a 
role in RdDM, MORC1 and MORC6 also have a more general role in formation of 
heterochromatin and its localisation to the nuclear membrane, seen by the loss 
of chromocentres in mutants of both genes. The only other function of MORC 
proteins so far determined experimentally is that both MORC1 and MORC2 are 
involved in pathogen response in the cytoplasm (Kang et al. 2008, Kang et al. 
2010). 
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3.3.7 Difference in gene expression of Arabidopsis MORCs 
Having identified that there are multiple MORC proteins within Arabidopsis, the 
expression patterns of the MORC genes were then analysed using 
Genevestigator. Genevestigator has a large database of microarray data that can 
be used to assess gene expression patterns in different mutant backgrounds, 
stages of development and tissue types (Hruz et al. 2008). For this analysis only 
microarray data from WT Columbia and C24 plants were used, except for RdDM 
mutant analysis, where rdr2-1 and dcl3-1 Columbia mutant microarray data was 
used. The reason that both Columbia and C24 used is that there is very little C24 
microarray data available compared to Columbia and so this could skew the 
results. Expression levels between Columbia and C24 when looked at separately 
show similar patterns in terms of whether a MORC gene is up or down regulated, 
but the exact level of gene expression is different between the two ecotypes 
(Appendix 1.7 page 374). Again this is likely to be due to the low number of C24 
microarray data available, but could also be a ecotype difference. Data was 
available on gene expression for MORCs 1, 2, 4, 5, 6 and 7 but no data was 
available for MORC3. The data used in this analysis were produced produce by 
the normalisation of absolute expression levels, which are measured by the 
intensity of the signal for the MORC gene probes on the array. Absolute values 
will vary between different microarrays so the data provided by Genevestigator 
is normalised using a trimmed mean to provide a relative intensity level. In this 
case the 90% trimmed mean is used, meaning that the top and bottom 5% of 
expression values are ignored and the mean calculated from the remaining 
values. This mean is then given an expression value that is the same for all 
microarray data stored in Genevestigator and the values for specific probes are 
calculated using the ratio between the trimmed mean and the absolute value.  
Initially MORC expression was assessed during development to determine if any 
of the MORC genes are developmentally regulated. Genevestigator has eight 
broad classifications for development of Arabidopsis, which are: germinated 
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seed, seedling, young rosette, developed rosette, bolting plant, young flowers, 
developed flower, flowers and siliques, mature siliques and plant senescence. 
The reason for these broad classifications is that compared to more specific 
classifications, more microarrays can be included into each classification, which 
will reduce the effects of specific conditions in the microarray that affect gene 
expression but are not linked to development. From the developmental 
expression data there is variation in expression between the MORC genes (Figure 
3.12 A). MORC5 expression is low at all developmental stages and is low enough 
that the relative intensity may be artefacts from the microarrays rather than 
actual expression. Both MORC2 and MORC7 have a similar expression pattern in 
that both have a generally low level of expression but expression increases from 
germination, peaking during bolting, before decreasing again. This could suggest 
that both MORC2 and MORC7 are involved in activities related to rosette 
development and bolting. MORC4 is relatively stable during plant growth but 
shows high levels of expression during seed development and plant senescence. 
However, as there are only six microarrays for plant senescence the large 
increase in MORC4 expression may not be connected to development but rather 
due to other factors. There is however a larger number of microarrays 
supporting the high expression levels of MORC4 in germinated seeds, so MORC4 
could have a role during germination. MORC1 expression oscillates during 
development, but is generally higher than all other MORC proteins, except during 
flowering. This would suggest that MORC1 is active throughout plant 
development. MORC6, like MORC1, is highly expressed, compared to the other 
MORC genes, but is up regulated during flowering and siliques formation and 
therefore could have a role during this developmental stage, for instance in the 
establishment of silencing of transposable elements in pollen and ovules 
(Mosher et al. 2009, Slotkin et al. 2009).  
As well as MORC expression during development the expression of MORCs in 
different plant tissues was also assessed and again MORC genes showed a 
difference in expression patterns (Figure 3.12 C). The expression pattern of 
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MORC6 would suggest that its role in flowering is specific to the stamen and 
pistil, as expression is high in these tissues whereas in siliques, sepals and petals 
MORC6 expression is similar to that of the vegetative tissues. This would suggest 
that MORC6 has a specialised role in pollen and ovule development. However, 
the number of microarrays for some of these tissues is low so the mean values 
may have been skewed by the small sample size. MORC5 again has a low level of 
gene expression and this is consistent across all tissues except pollen, so MORC5 
may also be involved in pollen development. The expression of the MORCs was 
also assessed in RdDM mutant lines for rdr2-1 and dcl3-1 in the Columbia 
background (Figure 3.12 B). Only a limited number of microarray data sets are 
available for the two mutants so other factors could skew the results and 
expression data is only available for the flowers and siliques developmental 
category. The expression pattern of MORC2 and MORC7 do not show much 
variation between the WT and mutant arrays. MORC1, MORC4, MORC5 and 
MORC6 do however show a change in expression. Expression is reduced for 
MORC1, MORC4 and MORC5 in both mutants and MORC6 in the dcl3-1 mutant, 
but there is increased expression of MORC6 in the rdr2-1 mutant. This change in 
expression, if genuine, could suggest that the MORC genes are regulated by 
RdDM or that the genes are up or down regulated in response to perturbation of 
the RdDM pathway. 
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Figure 3.12: Gene expression of the MORC gene in Arabidopsis during 
development, in RdDM mutant backgrounds and in different tissues 
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Graphs produced by Genevestigator of microarray data on MORC gene expression for 
different developmental stages (A), RdDM mutant backgrounds (B) and tissues (C). For 
each graph a key shows which MORC corresponds to each coloured circle; the circles 
themselves represent the mean level of gene expression for that MORC gene. The error 
bars are two standard errors of the mean but are mostly obscured by the circles 
themselves. Gene expression is measured using a relative intensity scale; low levels of 
gene expression are considered to be genes with a relative intensity among the 25% 
lowest intensities for all genes and medium levels of gene expression are considered to 
be those within the interquartile range (IQR) of relative intensity. A: Shows gene 
expression at different developmental stage, the stages are shown as pictures. The 
number of microarrays from which the mean of each MORC is derived is shown below 
each developmental stage. B: Shows gene expression in flowers and siliques in the rdr2-
1 and dcl3-1 mutants. Again the number of microarrays from which the means are 
produced for each mutant line is shown at the bottom of the graph. C: Shows gene 
expression in different tissues and the tissue type for each data point is shown to the 
left of the graph. The number of microarrays used to produces the means for each tissue 
type are shown to the right of the graph. 
3.3.8 Conserved protein structure of MORC protein family 
Having identified that there are seven MORC proteins in Arabidopsis, their 
protein sequence was compared against each other in order to identify 
differences in protein structure. All MORCs in Arabidopsis contain the core GHKL 
ATPase domain and a single coiled coil domain, with the exception being 
AtMORC3 that lacks part of the core GHKL domain (Figure 3.13). Five of the 
MORCs also have areas of low sequence complexity, these are areas with a bias 
towards a specific amino acid or acids and are known as low-complexity regions 
(LCRs) (Coletta et al. 2010). Their exact role is unclear but proteins with LCRs bind 
to a larger number of other proteins than other proteins in the same family that 
lack LCRs (Ekman et al. 2006). It is also suggested that LCR found at the ends of 
proteins are associated with proteins involved in transcription whereas proteins 
with LCRs found in the centre are involved in translation or stress response 
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(Coletta et al. 2010). The five MORC proteins with LRCs have LCRs at both 
terminal and central regions of the protein, except MORC3 which only has a 
central LCR (Figure 3.13). This would suggest, along with the truncated GHKL 
domain, that MORC3 has a more specialised function than the other MORCs, 
perhaps in either translation or stress response. The fact that the other MORCs 
have both terminal and central LCRs could suggest they are involved in 
transcription or stress response, although further work would be required to 
prove this. The lack of LCRs for MORC5 and MORC6 may suggest that these two 
proteins have a reduced number of binding partners than the other MORCs, 
although again this would need to be tested experimentally. 
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Figure 3.13: Conserved domain structure of the Arabidopsis MORC protein 
family 
Diagrams showing the domain structure of the Arabidopsis MORC proteins and Mus 
musculus MORC1 protein. For each protein the total size is given on the right and the 
start and end amino acid for each domain is given above and below each schematic. The 
GHKL ATPase domain is shown in red; the coiled coil domain is shown in green; and the 
zinc finger domain is shown in orange. Low complexity regions (LCRs) are highlighted in 
purple. The MmMORC1 protein is representative of Metazoa MORCs while the 
Arabidopsis MORCs are representative of Plantae MORCs. For MmMORC1 there is LCR 
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not shown as it overlaps with the 2nd coiled coil domain. Its position is between the 904th 
and 917th amino acids. 
The Arabidopsis MORC proteins were also compared against orthologs from 
Plantae and Metazoa species in order to identify differences in protein structure 
between species. The species chosen were: Medicago truncatula, Populus 
trichocarpa, Vitis vinifera, Oryza sativa, Zea mays, Physcomitrella patens, 
Selaginella moellendorffii, Mus musculus, Homo Sapiens, Bos taurus, Xenopus 
tropicalis, Danio rerio, Caenorhabditis elegans, Nematostella vectensis and 
Myroides odoratimimus. M. odoratimimus is a prokaryote with a MORC homolog 
and acts as an outgroup to the other MORCs. Seven Plantae species, excluding 
Arabidopsis, were chosen and include three dicots (M. truncatula, P. trichocarpa 
and V. vinifera), two monocots (O. sativa and Z. mays), P. patens as an example 
of a lower plant and S. moellendorffii which is a member of the oldest extant 
vascular plant lineage. Seven Metazoan species were also chosen and includes 
two invertebrate species (C. elegans and N. vectensis), three mammalian species 
(H. Sapiens, M. musculus and B. taurus), an amphibian species (X. tropicalis) and 
a fish species (D. rerio). These species were chosen in order to provide 
information on MORC protein structure in a broad range of Plantae and 
Metazoan lineages representing different evolutionary stages. The MORCs were 
identified by BLAST searches using the MORC1 sequence from Arabidopsis and 
selection of hits with more than 40% sequence homology to the MORC1 
sequence. This method may not identify all MORCs within these species and a 
more exhaustive search would be required to identify any other MORCs, but 
should be sufficient for comparisons of MORC protein structure. The number of 
MORCs identified in each species varied, with the highest being Physcomitrella 
patens with nine MORCs and the lowest M. musculus, D. rerio and C. elegans 
with one MORC identified in each species (Table 3.8). However, generally Plantae 
species have more MORC proteins than Metazoan with an average of 5 MORCs 
per species compared to 2.1 MORCs per species in Metazoa. This could suggest 
greater diversification of function in Plantae than Metazoa. A total of fifty six 
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MORC proteins were identified, of which forty are from Plantae, fifteen are from 
Metazoa and one is from prokaryotes. 
Both Plantae and Metazoan MORC proteins are characterised by the presence of 
the GHKL ATPase domain (Table 3.8 and Appendix 1.8 page 375). Most MORCs 
also contain at least one coiled coil domain, allowing interaction with other 
proteins. There are however exceptions, with M. truncatula, P. patens, P. 
trichocarpa, B. taurus and N. vectensis each having one MORC that lacks a coiled 
coil domain and all S. moellendorffii MORCs lack the coiled coil domain. The lack 
of coiled coil domains in S. moellendorffii is likely to be due to incomplete 
sequences as the length of the sequences were noticeably shorter compared to 
other species and the fact that both the higher plants and P. patens, which 
diverged from other plant species before S. moellendorffii, have MORC proteins 
with coiled coil domains. However, for the species that have a single MORC 
protein lacking a coiled coil domain the sequences appear to be full length and so 
would suggest that these proteins may have a different function from other 
MORCs. The fact that the Plantae (P.patens)and Metazoan (N. vectensis) species 
that were first to diverge from the other species in their respective kingdoms 
both have a MORC protein lacking a coiled coil domain could suggest that the 
last common ancestor to plant and animal species contained a MORC protein 
lacking this domain. This has subsequently been lost in most higher Plantae and 
Metazoan species but some species have retained it and so this MORC may have 
species specific functions. The bacterial MORC homolog in M. odoratimimus 
contains a coiled coil domain and therefore would suggest the prokaryotic 
ancestor to MORC proteins had a coiled coil domain meaning that the MORCs 
lacking this domain found in lower eukaryotic species may have lost the domain 
rather than the other MORCs gaining the coiled coil domain. However more 
prokaryotic MORC homologs would need to be assessed to determine if this 
indeed true.  
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Name Organism Kingdom 
Protein 
length (aa) 
GHKL ATPase Domain 
(aa) 
Coiled Coil Domains (aa) 
Zinc Finger 
Domain (aa) 
AtMORC1 Arabidopsis thaliana Plantae 635 100-234 688-633 None 
AtMORC2 Arabidopsis thaliana Plantae 626 92-227 579-618 None 
AtMORC3 Arabidopsis thaliana Plantae 486 001 -91 440-482 None 
AtMORC4 Arabidopsis thaliana Plantae 816 169-311 718-813 None 
AtMORC5 Arabidopsis thaliana Plantae 706 116-251 587-666 None 
AtMORC6 Arabidopsis thaliana Plantae 663 127-272 615-662 None 
AtMORC7 Arabidopsis thaliana Plantae 707 178-320 618-702 None 
MtMORC1 Medicago truncatula Plantae 943 346-463 889-943 None 
MtMORC2 Medicago truncatula Plantae 577 69-206 None 458-503 
PtMORC1 Populus trichocarpa Plantae 627 95-225 573-617 None 
PtMORC2 Populus trichocarpa Plantae 653 123-253 None None 
PtMORC3 Populus trichocarpa Plantae 518 132-268 29-50 None 
PtMORC4 Populus trichocarpa Plantae 862 171-311 728-812 None 
VvMORC1 Vitis vinifera Plantae 653 99-231 601-644 None 
VvMORC2 Vitis vinifera Plantae 641 87-219 589-632 None 
VvMORC3 Vitis vinifera Plantae 709 143-281 648-704 None 
VvMORC4 Vitis vinifera Plantae 631 65-199 670-627 None 
VvMORC5 Vitis vinifera Plantae 830 170-310 735-822 None 
OsMORC1  Oryza sativa Plantae 629 64-190 575-618 None 
OsMORC2  Oryza sativa Plantae 682 154-289 622-682 None 
OsMORC3  Oryza sativa Plantae 819 270-408 737-792 None 
OsMORC4  Oryza sativa Plantae 788 139-281 679-787 None 
OsMORC5  Oryza sativa Plantae 715 143-280 658-709 None 
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Name Organism Kingdom 
Protein 
length (aa) 
GHKL ATPase Domain 
(aa) 
Coiled Coil Domains (aa) 
Zinc Finger 
Domain (aa) 
ZmMORC1 Zea Mays Plantae 771 134-276 667-771 None 
ZmMORC2 Zea Mays Plantae 798 154-297 688-797 None 
PpMORC1 Physcomitrella patens Plantae 790 158-292 689-756 None 
PpMORC2 Physcomitrella patens Plantae 800 157-292 688-795 None 
PpMORC3 Physcomitrella patens Plantae 752 112-245 641-748 None 
PpMORC4 Physcomitrella patens Plantae 848 196-318 737-766 and 794-846 None 
PpMORC5 Physcomitrella patens Plantae 666 158-302 None 564-609 
PpMORC6 Physcomitrella patens Plantae 801 156-288 688-796 None 
PpMORC7 Physcomitrella patens Plantae 785 159-277 670-781 None 
PpMORC8 Physcomitrella patens Plantae 386 14-114 337-363 None 
PpMORC9 Physcomitrella patens Plantae 1226 502-579 1109-1139 and 1162-1189 None 
SmMORC1 Selaginella moellendorffii Plantae 394* 25-160 None None 
SmMORC2 Selaginella moellendorffii Plantae 417* 44-188 None None 
SmMORC3 Selaginella moellendorffii Plantae 390 19-145 None None 
SmMORC4 Selaginella moellendorffii Plantae 387* 53-188 None None 
SmMORC5 Selaginella moellendorffii Plantae 477 31-155 None 419-468 
SmMORC6 Selaginella moellendorffii Plantae 364 59-157 None None 
MmMORC1 Mus musculus Metazoa 950 24-162 281-311 and 885-916 480-529 
HsMORC1 Homo sapiens Metazoa 984 25-162 283-353 and 900-934 481-530 
HsMORC2 Homo sapiens Metazoa 1032 26-164 
285-362, 547-583 and 963-
1013 
494-543 
HsMORC3 Homo sapiens Metazoa 939 26-159 686-738 and 767-873 408-453 
HsMORC4 Homo sapiens Metazoa 937 48-179 762-878 424-471 
BtMORC1 Bos taurus Metazoa 981 25-163 283-353 and 900-934 482-531 
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Name Organism Kingdom 
Protein 
length (aa) 
GHKL ATPase Domain 
(aa) 
Coiled Coil Domains (aa) 
Zinc Finger 
Domain (aa) 
BtMORC2 Bos taurus Metazoa 1038 26-164 
285-322, 547-583, 746-763 
and 974-1019 494-543 
BtMORC3 Bos taurus Metazoa 713 26-163 None 409-454 
XtMORC1 Xenopus tropicalis Metazoa 890* 69-206 840-863 530-577 
XtMORC2 Xenopus tropicalis Metazoa 943 26-164 284-324 and 547-583 494-543 
XtMORC3 Xenopus tropicalis Metazoa 902 26-158 674-759 and 781-837 406-451 
DrMORC2 Danio rerio Metazoa 1035 26-168 
285-322, 548-584, 720-757 
and 870-1016 
494-543 
CeMORC1 Caenorhabditis elegans Metazoa 845 31-145 284-311 None 
NvMORC1 Nematostella vectensis Metazoa 436* 13-142 None 382-431 
NvMORC2 Nematostella vectensis Metazoa 689 28-160 293-322 and 556-594 503-552 
MoMORCH Myroides odoratimimus Bacteria 668 20-161 448-480 None 
Table 3.8: Comparison of domain structure of Plantae and Metazoa MORC proteins 
Table listing MORC proteins in Plantae and Metazoa and also a MORC homolog (MORCH) from the bacteria species Myroides odoratimimus (Mo). The 
Plantae species are: Arabidopsis thaliana (At), Medicago truncatula (Mt), Populus trichocarpa (Pt), Vitis vinifera (Vv), Oryza sativa (Os), Zea mays (Zm), 
Physcomitrella patens (Pp) and Selaginella moellendorffii (Sm). The Metazoa species are: Mus musculus (Mm), Homo Sapiens (Hs), Bos taurus (Bt), 
Xenopus tropicalis (Xt), Danio rerio (Dr), Caenorhabditis elegans (Ce) and Nematostella vectensis (Nv). The kingdom that each species belongs to is 
shown in the table. For all species there are multiple MORCs in each species bar M. Musculus, D. rerio and C. elegans which have only one each. For 
each MORC the length of the protein is given in amino acids (aa). The position of the start and end of the GHKL ATPase domains, coiled coil domains 
and zinc finger domains are given as amino acid positions in the sequence. For those sequences with an asterisk next to the protein length, these 
sequences are incomplete as they lack the methionine start codon. 
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There are two clear differences between Plantae and Metazoa MORCs. One is 
that Plantae MORC proteins have a single coiled coil domain whereas Metazoa 
MORC proteins can have multiple coiled coil domains, which may suggest a 
divergence in function between Plantae and Metazoa MORCs (Table 3.8 and 
Figure 3.13). The other difference between Plantae and Metazoa is the presence 
of a CW zinc finger domain in Metazoa MORCs and absence in Plantae MORCs, 
with the exception M. truncatula, P. patens and S. moellendorffii which each 
have a single MORC that has a zinc finger motif. This raises the question of 
whether the Plantae MORCs have lost the zinc finger domain or the Metazoa and 
three Plantae MORCs have gained the zinc finger domain. The bacterial outgroup 
used in the alignment also lacks the zinc finger motif and would therefore 
suggest that the Metazoa and three Plantae MORCs have gained the zinc finger 
domain rather than a loss of the zinc finger domain in Plantae MORCs. This 
would require further analysis to prove as only one bacterial MORC homolog was 
used and more Plantae and Metazoa species would need to be tested.  
There are four conserved sequence motifs found in the GHKL ATPase domain 
that are characteristic of this specific ATPase (Table 3.6) (Bergerat et al. 1997). 
The four motifs could be identified in all MORC proteins, except AtMORC3 and 
PpMORC8 that both lack motif I and in the case of AtMORC3 half of motif II 
(Figure 3.13 and Appendix 1.8 page 375). Both these proteins are truncated at 
the N-terminus but AtMORC3 is unlikely to be a evolutionary conserved form of 
PpMORC8 as it would appear to be the product of a recent gene duplication in 
the Arabidopsis genus. These two proteins may have a specialised function due 
to the large scale changes in the main functional domains or are in the process of 
becoming pseudogenes. 
3.3.9 Evolution of the MORC protein family in eukaryotes 
From the assessment of the domain structure of MORC proteins in both Plantae 
and Metazoa there appears to be a clear distinction between the two kingdoms 
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in terms of domain structure of MORCs. To assess the evolutionary relationship 
between the MORCs both between and within the two kingdoms a phylogenetic 
tree was produced using the fifty six protein sequences used in the protein 
sequence alignments. The tree produced is a phylogram so the length of the 
branches represents the percentage change in amino acid sequence from the last 
common ancestor with other sequences and can be a used as a measure of 
evolutionary separation, but does not indicate exact time in years since 
divergence. The prokaryote MORC sequence from M. odoratimimus was again 
used as an outgroup for the phylogram, as it will be the most evolutionary 
distant from the eukaryote sequences. 
As expected the Plantae and Metazoa MORCs form separate clades, except 
MtMORC2, PpMORC6 and SmMORC5. Both MtMORC2 and PpMORC6 separate 
from all other MORC proteins and SmMORC5 shows closest similarity to Metazoa 
MORCs, rather than Plantae MORCs (Figure 3.14). These three MORC proteins 
contain a zinc finger motif domain, which is not seen in any other Plantae species 
and therefore would suggest that this protein has evolved separately from other 
Plantae MORCs. The fact that S. moellendorffii and P. patens are lower plant 
species may suggest that early Plantae species did have a MORC protein with a 
zinc finger domain, but this has been lost in higher plants, except M. truncatula. 
The reason for M. truncatula maintaining the zinc finger domain may be related 
to the fact that it is the only legume species tested in the phylogenetic tree and 
therefore the zinc finger containing MORC protein may be required for a function 
specific to legumes. Attempts were made to identify MORCs in the legumes 
Gylcine max and Lotus japonicas to test this hypothesis but did not identify any 
full length sequences that could be used to analyse the domain structure and 
construct a phylogenetic. Further testing is therefore required in order to 
determine if legumes require this zinc finger containing MORC and if higher 
order Plantae species have lost this zinc finger containing MORC. 
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Figure 3.14: Phylogenetic tree of MORCs in the Plantae and Metazoa kingdoms 
Phylogram of Plantae and Metazoa MORC proteins from the following species: Myroides 
odoratimimus (Mo). Arabidopsis thaliana (At), Medicago truncatula (Mt), Populus 
trichocarpa (Pt), Vitis vinifera (Vv), Oryza sativa (OZ), Zea mays (Zm), Physcomitrella 
patens (Pp), Selaginella moellendorffii (Sm), Mus musculus (Mm), Homo Sapiens (Hs), 
Bos taurus (Bt), Xenopus tropicalis (Xt), Danio rerio (Dr), Caenorhabditis elegans (Ce) and 
Nematostella vectensis (Nv). The prokaryote M. odoratimimus.is used as a outgroup for 
this tree and is shown at the bottom of the phylogram in red. Plantae species are shown 
in green while Metazoa species are shown in purple. A scale for the phylogram is shown 
at the bottom right and shows the length on the phylogram representing a 0.1 (10 %) 
change in the amino acid sequence. The brackets to the right of the phylogram denote 
MORC evolutionary clades. 
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Within the two kingdoms the other MORC proteins form distinct evolutionary 
clades. There are two clades of MORC protein in Metazoa, described hence forth 
as Metazoan (MZ) 1 and MZ 2. The two clades would suggest that there has been 
divergence in the function of MORC proteins into two distinct classes, although 
the nature of these functions is unknown due to the lack of data on MORC 
function. This separation into the two clades occurs in Anthozoa, Amphibia and 
Mammalia MORCs so would therefore suggest that the two types of MORC 
existed early in Metazoa evolution. The C. elegans MORC has not been assigned 
a clade in Figure 3.14 due to the large difference between it and other Metazoan 
MORCs, although it is most similar to the MZ 1 clade. The MZ 1 clade can be 
subdivided into two sub-clades, MZ 1A and MZ 1B, MZ 1A comprising of the 
mammalian and amphibian MORC1 orthologs and MZ 1B comprising of 
Metazoan MORC2 orthologs (Figure 3.14). Two of the MZ 1A sub-clade have 
been previously shown to be expressed specifically in the male germ cells 
whereas HsMORC2, which is part of the MZ 1B sub-clade is expressed in somatic 
tissue as well as germ cells (Nagase et al. 1998, Inoue et al. 1999, Wang et al. 
2010). This means that the appearance of two sub-clades could be the results of 
the MORCs in the MZ 1A sub-clade having a specialised function in vertebrate 
male germ cells.  
There are also two clades in Plantae, described as Plantae (PL) 1 and PL 2 from 
henceforth, and all plant species except M. truncatula have at least one MORC 
protein in each clade, suggesting that two clades must have existed early in the 
plant evolution (Figure 3.14). Interestingly both lower Plantae species have only 
one sequence in the PL2 clade whereas higher plants have a number of paralogs 
in this clade. This could suggest that there has been a divergence in function of 
MORCs within this clade in higher plants and it should be noted that MORC6 is 
within this clade so it is possible this divergence is in relation to RdDM. In the PL1 
clade the two lower plant species separate both from each other and from the 
higher plant species to the point that they could form two sub-clades. This would 
again indicates a divergence in function between the higher plant and the lower 
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plant MORCs. Within the PL2 clade there are two sub-clades PL2A and PL2B of 
which PL2A consists of AtMORC1 homologs and PL2B consists of AtMORC6 
homologs. This again could suggest functional divergence and it should be noted 
that AtMORC1 and AtMORC6 both have a function in RdDM, but AtMORC1 also 
has a function in pathogen response so it could be related to this difference in 
function (Kang et al. 2008, Kang et al. 2010, Moissiard et al. 2012). Within each 
clade different species have undergone expansion in the number of MORC 
proteins, for instance in Arabidopsis only AtMORC6 resides within the PL 2B 
clade, but both Populus and Vitis have two AtMORC6 orthologs within this sub-
clade. Assuming that the phylogram is correct in when the last common ancestor 
for the MORCs are, it would also appear both Plantae clades are most similar to 
the MZ 2 clade of Metazoa, which may suggest that Plantae MORCs are more 
functionally similar to Metazoan MORCs in the 2nd clade.  
Looking specifically at MORC evolution with respect to Arabidopsis, the 
phylogram shows that AtMORC6 is distinct from the six other MORCs and that 
the other MORCs fall into two groups, these groups comprising AtMORC4, 5 and 
7 (PL 1 clade) and AtMORC1, 2 and 3 (PL 2A clade) (Figure 3.14). Comparisons 
between these two groups show that AtMORC1 and its homologs are more 
similar to each other than AtMORC4 and its homologs. The percentage 
difference between AtMORC1, 2 and 3 is small indicating a recent last common 
ancestor and this idea is supported by the fact that these MORCs are found 
together on chromosome four, hence are most likely due to recent gene 
duplication events (Figure 3.14). This similarity is supported by the fact that both 
AtMORC1 and AtMORC2 are involved in pathogen response in Arabidopsis and 
have similar domain structure (Figure 3.13) (Kang et al. 2008, Kang et al. 2010). 
However, AtMORC3 has not been reported to be involved in pathogen response 
and appears to have undergone a truncation of the GHKL ATPase domain, so may 
have an entirely different role to the other two PL 2A MORCs. The other group 
shows more divergence with AtMORC4 being the most distantly related of the 
three MORCs. This can be seen by the fact that it is nearly one hundred amino 
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acids longer than the other two proteins (Figure 3.13). There is no information 
on the functions of AtMORC4, 5 and 7 so it cannot be determined if the 
differences affect function. 
3.4 Discussion 
3.4.1 Identification of MORC6 as the mutant RdDM gene 
Premature stop codon mutations in the MORC6 gene have been identified in 
lines M1, M9 and rmd6, suggesting that MORC6 is responsible for the 
reactivation of the GFP transgene and this was confirmed by a complementation 
assay with a known morc6 line. Two groups have identified MORC6 as a 
component of the RdDM pathway in Arabidopsis (Lorković et al. 2012, Moissiard 
et al. 2012). The previously identified morc6 mutant lines have been designated 
atmorc6-1, atmorc6-2, atmorc6-3 and atmorc6-4, therefore the three mutants 
identified in this study have been designated atmorc6-5 (M1), atmorc6-6 (M9) 
and atmorc6-7 (rmd6) (Table 3.9). The T-DNA insertion line (atmorc6-3) has been 
shown to be a full knockout of MORC6 as no mRNA transcript can be detected 
for this gene, however both previous studies did not show whether MORC6 is 
expressed as a truncated protein or whether the transcript is targeted by non-
sense mediated decay in the three EMS morc6 mutants (Lorković et al. 2012, 
Moissiard et al. 2012). This is also true for the three mutants identified in this 
study; however assuming the mutants express a truncated form of the MORC6 
protein, there is predicted to be a difference in the severity of the mutations. In 
all EMS mutant lines the coiled coil domain of MORC6 is missing so the protein 
should not be able to interact with other proteins, such as DMS3, or dimerise 
with itself or other MORCs. This would be expected to inhibit any MORC6 
function that requires MORC6 to bind to other proteins, but may not prevent any 
function that does not require interaction with other proteins. M1 lacks the 
GHKL ATPase domain and so could be considered a full MORC6 knockout, 
whereas the other five EMS morc6 lines contain a truncated form of the GHKL 
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domain. It has been shown that such a truncation reduces, but does not 
eliminate, ATPase activity in atmorc6-4, so it is possible that the other four 
MORC6 mutant proteins also have residual ATPase activity and may not be full 
knockouts of MORC6 (Lorković et al. 2012). However, atmorc6-4 produces a 
longer truncated protein than the other four morc6 lines and so would be 
expected to be the weakest allele in terms of loss-of-function. To determine 
whether the other MORC proteins have ATPase activity would require 
biochemical testing, but an indication of their activity can be derived from 
comparing the phenotype of M1, a full MORC6 knockout, against the phenotypes 
of M9 and the other morc6 lines to determine if they are full knockouts. 
Mutant Mutation type Exon affected Codon affected Identified by 
atmorc6-1 EMS 9 267 Moissiard 
atmorc6-2 EMS 9 293 Moissiard 
atmorc6-3 T-DNA  4 NA GABI-KAT line 
atmorc6-4 EMS 13 439 Lorković 
atmorc6-5 EMS 2 41 This study 
atmorc6-6 EMS 9 267 This study 
atmorc6-7 EMS 12 392 This study 
Table 3.9: morc6 mutant lines in Arabidopsis 
Table showing all seven morc6 lines in Arabidopsis thaliana and which study they were 
discovered by. The type of mutation is shown for each line, either an EMS base 
substitution mutation or T-DNA insertion mutation. The exon and codon where the 
mutation is located is given for each mutant, apart from the T-DNA insertion line where 
only the affected exon is given. 
The MORC6 gene is homologous to the mouse Microrchidia 1 (MORC1) gene, 
hence was given the name AtMORC6 or MORC6, but is also referred to as 
defective in meristem silencing 11 (dms11) (Lorković et al. 2012, Moissiard et al. 
2012). MORC proteins are characterised by the presence of a GHKL ATPase and 
coiled coil domain and are found in both eukaryotes and prokaryotes (Perry and 
Zhao 2003, Iyer et al. 2008). The GHKL ATPase domain is one of several ATPase 
domain families that catalyses the hydrolysis of ATP providing energy for protein 
function and this particular family has a unique ATP binding fold, known as the 
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Bergerat fold, which distinguishes the GHKL family from other ATPases (Bergerat 
et al. 1997). The Bergerat fold consists of four βsheets and three α helices that 
form a unique cone shaped structure and contains four highly conserved 
sequence motifs, known as the N box and G1-G3 boxes, that bind the ATP 
molecule (Bergerat et al. 1997, Mushegian et al. 1997, Ban and Yang 1998, Dutta 
and Inouye 2000). This domain was initially identified in four protein families: 
DNA gyrases, histidine kinases, mismatch repair enzymes and chaperone 
proteins; hence the domain is known as the Gyrase, HSP90, histidine kinase, 
MutL ATPase (GHKL) domain, HSP90 being a chaperone and MutL being a 
mismatch repair enzyme (Bergerat et al. 1997, Ban and Yang 1998, Tanaka et al. 
1998, Ban et al. 1999, Bilwes et al. 1999, Dutta and Inouye 2000). The GHKL 
ATPase domain is thought to have evolved from a bacterial restriction enzyme 
system and to be mainly associated with enzymes that carry out chromatin 
modification (Iyer et al. 2008). The coiled coil domain allows for protein-protein 
interaction (Crick 1952, Mason and Arndt 2004). 
Despite MORC6 been previously identified as an RdDM component and therefore 
no longer a novel mutant in the pathway, the mutants identified in this study can 
be used to expand on the phenotype and role of MORC6 in RdDM, especially as 
the two previous studies give differing phenotypes for morc6 mutants and as 
such have drawn different conclusions regarding the exact role of the MORC6 
protein in the pathway. The study by Moissiard shows that there is large scale up 
regulation of RNA transcripts in the morc6 mutants and that these are associated 
with loci that are silenced by the RdDM pathway (Moissiard et al. 2012). 
However, there are no global changes in either siRNA or DNA methylation levels 
in the morc6 mutant, although there are localised increases and decreases in 
methylation. The morc6 mutants do not have changes in the repressive histone 
mark H3K9me2, but do show loss of higher order chromatin structure and this is 
seen by decondensation of pericentromeric higher order chromatin structures 
known as chromocentres. It was also shown that MORC6 localised to the nuclear 
bodies adjacent to these chromocentres and so this study concluded that 
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MORC6 was likely to be involved in the formation of higher order chromatin 
structure in response to DNA methylation and repressive histone marks. It is 
thought that this higher order structure reinforces silencing by RdDM and that 
perturbation of MORC6 results in the loss of these higher order structures. 
The study by Lorković also showed local changes in DNA methylation, although 
no global measure of DNA methylation was carried out (Lorković et al. 2012). 
DNA methylation is lost in the GFP reporter and at three intergenic (IGN) RdDM 
targets , but other targets such as the transposable elements AtSN1 and SoloLTR 
do not lose methylation. This loss in methylation at the GFP reporter transgene 
was also associated with a loss in H3K9me2 repressive histone marks and a gain 
in histone acetylation, which is a mark of euchromatin. This loss of DNA 
methylation and histone repressive marks was not associated with a decrease in 
siRNAs but there was a decrease in the transcripts produced by PolV. It was 
therefore concluded that MORC6 is involved in the production of the PolV 
transcript and the resulting methylation of the DNA. To support this idea it was 
shown that MORC6 interacts with, and has a similar expression pattern to DMS3, 
a hinge domain protein previously identified as a RdDM component (Kanno et al. 
2008, Ausin et al. 2009, Lorković et al. 2012). DMS3 mutants also cause a 
reduction in DNA methylation and loss of PolV transcripts. The MORC6-DMS3 
complex resembles a structural maintenance of chromosomes (SMC) protein, 
which have ATPase and hinge domains, but are usually encoded by one gene 
rather than two separate genes as is the case here (Hirano 2002, Hirano 2005). 
MORC6 contains two domains, a GHKL ATPase and coiled coil domain and it is 
through the coiled coil domain that it interacts with DMS3, but can also dimerise 
with itself to form homeodimers (Lorković et al. 2012). This suggests that MORC6 
may function in the RdDM pathway in a complex with DMS3, but may also have 
other functions in RdDM that do not require DMS3. The MORC6-DMS3 complex 
is unusual as there is only one other known SMC with a GHKL domain, the mouse 
SmcHD1, which is involved in X chromosome inactivation through CG 
methylation (Blewitt et al. 2008, Lorković et al. 2012). 
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3.4.2 Arabidopsis MORC family 
MORC6 is one of a family of seven MORC proteins found in Arabidopsis thaliana 
and a literature search reveals that the MORC4, MORC5 and MORC7 genes have 
not previously been characterised, but MORC1, MORC2 and MORC3 have been. 
The three MORC genes that have been previously characterised were first 
identified in a screen for mutants with reduced pathogen response to the Turnip 
Crinkle Virus (TCV) and it is because of this that MORC1 is also named 
Compromised recognition of TCV-1 (CRT1) and MORC 2 and MORC3 are named 
Compromised recognition of TCV homolog 1 (CRH1) and CRH2 respectively (Kang 
et al. 2008, Kang et al. 2010). The initial study identified MORC1 as a pathogen 
response gene but did not demonstrate a role for the close homologs, MORC2 
and MORC3 (Kang et al. 2008). A later study showed that both MORC1 and 
MORC2 are involved in general pathogen response and are not specific to TCV 
infection, but was unable to report a function for MORC3 as homozygous morc3 
mutants are embryonically lethal. This suggests that MORC3 has a vital role in 
the embryo (Kang et al. 2010). Both MORC1 and MORC2 act early on in pathogen 
response and interact with plant resistance (R) proteins and mutation in these 
two genes result in a failure to control viral replication or systemic spread in TCV 
infections. 
MORC1 has also been shown to be an RdDM component, thus has at least two 
cellular functions. This dual role is unusual as it is uncommon for proteins 
involved in chromatin modification to also have another function in a 
cytoplasmic pathway, although the RdDM components PolV and AGO4 have also 
been previously reported to function in pathogen response (Agorio and Vera 
2007, López et al. 2011, Moissiard et al. 2012). It is not known whether PolV, 
AGO4 and MORC1 interact with each other in pathogen response. This dual role 
for MORC1 raises the question of how it is involved in two such different 
pathways. The presence of both the coiled coil domains and LCRs in MORC1 may 
allow it to interact with a large number of different proteins and so its function 
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could be as a scaffold protein for a number of diverse pathways. However, this 
would require testing through interaction studies and biochemical analysis to see 
if MORC1 has any specific activity in the two pathways or acts as a general 
scaffold protein. In terms of its functions in RdDM, morc1 mutants are reported 
to have a similar phenotype to morc6 mutants and double mutants of the two 
genes do not result in a significant increase in the severity of the phenotype, 
therefore indicating that MORC1 and MORC6 act redundantly in RdDM 
(Moissiard et al. 2012). It is possible that other proteins in this family are also 
involved in RdDM and this has been suggested as a reason why loss of DNA 
methylation is loci specific in morc6 (Lorković et al. 2012). Of the five MORCs that 
have no known RdDM function, MORC2 is the most likely to have a role in RdDM 
due to its close homology to MORC1 and the fact that both it and MORC1 have 
previously been shown to act redundantly in pathogen response (Kang et al. 
2008, Kang et al. 2010). This hypothesis would need to be tested experimentally 
through DNA methylation analysis of mutants in the five untested MORC genes.  
From bioinformatics analysis of protein sequence and domain structure there 
has clearly been divergence in the roles of the MORC proteins such that not all 
MORCs may be involved in RdDM. Two studies have failed to isolate homozygous 
mutants in morc3, which is suggestive that mutations in this gene are lethal, at 
least during embryogenesis or seed germination (Kang et al. 2008, Kang et al. 
2010). This lethality of morc3 mutants would suggest a divergence in its role 
from that of MORC1, MORC2 and MORC6, which when mutated are not lethal, 
and this is supported by the fact that its GHKL ATPase domain is significantly 
altered compared to the other MORCs. MORC3 lacks the first and half of the 
second highly conserved motifs of GHKL ATPase domains and the domain itself is 
smaller than any other Plantae or Metazoa MORC. It is not known if any other 
Arabidopsis MORC has a similar role to MORC3 as although morc1, morc2 and 
morc6 mutants are not lethal, morc4, morc5 and morc7 mutants have yet to be 
reported on. None of the other six MORC proteins have such a large scale 
alteration to the GHKL domain as MORC3 but there are sequence differences 
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between the MORCs that may alter 3D structure and function. Experimental 
testing would be required to determine the effects of these sequence 
differences. 
The other main difference in terms of protein sequence between the MORC 
proteins is that both MORC5 and MORC6 lack the low complexity regions (LCR) 
found in the other MORC proteins. These regions are associated with proteins 
that act as hubs for protein binding and LCRs are therefore thought to increase 
the number of proteins that can bind (Ekman et al. 2006). This would therefore 
suggest that MORC1, MORC2, MORC3, MORC4 and MORC7 have an increased 
number of protein binding partners than MORC5 and MORC6 and therefore act 
as hub proteins, which could translate into these proteins being involved in a 
greater number of cellular pathways. MORC5 and MORC6 would therefore be 
more specific in their binding partners and hence be involved in a more limited 
number of pathways. This difference could explain why MORC1 has been shown 
to act in pathogen response and RdDM, which require MORC1 to bind to an 
entirely different set of proteins. However, the significance of the LCR 
differences between the MORC proteins would need to be verified by interaction 
studies for all MORCs. 
Gene expression data on the MORC proteins also shows differences between the 
MORC proteins. Microarray data for MORC5 expression is low both throughout 
development and in different tissue types, to the extent that it could be 
considered background noise from the microarray rather than expression of the 
MORC5 gene. This could suggest that MORC5 is actually a pseudogene or in the 
process of becoming one, but this would require further analysis of its expression 
pattern. The expression pattern of MORC6 is also of interest as it shows MORC6 
expression increases during flowering and is highest in pollen and therefore may 
have a similar function to that of the Mus musculus MORC1 protein, which is 
required for spermatogenesis, although its exact function in this process is 
unknown (Watson et al. 1998, Inoue et al. 1999). However, unlike mmmorc1 
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mutants where male mice are sterile, atmorc6 mutants are not sterile, which 
would suggest that there is either redundancy with other MORC proteins or that 
AtMORC6’s function in pollen is different to MmMORC1. There is also high 
expression in the female floral organs so MORC6 may instead be involved in the 
re-establishment of heterochromatin in the embryo and pollen and this could be 
linked to the increase in RdDM associated siRNAs during embryogenesis (Mosher 
et al. 2009, Slotkin et al. 2009). 
3.4.3 MORC function in other species 
The first MORC or Microrchidia gene to be identified and characterised was 
discovered in a forward genetic screen for mutants with defective 
spermatogenesis in mice (Mus musculus) (Watson et al. 1998). Homozygous male 
mice had a reduction in size of the testes, hence the gene name, but no 
phenotype was observed in homozygous female mice, indicating that the gene 
had a male specific function. Later studies showed this to be the case as MORC1 
is only expressed in male germ cells (Inoue et al. 1999). It was shown that morc1 
mutants caused an arrest of spermatogenesis at prophase I during either the 
leptotene or zygotene stages and that MORC localises to the nucleus in germ 
cells, thus suggesting that MORC1 has a role in chromatin organisation during 
meiosis. One of the human homologs of MORC also localises to the male germ 
cells, but other human homologs are found in somatic cells.  
MORC proteins have been studied in greatest detail in humans in which there are 
four MORC genes (Inoue et al. 1999, Liggins et al. 2007, Takahashi et al. 2007, 
Mimura et al. 2010, Shao et al. 2010, Wang et al. 2010). MORC1 is expressed in 
human male germ cells so is thought to have a similar function to the mouse 
MORC1 gene, but the other three human MORC genes are somatically expressed 
(Inoue et al. 1999), MORC2 is highly expressed in the testis, ovary and brain 
tissue and the protein is found predominantly in the nucleus but is also found in 
the cytoplasm at lower levels (Nagase et al. 1998, Wang et al. 2010). The MORC2 
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protein is a tumour suppressor gene and has been shown to repress gene 
expression, including the Carbonic Anhydrase IX gene which promotes growth 
and survival in tumour cells (Shao et al. 2010, Wang et al. 2010). Only the coiled 
coil domain and a proline rich domain, which mediates DNA binding, are 
required for this transcriptional repressor activity, suggesting that MORC2 may 
have other activities that require the GHKL ATPase and zinc finger domains. 
MORC4 has also been implicated in cancer but its exact function is unknown 
(Liggins et al. 2007). The other human MORC protein, MORC3, is required for p53 
activity and localisation into the promyelocytic leukemia (PML) nuclear bodies 
(NB) during cell senescence and the mutation of MORC3 results in reduced p53 
function (Takahashi et al. 2007). This activity of MORC3 requires the formation of 
MORC3 homodimers through the coiled coil domains of the two MORC3 proteins 
and it is thought that the dimer acts as a clamp (Mimura et al. 2010). Through 
conformational changes to the dimer, caused by ATP binding and hydrolysis, the 
dimer can close upon ATP binding and open upon ATP hydrolysis; and this closing 
and opening of the dimer results in the association and disassociation of MORC3 
with the PML NBs respectively.  
In terms of MORC proteins in other species having a role in RNA silencing and 
RNA interference, as is seen in Arabidopsis, previous studies have shown that 
MORC proteins are active predominantly in the nucleus and are involved in 
chromatin organisation or gene repression (Watson et al. 1998, Takahashi et al. 
2007, Iyer et al. 2008, Mimura et al. 2010, Shao et al. 2010, Wang et al. 2010, 
Moissiard et al. 2012). However although these activities are similar to that of 
the Arabidopsis MORC1 and MORC6 genes, no other study has shown a direct 
link between a MORC protein and RNA silencing or RNA. One of the studies that 
identified MORC6 as a RdDM component did show that in Caenorhabditis 
elegans, mutation of its sole MORC gene resulted in a loss of silencing of a GFP 
reporter and that this loss is phenotypically similar to the mutant in the RNA 
intereference component rde4 (Tabara et al. 2002, Moissiard et al. 2012). 
However, no direct interaction was shown between the MORC protein and C. 
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elegans RNA interference machinery. Further study of MORC function in relation 
to chromatin modification and RNA silencing in other species is therefore 
required to demonstrate whether MORC function in Arabidopsis is conserved in 
other species.  
3.4.4 Evolution of Plantae and Metazoa MORCs 
In Arabidopsis there has been a number of recent gene duplication events, seen 
in the close relationship between MORC1, MORC2 and MORC3 in terms of 
genome location and sequence similarity. These MORCs have undergone 
diversification of function, particularly MORC3, which has a truncated GHKL 
ATPase domain and homozygous mutations are lethal. However, both MORC1 
and MORC2 function in pathogen response, suggesting that there has not been 
as much divergence in terms of function between these two proteins as has 
occurred for MORC3. No other Plantae species used in this study had a gene 
duplication of MORC1 homologs, therefore suggesting that this duplication is 
recent and may have occurred only in Arabidopsis thaliana, although this would 
require a search for MORC1, MORC2 and MORC3 homologs in other species 
within the Arabidopsis genus. AtMORC6 has not undergone any gene 
duplications, although gene duplication events have occurred in MORC6 
homologs in both Populus and Vitis. The final clade, MORC4 homologs, has 
undergone gene duplication events as there are three Arabidopsis MORC genes 
within this clade and they are MORC4, MORC5 and MORC7. These three MORC 
genes are not as closely linked as the MORC1 homologs so this duplication may 
have occurred earlier in evolution than the duplication of MORC1, MORC2 and 
MORC3. Exactly when is not known, but it appears to have occurred after the last 
common ancestor with Populus and Vitis.  
MORC proteins are found in both Plantae and Metazoa and have orthologs in 
prokaryotes (Iyer et al. 2008). The main difference between MORCs in the two 
kingdoms is the presence of a zinc finger domain in Metazoan MORC proteins 
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but the lack of such a domain in the majority of Plantae MORCs. This could 
suggest divergence in function, although it is possible that Plantae MORCs 
interact with another protein that provides the zinc finger motif function. It is 
likely that this difference arose after the loss of the zinc finger motif in Plantae as 
zinc finger domains are found in lower plant species. However, as the prokaryotic 
homolog also lacks a zinc finger domain further investigation is required to 
support this conclusion. Plantae MORCs also only have one coiled coil domain 
whereas Metazoan MORCs can have one or more and this would result in either 
increased binding through these domains or alteration in protein folding due to 
interactions between the domains. This again may suggest a change in function, 
but this would require testing experimentally. Amongst the Plantae species there 
are two exceptions one in M. truncatula and the other in P. patens that contain a 
zinc finger protein but no coiled coil domain and could therefore have an entirely 
different function to other Plantae MORCs. This MORC may have been required 
in lower plants but not higher plants except M. truncatula which is the only 
legume analysed so may have retained this MORC for a legume specific function. 
These two MORCs do not fall within either a Plantae or Metazoan MORC clade 
and would suggest a very different evolutionary history to other MORCs, thus 
would be an interesting prospect for further investigation.  
In both Plantae and Metazoa there has been an expansion in MORC proteins 
with each kingdom containing two clades of MORC and in both cases one of 
these clades can be sub-divided into two sub-clades. One of these sub-clades is 
associated with higher plant and animal species respectively and therefore may 
suggest the emergence of a third clade in higher organisms. Since both Plantae 
and Metazoa have two clades it is possible that the common ancestor of these 
two kingdoms had two MORC proteins. Although the phylogram shown in this 
study does not support this in terms of similarity between the MORC clades it 
should be noted that the phylogram represents differences between MORC 
sequence rather than time since divergence, hence it is possible that Metazoan 
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MORC proteins have undergone more rapid evolution than their Plantae 
counterparts.  
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4.1 Introduction 
4.1.1 Dual transgene silencing system 
The screen of the EMS mutant library for novel RdDM mutants identified M1 and 
M9 as alleles in morc6. The EMS mutant library used a dual transgene system to 
identify mutants in the RdDM pathway, consisting of a 35S promoter driven GFP 
gene (35Sp:GFP) and a nopaline synthase (NOS) promoter driven inverted repeat 
of part of the 35S promoter (NOSp:35S IR). How this system works has been 
described in detail in the introduction of chapter three (page 124); but briefly, 
the 35S IR transgene, through self-complementarityproduces a dsRNA transcript 
that is recognised by the RdDM pathway which, due to sequence homology, will 
target and methylate the 35S promoter of the GFP transgene and therefore 
silence the transgene. RdDM mutants lose this silencing of the GFP transgene 
and so are fluorescent. Having used this fluorescence to first identify the M1 and 
M9 mutants, their effect on the silencing of the GFP transgene will be studied in 
detail in this chapter. Before discussing this I will briefly cover other transgene 
silencing systems and the advantages and disadvantages for each system. 
This GFP dual transgene system, used in this study, has several advantages. 
Firstly identification of RdDM mutants is straightforward as putative mutants can 
be screened for GFP fluorescence. The system can also detect RdDM mutants 
with a weak phenotype as partial release of GFP can still be detected in this 
system. GFP fluorescence can also be used to assess the effect of the RdDM 
mutant on different tissue types. The main disadvantage of this system is that 
both transgenes are required for the system to work. It is a lengthy process 
transforming both transgenes into a plant line and demonstrating that they are 
both functional. This makes it prohibitive to test RdDM mutants, which currently 
lack the transgenes system.  
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4.1.2 Other transgene silencing systems 
As well as the transgene system used in this study there are several other 
systems that have been used to identify RdDM mutants each with their own 
strengths and weaknesses. In this section I will briefly go over how each system 
works and the advantages and disadvantages for each system. There are several 
systems that are similar to the one used in this work. In each case a reporter 
transgene is silenced by an inverted repeat of the promoter used to drive the 
reporter gene. In one case the seed specific α’ promoter was used to drive a GFP 
reporter transgene while the inverted repeat of the α’ promoter is driven by the 
NOS promoter (Kanno et al. 2004). As the α’ promoter is seed specific it allows 
for detection of RdDM mutants in seeds speeding up the process of detecting 
mutants. However as the GFP transgene is only expressed in seeds it cannot be 
used to look at tissue specific effects of RdDM mutants. The other similar 
transgene system uses a NOS promoter driven kanamycin resistance gene (NPTII) 
transgene as a reporter and a 35S promoter driven inverted repeat of the NOSp 
transgene as a silencer (Aufsatz et al. 2002b). RdDM mutants are then selected 
by resistance to kanamycin from release of silencing of the NPTII transgene. This 
makes identification of RdDM mutants straightforward as only RdDM mutants 
will survive on kanamycin plates. It does however mean that RdDM components 
with a small effect on silencing may not be detected as their partial reduction in 
silencing of the NPTII gene may not be enough to confer resistance to 
kanamycin. Tissue specific effects can also not be detected in this system. 
One system utilises the silencing of the FWA flowering time gene (Cao and 
Jacobsen 2002b, Chan et al. 2004). In WT plants the expression of the FWA gene 
is silenced by methylation of two SINE related direct repeats at the 5’ end of the 
FWA gene (Soppe et al. 2000, Yuki et al. 2007). Methylation of FWA is normally 
stably transmitted from parent to progeny. Loss of methylation at the repeats 
causes FWA expression and leads to a delay in flowering time. If a FWA 
transgene is transformed into WT plants it is methylated by RdDM and does not 
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affect flowering time. In RdDM mutants this de novo methylation of the 
transgenic FWA does not occur and the transgenic FWA is expressed, resulting in 
late flowering. The FWA gene can therefore be introduced into mutant lines, 
both known and unknown to test if they are involved in the RdDM pathway (Cao 
and Jacobsen 2002b, Chan et al. 2004). As only a single transgene is required this 
system is effective at testing putative RdDM mutants, which currently lack a 
transgene system. The delay in flowering time also provides an indication of 
RdDM mutant’s effect on the pathway, whether it has a large or small effect on 
methylation. The disadvantage with this system is that identification of mutants 
takes longer than other systems as the screen is based upon flowering time. Also 
as the system is specific to flowering it cannot be used to identify tissue specific 
effects.  
In the RD29Ap:LUC transgene system rescue of bioluminescence is used to 
identify RdDM mutants. LUC is a firefly luciferase gene which results in 
bioluminescence when expressed. The RD29A promoter responds to either cold, 
salt, drought or abscisic acid stress (Yamaguchi-Shinozaki and Shinozaki 1994). 
The WT transgenic line of RD29Ap:LUC stably expresses LUC in stress conditions, 
but in the ros1 mutant the transgene is silenced by hypermethylation (Gong et al. 
2002). ROS1 is a DNA glycosylase involved in demethylation of DNA. So in ros1 
mutants DNA methylation is not removed and de novo hypermethylation can 
occur. The hypermethylation of RD29Ap:LUC can be reversed by mutating RdDM 
components (He et al. 2009a). Putative RdDM mutants can thus be identified by 
bioluminescence. The main advantages of this system are that mutants can easily 
be identified by bioluminescence and that RdDM mutants with a partial effect 
can be identified. The system also allows for identification of tissue specific 
effects. The disadvantage with this system is that any RdDM mutants identified 
will be in a ros1 mutant background. As the demethylation pathway is inactive in 
these plants this could conceivably influence the phenotype the RdDM mutant 
displays. This system cannot be easily transferred to existing mutants as the 
system requires the plants to be homozygous for a ros1 mutation. 
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The SDC:GFP transgene has recently been developed to identify mutants in both 
the RdDM and CMT3 pathways (Moissiard et al. 2012). In most plant tissues the 
SDC gene is silenced by both DRM2 and CMT3, which act redundantly (Zhang et 
al. 2006). Methylation is targeted to seven tandem repeats in the SDC promoter 
and these repeats are present in the promoter of the transgene (Henderson and 
Jacobsen 2008, Moissiard et al. 2012) This means that in WT plants the SDC 
promoter is methylated and GFP is not expressed but silencing can be released 
in drm2 cmt3 double mutants, although not in single mutants (Moissiard et al. 
2012). RdDM mutants can be identified by using the SDC:GFP transgene in a 
cmt3 background or for mutants that inhibit both CMT3 methylation and RdDM 
the SDC:GFP transgene can instead be used in a WT background. The advantages 
of this system are that mutants can easily be identified by GFP fluorescence and 
the level of fluorescence can give an indication of the mutant’s effect on the 
RdDM pathway. The disadvantage of this system is that to transfer the SDC:GFP 
transgene into a RdDM mutant line currently the transgene would also require 
the creation of a double mutant of the RdDM mutant and cmt3 in order for the 
system to work. 
The final transgene system that will be discussed is the JAP transgene system. 
The JAP line contains a single transgene. It comprises an inverted repeat of the 
PHYTOENE DESATURASE (PDS) gene driven by the phloem specific SUC2 
promoter (Smith et al. 2007). The inverted repeat triggers PTGS silencing of 
endogenous PDS gene resulting in photo bleaching of cells where PDS is silenced. 
The silencing of PDS is initially restricted to the phloem, but transmission of 
siRNAs out of the phloem trigger silencing in surrounding mesophyll tissue. 
Although strictly a PTGS process, RdDM is involved in both producing dsRNA 
from the transgene and also regulation of the transgene. RdDM proteins 
involved in the production of dsRNA, such as NPRD1, RDR2 and CLSY1, are 
required for PDS PTGS silencing and mutants in these proteins do not silence the 
PDS gene. As well as this role in dsRNA production, RdDM also acts as a regulator 
of PTGS from this transgene. Mutants in dcl3 and ago4 result in PTGS of PDS 
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spreading across the entire leaves. This indicates that RdDM triggers DNA 
methylation of the transgene, which reduces the extent of PTGS silencing. The 
main advantages of this system are that the phenotype of RdDM mutants are 
easily identifiable and the phenotype can inform as to whether the mutant is 
involved in dsRNA production or siRNA production and DNA methylation. The 
disadvantage of this system is that some RdDM mutants do not affect PDS 
silencing, such as DRD1 and NRPD2. The system may therefore not identify all 
RdDM mutants. 
4.1.3 Aims of chapter 
The aim of this chapter is to characterise the silencing phenotype of the 
35Sp:GFP transgene in the M1 and M9 mutants. This will be done by studying: 
A) Visible phenotype. Visualise the GFP silencing pattern in different plant 
tissues. 
B) The molecular phenotype. Ascertain siRNA levels and DNA methylation status 
of the 35S promoter. 
4.2 Results 
4.2.1 Delay in the silencing of GFP in M1 and M9 
In the two alleles of MORC6, M1 and M9, expression of the GFP transgene is 
enabled. Although it was observed that in seedlings GFP expression in M1 and 
M9 is comparable to 142, in adult plants M1 and M9 have lower levels of GFP 
than 142. This indicates that both M1 and M9 still have some capacity to silence 
the GFP transgene. To assess this plants from lines 142, 142S, M1 and M9 were 
observed and imaged using a fluorescence microscope at weekly intervals from 
germination. At 7 days post germination (dpg) GFP fluorescence in M1 and M9 is 
similar to that of 142, whereas for the parental line 142S, plants appear fully 
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silenced at 7 dpg (Figure 4.1 A-D). At 14 dpg GFP fluorescence in both M1 and 
M9 is reduced and is at an intermediate level between that of 142 and 142S 
(Figure 4.1 E-H). The intermediate level of fluorescence at 14 dpg is comparable 
to that previously seen in adult plants (Figure 3.4). This indicates that both M1 
and M9 undergo reduced levels of silencing compared to the parental 142S and 
that establishment of silencing is delayed in both mutants.  
 
Figure 4.1: Change in GFP silencing between 7 dpg and 21 dpg in M1 and M9 
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Seedlings were grown on soil in long day growth rooms and were imaged using a 
fluorescence microscope. Images of seedlings were taken of lines 142, 142S, M1 and M9 
at 7 dpg and 14 dpg. A scale bar is shown at the bottom of each image. 
In order to confirm this delay in silencing establishment a northern blot for GFP 
mRNA was completed. The aim of this analysis was to see if the onset of visible 
silencing that occurs between 7 dpg and 14 dpg correlates with a reduction in 
GFP mRNA in M1 and M9. RNA samples from aerial tissue of plants that were pre 
visual silencing onset (7 dpg) and post visual silencing onset (21 dpg) were taken 
from lines 142, 142S, M1, M9, rdr2-1 and rmd3. rdr2-1 lacks the GFP transgene 
so acts as a negative control for GFP mRNA detection (Xie et al. 2004). rmd3 is a 
mutant in the large subunit of PolIV (nrpd1) identified in the previous screen of 
the EMS mutant library used in this study (Eamens et al. 2008). At 7 dpg GFP 
mRNA levels in lines M1, M9 and rmd3 are similar to 142 (Figure 4.2). GFP mRNA 
in 142S is present at 7 dpg but at very low levels, compared with 142 or the three 
RdDM mutants. There is a marked decrease in GFP mRNA in all three RdDM 
mutant lines at 21 dpg. This provides molecular evidence of a delay in silencing 
onset in M1 and M9. The delay in silencing in rmd3 correlates with previous 
research, that silencing is delayed in nrpd1 mutants (Herr et al. 2005). There is 
also a decrease in GFP mRNA in 142S at 21 dpg compared to 7 dpg. However, the 
decrease is small and could be due to the proportion of tissue types in each 
sample. At 7 dpg the majority of tissue collected will be from cotelydon leaves, 
whereas at 21 dpg a larger proportion will be rosette leaves. It has been 
observed that silencing in 142S is comparably weaker in the cotelydon leaves 
than rosette leaves. This would explain the decrease in GFP mRNA between 7 
dpg and 21 dpg. The difference in the proportions of tissue types may also affect 
the M1 and M9 GFP mRNA levels, however as the change in 142S is small it could 
be argued that the effect of tissue types will be minor in M1 and M9. 
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Figure 4.2: Changes in the expression of GFP mRNA between 7dpg and 21 dpg 
Image of a northern blot probed with radio-labelled probes for GFP and ACTIN 2. 7 dpg 
and 21 dpg RNA samples of lines rdr2-1, 142, 142S, M1, M9 and rmd3 were used. 
Approximately 3 µg of total RNA was run for each sample. After being probed for GFP 
mRNA the blot was stripped and re-probed for ACTIN 2 mRNA as a loading control. rdr2-
1 does not possess the GFP transgene so acts as a negative control. 142 has ubiquitous 
GFP expression so acts as the positive control. 
4.2.2 Mosaic silencing pattern of GFP in the epidermal 
layers of leaves 
In order to further characterise the silencing phenotype and establish the exact 
time when silencing occurs in M1 and M9 a time course of GFP fluorescence was 
completed. Silencing was assessed daily on whole leaf samples from 7 dpg 
onwards, until silencing was established in the mutants, using confocal 
microscopy. The time course was repeated three times. GFP fluorescence was 
assessed in both the upper and lower epidermal layers of plant leaves. Only 
these two layers were used in the time course due to the difficulty in imaging the 
mesophyll layers in whole leaves. Due to absorption and refraction of the laser 
beam and light emitted by GFP the confocal microscope cannot image further 
than the first layer of mesophyll cells. In order to see if silencing in the epidermal 
layers varied between leaves of different ages, all odd numbered adult rosette 
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leaves (Figure 4.3) were imaged. Leaves were imaged from the parental line 142S 
and the two mutants M1 and M9. Leaves from line 142 were also imaged in 
order to show levels of GFP fluorescence without silencing. All plant lines were 
grown under a 16 hour long day growth regi`me. For time points where the 
hours post dawn are given, dawn is considered to be when lights turn on, which 
is at 5am in the growth rooms used for the time course. Before imaging under 
the confocal microscope leaves were first stained with propidium iodide. This 
stains plant cell walls, so any silenced cells which lack GFP, can be identified. All 
images taken of the epidermal layers were from a single focal plane as the 
curvature of the epidermal layers was low enough to allow visualisation of large 
areas of the leaf surfaces.  
 
Figure 4.3: Choice of leaves for confocal time course 
Diagram of Arabidopsis rosette from above. Each leaf is numbered according to when it 
appeared. The leaves marked with C are cotyledon leaves. Leaves where numbers are in 
white and are in a black circle are those used in the confocal time course. 
For the time points before the onset of silencing in M1 and M9 only the 10 dpg 
time point is shown as it is representative of the observed pre silencing 
phenotype. Before the onset of silencing GFP fluorescence in both M1 and M9 is 
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comparable to 142 (Figure 4.4 A, B and E to H). In these lines GFP and propidium 
iodide fluorescence co-localise. GFP is targeted to the endoplasmic reticulum 
while propidium iodide is a cell wall marker (Haseloff et al. 1997, Moreno et al. 
2006). The reason they co-localise is that the large vacuoles in pavement cells 
push the cytoplasm to the plasma membranes. Due to the resolution of the 
images this results in the apparent co-localisation. In 142S there is silencing of 
the GFP transgene in the majority of cells as seen by the lack of GFP fluorescence 
(Figure 4.4 C and D).  
The pavement cells in the 142 upper epidermis appear larger than those in the 
other lines (Figure 4.4 B). This is due to where the image was taken on the leaf. 
As leaves age and reach the second morphogenesis stage of leaf development, 
cell replication halts and cells undergo cell expansion to increase the size of the 
leaf (Andriankaja et al. 2012). Cell expansion does not occur at the same time in 
all cells but instead initially occurs at the leaf tip and then moves basipetally 
(Donnelly et al. 1999, Kazama et al. 2010). This occurs before the 10 dpg time 
point and will result in different sizes of pavement cells throughout the leaf. Thus 
the cells in the 142 upper epidermis image are likely to be nearer the leaf tip 
than those in the other images. In several images there are circles of 
fluorescence in the propidium iodide channel (Figure 4.4 A, B and H). These 
circles are chloroplasts from the mesophyll layer below the epidermal layers 
being imaged. Due to the setup of the confocal microscope both propidium 
iodide and chlorophyll fluorescence will be detected in the same channel. The 
reason why fluorescence from the mesophyll layer is detected is due to the size 
of the pin hole. In order to achieve excitation and emission by both propidium 
iodide and GFP in the epidermal layer, the size of the pin hole had to be large. 
Increasing the pin hole results in the excitation of fluorophores, such as 
chlorophyll, above and below the focal plane.
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Figure 4.4: GFP expression in the epidermal layers prior to the onset of silencing in M1 and M9  
The 1st leaves of 10 dpg seedlings were imaged under a confocal microscope to observe GFP expression. The upper and lower epidermis 
of each leaf was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP (cyan) and one 
for propidium iodide and chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP 
channel (ii) and propidium iodide and chlorophyll channel (iii) are shown. Leaves from the following plant lines were imaged: 142 (A and 
B), 142S (C and D), M1 (E and F) and M9 (G and H). A scale bar is shown for each image in the combined image. Images are representative 
of the three leaves visualised.
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At 13 dpg the M9 mutant line establishes silencing in the lower epidermis of the 
1st leaf. This onset is rapid and occurs within a six hour period. However, this is 
only true for the lower epidermis, the upper epidermis does not establish 
silencing and the mesophyll layers have not been assessed in this time course. At 
7 hours post dawn (hpd) M9 and 142 have similar levels of GFP fluorescence 
(Figure 4.5). However, by 13 hpd the lower epidermis has established silencing 
while the upper epidermis is unaffected (Figure 4.6). This silencing onset was 
also observed in the 3rd leaf, demonstrating that this delay is not leaf specific 
(Appendix 2.1 page 387). M1 does not silence at 13 dpg. As only the lower 
epidermal layer silences at this time point, this suggests a tissue specific nature 
to the silencing pattern. Once established the silencing pattern is mosaic in 
nature with some areas showing mostly GFP fluorescent/unsilenced cells (Figure 
4.6 E) and others mostly silenced cells (Figure 4.6 F). Within these areas there are 
lone or small groups of silenced or unsilenced cells respectively. As silencing 
amongst the pavement cells in the lower epidermis is mosaic in nature this 
suggests that silencing is stochastic. The mosaic silencing pattern is also seen in 
the 3rd leaf (Appendix 2.1 page 387). This stochastic silencing is unusual as it has 
been shown that the silencing signal can be transmitted from cell to cell (Smith 
et al. 2007, Molnar et al. 2010, Melnyk et al. 2011). As silenced and unsilenced 
cells can reside next to each other this suggest that either the silencing signal 
cannot be transmitted or that the ability of cells to respond to this signal is 
affected. 
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Figure 4.5: M9 does not silence the GFP transgene at 7 hpd on the 13th dpg in either epidermal layer 
The 1st leaves of 13 dpg seedlings were imaged under a confocal microscope to observe GFP expression. These images were taken at 7 hpd. The upper 
and lower epidermis of each leaf was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP (cyan) 
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and one for propidium iodide and chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP channel (ii) 
and propidium iodide and chlorophyll channel (iii) are shown. Leaves from the following plant lines were imaged: 142 (A and B), 142S (C and D) and 
M9 (E and F). A scale bar is shown for each image in the propidium channel only image. Images are representative of the three leaves visualised. 
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Figure 4.6: Silencing of GFP has occurred in the lower epidermal layer of M9 leaves by 13 hpd on the 13th dpg 
The 1st leaves of 13 dpg seedlings were imaged under a confocal microscope to observe GFP expression. These images were taken at 13 hpd. The 
upper and lower epidermis of each leaf was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP 
(cyan) and one for propidium iodide and chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP 
channel (ii) and propidium iodide and chlorophyll channel (iii) are shown. Leaves from the following plant lines were imaged: 142 (A and B), 142S (C 
and D) and M9 (E, F and G). E and F show areas of the leaf where silencing is less (E) or more (F) prevalent. A scale bar is shown for each image in the 
propidium channel only image. Images are representative of the three leaves visualised.
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M1 establishes silencing at 14 dpg in the lower epidermis but not the upper 
epidermis. Like M9, the lower epidermis of M1 goes from unsilenced at 7 hpd 
(Figure 4.7) to partially silenced by 13 hpd (Figure 4.8). As both M1 and M9 
silence in the lower epidermis at such specific time points this could indicate that 
a specific developmental event leads to the onset of silencing in the mutants. 
This event may also be tissue specific as the upper epidermis is unaffected at this 
time point and observation of the mesophyll layer using a fluorescence 
microscope suggests that this layer has an earlier onset of silencing. The single 
day difference in onset of silencing in the lower epidermis between M1 and M9 
is suggestive that the M1 allele of MORC6 has a greater effect on silencing and so 
is a more severe allele. Again, once silencing is established, silencing is mosaic, as 
there are areas of unsilenced cells with lone or small groups of silenced cells 
amongst them (Figure 4.8 E) and areas of silenced cells with lone or small groups 
of unsilenced cells amongst them (Figure 4.8 F). This delay and mosaic silencing 
pattern also occurs in both 3rd and 5th leaves (Appendix 2.2 page 391).  
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Figure 4.7: M1 does not silence the GFP transgene at 7 hpd on the 14th dpg in either epidermal layer 
The 1st leaves of 14 dpg seedlings were imaged under a confocal microscope to observe GFP expression. These images were taken at 7 hpd. The upper 
and lower epidermis of each leaf was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP (cyan) 
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and one for propidium iodide and chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP channel (ii) 
and propidium iodide and chlorophyll channel (iii) are shown. Leaves from the following plant lines were imaged: 142 (A and B), 142S (C and D) and 
M1 (E and F). A scale bar is shown for each image in the propidium channel only image. Images are representative of the three leaves visualised. 
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Figure 4.8: Silencing of GFP has occurred in the lower epidermal layer of M1 leaves by 13 hpd on the 14th dpg 
The 1st leaves of 14 dpg seedlings were imaged under a confocal microscope to observe GFP expression. These images were taken at 13 hpd. The 
upper and lower epidermis of each leaf was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP 
(cyan) and one for propidium iodide and chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP 
channel (ii) and propidium iodide and chlorophyll channel (iii) are shown. Leaves from the following plant lines were imaged: 142 (A and B), 142S (C 
and D) and M1 (E, F and G). E and F show areas of the leaf where silencing is less (E) or more (F) prevalent. A scale bar is shown for each image in the 
propidium channel only image. Images are representative of the three leaves visualised.
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To see if the silencing pattern established at 13 dpg and 14 dpg for M9 and M1 
respectively remained stable or if levels of silencing increased, silencing was 
assessed in 20 dpg leaves. Although the mosaic silencing pattern of the lower 
epidermis, seen at 13 dpg and 14 dpg, is still apparent, newly emerging leaves 
show a progressive increase in the level of silencing (Figure 4.9-Figure 4.12). This 
is particularly obvious when comparing the oldest leaf to emerge (1st leaf) 
against the youngest leaf to emerge (7th leaf) (Figure 4.9 and Figure 4.12). The 
areas of silenced cells are both larger and more prevalent in the 7th leaf than the 
1st leaf. This may be linked to the onset of silencing as the 1st leaf was present 
when silencing occurred whereas the 7th leaf was not. It would suggest that cells 
present before silencing onset do not respond to silencing to the same extent as 
cells that appeared after silencing onset. As well as this difference in silencing 
according to when leaves emerge there is also a difference between M1 and M9. 
In M9 there are fewer GFP expressing cells than in M1 thus indicating that 
silencing is more prevalent in M9. This provides further evidence that M1 is a 
more severe allele of MORC6.  
Silencing can also occur in the upper epidermis but is dependent when the leaf 
emerged. There is no silencing in the 1st leaf for either M1 or M9 (Figure 4.9 G 
and J). Small areas of silenced cells are present in M9 in the 3rd leaf but not in M1 
(Figure 4.10 G and J). Both M1 and M9 have areas of silencing in the 5th leaf, 
although these are more prevalent in M9 (Figure 4.11 G and J). In the 7th leaf 
silencing of the upper epidermis has reached similar levels to the lower 
epidermis in M9 while in M1 the areas of silencing are still small but have 
increased in prevalence compared to the 5th leaf (Figure 4.12 G and J). The exact 
time point when silencing is initiated in the upper epidermis of M1 and M9 is not 
known, but occurs between 15 dpg and 20 dpg. The difference in the strength of 
silencing of the upper epidermis between M1 and M9 also supports the 
suggestion that M1 is a more severe allele than M9. 
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Differences in both the silencing pattern and time of onset between the upper 
and lower epidermal layers demonstrate tissue specificity in silencing pattern. 
The delay in silencing also suggests that silencing may be dependent on a 
developmental event. This could suggest that there is both a tissue and 
developmental component to MORC6 expression. MORC6 expression would 
therefore be highest at earlier time points than later time points and higher in 
the upper epidermis than the lower epidermis. Redundancy with other proteins, 
possibly other MORCs, with different expression patterns would cause the 
development of silencing observed.  
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Figure 4.9: Mosaic silencing pattern of the lower epidermis in 1st leaves of 20 dpg M1 and M9 plants 
The 1st leaves of 20 dpg seedlings were imaged under a confocal microscope to observe GFP expression. The upper and lower epidermis of each leaf 
was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP (cyan) and one for propidium iodide and 
chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP channel (ii) and propidium iodide and 
chlorophyll channel (iii) are shown. Leaves from the following plant lines were imaged: 142 (A and B), 142S (C and D), M1 (E, F and G) and M9 (H, I and 
J). E and F and H and I show areas of the leaf where silencing is less (E and H) or more (F and I) prevalent for M1 and M9 respectively. A scale bar is 
shown for each image in the propidium channel only image. Images are representative of the three leaves visualised. 
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Figure 4.10: Mosaic silencing pattern of the lower epidermis in 3rd leaves of 20 dpg M1 and M9 plants and silencing of the upper 
epidermis in M9 
The 3rd leaves of 20 dpg seedlings were imaged under a confocal microscope to observe GFP expression. The upper and lower epidermis of each leaf 
was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP (cyan) and one for propidium iodide and 
chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP channel (ii) and propidium iodide and 
chlorophyll channel (iii) are shown. Leaves from the following plant lines were imaged: 142 (A and B), 142S (C and D), M1 (E, F and G) and M9 (H, I and 
J). E and F and H and I show areas of the leaf where silencing is less (E and H) or more (F and I) prevalent for M1 and M9 respectively. A scale bar is 
shown for each image in the propidium channel only image. Images are representative of the three leaves visualised. 
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Figure 4.11: Mosaic silencing pattern of the lower epidermis and silencing of the upper epidermis in 5th leaves of 20 dpg M1 and M9 
plants  
The 5th leaves of 20 dpg seedlings were imaged under a confocal microscope to observe GFP expression. The upper and lower epidermis of each leaf 
was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP (cyan) and one for propidium iodide and 
chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP channel (ii) and propidium iodide and 
chlorophyll channel (iii) are shown. Leaves from the following plant lines were imaged: 142 (A and B), 142S (C and D), M1 (E, F and G) and M9 (H, I and 
J). E and F and H and I show areas of the leaf where silencing is less (E and H) or more (F and I) prevalent for M1 and M9 respectively. A scale bar is 
shown for each image in the propidium channel only image. Images are representative of the three leaves visualised. 
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Figure 4.12: Mosaic silencing pattern of the upper and lower epidermis in 7th leaves of 20 dpg M1 and M9 plants  
The 7th leaves of 20 dpg seedlings were imaged under a confocal microscope to observe GFP expression. The upper and lower epidermis of each leaf 
was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP (cyan) and one for propidium iodide and 
chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP channel (ii) and propidium iodide and 
chlorophyll channel (iii) are shown. Leaves from the following plant lines were imaged: 142 (A and B), 142S (C and D), M1 (E, F and G) and M9 (H, I and 
J). E and F and H and I show areas of the leaf where silencing is less (E and H) or more (F and I) prevalent for M1 and M9 respectively. A scale bar is 
shown for each image in the propidium channel only image. Images are representative of the three leaves visualised.
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4.2.3 Is the onset of silencing linked to developmental 
stage? 
As discussed previously, as silencing of the lower epidermis occurs at such a 
specific point, it is possible that MORC6 is required for silencing during early 
development. To investigate whether there is any link to development, plants 
were grown in short day (8 hour day length) conditions. In the previous time 
course, plants were grown in 16 hour day length conditions. Due to the reduced 
hours of light the development of the plants will be retarded. This means that 
both M1 and M9 will be at an earlier stage of plant growth at 13 dpg and 14 dpg 
than in long day conditions. Plants have 4 rosette leaves at 13 dpg and 5 rosette 
leaves at 14 dpg in long day growth rooms. But in short day conditions plants 
only have 2 rosette leaves at both 13 dpg and 14 dpg. The 1st leaf itself will also 
be at a earlier stage of leaf development at 13 dpg and 14 dpg in short day 
conditions than in long day conditions. If silencing is linked to development 
theoretically both M1 and M9 will silence later in the short day conditions.  
Both M1 and M9 silence at the same time in short day growth rooms as seen in 
long day growth rooms. Silencing of the 1st leaf lower epidermis was assessed in 
M1 and M9 at 15 dpg when silencing has occurred in both M1 and M9. At 15 dpg 
plants in short day growth rooms are still at the 2 rosette leaf stage. Plants were 
initially observed using a fluorescence microscope and representative images 
taken by confocal microscopy (Figure 4.13). Only the lower epidermis is shown as 
the upper epidermis does not silence at this stage in long day conditions. Both 
M1 and M9 show a mosaic silencing pattern (Figure 4.13 C-F). It is clear, from this 
experiment, that the onset of silencing is not linked to a specific plant growth 
stage or point in leaf developmental but instead on time after germination. 
However, the exact point at which M1 and M9 silence in short day conditions 
was not determined.
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Figure 4.13: Mosaic silencing is still established in both M1 and M9 by 15 dpg in the lower epidermis 
The 1st leaves of 15 dpg seedlings grown in short day conditions were imaged under a confocal microscope to observe GFP expression. The leaves 
were first stained with propidium iodide which binds to the cell walls. All images are of the lower epidermal layer. Two separate channels were used, 
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one for GFP (cyan) and one for propidium iodide and chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just 
the GFP channel (ii) and propidium iodide and chlorophyll channel (iii) are shown. Leaves from the following plant lines were imaged: 142 (A), 142S 
(B), M1 (C and D) and M9 (E and F). A scale bar is shown for each image in the propidium channel only image. Images are representative of the 
approximately 100 plants from each line visualised under UV fluorescence microscope.
4. Silencing phenotype of the 35Sp:GFP transgene system in the MORC6 mutants 
231 
 
4.2.4 Mosaic silencing pattern in the mesophyll layers 
The time course experiment showed a mosaic silencing pattern in the upper and 
lower epidermal layer. It also showed that the severity of the loss of silencing is 
negatively correlated with the time at which a leaf emerged. In order to 
investigate whether a similar silencing pattern occurs in the mesophyll layers, 
leaves were imaged using UV fluorescence microscopy. The adaxial and abaxial 
sides of odd numbered rosette leaves from 21 dpg plants were imaged (Figure 
4.3). Leaves were taken from lines 142, 142S, M1 and M9. GFP fluorescence seen 
under the fluorescence microscope is mainly from the mesophyll layers. This is 
due to both the greater number of mesophyll cells compared to epidermal 
pavement cells and that GFP fluorescence is comparatively lower in the 
epidermal layers than the mesophyll layer. The difference in fluorescence level is 
because mesophyll cells have a larger cytoplasm than pavement cells, due to the 
large vacuole in pavement cells.  
GFP fluorescence in 142 is ubiquitous on both the adaxial and abaxial side of the 
leaves. Fluorescence is particularly strong in the leaf veins. In 142S the majority 
of cells are silenced. Images for 142 and 142S can be found in Appendix 4.3 (page 
399). In both M1 and M9, silencing is similar to that seen under the confocal 
microscope. The abaxial side of the leaves in M1 and M9 show a mosaic silencing 
pattern, with areas of silencing and areas of GFP expression (Figure 4.14). There 
appears to also be a relationship between the level of silencing and leaf 
emergence time. Prevalence and size of the areas of silencing increase from the 
1st leaf, where levels of silencing are low, to the 7th leaf, which has higher levels 
of silencing in both M1 and M9 (Figure 4.14 C, D, G, H, K, L, O and P). This 
suggests that silencing in the spongy mesophyll layer is similar in nature to that 
seen in the lower epidermis. The silencing patterns also clearly show a difference 
between M1 and M9. Levels of silencing appear to be greater in M9 than M1. 
Again this indicates that M1 is the stronger of the two alleles. 
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On the abaxial side of leaves there is strong fluorescence in the veins, although 
this is reduced compared to 142 (Figure 4.14 and Appendix 4.3 page 399). 
Silencing of the palisade mesophyll layer is dependent on the time of leaf 
emergence. There is no silencing on the adaxial side of the 1st and 3rd leaves of 
M1 and M9, but there are small areas of silencing on the 5th leaf and larger areas 
of silencing on the and 7th leaf (Figure 4.14 A, B, E, F, I, J, M and N). This pattern is 
similar to that of the upper epidermis, indicating that palisade layer silencing is 
comparable to the upper epidermis. As both the palisade and spongy mesophyll 
layers mosaic silencing pattern closely resembles that of the upper and lower 
epidermal layers respectively, this would suggest that the final silencing pattern 
is dependent on whether the cells are adaxial (upper epidermis and palisade 
mesophyll layer) or abaxial (lower epidermis and spongy mesophyll layer) rather 
than a specific single tissue type. However, it should be noted that time of onset 
of silencing is different between the epidermal layers and mesophyll layers so 
there still may be some level of tissue specificity in silencing pattern. 
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Figure 4.14: Mosaic silencing pattern of GFP on the adaxial and abaxial sides of 
M1 and M9 leaves at 21 dpg 
Images of the adaxial and abaxial side of odd numbered leaves from lines M1 and M9, 
taken under a fluorescence microscope at 21 dpg. Each image shows an enlargement of 
the mid-section of each leaf. Images A, B, C and D are of the 1st leaf, images E, F, G and H 
are of the 3rd leaf, images I, J, K and L are of the 5th leaf and images of M, N, O and P are 
of the 7th leaf. The first column (A, E, I and M) are image of the adaxial side of M1 leaves. 
The second column (B, F, J and N) are images of the adaxial side of M9 leaves. The third 
column (C, G, K and O) are image of the abaxial side of M1 leaves. The fourth column (D, 
H, L and P) are images of the abaxial side of M9 leaves. A scale bar is shown at the 
bottom right of each image. 
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The fluorescence microscopy imaging on the mesophyll layer suggests that the 
palisade mesophyll layer has a silencing pattern similar to the upper epidermis 
while the spongy mesophyll layer has a pattern similar to that of the lower 
epidermis. To further investigate this observation the mesophyll layers were 
imaged using confocal microscopy. Since confocal microscopy on whole leaves 
could not image beyond the first layer of the mesophyll layer, sectioning was 
used. Sections in the adaxial to abaxial plane were taken from the mid-leaf of 40 
dpg 1st leaves, from lines 142, 142S, M1 and M9. Images were then taken of the 
main vein and the mesophyll layer using a confocal microscope. Previously the 
epidermal layers were imaged in one focal plane. However, for the mesophyll 
layers it was not possible to image in a single focal plane. This is due to the 
curvature of the leaf sections causing different cells in the first layer of the 
section to be visible in different focal planes (Figure 4.15). To produce an image 
of the entire mesophyll layer the sections were Z-stacked. Z-stacking takes 
multiple images at different focal planes. The images can then be combined into 
a composite image. In this case maximum intensity was used. This is where each 
pixel in the final image comes from the image in the Z-stack with the highest 
intensity of fluorescence at that pixel.  
 
Figure 4.15: Explanation of use of z-stacking. 
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Shows a 2D diagrammatic representation of imaging a leaf section on a slide under a 
confocal microscope. Depth and length are shown and for simplicity the section in this 
diagram is also one cell wide. The red and green ovals represent silenced and unsilenced 
mesophyll cells respectively. The purple lines represent different focal planes and the 
two boxes on the right show the resulting images from these two focal planes. Only a 
single cell is visible in the first focal plane whereas multiple cells are visible in the 
second. 
In line 142, GFP fluorescence can be seen throughout the sections and is 
particularly high in the vein itself (Figure 4.16 A and B). Expression is higher in the 
spongy mesophyll layer than the palisade layer (Figure 4.16 I and J). This could 
indicate that there is tissue specific expression of the GFP transgene. It should be 
noted that cells in the sections are ill-defined in the images. There are two 
reasons for this. Firstly the Z-stacks may, as well as the first layer of cells, also 
extend into the layer of cells below. When the composite image is produced 
overlapping cells in the top layer and the layer below will be superimposed onto 
each other, leading to blurred boundaries between cells. The second reason is 
for each image in the Z-stack, there is bleed through of fluorescence from layers 
above and below the focal plane of that image. The pin hole of the laser, which 
controls the focus of the laser, is set high in order to detect fluorescence from 
the samples. Larger pin holes means the laser is less focused and will excite 
fluorophores above and below the focal plane. Therefore as the pin hole is large 
there will be more fluorescence from these layers. This results in a loss of 
definition of cells in the plane being imaged. The silencing pattern in the 
mesophyll layer of line 142S is similar to that seen in the epidermal layers, in that 
the majority of cells are silenced but there are isolated unsilenced, GFP 
fluorescent, cells (Figure 4.16 K and L). The unsilenced cells appear in both the 
palisade and spongy mesophyll layers, so tissue specificity does not appear to be 
the cause of this lack of silencing. There is also no GFP fluorescence in the main 
vein in the leaf (Figure 4.16 C and D).  
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In M1 there is a clear decrease in GFP fluorescence compared to 142 (Figure 
4.16). There is however still strong GFP fluorescence in the main vein (Figure 
4.16 E and F). In the palisade and spongy mesophyll layers, silencing of GFP is 
mosaic as there are areas of silenced and unsilenced mesophyll cells (Figure 4.16 
M and N). The mosaic silencing pattern is stochastic in nature as within each 
mesophyll layer cells can be either silenced or unsilenced. Compared to 142, GFP 
expression in the palisade layer in M1 is not reduced to the same extent as in the 
spongy mesophyll layer. The loss of silencing in M1 is therefore more 
pronounced in the palisade layer than the spongy mesophyll layer, suggesting 
that there is cell type specificity in silencing. This is similar to what was observed 
from fluorescence microscopy, in that the palisade mesophyll cells appeared to 
have a smaller reduction in GFP expression than the spongy mesophyll cells. In 
the epidermal layers there is more GFP expression in the upper epidermis than 
the lower epidermis. As the two upper layers (palisade mesophyll cells and upper 
epidermal pavement cells) show a greater loss in silencing to the two lower cell 
layers (spongy mesophyll cells and lower epidermal pavement cells), this could 
suggest a adaxial to abaxial gradient in silencing response in the leaves of the 
mutants. 
Like M1, M9 also shows a marked decrease in GFP expression from that seen in 
142 (Figure 4.16). This decrease is however greater in M9 than M1, indicating 
that levels of silencing are higher in M9 than M1. This can be seen from the 
reduction in fluorescence in the main vein compared to M1 Figure 4.16 F and H). 
This correlates with what is seen in the epidermal layers in that M1 has a greater 
loss of silencing than M9, again indicating that M9 is the weaker of the two 
alleles. As in M1, silencing is mosaic in both mesophyll layers (Figure 4.16 O and 
P). There is also a difference between the two mesophyll layers. Compared to 
142, the loss of GFP fluorescence is greater in the spongy mesophyll than the 
palisade mesophyll layer. M9 also shows greater levels of GFP fluorescence in the 
upper epidermis than the lower epidermis. This suggests that, like M1, there is a 
possible adaxial to abaxial gradient in silencing in the leaves. 
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Figure 4.16: Cross sections of a 142, 142S, M1 and M9 leaves at 40dpg showing mosaic silencing in the mesophyll layers 
Confocal microscopy images of cross sections from the 1st adult rosette leaf of 40 dpg old plants from lines 142, 142S, M1 and M9. All sections were 
taken from the mid-leaf. Two channels were used for imaging GFP (cyan) and chlorophyll (red). For each separate image a combined image of both 
channels (A, C, E, F, I, K, M and O) and a image of just the GFP channel (B, D, F, H, J, L, N and P) are shown. All images are maximum intensity 
projections from the z stacks of each section. A-H: are images of the main vein and surrounding tissue. The white circle in images A-H highlights the 
main vein in each image. I-P: are images of the mesophyll layer. A, B, I and J are images from line 142. C, D, K and L are images from line 142S. E, F, M 
and N are images from line M1. G, H, O and P are images from line M9. In all cases the leaf cross sections are orientated so that the adaxial side of the 
cross section is at the top of each image. A scale bar is shown for each combined image.  
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4.2.6 Root specific GFP silencing pattern 
From the different silencing pattern of the upper and lower epidermal layers and 
mesophyll layers, it was concluded that there may be tissue or cell type specific 
differences in silencing for M1 and M9. The silencing pattern in roots was 
observed to see if there was a tissue or cell type specific effect on silencing in 
roots. Roots from plant lines 142, 142S, M1 and M9 were imaged at 33 dpg 
under a UV fluorescence microscope. Background autofluorescence, shown in 
red in the images, is present in the main roots and can be seen in 142S, M1 and 
M9, but no autofluorescence can be detected in 142 (Figure 4.17). This is likely to 
be due to the camera used to take these images being unable to detect the 
background autofluorescence above the GFP fluorescence in 142.  
142 had ubiquitous GFP expression in both the main and lateral roots (Figure 
4.17 A). However, silencing in 142S differed from that seen in leaves as there was 
only partial silencing of the GFP transgene (Figure 4.17 B). Silencing in 142S is 
strongest in the main roots, while in the lateral roots GFP fluorescence is closer 
to that of 142. Although compared to 142, GFP fluorescence was reduced, it was 
not to the same extent as it is in leaves and would suggest that there is reduced 
expression of the 35S IR transgene in root tissue compared to leaf tissue. 
However, this is unexpected as the NOS promoter has been previously shown to 
be more strongly expressed in root tissue than leaf tissue (An et al. 1988). The 
probable cause of this is that regulatory elements in the genome where the 35S 
IR transgene is inserted are repressing its transcription in roots. It is also possible 
that RdDM silencing of the GFP transgene is reduced in roots rather than a 
reduction in the expression of the 35S IR transgene. In both M1 and M9 GFP 
expression has increased compared to 142S, with GFP fluorescence in the lateral 
roots being similar to that seen in 142 (Figure 4.17C and D). Interestingly M9 
shows higher levels of GFP fluorescence in the main root than M1, which is 
contrary to what is seen in leaves where the opposite is true. The reversal in 
levels of silencing between M1 and M9 could be due to one of the other EMS 
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mutations carried in the M1 and M9 lines affecting silencing levels, rather than 
being a feature of the morc6 mutations themselves. 
 
Figure 4.17: Differences in silencing pattern of GFP in roots of 142, 142S, M1 
and M9 33 dpg plants 
Plants were grown on vertical MS plates in long day growth rooms until 33 dpg then 
imaged in situ using a fluorescence microscope. Images of roots from lines 142 (A), 142S 
(B), M1 (C) and M9 (D) are shown. For each line there is a combined image of GFP 
(green) and plant autofluorescence (red) (i) and seperate images of GFP (ii) and plant 
autofluorescence (iii). A scale bar is shown as the bottom of each image. Images are 
representative of 8 plants for 142, M1 and M9 and 10 plants for 142S. 
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4.2.7 Difference in the proportion of silenced to unsilenced 
mesophyll cells between the M1 and M9 mutants 
Observation of the silencing patterns in M1 and M9 by confocal and fluorescence 
microscopy suggest that levels of silencing are higher in M9 than M1. This 
suggests that the mutation in M1 has a more severe effect on the MORC6 
protein’s function than M9. To get an actual quantitative value of the extent of 
silencing in both M1 and M9 in leaves, cell sorting and flow cytometry was used 
to separate unsilenced cells from silenced cells. The main aim of the cell sorting 
was to extract DNA from these two cell populations in order to look at DNA 
methylation, which is discussed later in this chapter (page 278). However, the 
sorting process also allowed for flow cytometry data on numbers of silenced and 
unsilenced cells to be obtained. Cell sorting uses the scattering of a laser beam to 
identify and sort different cells. The cell properties that can be deduced from the 
scattering of the laser beam include: cell size, cell shape, cell viability, granularity 
of the cytoplasm and fluorescence of different flurophores (Rieseberg et al. 
2001). The cell sorter can then pick cells, referred to as events, which match 
specific properties and separate these from the other cells. Multiple cell types 
can be separated into different collection tubes in this way. Information of the 
properties of each cell that passes through the cell sorter can, as in this case, also 
be used to determine the proportion of a specific cell type within an entire 
population.  
For plant cells to be sorted they must first be unicellular and so protoplasts were 
produced from adult rosette leaves from five week old (35 dpg) plants from lines 
142, 142S, M1 and M9. The majority of these protoplasts will be derived from 
mesophyll cells. Initially the exact properties for unsilenced and silenced 
protoplasts were not known. To identify the properties that denote silenced and 
unsilenced protoplasts, cell sorting of protoplasts from 142 and 142S was 
completed. In 142 all cells are GFP fluorescent (GFP positive) so will give the 
properties of unsilenced protoplasts, while in 142S the majority of cells are 
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silenced so lack GFP (GFP negative) and will give the properties for silenced 
protoplasts.  
For cell sorting of the protoplast samples four properties were measured: frontal 
scatter (fsc), side scatter (ssc), GFP fluorescence and chlorophyll fluorescence. fsc 
is a measure of cell size whereas ssc is a measure of the granularity of cytoplasm. 
Granularity is a measure of ‘complexity’ of the cells or how many organelles are 
found in the cytoplasm, the more organelles the higher the ssc measurement. 
GFP fluorescence is measured by looking at the intensity of emissions from each 
cell at a wavelength of 530 nm. GFP expression and fluorescence will increase 
the intensity of the emissions at this wavelength. Chlorophyll fluorescence is 
measured in the same way as GFP except emissions at a wavelength of 670 nm 
are measured. GFP and chlorophyll fluorescence were used to identify silenced 
and unsilenced protoplasts. The fsc and ssc measurements were used to identify 
protoplasts since after protoplast production, as well as plant protoplasts there 
will also be cellular debris and undigested plant tissue present in the solution. 
The protoplasts can be separated from this debris using cell size and granularity. 
Protoplasts will be larger and more complex than cellular debris but smaller and 
less complex than undigested plant tissue. 
First the properties of the unsilenced protoplast population were identified using 
142. In order to select protoplasts from cellular debris the fsc and ssc were 
measured (Figure 4.18 A). The fsc and ssc of cellular debris will be lower than 
that of protoplasts. Therefore events with a high fsc and ssc were considered 
protoplasts. However, to avoid undigested tissue or droplets that contain several 
protoplasts, events with a very high fsc or ssc were also not selected. The 
fraction of the sample that contains the protoplast population is highlighted in 
Figure 4.18 A by the R1 box. All graphs in Figure 4.18 are gated using these 
properties. This means that only objects where the fsc and ssc measurements 
are within the area highlighted by R1 are shown in the other graphs. Within the 
R1 region there will still be debris as well as protoplasts, however these cannot 
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be separated from protoplasts using just size and granularity. In order to identify 
the protoplasts within this region, GFP and chlorophyll fluorescence intensity 
was then analysed. When histograms of intensity of GFP and chlorophyll 
fluorescence were plotted against each other in a dot plot a large population was 
identified with specific chlorophyll and GFP intensities (Figure 4.18 B). This is 
represented in Figure 4.18 B by the green R2 box in the enlarged section of the 
graph. This population is likely to be the GFP positive/unsilenced protoplast 
population and so gives the properties of unsilenced protoplasts.  
 
Figure 4.18: Identification of GFP positive protoplasts in line 142 
Graphs showing results of flow cytometry analysis of the 142 protoplast sample. A: Dot 
plot of ssc against fsc. The values for the y axis and x axis are relative values of ssc and 
fsc respectively. The dots colour indicates how many events are found at this point. It 
ranges from red (low number events) to purple (high number events). The R1 box 
highlights the area of the graph where protoplasts are found. Anything below or to the 
left of the R1 box is likely to be cell debris, while anything above or to the right of the R1 
box is likely to be multiple protoplasts still attached to each other. The R1 box acts as a 
gate to the other 3 graphs, so only points found within the R1 box are shown on the 
4. Silencing phenotype of the 35Sp:GFP transgene system in the MORC6 mutants 
244 
 
other graphs. B: Dot plot of chlorophyll fluorescence intensity against GFP fluorescence 
intensity. Both axes give relative values of intensity for the two flurophores. The R2 box 
highlights the GFP positive protoplast population. The R2 box and surrounding area of 
the graph has been blown up and the R2 box is highlighted in green in this enlargement. 
C: Histogram of intensity of GFP fluorescence. D: Histogram of intensity of chlorophyll 
fluorescence. For both C and D the area of the histogram corresponding to the GFP 
positive protoplasts is highlighted in green. The x axes for both C and D are relative 
measurements of intensity. 
After identifying a population of protoplasts, which is likely to be derived from 
GFP positive cells in 142, the GFP negative/silenced population was identified in 
142S. As in 142 the protoplast population was first sorted using fsc and ssc to 
separate the protoplasts from cellular debris (Figure 4.19 A). The same fsc and 
ssc parameters as 142 were used. All other graphs were then gated with these 
parameters to show only events that are large and complex enough to be 
protoplasts. Once completed, a dot plot of GFP and chlorophyll fluorescence was 
plotted (Figure 4.19 B). From this graph a large protoplast population was 
identified, which had a different GFP intensity to the population identified in 142. 
This new population is represented in Figure 4.19 B by the red R3 box in the 
enlarged area of the graph. The R3 population made up 97.09% of the total 
population of protoplasts (Table 4.1). There is a smaller population of 
protoplasts, 2.91% total population, within the R2 box (Figure 4.19 B Table 4.1). 
This is to be expected as 142S has a small number of unsilenced cells. When 
chlorophyll and GFP intensity is compared separately between the R2 and R3 
populations there is a clear difference for GFP (Figure 4.19 C and D). Chlorophyll 
intensity does not change between R2 and R3. This indicates a loss of GFP 
fluorescence in the R3 population. Thus R3 is likely to be the GFP negative 
protoplast population and so provides the parameters for the silenced protoplast 
population. 
4. Silencing phenotype of the 35Sp:GFP transgene system in the MORC6 mutants 
245 
 
 
Figure 4.19: Identification of GFP negative protoplasts in line 142S 
Graphs showing results of flow cytometry analysis of the 142S protoplast sample. A: Dot 
plot of ssc against fsc. The values for the y axis and x axis are relative values of ssc and 
fsc respectively. The dots colour indicates how many events are found at this point. It 
ranges from red (low number events) to purple (high number events). The R1 box 
highlights the area of the graph where protoplasts are found. Anything below or to the 
left of the R1 box is likely to be cell debris, while anything above or to the right of the R1 
box is likely to be multiple protoplasts still attached to each other. The R1 box acts as a 
gate to the other 3 graphs, so only points found within the R1 box are shown on the 
other graphs. B: Dot plot of chlorophyll fluorescence intensity against GFP fluorescence 
intensity. Both axes give relative values of intensity for the two flurophores. The R2 box 
highlights the GFP positive protoplast population. The R3 box highlights the GFP 
negative protoplast population. This area of the graph has been blown up. C: Histogram 
of intensity of GFP fluorescence. D: Histogram of intensity of chlorophyll fluorescence. 
For both C and D the areas of the histograms corresponding to the GFP positive 
protoplasts is highlighted in green while the areas of the histograms corresponding to 
the GFP negative protoplasts is highlighted in red. The x axes for both C and D are 
relative measurements of intensity. In D the GFP positive and negative protoplast 
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populations overlap each other so the GFP positive population is hidden by the negative 
population. 
In order to confirm that R2 is the GFP positive population and R3 is the GFP 
negative population, a mixed protoplast population derived from both 142 and 
142S was used. The mixed population of 142 and 142S was made by mixing 1 ml 
of the 142 protoplast solution with 1 ml of the 142S protoplast solution. This 
should give a protoplast population where approximately half are GFP positive 
and half are GFP negative. The sample was first sorted and gated using fsc and 
ssc and the then a dot plot of GFP and chlorophyll fluorescence intensity was 
plotted (Figure 4.20 B). This produced two large populations of protoplasts in the 
R2 and R3 boxes. R3 again had reduced GFP intensity compared to R2, but 
chlorophyll intensity was unchanged between the two populations. Out of the 
total number protoplasts in R2 and R3, 48.27% were from the R2 population and 
51.73% were from the R3 population (Table 4.1). The two populations are 
therefore roughly equal to each other. This suggests that the GFP positive and 
GFP negative populations have been correctly identified.  
4. Silencing phenotype of the 35Sp:GFP transgene system in the MORC6 mutants 
247 
 
 
Figure 4.20: Confirmation of identification of GFP positive and negative 
protoplasts using mixed 142 and 142S sample 
Graphs showing results of flow cytometry analysis of the 142S protoplast sample. A: Dot 
plot of ssc against fsc. The values for the y axis and x axis are relative values of ssc and 
fsc respectively. The dots colour indicates how many events are found at this point. It 
ranges from red (low number events) to purple (high number events). The R1 box 
highlights the area of the graph where protoplasts are found. Anything below or to the 
left of the R1 box is likely to be cell debris, while anything above or to the right of the R1 
box is likely to be multiple protoplasts still attached to each other. The R1 box acts as a 
gate to the other 3 graphs, so only points found within the R1 box are shown on the 
other graphs. B: Dot plot of chlorophyll fluorescence intensity against GFP fluorescence 
intensity. Both axes give relative values of intensity for the two flurophores. The R2 box 
highlights the GFP positive protoplast population. The R3 box highlights the GFP 
negative protoplast population. This area of the graph has been blown up. C: Histogram 
of intensity of GFP fluorescence. D: Histogram of intensity of chlorophyll fluorescence. 
For both C and D the areas of the histograms corresponding to the GFP positive 
protoplasts is highlighted in green while the areas of the histograms corresponding to 
the GFP negative protoplasts is highlighted in red. The x axes for both C and D are 
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relative measurements of intensity. In D the GFP positive and negative protoplast 
populations overlap each other. 
For final proof that the R2 and R3 populations were indeed the GFP negative and 
GFP positive protoplast populations the R2 and R3 populations were separated 
using the cell sorter. Protoplasts from the R2 and R3 fractions were assessed 
under a confocal microscope for GFP fluorescence. Protoplasts in the R3 
population had chlorophyll fluorescence but lacked GFP fluorescence (Figure 
4.21 A). Protoplasts from the R2 population had both GFP and chlorophyll 
fluorescence Figure 4.21 B). This confirms that the R2 population is the GFP 
positive protoplast population and the R3 population is the GFP negative 
protoplast population.  
 
Figure 4.21: Confocal images confirming the identification of GFP positive and 
negative protoplasts in a mixed population 
Confocal images of a single GFP negative (A) and GFP positive (B) protoplast. Images are 
a composite of a bright field image of a protoplast overlayed with a chlorophyll channel 
(red) and GFP channel (cyan). The scale bars for each image are shown. Both A and B 
come from a mixed population of 142 and 142S protoplasts. Images are representative 
for each fraction. 
Having proven that GFP positive and GFP negative protoplasts could be correctly 
identified by cell sorting the results from the cell sorter could then be used to 
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assess the ratio of GFP positive (unsilenced) to GFP negative (silenced) 
protoplasts in the M1 and M9 mutants. Graphs showing fsc, ssc and chlorophll 
and GFP fluorescence for M1 and M9 are shown in Appendix 2.4 (page 400). The 
number of GFP positive and GFP negative protoplasts and their relative 
proportions are given in Table 4.1. There is a clear difference between M1 and 
M9. In M9 53.03% of the protoplasts are GFP positive whereas for M1 the value 
is 82.64%. These values do not match with what is observed in the upper 
epidermis, where the majority of cells are GFP positive, but are a closer match to 
what is observed in the lower epidermis where there are similar numbers of GFP 
negative and GFP positive cells in M9 and more GFP positive cells than negative 
cells in M1. However, as stated previously, the majority of the protoplasts in the 
M1 and M9 samples will be derived from mesophyll cells, so the percentages of 
GFP positive and negative protoplasts should be similar to that of levels of 
silencing in the mesophyll layers.  
From confocal and fluorescence microscope observations the majority of cells in 
the palisade mesophyll layer are GFP positive whereas the spongy mesophyll 
layer has both GFP positive and GFP negative cells. As an average of both these 
cell layers the percentage of GFP negative and GFP positive protoplasts are 
similar to the observed phenotype. As each protoplast sample was derived from 
forty leaves from different plants it should also average out the difference in 
levels of silencing between leaves that emerged at different times. This again 
shows that the M1 is a more severe allele of the MORC6 than M9.  
Sample 
Number of 
GFP positive 
protoplasts 
Number of 
GFP negative 
protoplasts 
Total 
number of 
protoplast
s 
Percentage 
protoplasts 
GFP positive 
(%) 
Percentage 
protoplasts 
GFP negative 
(%) 
Mixed sample 
142 and 142S 
1777 1904 3681 48.27 51.73 
142 11001 9 11010 99.92 0.08 
142S 8106 270300 278406 2.91 97.09 
M1 810300 170200 980500 82.64 17.36 
M9 227500 201500 429000 53.03 46.97 
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Table 4.1: Differences in the proportion of silenced and unsilenced protoplasts 
in M1 and M9 
Table shows the total number of GFP positive and negative protoplasts for a mixed 
sample of 142 and 142S, 142, 142S, M1 and M9. The mixed sample of 142 and 142S was 
made up of approximately equal numbers of 142 and 142S protoplasts. The percentage 
of the total number of protoplasts that are GFP positive and negative is also given.  
4.2.8 No reduction in 35S siRNA levels in mutants 
Both M1 and M9 disrupt silencing of the GFP transgene but it was not known 
which point in the RdDM pathway was affected. To determine if the mutants 
affected siRNA production a siRNA northern blot to assess 35S siRNAs levels was 
completed on RNA samples from 7 dpg and 21 dpg leaves and floral tissue. 
Samples were taken from lines 142, 142S, M1 and M9. The blot was first probed 
for 35S siRNAs and then miR167, which acts as a loading control, using radio-
labelled probes. In the 142 samples the levels of 35S siRNAs were so low that 
they were hard to distinguish from background unspecific binding (Figure 4.22). 
This could suggest that 142 does produce 35S siRNAs at a very low level but not 
enough to trigger RdDM. For 142S, 35S siRNAs could be detected in the 21 dpg 
sample at low levels and at higher levels in the floral sample, but for the 7 dpg 
sample they were similar to 142, which may suggest that this and the 142 signal 
is background noise rather than a genuine band. Comparisons of the M1 and M9 
21 dpg and floral samples to 142S showed no difference between 142S and M9, 
but there was a decrease in 35S siRNAs in the M1 floral sample. However, the 
amount of M1 RNA on the initial gel is lower than the other floral samples so 
could suggest that this is the cause of the apparent reduction in 35S siRNA levels. 
The miR167 loading control shows that the RNA levels were similar between the 
7 dpg and 21 dpg samples but that there is a difference in the floral samples. The 
miR167 signal in 142 is comparable to the 7 dpg and 21 dpg samples but 142S, 
M1 and M9 are all lower. The reason for this could be poor transfer of RNA for 
these three samples or that during the stripping process to remove the 35S 
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probe and the Solo-LTR probe (mentioned in the next chapter page 312), before 
the blot was probed for miR167, also inadvertently removed RNA from these 
samples. For this reason a second blot with just floral samples of lines 142, 142S, 
M1, M9 and rmd3 was completed. rmd3 is a nrpd1 mutant so should be 
defective in siRNA production and was indeed shown to lack 35S siRNAs (Figure 
4.23). siRNAs were also detectable in 142 but at low levels so again this could be 
either the result of non-specific hybridisation or that 142 does produce low levels 
of 35S siRNAs that are not abundant enough to trigger silencing. As with the 
previous blot, there was a slight reduction in 35S siRNAs in M1 compared to 
142S, but whereas previously 142S and M9 had similar siRNA levels, in this blot 
35S siRNA levels are higher in M9. One possible reason for this difference in 
siRNA levels may be the fact that 24 nt siRNA levels vary depending on the stage 
of floral development so the stage of the flowers collected may affect abundance 
accordingly (Mosher et al. 2009). However, there was also a problem with the 
miR167 loading control as both M1 and M9 showed reduced levels compared to 
142 and 142S. The fact that the miR167 loading control is not consistent for all 
samples in either blot makes comparisons of 35S siRNAs difficult and suggests 
that it may not be ideal as a control. However, since 21 dpg levels in M1 and M9 
are similar to 142S and there is not a large reduction in 35S siRNAs for either M1 
or M9 in floral samples it would suggest that MORC6 is not involved in siRNA 
production. 
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Figure 4.22: Detection of 35S siRNAs at different developmental stages in M1 
and M9 
Image of a northern blot probed with a 32P-labelled probes for the 35S promoter (top) 
and miR167 (middle). 7 dpg, 21 dpg and floral RNA samples of lines 142, 142S, M1 and 
M9 were used, the order of these is indicated. The bottom image is of the 
polyacrylamide gel stained with ethidium bromide before being blotted. This shows 
loading of RNA onto the gel. The miR167 is a loading control for the blot. 
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Figure 4.23: Detection of 35S siRNAs in M1 and M9 floral tissue 
Image of a northern blot probed with a 32P-labelled probes for the 35S promoter (top) 
and miR167 (bottom). Floral RNA samples of lines 142, 142S, M1, M9 and rmd3 were 
used, the order of these is indicated. The miR167 is a loading control for the blot. rmd3 
acts as a negative control as it is a mutant in RdDM siRNA production. 
4.2.9 Reduction in DNA methylation of the 35S promoter in 
M1 and M9  
Having determined the effect of MORC6 on abundance of 35S siRNAs, its effect 
on DNA methylation of the 35S promoter was also assessed in order to resolve 
MORC6 function in RdDM of the GFP transgene. To ascertain if there is any 
change in the DNA methylation profile of the 35S promoter in M1 and M9, 
bisulfite sequencing was used. Bisulfite treatment of DNA changes unmethylated 
cytosines into uracils but does not convert methylated cytosines (Shapiro et al. 
1970, Wang et al. 1980). These changes can then be detected by sequencing the 
35S promoter of bisulfite treated DNA and then comparing it against the original 
sequence to identify cytosine residues that have not been converted and 
therefore are methylated.  
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As both M1 and M9 have a delay in silencing establishment, bisulfite sequencing 
was carried out on DNA samples taken at 7 dpg and 28 dpg. However, as the 
time point for when silencing occurs in the mesophyll layer is unknown there 
may be silencing in the 7 dpg sample. DNA from rosette leaves of lines 142, 142S, 
M1 and M9 were bisulfite treated and the 35S promoter sequence was amplified 
by PCR from the treated DNA. These PCR fragments were then cloned into the 
pGEM vector before being transformed into bacteria. The plasmids from at least 
ten individual colonies were extracted and sequenced. Plasmids from each 
colony should contain a 35S promoter fragment that originates from different 
DNA strands. As RdDM is cell autonomous with respect to which cytosines are 
methylated, each DNA strand will have a different DNA methylation pattern. The 
methylation pattern from at least 10 DNA strands must be sequenced in order to 
get a consensus of DNA methylation in the rosette leaves. 142 does not silencing 
the GFP transgene so should lack DNA methylation of the 35S promoter, so all 
cytosines should be converted by bisulfite treatment. As bisulfite conversion was 
carried out on samples from all four lines concurrently, 142 should therefore act 
as a control for the efficiency of bisulfite conversion. 142S will give the WT DNA 
methylation pattern of the 35S promoter. 
Only part of the 35S promoter was sequenced (Figure 4.24), although this section 
does cover all of the area targeted by the 35S IR transgene. In order to prevent 
amplification of the 35S IR transgene, the region being sequenced also extends 
into the CDS of the GFP gene so only the 35Sp:GFP transgene will be amplified 
and not the 35S IR transgene. The primers have also been designed to amplify 
only the lower strand. This means that only methylation on the lower strand and 
not the upper strand will be detected in this assay. There are ninety seven 
cytosine residues on the lower strand within the region amplified for bisulfite 
sequencing (Figure 4.24). Of these seventy seven cytosine residues lie within the 
section targeted by the 35S IR. There are a further eighteen cytosine residues 
within the 35S promoter sequence that have not been targeted and two within 
the GFP CDS. It is possible that methylation will spread from the area targeted by 
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the 35S IR and cause the methylation of these cytosines. Several studies have 
shown evidence of spread of methylation in both a transgene and endogenous 
environment (Daxinger et al. 2009, Ahmed et al. 2011). 
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Figure 4.24: Region of 35Sp:GFP transgene being analysed by bisulfite sequencing 
Figure shows the complete sequence of the 35Sp:GFP transgene (top line, named 35Sp_GFP) and the region of the transgene being sequenced 
(bottom line, named BS14-BS22). This diagram shows the sequence of the upper strand. The position in the sequence for start and end base for each 
line is given and every 10 bps of the 35Sp:GFP transgene is marked above the sequence. The 35S promoter is shown in purple and cyan. The area 
highlighted in cyan is the region of the 35S promoter targeted by the 35S IR transgene. The GFP CDS is shown in green with the start codon in blue 
and the stop codon in red. The region being sequenced is in black and spans both the 35S promoter and part of the GFP CDS. Guanine residues, in the 
region being sequenced have been highlighted. Their sequence contexts are given, red means CG, blue means CHG and green means CHH, where H 
stands for C, T or A. The guanine residues are numbered from 1 to 97 below each residue. 
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35S promoter sequences were analysed using the online CyMATE tool, which 
presents results diagrammatically (Figure 4.25) (Hetzl et al. 2007). This tool is 
able to identify methylated and unmethylated cytosines. The DNA methylation 
pattern of 7 dpg samples was assessed first. In the 7 dpg 142 sample there was a 
maximum of three unconverted cytosines per sequence, indicating a good rate of 
bisulfite conversion (Figure 4.25 A). The maximum number of unconverted 
cytosine residues per sequence in 142 was used to determine if sequences in 
142S, M1 and M9 were methylated or unmethylated. In this case sequences with 
more than three unconverted cytosine residues were considered to be 
methylated and sequences with three or less were considered to be 
unmethylated.  
Methylation in the 142S at 7 dpg is restricted to the seventy seven cytosine 
residues within the region targeted by the 35S IR (Figure 4.25 B and Figure 4.26 
B). This indicates that in this system DNA methylation does not spread from the 
region targeted by siRNAs. Within the methylated region there is variation in 
levels of DNA methylation between sequences. In some sequences nearly all 
cytosines are methylated while in other sequences the majority of cytosine 
residues are unmethylated. One sequence is unmethylated. The presence of an 
unmethylated sequence matches data from the cell sorting and confocal 
microscopy, in that there is a small subset of unsilenced cells in 142S. As the 
population of unsilenced cells is small it is likely that the sequences with low 
levels of methylation are silenced and therefore that small numbers of 
methylated cytosines are sufficient for silencing to occur in this transgene 
system. Both M1 and M9 have two groups of sequences (Figure 4.25 C and D). 
One group lacks methylation and the other maintains methylation. The number 
of methylated sequences is smaller in both M1 and M9 than the unmethylated 
sequences, although for M1 as well as the three methylated sequences there are 
two further sequences with just four methylated cytosine residues (Figure 4.25 
C). It is unclear whether these two sequences are methylated at a very low level 
or the cytosines have failed to be converted during bisulfite treatment. Amongst 
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the group of methylated sequences, levels of methylation are low, as for all 
sequences there were more unmethylated than methylated cytosine residues. In 
most cases methylation of cytosines residues was unique to one sequence, with 
very few cases of more than two sequences methylating the same cytosine 
residue (Figure 4.26 C and D).  
 
Figure 4.25: Presence of methylated and unmethylated sequence in M1 and M9 
at 7 dpg 
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Alignment of bisulfite sequences to the unconverted sequence for 7 dpg samples from 
lines 142 (A), 142S (B), M1 (C) and M9 (D). The top sequence, where all shapes are filled 
in, is the unconverted sequence. The black lines show where each cytosine residue is 
found in the sequence. Red circles are CG sites, the blue squares are CHG sites and 
green triangles are CHH sites. If the shapes are filled this indicate that cytosine is 
methylated. At the beginning of the 142S (B) M1 (C) and M9 (D) sequences red circles 
indicate that this sequence is methylated while purple circles indicate that only four 
cytosines are methylated. Any cytosine residue to the left of the purple vertical line in 
the 142S (B) M1 (C) and M9 (D) alignments is targeted by the 35S IR transgene while 
cytosines to the right are not targeted.  
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Figure 4.26: Reduction in methylation of the 35S promoter methylation at 7 dpg in M1 and M9 
Bar charts of percentage methylation at each cytosine residue in 7 dpg samples from lines 142 (A), 142S (B), M1 (C) and M9 (D). The x shows the 
position of the cytosine residues in the sequence. The y axis shows percentage methylation. The colour of the bar corresponds to the sequence 
context of the cytosine, red is CG, blue is CHG and green is CHH. The black line above the bars represents the region targeted by the 35S IR transgene.
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Further analysis of methylation at 7 dpg shows that although the percentage 
methylation of CG, CHG and CHH is reduced, the proportion of each type of 
methylation is not significantly altered in M1 or M9 compared to 142S (Figure 
4.27 A and B). Multi-dimensional scaling (MDS) analysis has been used to 
demonstrate that the sequences considered methylated are significantly 
different from those considered to be unmethylated and that the methylated 
cytosines are mostly unique to single methylated sequences. MDS calculates how 
different each sequence is from another sequence in two dimensions. This was 
done by looking at whether the methylation status for each individual cytosine 
residue is different or the same in the two sequences. MDS then calculates the 
differences in the two dimensions for every pair of sequences. The sequences 
can then be placed on a scatter plot where the x and y axis distance between 
each sequence represents the calculated difference between the two sequences 
in dimension 1 and dimension 2, respectively. These calculated differences are 
relative, so different MDS analyses cannot be compared directly to each other. In 
142S the sequences are widely distributed (Figure 4.27 C). This is because there 
is variation in the methylation pattern between each sequence and this 
translates into large differences in dimensions 1 and 2. However, for both M1 
and M9 there are two clear groups, as the sequences considered unmethylated 
cluster together while the sequences that maintain methylation do not cluster 
together but are clearly separated from the unmethylated sequences. The fact 
that the methylated sequences do not cluster shows that cytosine methylation in 
each sequence is mostly unique to that sequence. MDS provides statistical 
evidence that the identification of two groups is robust.  
The presence of methylated and unmethylated sequences is unexpected, as the 
morc6 mutants previously characterised have either no effect on DNA 
methylation or a minor decrease in methylation levels and therefore that DNA 
methylation in M1 and M9 would be unaffected or show a modest reduction 
(Lorković et al. 2012, Moissiard et al. 2012). The loss of DNA methylation in the 
majority of sequences for M1 and M9 would therefore suggests that MORC6 in 
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fact, does have a role in DNA methylation, although this role could be specific to 
the transgene locus. The presence of methylated sequences is also unusual, as at 
7 dpg, GFP fluorescence and GFP mRNA levels in M1 and M9 are comparable to 
142, suggesting that silencing does not occur at this stage. The cells with 
methylated sequences are therefore not responding to the methylation of the 
35S promoter, but could be the cells that silence at a later stage. As methylation 
is present at this point the delay could be due to a failure of MORC6’s role in 
higher order heterochromatin formation in the M1 and M9 mutants. These 
results would therefore suggest a dual role for MORC6 in RdDM, as both a 
chromatin modifier and a role in DNA methylation itself. However, as the onset 
of silencing has not been visualised in all tissues it is possible that some level of 
silencing does occur at this stage and that the methylated sequences may belong 
to cells that are already silencing.  
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Figure 4.27: Further analysis of the loss of methylation in M1 and M9 at 7 dpg  
A: Bar chart giving the proportions of total cytosines in all (purple), CG (red), CHG (blue) and CHH (green) configurations that are methylated. The x 
axis shows the plant line the sequences come from. The y axis is percentage methylation. B: Pie charts for lines 142S, M1 and M9 that show the 
proportion of the total methylated cytosines that are CG (red), CHG (blue) and CHH (green). The percentage of the total methylated cytosines is also 
given for each segment of the chart. C: Scatter plots of MDS analysis results for lines 142S, M1 and M9. The x axis is dimension 1 and the y axis is 
dimension 2, both these scales are relative values for difference between sequences. Red dots are methylated sequences, purple dots are sequences 
with only four methylated cytosines and blue dots are those that are assigned as being unmethylated sequences. The read numbers correspond to 
those in Figure 4.25 for 142S, M1 and M9. The positions of several read on the plots in M1 and M9 overlap, this is indicated by several labels 
surrounding a dot.  
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DNA methylation of 28 dpg DNA samples were also assessed. At this point 
silencing has occurred in all leaf tissues. The 142 control showed good 
conversion of cytosines with a maximum of one unconverted cytosine per 
sequence (Figure 4.28 A). This value was used as the cut off for methylated and 
unmethylated sequences for the 142S, M1 and M9 28 dpg samples. As seen in 
the 7 dpg sample, levels of methylation in 142S vary between sequences and 
there are a small number of unmethylated sequences (Figure 4.28 B). Unlike in 
the 7 dpg sample, there was a hypermethylated sequence where methylation 
extends into the region of the 35S promoter not targeted by the 35S IR 
transgene. As the 142 control shows good conversion this is unlikely to be caused 
by failure of cytosine conversion but instead it suggests that in a small number of 
cells in this transgene system, methylation can spread from the siRNA target site. 
DNA methylation in 142S may also not be stochastic, but instead specific 
cytosine residues are favourably methylated. For cytosines where 50% or more 
of the sequences are methylated at that residue, there were twenty four 
residues in the 28 dpg 142S sample and thirty one residues in the 7 dpg 142S 
sample, of which, twenty three are found in both samples (Figure 4.26 B, Figure 
4.29 B and Table 4.2). The reason why these cytosines are strongly methylated is 
unclear, but could be connected to sequence preference by DRM2 or related to 
siRNA levels. Methylation in the 142S line would also appear to be higher for 
cytosines located within the first 140 bp of the part of the 35S promoter that has 
been sequenced (Figure 4.26 B Figure 4.29 B). Again the reason for why there is 
this preference is unknown. 
Site Cytosine residue 
configuration 
Percentage 
Methylation 7 dpg 
(%) 
Percentage 
Methylation 28 dpg 
(%) 
9 CHG 50.00 53.85 
10 CHH 60.00 76.92 
11 CHH 50.00 61.54 
12 CHH 70.00 69.23 
13 CHH 80.00 69.23 
14 CHH 60.00 69.23 
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Site Cytosine residue 
configuration 
Percentage 
Methylation 7 dpg 
(%) 
Percentage 
Methylation 28 dpg 
(%) 
15 CHH 90.00 76.92 
16 CHH 70.00 61.54 
17 CG 50.00 61.54 
18 CG 70.00 61.54 
19 CHG 70.00 69.23 
34 CHH 70.00 69.23 
39 CHH 79.00 61.54 
44 CHG 60.00 69.23 
45 CHH 60.00 53.85 
51 CHH 80.00 53.85 
55 CHH 50.00 69.23 
60 CHH 60.00 69.23 
61 CHG 80.00 61.54 
69 CHG 70.00 69.23 
70 CHH 50.00 61.54 
75 CG 70.00 53.85 
76 CG 50.00 61.54 
Table 4.2: Cytosine residues with 50% or more methylation in 142S  
Table shows the cytosine residues with 50% or more methylation that are found in both 
the 7 dpg and 28 dpg 142S methylation profiles. The site number refers to the cytosine 
number given to each cytosine in Figure 4.24. The configuration of each cytosine is 
given. The percentage methylation in the 7 dpg and 28 dpg sample is given. 
As seen at 7 dpg, there are two groups of sequences in M1 and M9, the largest 
being unmethylated sequences with a smaller group of methylated sequences 
(Figure 4.28 C and D). There are four methylated sequences in M1 and two in 
M9, but there are also three sequences in M1 and two in M9 where there are 
two or three methylated cytosine residues. It is unclear whether these sequences 
are actually methylated or whether it is cytosine conversion failure, particularly 
as they have the same level of cytosine methylation as 7 dpg 142 control 
sequences. Of the sequences that are clearly methylated, both M9 methylated 
sequences have low levels of methylation, at the lower end of what is seen in 
methylated 142S sequences (Figure 4.28 D and Figure 4.29 D) and in M1 four of 
the five methylated sequences also have low levels of methylation, while the 
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fifth sequence has high levels of methylation, comparable to highly methylated 
142S sequences (Figure 4.28 C and Figure 4.29 C). As methylation in both the 7 
dpg and 28 dpg M1 and M9 samples is low, bar one sequence, this would suggest 
that DNA methylation, in cells that do methylate the 35S promoter, is reduced 
and therefore that DNA methylation by RdDM is also impaired in these cells. If 
WT methylation was maintained in this subsection of cells it would be expected 
that more cells would have higher levels of DNA methylation. 
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Figure 4.28: Presence of methylated and unmethylated sequence in M1 and M9 
at 28 dpg 
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Alignment of bisulfite sequences to the unconverted sequence for 28 dpg samples from 
lines 142 (A), 142S (B), M1 (C) and M9 (D). The top sequence, where all shapes are filled 
in, is the unconverted sequence. The black lines show where each cytosine residue is 
found in the sequence. Red circles are CG sites, the blue squares are CHG sites and 
green triangles are CHH sites. If the shapes are filled this indicate that cytosine is 
methylated. At the beginning of the 142S (B) M1 (C) and M9 (D) sequences red circles 
indicate that this sequence is methylated while purple circles indicate that only two or 
three cytosines are methylated. Any cytosine residue to the left of the purple vertical 
line in the 142S (B) M1 (C) and M9 (D) alignments is targeted by the 35S IR transgene 
while cytosines to the right are not targeted. 
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Figure 4.29: Reduction in methylation of the 35S promoter methylation at 28 dpg in M1 and M9 
Bar charts of percentage methylation at each cytosine residue in 7 dpg samples from lines 142 (A), 142S (B), M1 (C) and M9 (D). The x axis shows the 
position of the cytosine residues position in the sequence. The y axis shows percentage methylation. The colour of the bar corresponds to the 
sequence context of the cytosine, red is CG, blue is CHG and green is CHH. The black line above the bars represents the region targeted by the 35S IR 
transgene.
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The proportion of CG, CHG and CHH residues, which are methylated does not 
change significantly in M1 (Figure 4.30 B). However, there is a shift in the 
proportions of CHG and CHH methylation in M9, in that there is an increase in 
CHG and decrease in CHH. although this change may be caused by the relatively 
small number of sequences analysed. To confirm that there are two groups 
within the M1 and M9 samples and that cytosine residue methylation is unique 
to a single sequence, MDS analysis was again used. MDS shows there are two 
clear groups for both M1 and M9, with unmethylated sequences clustering 
together (Figure 4.30 C). The methylation sequences do not group together, but 
are clearly separate from the unmethylated sequences. This lack of grouping is 
again due to the unique methylation pattern for each sequence. As there are 
unmethylated sequences in both the M1 and M9 7 dpg and 28dpg samples and 
methylated sequences have low levels of methylation, this would support a role 
for MORC6 in DNA methylation, at least for this particular locus. 
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Figure 4.30: Further analysis of the loss of methylation in M1 and M9 at 28 dpg 
A: Bar chart giving the proportions of total cytosines in all (purple), CG (red), CHG (blue) and CHH (green) configurations that are methylated. The x 
axis shows the plant line the sequences come from. The y axis is percentage methylation. B: Pie charts for lines 142S, M1 and M9 that show the 
proportion of the total methylated cytosines that are CG (red), CHG (blue) and CHH (green). The percentage of the total methylated cytosines is also 
given for each segment of the chart. C: Scatter plots of MDS analysis results for lines 142S, M1 and M9. The x axis is dimension 1 and the y axis is 
dimension 2, both these scales are relative values for difference between sequences. Red dots are methylated sequences, purple dots are sequences 
with only two or three methylated cytosines and blue dots are those that are assigned as being unmethylated sequences. The read numbers 
correspond to those in Figure 4.28 for 142S M1 and M9. The positions of several reads on the plots in M1 and M9 overlap, this is indicated by several 
labels surrounding a dot.
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It is expected that the sequences lacking DNA methylation of the 35S promoter 
come from cells that express GFP and that sequences that were methylated 
come from cells in which GFP is silenced. In order to confirm this, cell sorting was 
used to separate silenced cells from unsilenced cells, the identification of which 
has been discussed previously (page 241). DNA was then extracted from the 
separate fractions, but only the M1 unsilenced protoplast sample had a sufficient 
number of protoplasts to produce DNA of high enough concentration for bisulfite 
sequencing (Table 4.1). The DNA from this sample was at low concentration, so 
to prevent loss of DNA, the DNA was not cleaved by restriction enzymes before 
bisulfite treatment. 142 DNA extracted from whole leaves was used as a control 
for bisulfite conversion. Sequencing of the 35S promoter from bisulfite treated 
DNA showed good conversion of cytosines with most sequences having a 
maximum number of three unconverted cytosine residues per sequence, 
however there was one 142 sequence, which had nine unconverted cytosines 
(Figure 4.31 A). This may be due to lack of bisulfite conversion, possibly due to 
the different DNA preparation technique used for this bisulfite conversion. It is 
also possible that a minority of cells in 142 methylate the 35S promoter and so it 
cannot be ruled out that the sequence is in fact methylated.  
In the M1 unsilenced DNA sample there was little evidence for DNA methylation 
of the 35S promoter, eight sequences have three or less unconverted cytosine 
residues per sequence, which is the same as the 142 sequences (Figure 4.31 B). 
There are however one sequence with four unconverted cytosine residues and 
another with six unconverted residues, although this is still less than the 142 
sequence with the most unconverted cytosines. Therefore the unconverted 
cytosines could be caused by a failure of conversion during bisulfite treatment, 
although methylation cannot be discounted. If these two sequences are 
methylated, their level of cytosine methylation is low, particularly when 
compared to levels in methylated M1 sequences from the 7 dpg and 28 dpg time 
points, which usually have between 15-25 methylated cytosines in each 
sequence (Figure 4.25 C and Figure 4.28 C). It is therefore likely that this level of 
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DNA methylation is insufficient for silencing of the 35S promoter. Although DNA 
methylation analysis of the silenced M1 protoplasts is lacking, it can be 
concluded from the lack of DNA methylation in the unsilenced protoplasts that 
DNA methylation should be restricted to the silenced protoplasts. However, it is 
unknown whether all silenced protoplasts are methylated and would require 
bisulfite sequencing of a silence sample in order to determine if this is the case. 
 
Figure 4.31: Lack of methylation in the unsilenced M1 protoplasts 
Alignment of bisulfite sequences to the actual sequnce for DNA samples from 
142 (A) and unsilenced M1 protoplasts (B). The top sequence where all shapes 
are filled in is the actual sequence. The black lines show where each cytosine 
residue is found on the sequence. Red circles are CG sites, the blue squares are 
CHG sites and green triangles are CHH sites. Filled in shapes indicate that 
cytosine is methylated. Red circles at the beginning of sequences indicate that 
this sequence is methylated. Sequences are considered methylated if they have 4 
or more methylated cytosines. 
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4.3 Discussion 
4.3.1 Role of MORC6 in RdDM pathway 
siRNA levels and DNA methylation in the M1 and M9 morc6 mutants was 
assessed. siRNA levels do not differ between the two morc6 mutants and WT 
lines indicating that morc6 does not affect siRNA production. As opposed to 
siRNA levels DNA methylation is affected in the morc6 mutants with a total loss 
of 35S promoter DNA methylation in the majority of mesophyll cells in M1 and 
half of the mesophyll cells in M9. There is DNA methylation in a subset of 
mesophyll cells in M1 and just under half the cells in M9, however even in these 
cells methylation is lower than seen in WT. This reduction in DNA methylation 
but lack of change in siRNA levels would suggest that morc6 is involved in the 
PolV and AGO4 complex that triggers DNA methylation. This would be contrary 
to the Moissiard paper which did not identify any significant reduction in DNA 
methylation and concluded that MORC6’s role in RdDM was purely as a higher 
order chromatin modifier (Moissiard et al. 2012). However, the second paper to 
identify MORC6 as a RdDM component showed that at a subset of the 
endogenous RdDM targets tested and the transgene reporter used in the study, 
DNA methylation levels were reduced in the morc6 mutant, but no change in 
methylation was observed at the majority of endogenous loci (Lorković et al. 
2012). This would therefore suggest that MORC6’s role in DNA methylation itself 
is loci specific and that the region of the genome where the GFP transgene is 
located is one such locus. To investigate whether the effect of morc6 on DNA 
methylation is loci specific, DNA methylation of endogenous targets of RdDM 
was assessed and will be discussed in the next chapter. 
As to MORC6’s exact role in DNA methylation, it has previously been shown that 
MORC6 interacts with DMS3 to form a complex similar to SMC proteins (Lorković 
et al. 2012). SMC function is varied and consequently the structure of the SMC 
complexes formed is varied (Hirano 2005). It is suggested that in this case the 
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MORC6 and DMS3 complex, described as SmcMORC6 henceforth, forms a ring 
which could hold DNA and/or RNA strands in place during PolV transcription, 
thus providing a stable scaffold for other proteins to bind and form complexes 
(Bender 2012). IDN2 and its homologs form complexes that bind to siRNA-AGO4 
complexes bound to the PolV transcript and it is thought that this binding and 
the consequential interaction of the zinc finger motifs of IDN2 and its homologs 
with DNA may trigger DRM2 to methylate the DNA (Ausin et al. 2012b, Zhang et 
al. 2012). SmcMORC6 clamping the DNA and RNA strand may therefore help 
facilitate this interaction between IDN2 and the DNA.  
DMS3 has been shown to form part of the DDR complex with DRD1 and RDM1, 
which is required for PolV transcription (Law et al. 2010). MORC6 is also required 
for PolV transcription for at least one RdDM endogenous target, therefore 
indicating that MORC6 is also part of the DDR complex (Lorković et al. 2012). The 
SmcMORC6 complexes are therefore likely to bind at multiple sites both 
upstream and downstream of PolV to help provide a platform for PolV 
transcription and a secure scaffold for initiation of DRM2 methylation. It should 
be noted that other, as yet undiscovered, proteins may also be involved in 
SmcMORC6 complexes as this is common amongst SMC proteins (Hirano 2005). 
Further analysis using yeast 2-hybrid or immuneprecipitation would therefore be 
required to identify any such proteins. 
As noted previously some cells maintain DNA methylation in morc6 mutants and 
the reason why methylation could persist in morc6 mutants is that there are six 
other MORC genes in Arabidopsis so there could be redundancy amongst the 
MORC genes. The fact that unlike other SMC proteins, which are encoded by one 
gene, DMS3 and MORC6 are encoded by separate genes would suggest that 
modularisation of SMC function has occurred in plants (Lorković et al. 2012). Due 
to the scale of loss of DNA methylation at the 35S promoter in this study it is 
likely that MORC6 is the main MORC protein involved in silencing of this 
promoter. Other MORC proteins may act as the main MORC for other loci, but 
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further work is required to determine whether this is indeed the case and if 
there is redundancy. Testing mutants in other MORC genes and producing 
double mutants should therefore be informative.  
There is also a delay in the onset of silencing in both M1 and M9, which may 
correlate with a change in DNA methylation. There is no obvious change in levels 
of 35S promoter DNA methylation between 7 dpg and 21 dpg yet there is a clear 
change in GFP expression from both visual and molecular data. However, it 
cannot be discounted that silencing is already occurring at 7 dpg as the exact 
point of silencing onset has not been established for all tissues. Assuming that 
there is delay in silencing, it raises the question as to why, despite no detection 
of a change in methylation, the cells do not silence immediately. An explanation 
is provided by  the other role for MORC6 suggested by Moissiard, that MORC6 is 
involved in higher order chromatin structure rearrangement (Moissiard et al. 
2012). Other SMC proteins are involved in higher order chromatin 
rearrangement, including chromosome condensation during mitosis and meiosis, 
and MORC6 has been shown to be involved in the correct organisation of 
pericentromeric DNA into chromocentres associated with the nuclear envelope 
(Hirano et al. 1997, Sutani et al. 1999, Moissiard et al. 2012). MORC6 may also 
reinforce DNA methylation by facilitating the formation of higher order 
heterochromatin at the 35S promoter. Other MORCs may therefore be able to 
compensate for the loss of MORC6 by methylating the DNA in some cells but are 
unable to form the higher order heterochromatin at earlier stages of 
development. The onset of silencing would therefore be associated with the 
establishment of the higher order chromatin by another MORC or other 
chromatin modifier. The reason for this delay in establishing higher order 
chromatin could be that the MORC or chromatin modifier in question is not as 
efficient as MORC6.  
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4.3.2 Cause of the late onset mosaic silencing pattern and 
influence of tissue type in morc6 mutants 
The M1 and M9 mutants in MORC6 display an unusual silencing phenotype. 
Silencing is delayed in onset, mosaic and influenced by tissue type. The silencing 
phenotype of the GFP transgene also shows that M1 causes a greater loss of 
silencing than M9 and thus is a stronger defective allele in MORC6. Both M1 and 
M9 are premature stop codon mutations, but in M1 the premature stop codon is 
in the 41st codon whereas in M9 the premature stop codon is the 267th codon. 
The MORC6 protein produced in M1 would lack all functional domains but in M9 
it is predicted to contain part of the GHKL ATPase domain, including three of the 
four conserved GHKL sequence motifs. This means that M9 still have some 
MORC6 functionality whereas M1 is likely to be a full loss-of-function allele. The 
T-DNA insertion morc6 mutant, morc6-3, used in one of the previous studies to 
identify MORC6 is a full knockout, but the other four morc6 mutants may still 
have some residual MORC6 function (Lorković et al. 2012, Moissiard et al. 2012). 
These four lines are all premature stop codon mutations in codons 267, 293 and 
439, which will produce a MORC6 protein of the same length or longer than that 
produced by M9. It would therefore be interesting to determine whether there 
are any differences between the phenotype of M1 and M9 and those observed in 
the other three morc6 mutants for endogenous targets of RdDM. This will be 
discussed in the next chapter. 
The mosaic silencing pattern of morc6 has not been previously reported in any 
RdDM mutant. This is not necessarily because other mutants do not silence 
mosaically, as no previous study has presented data on silencing patterns using 
confocal microscopy. Also many studies have used transgene systems where this 
type of phenotype cannot be detected due to the nature of the reporter gene. 
The mosaic silencing pattern is unusual as it occurs in cells from the same cell 
type, therefore it is unlikely to be due to differences in expression of MORC6 or 
other genes that may affect silencing. It is known that 24nt siRNAs involved in 
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RdDM can act as  a mobile silencing signal that can transmit silencing from cell to 
cell and across the entire plant, via phloem transport (Smith et al. 2007, Molnar 
et al. 2010). It is not known whether 35S siRNAs can be transported from cell to 
cell, however as levels in M1 and M9 are not significantly different from WT it is 
not the lack of siRNAs causing the mosaicism. Indeed the mosaic phenotype of 
M1 and M9 is similar to the positional-effect variegation phenomenon, which 
was first observed in the eye pigmentation of Drosophila melongaster and has 
also been observed in other species, including mice (Muller 1930, Robertson et 
al. 1995, Wallrath and Elgin 1995). The White gene is required for red eye 
pigmentation in Drosophila and a mutant in this gene was identified which 
displayed a mosaic pattern of cells exhibiting varying levels of pigmentation 
(Muller 1930). Investigation of this mutant revealed that a chromosome 
rearrangement had moved the White gene so that it was now adjacent to a 
pericentromeric region and that it was this region that was responsible for 
suppressing the gene and causing the loss in pigmentation, but that this silencing 
did not occur in all cells (Wallrath and Elgin 1995). This mechanism of silencing is 
unlikely to be the cause of the loss of silencing of the 35S promoter as in WT 
plants silencing is triggered by the 35S IR transgene rather than adjacent 
heterochromatic regions, but does show that stochastic silencing events in single 
cell types is possible.  
The likely cause of the mosaicism in the M1 and M9 mutants may instead be due 
to a reduction in the efficiency of RdDM. MORC6 forms part of the DDR complex, 
required for PolV transcription and may also be involved in clamping the DNA 
and PolV transcript together, thus enabling IDN2 and its homologs to successfully 
bind to the PolV transcript-siRNA duplex and interact with the DNA through their 
zinc finger motifs (Ausin et al. 2012b, Lorković et al. 2012, Zhang et al. 2012). 
Loss of MORC6 would therefore perturb both PolV transcription and IDN2 
binding resulting in a failure of RdDM to methylate the 35S promoter. However, 
PolV transcription and correct IDN2 binding may still occur but less frequently 
than in WT, hence why some cells methylate and others do not. As these 
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processes are downstream of siRNA production they would be independent of 
cell to cell siRNA transmission so that silencing would be cell autonomous. This 
inefficiency in RdDM is highlighted by the difference between M1 and M9, as in 
M1, which is probably a full knockout of morc6, only 17.36% of mesophyll cells 
silence the GFP transgene whereas in M9, which may have some residual MORC6 
function, 46.97% of mesophyll cells silence the transgene. This shows that even a 
partially functional MORC6 protein improves the effectiveness of RdDM. 
Mosaicism has previously been described in a morc6 mutant regarding 
chromocentre formation. When cells were assessed in morc6 mutants for 
presence of chromocentres it was found that cells either lacked defined 
chromocentres, had ill-defined chromocentres or had chromocentres that were 
unaffected (Moissiard et al. 2012). morc1 has a similar phenotype to morc6, but 
has a greater reduction in the percentage of unaffected chromocentres, 
suggesting that although there is redundancy between the two MORC proteins, 
MORC1 has the greater role in chromocentre formation. It should however be 
noted that the morc6 mutant that was used to assess the chromocentre 
phenotype may not have been a full knockout so the effect of a full knock out of 
morc6 may be greater. Unexpectedly the double mutant of morc1 and morc6 has 
a weaker phenotype than the two single mutant lines and the reason for this 
change in phenotype is unknown, but may be due to the up regulation of 
another chromatin modifier in response to the double but not the single 
mutants. Further investigation to determine if any other chromatin modifiers are 
indeed up regulated would be required to determine if this is the cause of this 
phenotype. It is possible that other MORC proteins are also involved in 
chromocentre formation and this would require further investigation by 
screening mutants in the other MORC genes for chromocentre definition.  
Both M1 and M9 show clear influence of tissue type in their respective silencing 
patterns. As mentioned previously the degree of silencing varies between 
tissues, shown by the lower levels of silencing in the upper epidermis of leaves 
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compared to the lower epidermis. Redundancy between MORC6 and other 
MORCs or chromatin modifiers could be an explanation for these differences, but 
this would require further investigation to prove, as although published 
microarray data suggests differences in expression between MORC proteins, the 
activity of the MORC proteins has not been assessed directly in different tissue 
types. In the case of the upper and lower epidermal layers, if there is redundancy 
between the MORC proteins it would suggest that the other MORCs or 
chromatin modifiers are more able to replace MORC6 in the lower epidermis 
than the upper epidermis and hence why the delay in silencing is longer and 
levels of silencing are lower in the upper epidermis than the lower epidermis. 
There is an adaxial to abaxial gradient to silencing in both M1 and M9, suggesting 
that there also may be a gradient in MORC6 expression, although there is no 
obvious explanation why such a gradient would occur. Silencing is stronger in 
leaves than roots, although in this case the difference in silencing may be related 
to the transgenes as this reduction in silencing in the roots is also observed in 
142S. Analysing the expression levels of the transgenes would determine if this 
root specific silencing pattern is related to reduced expression of the 35S IR or a 
reduction in GFP silencing. The reason for this difference is unclear as both 
transgenes should be ubiquitously expressed throughout the plant. A possible 
explanation is that expression of one or both of the transgenes is affected by 
nearby endogenous regulatory regions that affect expression levels and hence 
could impact silencing levels. Another possibility is that either the GFP or 35S IR 
transgene may reside in a region of the genome that has different chromatin 
state between tissue types, which could affect silencing.  
A delay in silencing has been seen in other RdDM mutants, notably in nrpd1 (Herr 
et al. 2005). In that study, silencing was delayed and initially occurred in localised 
areas before spreading outwards. However, for M1 and M9 the onset of silencing 
depends on the tissue type, with the upper epidermis silencing between 14 dpg 
and 20 dpg and the mesophyll layers silencing before 10 dpg. This would suggest 
that tissue type influences time of onset as well as the strength of silencing in the 
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morc6 mutants. There is also molecular evidence for a delay in silencing of the 
GFP transgene as levels of GFP mRNA decrease between 7 dpg and 21 dpg in M1 
and M9. However, as the 7 dpg samples will have a higher proportion of RNA 
from cotyledon leaves than the 21 dpg samples this decrease may be down to 
the difference in tissue composition. Silencing of GFP in 142S is not as strong in 
cotyledon leaves as rosette leaves, hence why GFP mRNA can be detected at 7 
dpg in 142S but not 21 dpg and so this could also occur in M1 and M9. But 
visualisation of GFP between 7 and 21 dpg shows that levels of GFP decrease 
between these two time points and therefore I would argue that the decrease 
does provide molecular evidence for a delay in silencing. The lower epidermis’ 
silencing pattern has been most thoroughly characterised and unlike in the nrpd1 
delay, silencing is sudden with cells going from unsilenced to a mosaic phenotype 
within six hours. The time of onset for epidermal silencing is also specific, being 
13 dpg and 14 dpg for M9 and M1 respectively and this seems to be linked to 
time after germination rather than a specific developmental stage. The delay 
itself could be caused by redundancy of MORC6 with other MORC proteins, 
expressed at a later stage; although the fact silencing is not linked to 
development and the difference seen between M1 and M9 would discredit this. 
Another possible explanation is that due to the loss of MORC6, RdDM silencing is 
less efficient and therefore may take longer to silence the GFP transgene. This 
would not be dependent on developmental stage, although it would be expected 
that if RdDM was less efficient the time of silencing would be more random.  
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5.1 Introduction  
5.1.1 Loci specific effects of RdDM mutants 
The effect of different RdDM mutants on DNA methylation varies. This can be 
seen at a global level as well as at specific targets. Global methylation in morc6 
and morc1 mutants is reported to be unaffected (Moissiard et al. 2012). Whereas 
the drm1, drm2 and cmt3 triple mutant causes near total loss of global CHG and 
CHH methylation (Lister et al. 2008). These two examples are extremes; most 
RdDM mutants have a more nuanced phenotype, whereby RdDM mutants’ effect 
on DNA methylation varies between different target loci. This target specific 
nature of methylation has been shown in several studies. A recent study, 
identified the IDN2 homologs IDP1 and IDP2 as RdDM components that bind to 
siRNAs bound to the PolV transcript and may mediate DRM2 methylation of the 
target DNA (Zhang et al. 2012). The study compared DNA methylation levels of 
the RdDM targets Solo LTR, MEA-ISR and AtSN1 in the mutant lines idn2, idp1, 
idp2 and nrpd1. idn2 and idp1 mutants only affected CHG and CHH methylation 
but not CG methylation, whereas nrpd1 led to reduction in DNA methylation in 
all cytosine sequence contexts for all the loci tested and idp2 did not affect DNA 
methylation in any sequence context. The effect of idn2 and idp1 on CHG and 
CHH methylation varied between the loci, with a reduction in methylation of Solo 
LTR in idn2 but not idp1, and reduced methylation of MEA-ISR for both. This 
shows a clear target specific effect of the idn2 and idp1 mutants.  
As mentioned above, mutation of MORC6 does not lead to large scale DNA 
methylation changes across the genome (Moissiard et al. 2012). This suggested 
that MORC6 is involved in establishing and maintaining higher order 
heterochromatin structure in response to DNA methylation at RdDM targets, 
rather than DNA methylation itself. However, a second study, which identified 
MORC6 as a RdDM component showed that morc6 does cause a loss of DNA 
methylation at specific loci and this loci-specificity is also seen in the first study 
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(Lorković et al. 2012, Moissiard et al. 2012). MORC 6 also forms a complex with 
the protein DMS3, but dms3 by comparison to morc6 exhibits a greater 
reduction in DNA methylation (Kanno et al. 2008, Ausin et al. 2009). It was 
therefore suggested either that the morc6 mutant was not a full knockout, 
resulting in a smaller reduction in DNA methylation, or that there is redundancy 
with other MORC proteins since there are six MORC homologs in Arabidopsis. 
The two morc6 mutant alleles identified in this study (M1 and M9) both cause a 
reduction in methylation of the transgene system used to identify mutants 
(Figure 4.25 and Figure 4.28). This suggests that morc6 may effect DNA 
methylation. Therefore this chapter will focus on the effect of M1 and M9 on 
endogenous RdDM targets. 
5.1.2 Selection of RdDM target loci to be tested 
Assessment of the DNA methylation status of specific RdDM targets will be 
presented in this chapter. However as there are a large number of endogenous 
target loci only a subset of these loci was tested. These loci broadly subdivide 
into three groups: endogenous genes, repetitive elements and transposable 
elements (TEs) (Huettel et al. 2006, Lister et al. 2008, Baev et al. 2010). At least 
one target from each group was chosen. In total five targets were chosen and 
these were: 5S rDNA, MEA-ISR, AtMu1, Solo LTR and AtSN1 (Table 5.1). The 5S 
rDNA repeats are an example of an endogenous gene target as well as a 
repetitive element; MEA-ISR is an example of a repetitive element target and 
AtMu1, Solo LTR and AtSN1 are examples of TEs.  
Abbreviated 
name 
Full name Target description 
5S rDNA 5S rDNA gene repeats Repeats of the 5S rDNA gene 
AtMu1 Arabidopsis thaliana 
Mutator-like 1 
Class II transposable element 
AtSN1 Arabidopsis thaliana SINE 1 Class I (reterotransposon) 
transposable element 
MEA-ISR MEDEA-Intergenic 
Subtelomeric Repeats 
Tandem repeats downstream of 
the MEDEA gene 
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Abbreviated 
name 
Full name Target description 
SoloLTR Solo Long Terminal Repeat LTR of LTR/Copia transposon 
Table 5.1: Endogenous targets of RdDM to be tested 
Endogenous targets of RdDM that were tested for changes in DNA methylation in this 
chapter. The abbreviated name, full name and what the target is are given. 
The 5S rDNA repeats are tandem repeats of the 5S rDNA gene and the resulting 
protein forms part of the 60S large ribosome subunit (Campell et al. 1992). There 
are estimated to be around one thousand copies of the 5S rDNA gene within 
these repeats. These thousand copies are arranged into four repeat cluster on 
chromosomes 3, 4 and 5, with two clusters on chromosome 5 (Murata et al. 
1997). The exact make up of these clusters varies between ecotypes, with some 
ecotypes lacking the repeat cluster of chromosome 3 (Fransz et al. 1998). There 
are two classes of 5S rDNA gene, a major and minor gene, which have one or two 
SNP differences (Cloix et al. 2002). Major versions of the 5S rDNA genes are 
constitutively expressed while minor genes are expressed in roots and the 
cotelydon stage of plant development, but are mostly silenced in adult aerial 
tissue (Mathieu et al. 2003). The shift to silencing is associated with formation of 
heterochromatin at the pericentromeric regions. This suggests that as well as 
decreasing the level of 5S rDNA expression in response to a reduced need for the 
ribosomal subunit that silencing of the 5S rDNA is also associated with larger 
alterations in heterochromatin during leaf development. Silencing of the minor 
5S rDNA genes involves multiple pathways including RdDM (Vaillant et al. 2007). 
Several RdDM mutants, including ago4 and dms3, show reduction in methylation 
of the 5S rDNA repeats while other mutants, such as drd1 and hda6, show no 
change in methylation (Aufsatz et al. 2002b, Kanno et al. 2004, Vaillant et al. 
2007, Ausin et al. 2009). 
The MEDEA-Intergenic Subtelomeric Repeats (MEA-ISR) is an example of a 
repetitive element target of RdDM (Deleris et al. 2010). MEA-ISR is a sequence of 
seven tandem repeats found downstream of the Polycomb group gene MEDEA, 
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part of a Polycomb Repressive Complex 2 type complex found in Arabidopsis 
(Kiyosue et al. 1999, Kohler et al. 2003). Each repeat is 183 bp long and shows 
homology with twelve other subtelomeric repeat elements (Cao and Jacobsen 
2002a). MEA-ISR has been used to characterise the effect of several RdDM 
mutants’ effect on endogenous DNA methylation, including drm2, idn2, clsy1, 
nrpe1, dcl3 and ktf1,  with some mutants, such as drm2, losing all methylation of 
MEA-ISR while others, such as dcl3, result in a partial loss in methylation (Ausin 
et al. 2009, Greenberg et al. 2011). 
TEs are the last group of endogenous RdDM targets, of which Arabidopsis 
thaliana Mutator-like (AtMu1), Arabidopsis thaliana SINE 1(AtSN1) and Solo Long 
terminal repeat (LTR) have been chosen for DNA methylation analysis. AtMu1 is 
a class two TE that belongs to the Mutator-like element (MULE) family in 
Arabidopsis  and is a homolog of the Mutator TEs found in maize (Yu et al. 2000). 
There are two AtMu1 TEs in the Columbia genome and both are transcriptionally 
inactive (Singer et al. 2001). They are silenced by DNA methylation and become 
transcriptionally active in DNA methylation defective mutants, such as ddm1. 
AtMu1 has been used to characterise several RdDM mutants including rdm4, ktf1 
and rdm1 (He et al. 2009b, He et al. 2009c, Gao et al. 2010). AtSN1 is another 
class two TE that belongs to the Short Interspersed Elements (SINE) family, of 
which there are two sub-families in Arabidopsis, AtSN1 and AtSN2 (Myouga et al. 
2001). There are seventy one AtSN1 elements, which vary in sequence and 
structure and are targets of RdDM silencing. These have been used to 
characterise a large number of RdDM mutants including nrdp1,nrpd4 and shh1  
(Hamilton et al. 2002, Herr et al. 2005, He et al. 2009a, Law et al. 2011). The final 
TE, Solo LTR, is a lone LTR so can also be considered a repeat element as well as a 
TE (Huettel et al. 2007). The solo LTR is the LTR of a LTR/Copia reterotransposon, 
which has been orphaned by either unequal crossing over or intrachromosomal 
recombination between LTRs (Shirasu et al. 2000, Huettel et al. 2007). The solo 
LTR is located on the left arm of chromosome five and is methylated in WT, but 
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loses methylation in RdDM mutants, including drd1 and ktf1 (Huettel et al. 2007, 
Bies-Etheve et al. 2009). 
5.1.3 RdDM effect on flowering time 
As well as RdDMs role in chromatin regulation, it is also involved in flowering 
time. The control of flowering time is complex and involves the action of four 
main regulatory pathways: the autonomous pathway, the vernalization pathway, 
the photoperiod pathway and gibberellin-dependent pathway (Wilson et al. 
1992, Koornneef et al. 1995, Alonso-Blanco et al. 1998, Blázquez et al. 1998, 
Koornneef et al. 1998a, Koornneef et al. 1998b, Amasino 2004). These pathways 
all regulate Flowering time Locus C (FLC), which is a repressor of flowering. It has 
been shown that the RdDM pathway is also involved in FLC regulation and 
represses expression through methylation of sites downstream of the poly-
adenylation site of FLC (Swiezewski et al. 2007). Deletion of this target site 
causes a late flowering phenotype, indicating that the action of RdDM is required 
for correct regulation of FLC.  
The FWA gene is another floral repressor that is controlled by DNA methylation, 
however in this case methylation is maintained by MET1 maintenance rather 
than RdDM (Kinoshita et al. 2004). However, in cases where methylation of FWA 
has been lost, such as in the decrease in DNA methylation 1 (ddm1) mutant, 
methylation can be re-established by RdDM (Kinoshita et al. 2004). The Jacobsen 
group also use a transgenic FWA gene to screen for RdDM mutants (Greenberg 
et al. 2011). In WT plants introduction of the FWA transgene results in DNA 
methylation of the transgene by RdDM and flowering time is unaffected; but in 
RdDM mutants the transgene is not methylated, resulting in a delay in flowering 
time.  
These findings would therefore suggest that RdDM mutants should exhibit a 
delay in flowering, which has been shown to be the case for dcl3, nrpd1 and 
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nrpe1 mutants (Pontier et al. 2005, Greenberg et al. 2011). However, the effect 
of RdDM mutants on flowering time depends on day length, with only a minor 
delay in flowering time in long day (16 hour) conditions compared to a greater 
change in short day (8 hour) conditions (Greenberg et al. 2011). This could 
therefore suggest an involvement in the photoperiod regulatory pathway that 
controls flowering time. 
5.1.4 Aims of chapter 
The aim of this chapter is to characterise the effect of the morc6 mutants on 
endogenous targets of RdDM. This will be done by studying: 
A) Effect of M1 and M9 mutants on DNA methylation of endogenous targets of 
DNA methylation 
B) Effect of M1 and M9 on siRNA production from endogenous targets 
C) The effect of M1 and M9 on flowering time in short day growth conditions 
5.2 Chapter-specific methods 
5.2.1 Methylation sensitive Southern blotting 
To assess whether endogenous RdDM targets have lost DNA methylation, 
methylation sensitive Southern blotting was used. Initially DNA samples were 
digested with either MspI or HaeIII and then run on a gel before being 
transferred to a membrane. This membrane is then probed with a radiolabelled 
probe for a specific locus, producing a specific banding pattern for that locus. The 
pattern is affected by methylation as both restriction enzymes are methylation 
sensitive. MspI is sensitive to CG and CHG while HaeIII is sensitive to CHG and 
CHH methylation (Figure 5.1). If methylation is present at the restriction site the 
restriction enzyme will not cleave the DNA, but will if methylation is not present. 
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Cleavage of restriction sites will create lower molecular weight (LMW) bands 
whereas as failure to cleave will produce higher molecular weight (HMW) bands. 
If methylation has been lost in the mutants this will increase the number of 
restriction sites that are cleaved, manifesting in a shift from HMW bands to LMW 
bands, compared to the WT lines. Bisulfite sequencing can also be used to assess 
DNA methylation and is in fact more informative as it can test all cytosine 
residues at a locus rather than a select few that are in restriction sites. The 
reason for the use of Southern blotting despite its limitations is that it is both 
more rapid and less expensive than bisulfite sequencing. 
 
Figure 5.1: How methylation of MspI and HaeIII restriction sites affects 
cleavage 
Diagram of the sequences of the restriction sites of MspI and HaeIII. The purple line 
shows where the respective restriction enzyme cleaves. MspI cleavage creates a two 
nucleotide overhang while HaeIII forms blunt ends. Red, blue or green Cs represent the 
cytosine residues in the restriction sites that if methylated will inhibit cleavage of that 
sequence. Red Cs are cytosine residues in a CG sequence context; blue Cs are cytosines 
in a CHG sequence context; and greens Cs are cytosines in a CHH sequence context. For 
the cytosines in the HaeIII restriction site they can either be in the CHG or CHH sequence 
configuration as the third base lies outside the restriction site. The letters above and 
below the restriction site sequence give the sequence context of the methylation 
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sensitive cytosines, with the colours of the letters again representing the sequence 
context of CG, CHG or CHH.  
5.2.2 Methylation sensitive PCR 
As well as methylation sensitive Southern blotting, methylation sensitive PCR 
was also used to asses AtSN1 DNA methylation changes. Like Southern blotting 
the DNA is first digested with the methylation sensitive restriction enzyme HaeIII, 
which detects CHG or CHH methylation (Figure 5.1). Two PCRs were then 
performed on 5 ng of the digested DNA, whereby one amplifies AtSN1, and the 
other amplifies part of SHH1. The AtSN1 PCR product spans a HaeIII cut site in 
AtSN1, while the SHH1 PCR product, described as SHH1 4 from hence forth, lacks 
a HaeIII cleavage site. The SHH1 4 product will always amplify in the HaeIII 
digested DNA so provides a positive control for presence of DNA and its 
concentration. The AtSN1 PCR product will only be produced if HaeIII has not 
cleaved the DNA at the AtSN1 restriction site due to the presence of 
methylation. The level of amplification of the AtSN1 PCR can therefore be used 
to provide a relative value for methylation levels at the locus. In order to provide 
a value for the amount of PCR product produced the intensity of the PCR product 
on a SYBR gel is measured using ImageJ and normalised against the SHH1 4 PCR 
product’s intensity. A PCR for AtSN1 was also performed on undigested DNA as 
another positive control for each sample to show that the AtSN1 PCR works in all 
instances.  
5.2.3 Flowering time assay 
A flowering time assay was carried out to assess whether the mutants affected 
flowering time. As mentioned in the introduction RdDM mutants can affect 
flowering time and this is most apparent in short day growth conditions (Pontier 
et al. 2005). For this reason the flowering time assay was carried out in short day 
(8 hour) conditions. Flowering time was considered to be the point when the first 
flower opened and the leaf number (LN) of that plant was then recorded 
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(Koornneef et al. 1998a). LN is the total number of adult rosette and cauline 
leaves and has been previously shown to correlate well with the number of days 
until flowering (Koornneef et al. 1991). To allow for statistical analysis of the 
results, the LN of at least one hundred plants from each line were recorded. In 
previous flowering time assays an analysis of variance (ANOVA) was used to test 
for statistical significance (Koornneef et al. 1998a). An ANOVA assumes that each 
data point is independent; that all data are normally distributed within groups; 
and variance is homogeneous between groups. For this study it is assumed that 
data points are independent as this is an assumption made in previous flowering 
time assays. To check if the data was normally distributed, the Kolmogorov-
Smirnova and Shapiro-Wilk tests of normal distribution were used before 
running the ANOVA. A Levene’s test of homogeneity of variance was used to 
check the variance between groups. If there was no significant difference an 
ANOVA could be used, but if there was a significant difference in variance 
between groups the Welch robust test of equality of means, which is similar to 
an ANOVA but take into account difference in variance, was used instead. 
As there is only one form of grouping being tested in this experiment, that being 
plant line, a one way ANOVA/Welch test was used. If the ANOVA/Welch test 
showed that there was a significant difference between the means for each line 
the Least Significant Distance (LSD) post hoc test was then used to identify which 
groups were different from each other, but if there was not a significant distance 
the Bonferroni post hoc test was used (Dytham 2005). This is because the LSD 
test is less powerful if the ANOVA/Welch test is not significant. 
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5.3 Results 
5.3.1 morc6 has no effect on DNA methylation of 
endogenous genes 
Methylation of the 35S promoter does not change between 7 dpg and 21 dpg 
and so methylation of endogenous loci was also tested at 7 dpg and 21 dpg to 
determine if this is also true for endogenous targets of RdDM and if M1 and M9 
affect methylation at these loci. To achieve this methylation sensitive Southern 
blotting was used and how this technique works is explained in in the methods 
section of this chapter (page 294). DNA samples from lines 142, 142S, M1, M9, 
rdr2-1 and rmd3 or nrpd1-2 were taken from 7 dpg and 28 dpg plants. Both 142 
and 142S give the WT methylation pattern for each locus tested, while rdr2-1, 
nrpd1-2 and rmd3 are previously characterised mutants in the RdDM pathway 
that lose DNA methylation at endogenous loci (Xie et al. 2004, Eamens et al. 
2008).  
The first locus tested was the 5S rDNA repeats which were chosen as an example 
of an endogenous gene targeted by RdDM. The 5S rDNA repeats had previously 
been tested during the initial characterisation of the mutant lines (Figure 3.3) but 
was of poor quality so the one shown in this chapter is a repeat. All three 
sequence contexts of methylation were assessed. DNA from the nrpd1-2 mutant 
line was used instead of rmd3 for the 5S rDNA Southern blots. Both nrpd1-2 and 
rmd3 are both full knockouts of the NRPD1 gene so will produce similar DNA 
methylation patterns, but are in different ecotypes with nrpd1-2 in the Columbia 
ecotype and rmd3 in the C24 ecotype (Eamens et al. 2008). rmd3 contains the 
transgene system used in this study and has a nonsense mutation in the nrpd1 
gene, whereas nrpd1-2 lacks the transgene system and has a T-DNA insertion 
which affects the NRPD1 gene. rmd3 is therefore preferentially used, however at 
the time when the 5S rDNA Southern blots were completed, rmd3 seed stocks 
were being replenished so were not used.  
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There is no change in MspI CG or CHG methylation of the 5S rDNA repeats in 
either M1 and M9 or rdr2-1 and nrpd1-2 (Figure 5.2 A). The banding pattern of 
the four mutant lines at 7 dpg is identical to that of 142 and 142S at 7 dpg, with 
no loss of HMW bands. Unfortunately, both 142 and 142S 21 dpg DNA samples 
were not properly digested by MspI, which can be seen from the presence of 
high molecular weight genomic DNA in both the Southern blot and ethidium 
bromide gel. Although the 21 dpg WT methylation pattern is unknown, since 
there is no change in digestion pattern between 7 dpg and 21 dpg for M1, M9 
and nrpd1-2, DNA methylation at 21 dpg in the mutants is likely to be the same 
as WT. There is also a problem with the rdr2-1 21 dpg banding pattern as the 
signal from DNA bands is weak due to the lower amount of DNA run on the gel 
for this sample, compared to other DNA samples on the gel. The low amount of 
DNA is caused by poor recovery of DNA after the precipitation of the restriction 
digestion reaction, as equal amounts of DNA were digested for all samples. 
Neither M1 nor M9 show a change in HaeIII CHG or CHH methylation of the 5S 
rDNA repeats (Figure 5.2 B). Both M1 and M9 have a banding pattern that is 
identical to the WT 142 and 142S patterns. There is also no change between the 
7 dpg methylation pattern and 21 dpg methylation patterns. As neither M1 nor 
M9 cause a change in CG, CHG or CHH methylation of the 5S rDNA repeats, this 
suggests that MORC6 does not affect 5S rDNA methylation. In contrast both rdr2-
1 and nrpd1-2 lose CHH methylation (Figure 5.2 B). This can be seen by the loss 
of HMW bands in both mutants. There is no change in methylation pattern 
between 7 dpg and 21 dpg in rdr2-1, however DNA methylation appears to 
change between 7 dpg and 21 dpg for nrpd1-2, as there is an increase in the 
HMW bands between 7 dpg and 21 dpg. This increase is small so may be due to 
differences in the amount of DNA loaded for each sample rather than a delay in 
methylation, although if genuine it would correlate with the previously observed 
delay in nrpd1 mutants (Herr et al. 2005). nrpd1-2 also has a greater effect on 
HaeIII CHG and CHH methylation of the 5S rDNA repeats than rdr2-1, seen by the 
presence of more HMW bands in rdr2-1 than nrpd1-2, suggesting that the effect 
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of nrpd1-2 on DNA methylation is greater than rdr2-1, at least for the 5S rDNA 
repeats.  
 
Figure 5.2: M1 and M9 have no effect on 5S RNA repeat CG, CHG and CHH 
methylation 
Southern blots of the 5S rDNA repeats. DNA from 7 dpg and 21 dpg plants of lines 142, 
142S, M1, M9, rdr2-1 and nrpd1-2 were used. The order of loading is given at the top of 
each blot. For each blot an image of the probed Southern blot and part of the ethidium 
bromide stained gel used for blotting are shown. The stained gel provides an indication 
of the amount of DNA loaded for each sample. A: Southern blot of the 5S rDNA 
assessing CG and CHG methylation. DNA was digested with MspI. B: Southern blot of the 
5S rDNA assessing CHG and CHH methylation. DNA was digested with HaeIII. 
5.3.2 morc6 has no effect on DNA methylation of repetitive 
elements 
Repetitive elements in the Arabidopsis genome are another major target of 
RdDM of which the MEA-ISR was assessed for changes to CG and CHG DNA 
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methylation in the morc6 mutants. Analysis of MEA-ISR CG and CHG methylation 
shows no loss of methylation in M1 and M9 compared to WT (Figure 5.3). In WT 
plants a HMW and a LMW band are detected, which are similar in intensity. This 
banding pattern is seen in both M1 and M9 at both 7 dpg and 21 dpg, indicating 
that there is no change in methylation between these time points and no 
reduction compared to WT. This would suggest that MORC6 therefore does not 
affect DNA methylation at the MEA-ISR locus. rdr2-1 and rmd3 both lose CG and 
CHG methylation at the MEA-ISR loci, seen by the loss of the HMW band in rdr2-
1 and near total loss in rmd3. There is no difference in methylation between 7 
dpg and 21 dpg in either mutant. Whereas for the 5S rDNA repeats rmd3 has a 
greater loss of DNA methylation, DNA methylation loss is greatest in rdr2-1 for 
the MEA-ISR locus, therefore indicating that these two known mutants 
differentially affect different targets. 
 
Figure 5.3: M1 and M9 have no effect on MEA-ISR CG and CHG methylation  
Southern blot looking at CG and CHG methylation of the MEA-ISR. DNA from 7 dpg and 
21 dpg plants of lines 142, 142S, M1, M9, rdr2-1 and rmd3 were used. The order of 
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loading is given at the top of the blot. DNA was digested with MspI, which is sensitive to 
CG and CHG methylation. An image of the probed Southern blot and part of the SYBR 
safe stained gel used for blotting are shown. The stained gel indicates the amount of 
DNA for each sample used for the Southern blot. 
5.3.3 Locus specific effect of morc6 on DNA methylation of 
transposable elements 
The final group of endogenous targets of RdDM are TEs. Three TEs were tested: 
AtMu1, Solo LTR and AtSN1. There is no change in DNA methylation for either 
M1 or M9 for the AtMu1 transposon as the banding pattern in both mutants is 
identical to the WT lines 142 and 142S (Figure 5.4). There is again also no change 
between 7 dpg and 21 dpg samples for either M1 or M9. AtMu1 is therefore 
another endogenous RdDM target where morc6 does not affect DNA 
methylation. The two previously characterised RdDM mutants, rdr2-1 and rmd3, 
both cause a loss in DNA methylation. This loss of DNA methylation is greater in 
rdr2-1 than rmd3, seen by the near total loss of HMW bands in rdr2-1 compared 
to the more modest increase in LMW bands in rmd3. Again this shows a locus 
specific effect for the rdr2-1 and rmd3 mutants due to the difference in 
methylation loss. 
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Figure 5.4: M1 and M9 have no effect on AtMu1 CHG and CHH methylation  
Southern blot looking at CHG and CHH methylation of AtMu1. DNA from 7 dpg and 21 
dpg plants of lines 142, 142S, M1, M9, rdr2-1 and rmd3 were used. The order of loading 
is given at the top of the blot. DNA was digested with HaeIII, which is sensitive to CHG 
and CHH methylation. An image of the probed Southern blot and part of the SYBR safe 
stained gel used for blotting are shown. The stained gel indicates the amount of DNA for 
each sample used for the Southern blot. 
There is a change in CG and CHG methylation of the Solo LTR locus in the M1 and 
M9 mutants (Figure 5.5). In WT samples two bands are detected, of which the 
HMW band is more intense than the LMW band. However, in the M1 and M9 
samples taken at 21 dpg the intensity of the HMW and LMW bands are equal, 
indicating a loss in DNA methylation. For the 7 dpg samples, both M1 and M9 
have a banding pattern that is more similar to WT in that the HMW band is more 
intense than the LMW band. Repetition of this blot using different DNA samples 
produced the same difference in the banding intensity for Solo LTR in lines M1 
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and M9 between 7 dpg and 21 dpg (Appendix 3.1 page 402). The reason as to 
why DNA methylation of the Solo LTR appears to decrease between 7 dpg and 21 
dpg could be that MORC6 is more active in DNA methylation at this locus at later 
developmental stages, so would have a greater effect on methylation at the later 
time point; but this would require further investigation to show this to be the 
case. However, from the 21 dpg samples there is a clear reduction of DNA 
methylation in M1 and M9, indicating that morc6 mutants affect DNA 
methylation of endogenous targets of RdDM as well as the transgene system 
used in this study. As the three other RdDM targets so far tested showed no 
change in DNA methylation, this would suggest that the effect of morc6 mutants 
is loci specific in terms of its effect on DNA methylation. 
The Solo LTR banding pattern could not be detected in the rdr2-1 so was not 
shown in Figure 5.5. The most likely cause for the lack of detection is ecotype 
differences. The two parental lines, M1, M9 and rmd3 are all C24 ecotype, hence 
the Solo LTR probe was produced from WT C24 DNA, however rdr2-1 is of the Col 
ecotype (Xie et al. 2004). The failure to detect the Solo LTR in rdr2-1 could 
therefore be due to sequence differences between the C24 based probe and the 
rdr2-1 genome. The Solo LTR could be detected in the rmd3 mutant and shows a 
modest reduction in DNA methylation at 7 dpg but not at 21 dpg. At 7 dpg the 
ratio between the HMW and LMW bands are of similar intensity, whereas at 21 
dpg the HMW band is stronger than the LMW, indicating an increase in DNA 
methylation. This again matches previously published results that nrpd1 mutants 
show a delay in silencing of a GFP transgene system (Herr et al. 2005). 
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Figure 5.5: M1 and M9 cause a reduction in CHG methylation of Solo LTR 
Southern blot looking at CG and CHG methylation of Solo LTR. DNA from 7 dpg and 21 
dpg plants of lines 142, 142S, M1, M9 and rmd3 were used. The order of loading is given 
at the top of the blot. DNA was digested with MspI, which is sensitive to CG and CHG 
methylation. An image of the probed Southern blot and part of the SYBR safe stained gel 
used for blotting are shown. The stained gel indicates the amount of DNA for each 
sample used for the Southern blot. Two lanes have been removed from the images of 
the blot and gel which is indicated by the white vertical line between the M9 21 dpg and 
rmd3 7 dpg samples. 
The final TE assessed in this study was AtSN1. Unlike the previous loci, 
methylation sensitive PCR was used instead of methylation sensitive Southern 
blotting. Although visually there appears to be little difference in levels of the 
AtSN1 PCR product between 142 and 142S there is a difference in the normalised 
AtSN1 values (Figure 5.6). Whereas for both 7 dpg and 21 dpg 142 has a 
normalised intensity of 0.68 142S has a intensity of 0.50 at 7 dpg and 0. 87 at 21 
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dpg (Figure 5.6 B). As there is little difference between the samples visually it is 
likely this difference is due to errors in measurement of intensity. This means 
that the difference seen in 142S is unlikely to be biologically relevant. By 
comparison to 142 and 142S both visually and through the normalised intensity 
values, there appears to be no change in DNA methylation in either M1 or M9. 
Visually the level of AtSN1 product in M1 and M9 are similar to 142 and 142S and 
although the relative intensity of M1 and M9 varies, it is within the variation 
seen in 142S (Figure 5.6). This would indicate that like three of the previous four 
endogenous RdDM targets, AtSN1 methylation is unaffected in morc6 mutants. 
By comparison DNA methylation is reduced in both rdr2-1 and rmd3. In rdr2-1 
there are reduced levels of AtSN1 PCR product, although the reduction is 
greatest at 21 dpg than 7 dpg, which is unexpected as it suggests methylation 
decreases from 7 dpg to 21 dpg. This possibly could be caused by tissue specific 
effects on loss of DNA methylation as a far greater proportion of the 7 dpg DNA 
sample will come from cotyledon leaves than the 21 dpg sample. AtSN1 PCR 
amplification is reduced in rmd3 compared to 142 and 142S levels, but there is a 
difference between 7 dpg and 21 dpg. Amplification is higher in the 21 dpg 
sample than the 7 dpg, however similar differences are seen in 142S so this could 
also be due to errors during measuring intensity. It should be noted that this 
method is non-quantitative so, although it provides an indication of differences 
in methylation levels between the mutants, it cannot be used to quantify the 
level of methylation. 
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Figure 5.6: M1 and M9 do not affect AtSN1 CHG and CHH methylation  
Methylation sensitive PCR analysis of CHG and CHH methylation for the AtSN1 TE. A: Gel 
images of PCR products produced from 7 dpg and 21 dpg DNA sample from lines: 142, 
142S, M1, M9, rdr2-1 and rmd3. The order is given above the gel photos. Three PCR 
products for each DNA sample are shown: AtSN1 from DNA digested with HaeIII (Top); 
SHH1 4 from DNA digested with HaeIII (Middle); and AtSN1 from undigested DNA 
(Bottom). The PCR products from HaeIII digested DNA were run on the same gel 
whereas the undigested DNA sample PCRs were run on a different gel. B: Graph showing 
the normalised intensity of AtSN1 PCR product in the HaeIII digested DNA samples 
AtSN1 is normalised to the intensity of the respective SHH1 4 PCR product. 
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5.3.4 Increase in global DNA methylation levels in morc6 
mutants 
Analysis of endogenous RdDM targets reveal localised effects of the morc6 
mutants but cannot be used to show global changes in DNA methylation. In 
order to determine if there are global effects on DNA methylation in M1 and M9 
a Epigentek Methyl Flash kit was used to measure genomic levels of methyl 
cytosines relative to WT. The kit measures methyl cytosine levels using an anti-
methyl cytosine antibody and then quantifying the amount of antibody bound to 
the DNA colorimetrically through a procedure similar to ELISA. This method 
provides a relative measurement of the number of genomic methyl cytosines. 
DNA from 7 dpg 142, 142S, M1 and M9 plants were tested using this kit. The 
relative levels of DNA methylation for 142S, M1 and M9 were normalised against 
the 142 value and this was repeated once using different sets of plants grown at 
different times so are considered to be biological replicates. 142 was used to 
normalise the other three samples as it should have WT levels of DNA 
methylation so will show the change in DNA methylation compared to WT. 142S 
should also have WT DNA methylation, however in both replicates DNA 
methylation is higher in 142S than 142, which is unexpected (Figure 5.7). The 
only difference between the lines is the 35S IR transgene, therefore this increase 
may be due the presence of the transgene. The transgene should only silence the 
GFP transgene, so its effect on DNA methylation is therefore unlikely due to the 
function of the transgene itself but instead its location in the genome. Another 
possibility is that a large scale change in the epigenome has occurred in the 142S 
line that is maintained in the M1 and M9 mutants that is unrelated to the 35S IR 
transgene. It should be noted that there is a difference in the change in DNA 
methylation levels for 142S, M1 and M9 between the two biological replicates, 
however as the technical replicates for each biological replicate were not 
significantly different from each other the pattern in each biological replicate is 
likely to be genuine. The difference between the two biological replicates could 
be due to natural variation in DNA methylation or an error in measuring in DNA 
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methylation between plates as the biological replicates were not done at the 
same time. 
Both M1 and M9 show an increase in levels of DNA methylation in both 
biological replicates compared to 142 and 142S (Figure 5.7). Again, as with 142S, 
the relative change in DNA methylation is different between the two biological 
replicates, which is either due to natural variation in DNA methylation levels or 
an error in measuring DNA concentration. There is also a difference in M9 
between the two biological replicates, in the 1st replicate M9 has a higher level of 
methylation than M1 but in the 2nd replicate methylation in M9 is lower than in 
M1. This again could reflect natural variation in DNA methylation levels or be an 
error in measurement as it is subjective when to stop the colour developing so 
there can be a difference in the intensity of the absorbance between plates. The 
relative DNA methylation levels would however suggest that methylation is 
higher in the two mutant lines than in 142S, which is unexpected as analysis of 
RdDM targets shows a reduction of DNA methylation at some target loci. This 
would therefore mean that at some specific loci there is loss of DNA methylation 
but overall there is an increase in DNA methylation.  
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Figure 5.7: Increase in global DNA methylation in morc6 mutants 
Analysis of global DNA methylation levels using an Epigentek Methyl Flash kit. A: table of 
relative levels of DNA methylation in 7 dpg 142, 142S, M1 and M9 plants. There are two 
biological replicates for each line and the values shown are the mean of two technical 
replicates, except the 1st biological replicate of 142S 7 dpg, which only has one technical 
replicate. For each replicate levels of DNA methylation are normalised to 142. B: graph 
of the relative levels of DNA methylation in 142, 142S, M1 and M9. Both biological 
replicates are shown, the 1st replicate is blue while the 2nd replicate is orange. 
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5.3.5 Solo LTR expressed in morc6 mutants 
From screening endogenous RdDM targets for loss of DNA methylation, only the 
Solo LTR showed a reduction in CG and CHG DNA methylation in M1 and M9. 
Although there is a reduction in methylation it was not known if this resulted in 
expression of the Solo LTR. To determine whether expression occurred in M1 and 
M9 a reverse transcriptase (RT) PCR for the Solo LTR was carried out on 28 dpg 
RNA samples. RNA samples were taken from the WT lines 142 and 142S; the 
morc6 mutants M1, M9 and rmd6; and rmd1, which is a nrpe1 mutant (Eamens 
et al. 2008). There is no Solo LTR expression in either WT lines but all three 
morc6 mutants and rmd1 show expression of Solo LTR and would therefore 
suggest that the reduction in DNA methylation in morc6 mutants does release 
expression of the Solo LTR (Figure 5.8). The expression of the Solo LTR is similar 
between M1, M9 and rmd1 but lower in rmd6 and would correlate with rmd6 
being the weaker of the three morc6 alleles. However, this PCR is only non-
quantitative so conclusions on exact differences in expression level of the Solo 
LTR between mutants cannot be made.  
 
Figure 5.8: Solo LTR expressed in morc6 mutants 
Gel images of RT PCR for Solo LTR from 28 dpg RNA samples from lines 142, 142S, M1, 
rmd6, M9 and rmd1. The order of the RNA samples in shown along the top with the RT 
samples shown on the left and no RT samples shown on the right. Both the Solo LTR and 
Actin PCR products are the expected size. The top row is the Solo LTR PCR for which 
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samples were taken at thirty five cycles and the bottom row is the Actin control PCR for 
which samples were taken at thirty cycles. 
5.3.6 morc6 mutants do not affect Solo LTR siRNA levels  
There is a decrease in DNA methylation at the Solo LTR locus, which therefore 
suggests that MORC6 has an effect on methylation but does not indicate at 
which point in the RdDM pathway MORC6 acts. To determine if MORC6 is 
involved in siRNA production, a northern blot of RNA samples that had been 
enriched for small RNAs was used to assess levels of Solo LTR 24 nt siRNAs. 
Samples were taken from leaves at 7 dpg and 21 dpg and floral tissue from lines 
142, 142S, M1 and M9. The northern blots was initially probed with a radio-
labelled 35S probe (described previously in chapter 4 page 250) before being re-
probed for Solo LTR. Solo LTR siRNAs are detectable in 7 dpg and 21 dpg samples 
but are at lower levels than in the floral samples, which is expected as 24 nt 
siRNAs are up regulated in floral tissue (Mosher et al. 2009). When M1 and M9 
Solo LTR levels in 7 dpg, 21 dpg and floral samples were compared against the 
respective 142 and 142S WT samples there was no difference in levels of Solo 
LTR 24 nt siRNAs, suggesting that MORC6 does not affect siRNA levels and is 
therefore not involved in siRNA production in the RdDM pathway (Figure 5.9). 
However, the miR167 probe, which is used as a loading control, showed a 
difference in loading between the floral samples with the 142S, M1 and M9 
samples being significantly lower than 142. This may indicate that there is a 
lower amount of RNA for these samples and consequently that Solo LTR 24 nt 
siRNAs levels are in fact higher in 142S, M1 and M9 compared to 142. The fact 
that on the acrylamide gel the level of M1 RNA was lower than all other samples 
would support this idea for M1, but the RNA levels for 142S and M9 were similar 
to that of 142. The reason for the reduction in 142S and M9 could be either poor 
RNA transfer during blotting or that as the blot must be first stripped of the Solo 
LTR probe before being probed with the miR167 probe, some of the RNA from 
these floral samples were removed during this process. Of these two possibilities 
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it is likely that the latter is true as 142 and 142S would not be expected to have 
differing Solo LTR 24 nt siRNA levels, but to determine which of these was the 
case a second blot of just the floral samples was also assessed (Appendix 3.2 
page 403). Again this blot showed no significant difference between 142, 142S, 
M1 or M9 Solo LTR 24 nt siRNAs. However, although 142 and 142S had similar 
levels of miR167, the levels in M1 and M9 were again lower. This again raises the 
question whether this difference is due to loss of RNA during the blot stripping 
process or if it is a genuine difference in RNA levels. However, from the 7 dpg 
and 21 dpg samples that have no problems with loading and the fact that there is 
no difference in the signal for Solo LTR siRNAs between floral samples, I would 
argue that the blots show no change in Solo LTR siRNA levels. 
 
Figure 5.9: Solo LTR siRNAs can be detected in M1 and M9  
Image of a northern blot probed with a 32P-labelled probes for Solo LTR (top) and 
miR167 (middle). 7 dpg, 21 dpg and floral RNA samples of lines 142, 142S, M1 and M9 
were used, as indicated. The bottom image is of the polyacrylamide gel stained with 
ethidium bromide before being blotted and shows RNA loading onto the gel. The 
miR167 probe acts as a loading control. 
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Levels of 24 nt siRNAs were also tested at another locus, AtREP2, which is a 
helitron transposon. For this blot RNA samples were extracted from 7 dpg and 21 
dpg leaves and floral tissues of lines 142, 142S, M1, M9, rdr2-1 and nrpd1-1. The 
two known RdDM mutants, rdr2-1 and nrpd1-1 are both involved in siRNA 
production so should have reduced siRNA levels and indeed no 24 nt siRNA was 
detected for AtREP2 in these samples (Figure 5.10). Comparison of M1 and M9 to 
the WT lines 142 and 142S showed no difference between 142, 142S and M1 but 
a decrease in M9. For this blot there was no difference in the loading control, 
which used a probe specific for tRNAmet. This would indicate that the decrease in 
M9 AtREP2 siRNAs is genuine and not due to reduced levels of RNA. However it 
would be expected that M1 should also show a decrease in At REP2 siRNAs if this 
was caused by the morc6 mutation. Since this is not the case the reason for this 
apparent decrease in AtREP2 siRNA levels could be due to differences in the 
stage of floral tissue collected for RNA extraction as the stage of the flower can 
affect  the levels of 24 nt siRNAs (Mosher et al. 2009).  
 
Figure 5.10: M1 and M9 do not affect AtREP2 siRNA levels 
Image of a northern blot probed with radio-labelled probes for AtREP2 (top) and tRNAmet 
(bottom). 7 dpg, 21 dpg and floral RNA samples of lines 142, 142S, M1. M9, rdr2-1 and 
nrpd1-1 were used, the order of these is indicated. The tRNAmet probe acts as a loading 
control.  
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5.3.7 Differing effect of M1 and M9 on flowering time 
In order to test whether morc6 mutants have an effect on flowering time, a 
flowering time assay was performed, which is described in detail in the methods 
section of this chapter (page 296). As well as M1 and M9, wild-type (WT) C24, 
142, 142S and rmd1 were also used in the flowering time experiment. 142S is the 
parental line of M1 and M9 so flowering time in these mutants must be 
compared against 142S in order to determine if a change has occurred. WT C24 
and 142 were also tested in order to assess if the transgenes used in this 
experiment have any effect on flowering time, 142 lacks the 35S IR transgene so 
can be compared against 142S to determine if there is an effect on flowering 
time for that transgene and WT C24 can be compared against 142 to determine if 
there is an effect of the GFP transgene. Both M1 and M9 have been backcrossed 
twice to the parental line to remove EMS mutations unrelated to the RdDM 
phenotype. However, some EMS mutations that are unrelated to the RdDM 
phenotype but linked to the mutant RdDM gene may not have been removed by 
this process and therefore may affect the flowering time. The fact that there are 
two alleles should lessen the effect of linked mutations as they should not have 
the same set of mutations as each other. rmd1 is a mutant in the largest PolV 
subunit, npre1, previously identified from EMS mutagenesis of 142S (Eamens et 
al. 2008). It would be expected that rmd1 should show a delay in flowering as a 
nrpe1 mutant showed a delay in silencing in short day conditions in a study by 
Pontier, although this was in the Columbia ecotype background whereas rmd1 is 
in the C24 background, so ecotype specific effects may alter flowering time 
(Pontier et al. 2005). 
Before statistical analysis of the leaf number (LN) was carried out the LN data for 
each line was assessed using the Kolmogorov-Smirnova and Shapiro-Wilk tests 
and a box whisker plot. The two statistical tests are used to see if the data was 
normally distributed and showed that the LN data for five of the lines was 
normally distributed but not for 142S (Appendix 3.3 page 404). As five of the 
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lines show normal distribution a test assuming normal distribution of the data 
could still be used but meant that the power of the test was reduced due to 142S 
not meeting one of the assumptions for the test. The box whisker plot showed 
that the range and distribution of WT C24, 142 and M9 were similar while 142S 
has a smaller range than these lines but its median is similar (Figure 5.11 A). M1 
and rmd1 have a different range to the other lines with a range shifted above 
and below that of the other lines respectively. This is also reflected in the means 
of each line with the M1 mean (66.18 leaves) being higher than that of the other 
lines and the rmd1 mean (53.90) being lower than the means of the other lines 
(Figure 5.11 B). The means for 142 (63.56 leaves) and 142S (62.96 leaves) are 
similar to each other with a lower mean for WT C24 (61.02 leaves) and M9 
(59.17). SPSS also defined several outliers in lines WT C24, 142, 142S, M1 and M9 
and an extreme value for 142S (Figure 5.11 A). Outliers were included in the 
statistical analysis while extreme values were not.  
The Levene’s test of variance showed a highly significant difference in variance 
between the lines, with a significance value of <0.001, therefore the Welch test 
was used instead of an ANOVA as the Welch test does not assume homogeneity 
in variance. The Welch test showed a highly significant difference (<0.001) 
between the means, so a least significant difference (LSD) post hoc test was used 
to identify which lines were significantly different. The LSD test showed that M1 
and rmd1 means are statistically different from all other lines (<0.001 
significance). This means that there is a significant delay in flowering time in the 
M1 mutant, however the mean of M9 was lower than both the M1 and parental 
means, and this difference is significant. M9 therefore flowers earlier than the 
parental line, which is opposite to that of M1, suggesting that the difference in 
flowering time is not due to the morc6 mutation as both lines would be expected 
to behave similarly. Other mutations carried in either M1 and M9 are therefore 
likely to account for this difference, one mutation carried by the M1 line gives 
rise to a necrotic lesion phenotype which is likely to impact on flowering time. 
This will be discussed in more detail in the next section (page 322). The earlier 
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flowering observed in the rmd1 mutant is unexpected as a previous study that 
measured flowering time in a nrpe1 mutant showed a delay in flowering (Pontier 
et al. 2005). This difference again could be due to other mutations carried in the 
rmd1 lines or difference in flowering time between ecotypes, as rmd1 is in a C24 
background whereas the nrpe1 mutant used in the Pontier study was in the 
Columbia background. Statistical analysis shows that there is no significant 
difference between the means of 142 and 142S but that there is a significant 
difference (<0.05) between WT C24 and 142, which may suggest that the GFP 
transgene but not the 35S IR transgene has an effect on flowering time. 
However, as the difference between the means is small it is possible that other 
biological factors, such as seed quality could account for the difference.  
5. Effect of MORC6 on silencing of endogenous targets of RdDM 
318 
 
 
Figure 5.11: Different effect of M1 and M9 on flowering time 
Graphs showing LN of lines: WT C24 (blue), 142 (green), 142S (red), M1 (yellow), M9 
(orange) and rmd1 (purple). A: Box whisker plot of LN distribution for each line. For each 
line the box shows the inter quartile range for each line, with the black line within each 
box being the median. The whiskers show the highest and lowest LN for each line, but 
do not include values that are outliers (circles) and extreme values (asterisk). B: Bar 
graph of mean LN for each line. The error bars represent two standard errors above and 
below the mean. Lines with a * above the bar (M1 and rmd1) have a significance of 
<0.001 to all other lines. For the other lines they are significantly different from each 
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other, bar those denoted by letters. The letters above each bar denote which lines they 
do not have a significant difference between, so any line with an A is not significantly 
different from any other line with an A and the same is true for B and C.  
During the flowering time assay it was observed that there was a difference in 
plant size between the lines. This difference was not apparent in long day (16 
hour) conditions, but only in short day (8 hour) conditions. In order to quantify 
this difference the rosette of each plant was weighed at the point when the first 
flower opened. The data showed a clear difference between 142 and WT C24, 
and 142S and the three RdDM mutants, the mean for WT C24 is 1.52 g and 1.87 g 
for 142 whereas for 142S and the RdDM mutants the means range from 0.88 g 
for 142S to 0.65 g for rmd1, clearly demonstrating a difference in size between 
the two groups (Figure 5.12 B). There is also far greater variation in rosette 
weight in lines WT C24 and 142 than the other four lines, which can be seen in 
the difference between the interquartile ranges. WT C24 has a interquartile 
range (IQR) of 0.54 g and 142 has a IQR of 0.57 g, whereas for 142S and the 
RdDM mutants the IQRs range from 0.29 g for M1 to 0.22 g for rmd1 (Figure 5.12 
A).  
The same statistical tests used for the leaf number analysis were used to test the 
rosette weight data. The data was normally distributed, but the Levene’s test 
showed a <0.001 significant difference in variance between the lines so the 
Welch test was again used instead of an ANOVA (Appendix 3.4 page 405). The 
Welch test was significant so a LSD post hoc test was used to identify which lines 
were significantly different from each other. The LSD test showed that WT C24, 
142 and 142S were significantly different from each other (<0.001), with 142 
having increased rosette weight compared to WT C24 and 142S having reduced 
rosette weight compared to WT C24. This could suggest that both the GFP and 
35S IR transgenes influence plant growth, possibly due to where each transgene 
is inserted into the genome (Figure 5.12). The decrease in 142S is far greater 
than the increase in 142 compared to WT, which may suggest that the dual 
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transgene background has a greater effect on plant growth than the single GFP 
transgene. However, it cannot be discounted that other experimental variables 
may be responsible for these differences, such as seed quality or light intensity, 
so requires repetition. M1 and M9 do not have a significant difference in rosette 
weight between each other, but both show a statistically significant decrease in 
weight compared to 142S, although this change is minor, with a decrease of less 
than 0.2 g compared to a decrease of 1.0 g between 142 and 142S. This could 
suggest that mutation of morc6 has a minor effect on growth, but not to the 
same extent as whatever is causing the decrease in growth in 142S. rmd1 also 
has a statistically significant decrease in rosette weight compared to 142S, 
although again the decrease is minor compared to the one between 142 and 
142S. The decrease does however suggest that nrpe1 affects plant size. This 
reduced rosette weight is only observed in short day conditions, with visual 
assessment of plant in long day conditions suggesting no significant difference in 
rosette weight between 142, 142, M1 and M9. However, this needs to be tested 
experimentally as smaller differences in rosette weight, not apparent in visual 
assessment, may exist.  
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Figure 5.12: Reduction in plant size of 142S, M1, M9 and rmd1 
Graphs showing rosette weight of lines: WT C24 (blue), 142 (green), 142S (red), M1 
(yellow), M9 (orange) and rmd1 (purple). A: Box whisker plot of rosette weight 
distribution for each line. For each line the box shows the inter quartile range for each 
line, with the black line within each box being the median. The whiskers show the 
highest and lowest rosette weight for each line, but does not include values that are 
outliers (circles). The y axis scale is in grams. B: Bar graph of mean rosette weight in 
grams for each line. The error bars represent two standard errors above and below the 
mean. Lines with a * above the bar (WT C24 and 142) have a significance of <0.001 to all 
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other lines. 142S (*1) has a significance of <0.001 to all lines except M1 to which it has a 
significance of <0.05. For the other lines they are significantly different from each other, 
bar those denoted by letters. The letters above each bar denote which lines they do not 
have a significant difference between, so any line with an A is not significantly different 
from any other line with an A and the same is true for B. 
5.3.8 M1 necrotic lesion phenotype 
During the flowering time assay it was observed that M1 developed necrotic 
lesions on its leaves approximately four weeks post germination. These lesions 
manifested as small areas of necrosis with multiple lesions found on a single leaf 
and this occurred on nearly all leaves on affected M1 plants (Figure 5.13). This 
phenotype was only observed in short day (8 hour) growth conditions and not in 
long day (16 hour) growth conditions. No other line, including M9, showed this 
necrotic lesion phenotype (Figure 5.13 and Table 5.2). The necrotic lesion 
phenotype occurred in 91.6% (131 of 143) M1 plants and this coupled with the 
lack of a necrotic lesion phenotype in M9 suggests that this phenotype, although 
interesting, is not related to the morc6 mutation but instead is caused by 
another mutation closely linked to the morc6 mutation in M1. 
Line Plants with necrotic lesions Plants without necrotic lesions 
142 0 121 
142S 0 128 
M1 131 12 
M9 0 136 
rmd1 2 131 
WT C24  0 148 
Table 5.2: Number of plants displaying necrotic lesion phenotype 
Table showing number of plant that have necrotic lesion or lack necrotic lesion for lines 
142, 142S, M1, M9, rmd1 and WT C24. Plants are considered to have necrotic lesions if 
they have at least five rosette leaves with at least one 1 mm diameter lesion.  
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Figure 5.13: Necrotic lesion phenotype of M1 
Images of leaves and whole plants showing the M1 necrotic lesion phenotype in short 
day growth conditions. A: Whole plant images of lines WT C24, 142, 142S, M1, M9 and 
rmd1 at 37 dpg. A scale bar is shown in the bottom of each image. B: Images of adaxial 
side of adult rosette leaves of lines 142S and M1 at 100 dpg. 
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5.4 Discussion 
5.4.1 MORC6 has a locus-specific effect on DNA 
methylation 
Analysis of DNA methylation of the 35S promoter revealed that in both M1 and 
M9 morc6 methylation is reduced. In order to test whether the phenotype was 
specific to the transgene only, a series of endogenous RdDM targets was 
analysed. Of the five loci tested only one, Solo LTR, showed a reduction in DNA 
methylation suggesting that MORC6’s role in DNA methylation is locus-specific. 
The loss of DNA methylation at the Solo LTR results in it being expressed but 
does not correspond to a reduction in siRNA levels suggesting that MORC6 is not 
involved in siRNA production at this locus and is therefore more likely to be 
involved in the DNA methylation process itself. The locus specificity matches the 
results seen in the two previous studies of MORC6 where global methylation was 
not affected but methylation was reducted at specific target loci (Lorković et al. 
2012, Moissiard et al. 2012). The studies showed no change in methylation for 
AtMu1 and AtSN1, which I have also tested and found no change in DNA 
methylation levels. However, neither study showed a significant reduction in 
Solo LTR methylation and the Moissiard study showed an increase in CHG 
methylation levels, whereas in this study Solo LTR has reduced CHG methylation. 
The study by Lorković assessed CHG and CHH methylation with the AluI 
restriction enzyme whereas I tested for CG and CHG methylation using MspI, so it 
is possible that methylation at AluI sites are unaffected at this locus. However, 
this is not the case for the Moissiard study which used bisulfite sequencing 
rather than a restriction enzyme. One of the limitations of methylation sensitive 
Southern blotting in that it can only detect methylation changes at a specific site 
whereas bisulfite sequencing can assess methylation across the entire locus. It is 
therefore unknown whether the apparent decrease in methylation at the MspI 
site in the Solo LTR in this study occurs for other cytosines at the locus. For this 
reason bisulfite sequencing of the Solo LTR should be carried out to confirm the 
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decrease in methylation seen in this study. Assuming that the decrease in Solo 
LTR CHG methylation is accurate one possible explanation for the difference in 
methylation of the Solo LTR between this study and the previous two is that 
there may be an ecotype specific effect on the methylation of this locus, as this 
study used plants in the C24 background whereas the other studies used plants 
in the Columbia background. Another possible explanation is that there appears 
to be a loss of methylation between 7 dpg and 21 dpg in morc6 mutants. The 
study by Moissiard analysed methylation at 14 dpg therefore it is possible that 
Moissiard assessed methylation before the decrease occurred. However, this 
would require bisulfite sequencing analysis of Solo LTR methylation at 7 dpg and 
21 dpg to demonstrate that such an effect occurs. If there is a decrease in DNA 
methylation from 7 dpg to 21 dpg this would suggest a complex role for MORC6 
in Solo LTR methylation.  
The other endogenous RdDM targets where a reduction in DNA methylation has 
been reported are Intergenic loci (IGN) 23, IGN25 and AtCopia28, none of these 
loci have been tested in this study so this change in DNA methylation cannot be 
confirmed (Lorković et al. 2012, Moissiard et al. 2012). As the GFP transgene also 
shows a reduction in methylation, this would suggest that the region in which it 
is inserted is also targeted by MORC6. However, analysis of the Illumina 
sequencing data failed to identify this region or whether there were multiple 
copies of the transgene at this locus. This is likely due the transgene location 
residing within a region of the C24 genome that has not been assembled. It 
would be interesting to determine the identity of the region and if MORC6 
affects DNA methylation when the insertion is not present. Of the fifteen RdDM 
targets tested in both this and the two previous studies, four show a reduction in 
DNA methylation. This is a significant subset of the RdDM loci tested and could 
therefore suggest that MORC6 is involved in DNA methylation at a large number 
of loci. However, the study by Moissiard found no large scale changes in DNA 
methylation so it is possible that, due to the low number of loci tested, this is an 
overestimation of the effect of MORC6 in DNA methylation (Moissiard et al. 
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2012). Another possibility for this disparity between locus specific loss of 
methylation and a lack of change in global methylation levels could be that a 
perturbation of RdDM by MORC6 could alter which regions of the genome are 
methylated, which is what has recently been shown to occur in nrpe1 mutants 
(Wierzbicki et al. 2012). To determine the extent of the locus-specific decrease in 
DNA methylation in morc6 mutants a further endogenous targets must be 
assessed using bisulfite sequencing.  
The reason for the locus-specific nature of MORC6’s role in DNA methylation is 
unclear but may be due to redundancy with other MORC proteins. There are six 
other MORC genes in the Arabidopsis genome and each could be specific to a 
subset of RdDM targets. Unlike Metazoan MORC proteins, Plantae MORC 
proteins lack a zinc finger domain so are unlikely to be able recognise specific 
DNA sequences and target specific loci themselves. However, Arabidopsis MORC 
proteins have a coiled coil domain that allows for protein-protein interactions 
and five MORCs have low complexity regions LCR that are thought to increase 
the number of interactions a protein can make (Coletta et al. 2010). These 
domains should allow the MORC proteins to interact with other proteins and it 
may be these that may infer the locus specificity. Differences in protein sequence 
amongst the Arabidopsis MORCs may result in each being able to bind to a 
different subset of proteins and so to be targeted to a different set of loci. This 
hypothesis would need to be tested by looking at Arabidopsis MORC protein-
protein interactions and locus interaction using ChIP. 
5.4.2 morc6 mutants show an increase in global DNA 
methylation levels 
Global DNA methylation levels in both M1 and M9 was higher than in the 
parental line. The parental line itself was also unusual as DNA methylation was 
higher in the 142S parental line than 142. The only known difference between 
these two lines is the presence of the 35S IR transgene, thus the transgene may 
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be the cause of the change in global DNA methylation levels. However, unless 
the transgene’s location affected the regulation of a methylation or 
demethylation gene, it would seem unlikely that the presence of the 35S IR 
transgene would cause such drastic changes to global methylation. Another 
explanation of this disparity between 142 and 142S is that there may have been 
a large scale change in the epigenome in 142S that is unrelated to the additional 
transgene, but the cause of this change is unknown. 142S also shows a reduction 
in size in short day conditions and this may be related to the increase in DNA 
methylation. Further work would be required to elucidate what is causing both 
the reduced size and increased methylation levels in 142S. There is also the 
question of whether this increase in methylation occurs across the entire 
genome or is localised, as it should be noted that 142S did not show an increase 
in methylation, compared to 142, in any of the five endogenous RdDM loci 
tested.  
Returning to the increase in global methylation in M1 and M9, the fact that 
global methylation is not reduced matches the findings of Moissiard, however 
they did not find an increase in methylation either (Moissiard et al. 2012). If the 
increase in DNA methylation in M1 and M9 is caused by the mutation of MORC6 
the increase could be a compensatory mechanism. MORC6 is predicted to have a 
role in higher order heterochromatin formation and the movement of this 
chromatin to the nuclear membrane (Moissiard et al. 2012). When perturbed in 
morc6 mutants the plant could compensate for this loss in high order 
heterochromatin by increasing DNA methylation. Indeed a similar compensatory 
event has been seen previously in DNA methylation pathways. In met1 drm1 
drm2 triple mutants, gene body CG methylation is eliminated, however CMT3 
acts to methylate CHG residues in the gene bodies to compensate (Cokus et al. 
2008). However both the differences in the mutants and WT lines could be due 
to technical issues with the kit used. In order to accurately quantify the DNA 
methylation levels the concentration of the DNA used must be known and this 
can be inaccurate particularly in low concentration samples. Steps were taken to 
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minimise this inaccuracy, including using a highly concentrated DNA sample and 
taking repeated measurements of the DNA concentration and using an average 
of these values. This should limit inaccuracies in regard to concentration and 
indeed the technical replicates for each sample were similar. However, another 
problem with the assay is that when comparing different plates the end point of 
the assay is subjective in regard to the intensity of the colour at which the 
measurement is taken for each plate. This could affect the relative DNA 
methylation levels and so explain the significant difference between the 1st and 
2nd biological replicates. It is possible that the difference is due to natural 
variation in DNA methylation but in this case I would favour a technical error. For 
this reason in order to get a more accurate assessment of global DNA 
methylation the analysis using the kit should be repeated with both biological 
and technical replicates on the same plate. This would need to be completed 
before making firm conclusions on changes in global DNA methylation in the 
mutants. 
5.4.3 morc6 mutant’s effect on flowering time 
The flowering time assay produced contrasting results for M1 and M9, with M1 
causing a delay in flowering time and M9 bringing forward flowering time. This 
difference is therefore not due to morc6 and indicates that other EMS mutations 
carried by the M1 and M9 mutants are affecting the assay. Both M1 and M9 have 
been backcrossed twice to remove other EMS mutations carried in the two lines, 
but as sequencing of M1 revealed this line still carries fifteen EMS mutations that 
lie in exons and that cause a change in amino acid sequence and there is likely to 
be more still segregating in the M1 population (Table 3.3). Mutations in one or 
several of these genes may therefore skew the results and make it hard to 
discern the effect of morc6 on flowering time. This is exemplified by the necrotic 
lesion phenotype in M1, where 91.6% of the plants used in the flowering time 
assay had the necrotic lesion phenotype. The necrotic lesion phenotype may also 
be the cause of the delay in flowering time in M1. To determine the actual effect 
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of morc6 mutants on flowering time the assay could be repeated on the F1 
progeny of a M1 M9 cross as this should be homozygous for morc6 but 
heterozygous for all other EMS mutants. As well as the reduction in length of 
flowering time in M9, rmd1 also has a reduced flowering time, seen in the lower 
leaf number (LN). This is contrary to previous findings that nrpe1 mutants cause a 
delay in flowering time (Pontier et al. 2005). This contradictory result may be due 
to ecotype differences in flowering as my study has used lines in a C24 
background whereas the nrpe1 mutant in the Pontier study was in the Columbia 
background. To determine if there if this is an ecotype difference morc6 and 
nrpe1 mutants in several difference ecotypes could also be tested using this 
assay.  
The necrotic phenotype would also be an interesting candidate for future study. 
The phenotype is observed in M1 but not M9 suggesting that it is not a result of 
the morc6 mutations but another mutation carried by M1 and the high 
percentage of M1 plants displaying the phenotype suggests that it is closely 
linked to the morc6 locus. It is also possible that as M1 is a null allele whereas 
M9 still produces a truncated MORC6 protein that this phenotype is in fact 
caused by MORC6 but is only apparent in a full kncokout. However, I would 
argue that the phenotype is not associated with the M1 morc6 mutation because 
there are three genes with an amino acid substitution and a known function that 
could cause the necrotic phenotype. The three candidate genes are NTT2, FMO1 
and LIG1, of which NTT2 is the best candidate as a previous study showed that 
ntt2 has a necrotic lesion phenotype in short day growth conditions (Reinhold et 
al. 2007). NTT2 is a ATP/ADP plastid antiporter and it is thought that a lack of ATP 
during the night in ntt2 mutants results in necrotic cell death through 
photooxidative damage (Reiser et al. 2004, Reinhold et al. 2007). However, the 
amino acid change in NTT2 in M1 is alanine to valine, which only results in a 
change in side chain size so may not necessarily affect function (Table 3.3). FMO1 
is involved in pathogen defence and mutants display a reduced ability to acquire 
immunity to the pathogen (Mishina and Zeier 2006). However, mutations of 
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FMO1 could only cause necrotic lesions in response to an infection, which is 
unlikely to have occurred. LIG1 is a DNA ligase involved in DNA replication and 
base excision repair, so in this case as base excision is compromised, cell death 
could occur if mutations are not repaired (Taylor et al. 1998). The amino acid 
substitution in LIG1 is glutamic acid to lysine so results in a change from an acid 
to a base and this could conceivably have an effect on LIG1 function. Another 
possibility is a gene with an unknown function, At1G11200, which has a 
premature stop codon mutation in M1.  
The flowering time assay also established that line 142S, and any line derived 
from it, has a reduced size compared with 142 and WT C24. This was quantified 
by measuring the rosette weight at the point of flowering. As mentioned during 
the discussion of the effect of the 142S on global DNA methylation, this may be 
due to a change in the 142S epigenome. Further work is required to determine 
whether this is the case and what the cause of the epigenetic change is. In short 
day conditions both M1 and M9 have a statistically significant decrease in plant 
size compared to 142S, although this is not seen in long day conditions. Again, as 
with the flowering time itself, there is a possibility of other mutations carried in 
the two mutant lines causing this result. However, as there is no statistically 
significant difference in plant size between M1 and M9 this would suggest that 
morc6 is involved in the reduction in plant size compared to 142S. rmd1 also 
causes a reduction in plant size so would also support the idea that RdDM 
mutants cause a reduction in plant size, possibly through failure to silence a 
negative regulator of growth or leaf expansion. However, this finding would need 
to be retested in lines that do not carry other mutations and are from different 
ecotypes, to determine if this is an ecotype-specific effect.  
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6.1 MORC6 function in RdDM 
The aim of this study was to identify novel RdDM genes and characterise both 
their phenotype and function in the pathway. This study has identified three 
mutant alleles in the MORC6 gene and determined that this gene has a role in 
RdDM. The MORC6 protein is a GHKL ATPase domain containing protein with a 
coiled coil domain at the C terminal end of the protein. However, two other 
studies have also identified MORC6 as an RdDM component, thus MORC6 is no 
longer a novel RdDM gene (Lorković et al. 2012, Moissiard et al. 2012). The 
phenotype from this study can however be used, in conjunction with the 
previous two studies to provide a better understanding of MORC6’s role in 
RdDM. The evidence from both this and the previous two studies into MORC6 
function in RdDM point to multiple roles in the pathway. In all three studies 
siRNA levels are not affected and so would preclude a role for MORC6 in siRNA 
production (Lorković et al. 2012, Moissiard et al. 2012). There is however a 
reduction in DNA methylation that occurs in a locus specific manner. This would 
therefore suggest that MORC6 has a role in facilitating the methylation of DNA 
by DRM2 and raises the question of what MORC6’s exact role during this process 
is. 
Findings from the study by Lorković suggest a possible function for MORC6 in 
DNA methylation. The study showed that MORC6 interacts with DMS3, a hinge 
domain containing protein, through coiled coil domains found on both proteins 
(Lorković et al. 2012). DMS3 has two coiled coil domains so can in theory interact 
with two MORC6 proteins and it was noted that the resulting complex bears a 
striking similarity to structural maintenance of chromosomes (SMC) protein, 
which are characterised by two ATPase domains, in this case provided by the two 
MORC6 proteins, and a hinge domain, provided by the DMS3 protein (Hirano 
2005, Lorković et al. 2012). The complex of DMS3 and two MORC6 proteins is 
therefore described as SmcMORC6 in accordance with nomenclature of other 
SMC proteins. SMC proteins function by oscillating between a closed and open 
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conformations, which is controlled by the binding and hydrolysis of ATP 
respectively (Figure 6.1 A) (Hirano 2005). Upon ATP binding to the two GHKL 
ATPase domains SmcMORC6 may undergo a conformational change resulting in 
the two MORC6 proteins binding to each other forming a closed circle that could 
clamp onto a DNA or RNA strand or strands (Figure 6.1 B). SMC proteins can also 
bind to other SMC proteins upon ATP binding and so form hooks that bring DNA 
or RNA strands into close proximity (Figure 6.1 B). It is not known whether 
SmcMORC6 can do either or both of these interaction types, so further analysis 
would be required to both confirm the existence of the SmcMORC6 complex and 
determine its conformational changes. The human MORC3 protein forms a 
homodimers that is thought to behave similarly to a SMC protein and so could 
indicate that a MORC6 homodimer may also be able to carry out a similar 
function (Mimura et al. 2010). It is known that MORC6 can form a homodimer as 
well as a binding to DMS3 but it is not known if either or both are involved in 
RdDM and if they are both involved whether they have differing functions.  
 
Figure 6.1: SmcMORC6 open and closed conformations and DNA binding 
possibilities 
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A: Model proposing how a SmcMORC6 complex undergoing ATP binding and hydrolysis 
may result in a change between the closed and open conformations of the complex. B: 
Model proposing the formation of circle (left) and hook (right) conformations of 
SmcMORC6. The hook formation requires the interaction between multiple SmcMORC6 
complexes. DMS3 is shown in red and the two MORC6 proteins are shown in purple. ATP 
is shown as a red and orange T shape, which is broken apart upon ATP hydrolysis. The 
DNA strands are shown as black double helices with grey bars representing the base-
base pairing. This diagram has been adapted from Hirano et al, 2005.  
In terms of the SmcMORC6 complex’s function in RdDM, DMS3 has previously 
been shown to form the DDR complex with RDM1 and DRD1 and this complex is 
required for PolV transcription of the target DNA (Kanno et al. 2008, Ausin et al. 
2009, Law et al. 2010, Lorković et al. 2012). Mutation of MORC6 results in a 
decrease in PolV transcript accumulation and so would suggest that MORC6 is 
also part of the DDR complex (Figure 6.2 B). In this case the SmcMORC6 complex 
is likely to form a circular conformation around the target DNA strand, rather 
than the hook conformation, and could, along with RDM1, provide a stable 
platform for the nucleosome modifier, DRD1 to modify the chromatin structure 
of the target DNA strand, thus allowing PolV transcription to occur (Kanno et al. 
2004, Gao et al. 2010, Lorković et al. 2012). Since DMS3 is required for the DDR 
complex this would favour a SmcMORC6 complex rather than a MORC6 
homodimer being involved. 
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Figure 6.2: Role of MORC6 in the RdDM pathway 
A: siRNA loaded AGO reentre the nucleus. B: PolV transcribes the target locus and this activity is facilitated by the DDR complex including MORC6. C: 
The siRNA loaded AGOs bind to the PolV transcript and this aided by interaction with KTF1. The siRNA-PolV transcript duplex is recognised by a IDN2 
heterodimer that then binds to the duplex. D: A SmcMORC6 complex, MORC6 homodimer (not shown) or MORC6 protein binds to the PolV transcript 
and target DNA locus which brings the two into close proximity. This allows the IDN2 heterodimer then interacts with the DNA through its zinc finger 
motifs, thus triggering DNA methylation by DRM2 and its co-factor DRM3. E Methylated cytosine binding proteins such as MBD6, MBD10, SUVH2 and 
SUVH9 bind to the DNA locus at methylation sites. F: The methylated cytosine binding proteins interact with histone modifiers, such as HDA6, SUP32 
and JMJ14 leading to modification of the nucleosomes into a heterochromatic state. G: DNA methylation and histone modification at the target locus 
is recognised and triggers higher order heterochromatin formation which then localises to the nuclear membrane. MORC6 and MORC1 proteins are 
involved in this process as either part of SMC like complex with DMS3, lone proteins or as homodimers. The nuclear envelope is depicted as a yellow 
line with protein channels within this membrane shown as pairs of silver ovals. Areas with a white background are within the nucleus and areas in 
pale yellow are in the cytoplasm. RNA strands are shown as in red while DNA strands are black. RNA nucleotides are shown as red and orange T 
shapes. A single nucleosome has been depicted in this diagram in blue and four of the eight histone proteins that make up the nucleosome are 
shown. DNA methylation marks are shown as white Ms in red circles while histone methylation marks are shown as black Ms in green circles. Histone 
acetylation marks are shown as black As in yellow circles and histone ubiquitination marks are shown as white Us in purple circles 
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Another possibility for SmcMORC6 function, suggested by Bender, is that the 
complex clamps both the target DNA and PolV transcript so that the two are in 
close proximity to each other (Bender 2012). This would provide part of the 
solution to how the binding of siRNA-loaded AGO4 complexes to the PolV 
transcript triggers DRM2 to methylate the corresponding DNA sequence. The 
current view of how this binding results in methylation is that initially siRNA-
AGO4 complexes bind to the PolV transcript soon after the complementary 
sequence to the siRNA has been transcribed. This step may be facilitated by KTF1 
which can interact with both AGO4 and PolV (Bies-Etheve et al. 2009, He et al. 
2009c, Wang and Dennis 2009, Rowley et al. 2011). The RNA duplex between the 
siRNA and PolV transcript is then recognised and bound by a dimer comprising of 
IDN2 or one of its homologs (IDP1, IDP2 or IDNL2) (Ausin et al. 2009, Ausin et al. 
2012b, Xie et al. 2012, Zhang et al. 2012). The zinc finger motifs of IDN2 and its 
homologs are then thought to interact with the DNA and it is proposed that this 
is the trigger for DRM2 to methylate the DNA. However, this mechanism only 
works if the DNA and RNA strands are in close enough proximity in order for 
IDN2 to bind to both the DNA and RNA. Thus SmcMORC6 may provide a 
mechanism by which the DNA and RNA strands are clamped together and hence 
are in close enough proximity for IDN2 binding (Figure 6.2 D). This function could 
occur in either the hook or circle formation and further work would be required 
to firstly demonstrate the clamping mechanism and secondly to determine which 
conformation the SmcMORC6 complex is in. Unlike the role in the DDR complex 
this role could also be carried out by a MORC6 homodimer. 
The study by Moissiard has also suggested another function for MORC6 in the 
pathway. The study found that in morc6 mutants, transcripts from RdDM targets 
were upregulated but that this does not always correspond to a reduction in 
DNA methylation (Moissiard et al. 2012). This suggests that although the loci are 
methylated they are not fully silenced and could therefore lack chromatin 
modification in response to the DNA methylation. Analysis of histone 
modification showed no change in morc6 mutants, however mutants have a 
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reduction in the proportion of pericentromeric chromocentres that is a result of 
a loss in higher order heterochromatin structure. Higher order chromatin 
involves the formation of tertiary and quaternary DNA structures such as 
solenoid-like coils of nucleosomes and the bunching together of large loops of 
these coils, both of which result in the DNA becoming more condensed and 
inaccessible to proteins that bind to DNA (Woodcock and Ghosh 2010, Li and 
Reinberg 2011). Although disruption of higher order chromatin formation  has 
not been demonstrated specifically for RdDM targets upregulated in morc6 
mutants, the changes in pericentromeric heterochromatin organisation would 
suggest MORC6 could have a role in higher order chromatin modification in 
RdDM. In this scenario MORC6 would facilitate the formation of higher order 
chromatin structures in response to DNA methylation at RdDM targets and the 
resulting heterochromatin would then associate with the nuclear envelope, thus 
becoming fully silenced (Figure 6.2 G) (Ye et al. 1997, Solovei et al. 2004, Fang 
and Spector 2005, Moissiard et al. 2012). However, it is not known what the 
exact function of MORC6 is in the formation of higher order chromatin. It is not 
also known if this activity requires DMS3 as no study has implicated DMS3 in 
higher order heterochromatin modification. This may suggest that a MORC6 
homodimer rather than SmcMORC6 is involved in higher order heterochromatin 
modification, but since SMC proteins are involved in such modifications it is 
possible that the SmcMORC6 complex is also involved in this process (Hirano 
2005).  
The three possible functions for MORC6 in RdDM so far described may also 
involve proteins other than DMS3. SMC proteins are known to bind to other 
proteins in order to provide specificity to the resulting complex, for example the 
condensin complex that have a role in chromosome condensation and 
separation during eukaryotic mitosis have several none SMC proteins associated 
with the complex (Hirano et al. 1997, Sutani et al. 1999, Fujimoto et al. 2005). 
Other proteins, such as zinc finger motif containing proteins, could therefore 
target the SmcMORC6 complex to specific loci which could explain why MORC6 
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appears to only have a role in DNA methylation at specific loci. Other proteins 
could facilitate catalytic activity, particularly with regard to higher order 
chromatin modificaiton. It is possible that some of the proteins that bind 
specifically to methylated cytosines in the RdDM pathway, SUVH2, SUVH9, MBD6 
and MBD10, could be recognised by MORC6, prompting its binding to the DNA 
and initiation of higher order chromatin modification (Johnson et al. 2008, Preuss 
et al. 2008). Further analysis using co-immuno precipitation and yeast 2-hybrid 
studies would be required to determine whether other proteins, in addition to 
DMS3, also bind to MORC6. 
The previous two studies suggest that MORC6 functions either as a dimer or as 
part of a complex with DMS3 (Lorković et al. 2012, Moissiard et al. 2012). 
However, evidence from this study would suggest MORC6 has a RdDM function 
that does not require either DMS3 or dimerisation. This is because there is a 
detectable phenotypic difference between M1, a full knockout of morc6, and 
M9, which is predicted to produce a truncated form of the MORC6 protein that 
includes part of the GHKL ATPase domain but not the coiled coil domain. In M1 
only around 20% of mesophyll cells silence the GFP transgene system used in this 
study, whereas in M9 around 50% of mesophyll cells silence the transgene. The 
fact that even a truncated form of the GHKL ATPase domain is capable of 
maintaining some level of silencing would suggest that the coiled coil domain 
and hence DMS3 and MORC6 dimerisation, is not required for some forms of 
MORC6 activity. The exact nature of this lone function of MORC6 is unknown as 
it is not known whether all cells in the silenced mesophyll cell population are 
methylated and so the solo function could be in DNA methylation or higher order 
chromatin modification or in both. It should be noted that although this function 
does not require the coiled coil domain it cannot be discounted that proteins 
could bind to the N-terminal section of MORC6 and so still be able to confer 
some level of normal function to the truncated protein.  
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6.2 Redundancy with other MORC proteins 
There are a total of seven MORC genes within the Arabidopsis genome, of which, 
only MORC1 and MORC6 have been shown to be involved in RdDM (Moissiard et 
al. 2012). It is not known if any of the other five MORC genes are involved in 
RdDM and further analysis is required in order to determine this. Of the other 
five MORC2 is the best candidate due to its close homology to MORC1 and the 
fact that both proteins have been shown to have a redundant role in pathogen 
response (Kang et al. 2008, Kang et al. 2010). MORC3 is perhaps the least likely of 
the five remaining MORC genes as homozygous mutants in this gene are 
embryonically lethal, suggesting a highly specialised role for MORC3 during early 
plant development. This role would be interesting to identify, even if not 
associated with RdDM, although the lethality of the homozygous mutant would 
make it difficult to test for MORC3’s function.  
Analysis of the two MORC genes with a known role in RdDM by Moissiard 
showed double mutants of morc1 and morc6 do not have a strong additive effect 
on the number of loci where there is an increase in expression levels compared 
to the single mutants (Moissiard et al. 2012). This means that they regulate the 
expression of a similar subset of loci and therefore show redundancy in regard to 
their targets. However, as both single mutants result in activation at these loci 
they are not redundant in terms of function. This is demonstrated by their effect 
on DNA methylation of the AtMu1 TE. In both this study and the one by 
Moissiard it was shown that morc6 mutants do not cause a reduction in 
methylation of AtMu1, however Moissiard showed that there is a reduction in 
AtMu1 methylation in a morc1 mutant. As both MORCs cause a release in AtMu1 
expression this would suggest that MORC1 is required for DNA methylation while 
MORC6 may be required for higher order chromatin modification. This would 
mean that for different loci the two MORC proteins have different functions in 
the RdDM pathway, either in DNA methylation or in higher order 
heterochromatin formation and so would explain the locus specific loss of DNA 
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methylation in morc6 mutants. Currently the methylation status of five RdDM 
targets has been assessed in morc1 mutants and fifteen for morc6 mutants, so 
more targets need to be tested to determine if there is indeed locus specificity 
between the two MORC proteins. If other MORC proteins are involved in RdDM 
these may also have a locus specific role in DNA methylation.  
In both morc1 and morc6 mutants the number of RdDM targets with increased 
expression levels is larger than the number of loci that have a reduction in 
methylation and so raises the question of why DNA methylation seems to have 
target specificity but not higher order chromatin modification. One explanation 
for this could be MORC1’s and MORC6’s respective binding partners. Sequence 
differences between the two MORCs could mean that they are able to bind a 
different set of proteins to each other. For example if these included different 
zinc finger proteins they would recognise different DNA sequences and hence 
target the MORCs to specific loci. The reason why higher order heterochromatin 
modification would not be affected in this way could be that as modification is in 
response to DNA methylation and repressive histone modification, the proteins 
that target MORC1 and MORC6 to the correct targets recognise DNA methylation 
and histone marks rather than specific sequences. Therefore there may be two 
subsets of proteins that bind to MORC1 and MORC6, ones that target the MORCs 
for DNA methylation activity and ones that target MORCs for higher order 
chromatin modification. This would require further investigation of protein 
interactions for MORC1 and MORC6 in order to prove. 
6.3 MORC activity in Plantae and Metazoa 
RdDM is a plant specific silencing pathway as the key components PolIV and PolV 
have only found in higher plants, but other eukaryotes do have similar 
transcriptional gene silencing pathways (Pal-Bhadra et al. 2004, Verdel et al. 
2004, Wang et al. 2006, Luo and Hall 2007, Ream et al. 2009). This raises the 
question of whether MORC proteins found in other eukaryotes are associated 
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with RNA silencing or RNA interference. Amongst higher plants, other species 
have orthologs of both the Arabidopsis MORC1 and MORC6 genes and so it 
would seem likely that these MORCs are associated with RdDM. However, there 
is no experimental evidence to support this and so would require further 
investigation. There has been large scale divergence in MORCs between the 
higher and lower plant species suggesting a significant expansion or change in 
function. It is also interesting to note that RdDM has evolved between lower and 
higher plants as lower plants have PolIV but lack PolV and so this rapid 
divergence in MORCs could be related to the changes in RdDM (Luo and Hall 
2007). The fact that MORC6 activity in DNA methylation centres around PolV 
would support this idea.  
There is some evidence that Metazoan MORC proteins may have a similar role to 
the Arabidopsis MORC6, however much of this evidence is circumstantial. 
Mutation of the C. elegans MORC1 protein has been shown to release silencing 
of a GFP transgene in seam cells (Moissiard et al. 2012). A similar release of 
silencing also occurs in mutants defective in the RNA interference component 
rde4, however no direct link has been demonstrated between the C. elegans 
MORC1 and the RNA interference pathway. C. elegans also lacks DNA 
methylation so any interaction between MORC1 and an RNA interference 
pathway cannot be connected to methylation as it is with RdDM in Arabidopsis 
(Simpson et al. 1986, Moissiard et al. 2012). The H. sapiens and M. musculus 
MORC1 proteins are both localised to the male germ cells and in mice mutation 
of the gene results in infertility (Watson et al. 1998, Inoue et al. 1999). M. 
musculus MORC1 is localised to the nucleus and is thought to be involved in 
higher order chromatin modification during meiosis. The PIWI RNA (piRNA) 
silencing pathway which silences transposable elements in Metazoan germ cells 
also results in male sterility when components of the pathway are mutated in 
mice (Carmell et al. 2007, Kuramochi-Miyagawa et al. 2008). Both RdDM and 
piRNA silencing target transposable elements and since MORC1 and MORC6 are 
associated with RdDM in Arabidopsis, it is possible that MORC1 may therefore be 
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associated with the PIWI pathway, however no direct link between the two has 
been observed (Carmell et al. 2007, Slotkin et al. 2009, Mosher et al. 2009, 
Lorković et al. 2012, Moissiard et al. 2012). When considering the domain 
structure of Metazoan MORC proteins the majority of MORCs have multiple 
coiled coil domains and a zinc finger motif as well as the GHKL ATPase domain. 
This means that they could theoretically be able to perform a similar function to 
that of the Arabidopsis MORC1 and MORC6, since their coiled coil domains could 
allow for dimerization and interaction with a DMS3 homolog, but they may also 
have other functions due to the presence of further coiled coil domains and the 
zinc finger motif. It is possible that Arabidopsis MORC1 and MORC6 bind to a zinc 
finger motif containing protein that provides similar functionality to the domain 
in Metazoan MORCs, but it would requires further investigation to determine if 
there is a divergence in function. This means that there is no conclusive evidence 
of an association between RNA silencing or RNA interference pathways and 
MORC proteins outside Arabidopsis. 
6.4 Future directions 
Having identified MORC6 as an RdDM component and shown that it has a locus 
specific effect on DNA methylation there are several avenues of research that I 
would wish to pursue if this project was continued. In terms of short term aims 
the first would be to use a cell sorter to separate the unsilenced and silenced 
protoplasts for the M9 line and then assess DNA methylation in the silenced 
population by bisulfite sequencing. This would demonstrate whether or not all 
silenced cells have methylation and therefore if loss of methylation results in loss 
of silencing of the GFP transgene. Another aim would be to re-assess the DNA 
methylation status of Solo LTR using bisulfite sequencing for 7 dpg and 21 dpg 
DNA samples to get a better idea of the changes to the DNA methylation pattern 
at this locus. This would then be expanded to include other loci that I have not 
tested in this study to try and identify further loci specific effects on DNA 
methylation in morc6 mutants. Ideally the methylome would be obtained for the 
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mutants and this could be analysed to identify regions where there are changes 
in DNA methylation. The final short term aim would be to test the DNA 
methylation status of DNA loci in other morc mutants to determine if these other 
MORCs are involved in RdDM and if they result in loss of methylation at different 
loci to MORC6. Double and triple morc mutants would also be created and their 
effect on DNA methylation compared against single mutants. this would show if 
there is redundancy between MORC proteins are certain loci. Long term aims for 
the project this would include carrying out protein interaction analysis to identify 
whether MORC6 functions in a complex. This should help to determine its 
function in higher order chromatin formation. Further biochemical analysis may 
also be required to determine this function in higher order heterochromatin 
formation. Another long term aim would be to assess the function of MORC 
proteins in other Plantae species, particularly the M. truncatula MORC that lacks 
a coiled coil domain but has a zinc finger motif. This protein would especially be 
of interest as the difference in domain structure would suggest an effect on 
function. 
6.5 Concluding remarks 
Since its discovery, our understanding of the RdDM pathway has increased 
rapidly so that now most of the mechanism is well understood. The identification 
of MORC6 in this study and the two previous studies adds to our understanding 
of the pathway. This protein has roles in higher order chromatin modification 
and DNA methylation in the RdDM pathway, of which its role in DNA methylation 
may help solve one of the unresolved issues in RdDM mechanism, that of how 
siRNAs trigger DRM2 to methylate the DNA target. There are six paralogs of 
MORC6 in Arabidopsis, some of which may also have roles in RdDM and are also 
part of a wider family of MORCs found in both Plantae and Metazoa. This family 
could have an ancient role in forming higher order chromatin structure.  
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7. Appendices 
Appendix 1 
Appendix 1.1 35Sp:GFP and NOSp:35S IR transgene 
sequences
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Figure 7.1A: DNA sequence of the 35Sp:GFP transgene 
The sequence shown is only of the transgene and does not show the flanking sequence of the transgene. The sequence highlighted in purple is the 
35Sp and the sequence highlighted in green is the GFP gene. The start and stop codons for the GFP gene are highlighted in blue and red respectively. 
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Figure 7.2A: DNA sequence of the NOSp:35S IR transgene 
The sequence shown is only of the transgene and does not show the flanking sequence of the transgene. The sequence highlighted in purple are the 
inverted repeat (IR) of the part of the 35Sp and the sequence highlighted in green is the NOS promoter. The section not highlighted is the intron of the 
CHS A gene, which allows for the correct formation of dsRNA from the IR. The section in black is linker sequence that forms a loop after the CHS intron 
is spliced out.
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Appendix 1.2 Allelism tests of M1 and M9 with hda6 and 
mom1 
 
Figure 7.3A: Allelism tests showing M1 and M9 are not mom1 and hda6 
mutants 
Images taken under UV light of parents and crosses. The parental lines shown are 142, 
142S, M1, M9, mom1 and hda6. For all crosses the names of the parents are given, the 
first name is the male and the second is the female. Images are representative for each 
line. The bright fluorescence seen on leaves for the 142S and mom1 x M9 images is due 
to necrosis and has no relevance to the silencing phenotype. The bright fluorescence 
seen on the right hand leaf of the M1 image is soil on the leaf. 
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Appendix 1.3 All homozygous SNPs in M1 
Chromosome 
Scaffold 
Number 
Position 
within 
scaffold 
(bp) 
Base 
in 
142S 
Base 
in 
M1 
Proportion 
of 
concordance 
Number of 
concordant 
reads 
Chr1_left_arm 4 199539 C T 0.86  127 
Chr1_left_arm 4 220454 C T 0.85 97 
Chr1_left_arm 4 22854 G A 0.87 111 
Chr1_left_arm 4 38773 C T 0.93 99 
Chr1_left_arm 14 129088 C T 0.86 113 
Chr1_left_arm 14 301830 C T 0.93 90 
Chr1_left_arm 20 197351 C T 0.89 89 
Chr1_left_arm 20 310670 C T 0.89 76 
Chr1_left_arm 20 388068 C T 0.91 105 
Chr1_left_arm 20 405956 C T 0.89 78 
Chr1_left_arm 20 610420 C T 0.86 96 
Chr1_left_arm 20 66903 C T 0.86 96 
Chr1_left_arm 24 210128 C T 0.83 90 
Chr1_left_arm 25 110148 C T 0.87 109 
Chr1_left_arm 25 204931 C T 0.87 127 
Chr1_left_arm 25 291069 C T 0.88 122 
Chr1_left_arm 25 328638 C T 0.85 112 
Chr1_left_arm 25 81944 C T 0.83 80 
Chr1_left_arm 26 129417 C T 0.87 103 
Chr1_left_arm 26 278549 C T 0.93 126 
Chr1_left_arm 26 318083 C T 0.90 96 
Chr1_left_arm 26 359473 C T 0.89 96 
Chr1_left_arm 32 166444 C T 0.90 107 
Chr1_left_arm 32 187188 C T 0.92 119 
Chr1_left_arm 36 705641 C T 0.91 125 
Chr1_left_arm 36 89588 C T 0.86 95 
Chr1_left_arm 48 31037 C T 0.93 132 
Chr1_left_arm 49 78579 G A 0.93 82 
Chr1_left_arm 57 2458 C T 0.94 65 
Chr1_left_arm 58 7103 C T 0.94 113 
Chr1_left_arm 66 21383 C T 0.95 120 
Chr1_left_arm 66 93482 C T 0.88 82 
Chr1_left_arm 69 147996 C T 0.96 127 
Chr1_left_arm 69 40455 C T 0.96 121 
Chr1_left_arm 69 95888 C T 0.96 126 
Chr1_left_arm 73 105251 C T 0.99 78 
Chr1_left_arm 73 200949 C T 0.98 105 
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Chromosome 
Scaffold 
Number 
Position 
within 
scaffold 
(bp) 
Base 
in 
142S 
Base 
in 
M1 
Proportion 
of 
concordance 
Number of 
concordant 
reads 
Chr1_left_arm 73 2832 C T 0.97 91 
Chr1_left_arm 73 56157 C T 0.98 106 
Chr1_left_arm 74 10327 C T 1.00 138 
Chr1_left_arm 74 481 C T 0.98 120 
Chr1_left_arm 79 103938 A C 0.83 15 
Chr1_left_arm 79 214406 C T 0.97 99 
Chr1_left_arm 79 24264 T C 0.93 14 
Chr1_left_arm 79 24290 T C 0.93 14 
Chr1_left_arm 79 24316 G T 0.93 14 
Chr1_left_arm 79 4095 C T 0.96 103 
Chr1_left_arm 84 118930 C T 0.97 86 
Chr1_left_arm 84 186948 C T 0.99 92 
Chr1_left_arm 88 173559 C T 0.97 109 
Chr1_left_arm 88 229237 C T 0.96 126 
Chr1_left_arm 88 296804 C T 0.99 134 
Chr1_left_arm 88 303908 T C 0.80 133 
Chr1_left_arm 98 20578 C T 0.98 112 
Chr1_left_arm 110 183196 C T 0.98 106 
Chr1_left_arm 110 333140 C T 0.93 124 
Chr1_left_arm 110 840513 C T 0.93 76 
Chr1_left_arm 110 959682 C T 0.90 112 
Chr1_left_arm 110 977488 C T 0.95 115 
Chr1_left_arm 115 44531 C T 0.96 111 
Chr1_left_arm 115 82933 C T 0.96 87 
Chr1_left_arm 115 88160 C T 0.93 81 
Chr1_left_arm 124 520 C T 0.89 104 
Chr1_left_arm 150 120473 C T 1.00 13 
Chr1_left_arm 177 225540 A G 1.00 13 
Chr1_left_arm 194 973 G A 1.00 12 
Chr1_left_arm 201 31931 A T 1.00 14 
Chr1_left_arm 334 22547 T C 0.81 189 
Chr1_left_arm 360 57313 C T 1.00 8 
Chr1_right_arm 569 32269 C T 0.83 202 
Chr1_right_arm 574 28015 G A 1.00 10 
Chr1_right_arm 597 6794 A G 0.82 36 
Chr1_right_arm 599 372 T G 1.00 14 
Chr1_right_arm 613 28105 T C 0.87 220 
Chr1_right_arm 622 10024 T G 1.00 12 
Chr1_right_arm 638 46124 A G 1.00 15 
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Chromosome 
Scaffold 
Number 
Position 
within 
scaffold 
(bp) 
Base 
in 
142S 
Base 
in 
M1 
Proportion 
of 
concordance 
Number of 
concordant 
reads 
Chr1_right_arm 693 113281 A C 0.86 12 
Chr1_right_arm 693 35337 A C 1.00 13 
Chr1_right_arm 693 35339 G T 0.93 13 
Chr1_right_arm 693 64633 T C 0.86 61 
Chr1_right_arm 717 31 C T 0.83 107 
Chr1_right_arm 772 50 T G 1.00 6 
Chr1_right_arm 806 27261 A T 1.00 12 
Chr1_right_arm 899 44011 T A 1.00 11 
Chr1_right_arm 916 50346 C A 0.80 4 
Chr1_right_arm 922 7942 A G 0.80 8 
Chr2_left_arm 1141 83041 G A 1.00 15 
Chr2_left_arm 1176 59497 T C 0.81 54 
Chr2_left_arm 1208 38725 T C 0.83 174 
Chr2_right_arm 1514 29 G A 0.80 12 
Chr2_right_arm 1544 2779 A C 1.00 16 
Chr2_right_arm 1544 2780 G A 1.00 16 
Chr2_right_arm 1544 2784 C A 1.00 20 
Chr2_right_arm 1549 54 A G 0.82 180 
Chr2_right_arm 1550 96974 T C 0.80 140 
Chr2_right_arm 1558 394259 T A 0.80 8 
Chr2_right_arm 1575 202590 T C 1.00 11 
Chr2_right_arm 1575 202591 C T 1.00 12 
Chr2_right_arm 1575 202593 T C 1.00 15 
Chr2_right_arm 1584 20730 T G 1.00 11 
Chr2_right_arm 1584 20731 G A 1.00 11 
Chr2_right_arm 1584 662620 G T 1.00 20 
Chr2_right_arm 1636 78709 C A 1.00 13 
Chr2_right_arm 1639 359665 T C 0.93 13 
Chr2_right_arm 1673 588538 T G 1.00 9 
Chr2_right_arm 1686 31716 A G 0.81 42 
Chr2_right_arm 1691 53015 T G 0.81 17 
Chr2_right_arm 1724 83633 A T 0.91 10 
Chr2_right_arm 1724 83634 T C 0.90 9 
Chr3_left_arm 1937 325912 A T 0.82 125 
Chr3_left_arm 1937 326605 T C 0.80 176 
Chr3_left_arm 1937 611249 A G 1.00 12 
Chr3_left_arm 1937 611250 G T 1.00 12 
Chr3_left_arm 1937 62824 T A 1.00 12 
Chr3_left_arm 1951 1001405 C T 0.86 42 
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Chromosome 
Scaffold 
Number 
Position 
within 
scaffold 
(bp) 
Base 
in 
142S 
Base 
in 
M1 
Proportion 
of 
concordance 
Number of 
concordant 
reads 
Chr3_left_arm 1976 109607 A G 0.82 9 
Chr3_left_arm 2010 18327 T C 1.00 22 
Chr3_left_arm 2010 18328 C T 1.00 22 
Chr3_left_arm 2020 13122 A T 1.00 11 
Chr3_left_arm 2038 845 T A 1.00 4 
Chr3_right_arm 2312 29492 C T 1.00 15 
Chr3_right_arm 2339 18007 C T 0.85 72 
Chr3_right_arm 2347 1073 C A 1.00 22 
Chr3_right_arm 2428 1813 A C 1.00 26 
Chr3_right_arm 2428 1814 T A 1.00 19 
Chr3_right_arm 2428 3385 C T 1.00 17 
Chr3_right_arm 2571 32431 C G 1.00 19 
Chr3_right_arm 2619 127658 T A 1.00 12 
Chr3_right_arm 2659 53774 T G 1.00 20 
Chr3_right_arm 2659 56942 G A 1.00 8 
Chr4_left_arm 2855 176204 A G 1.00 15 
Chr4_left_arm 2855 56718 T A 0.89 71 
Chr4_right_arm 2956 68240 T C 0.83 126 
Chr4_right_arm 2956 68264 T C 0.83 129 
Chr4_right_arm 2980 147 G C 0.80 224 
Chr4_right_arm 2991 3546 G T 1.00 13 
Chr4_right_arm 3020 1811 G T 1.00 9 
Chr4_right_arm 3022 84053 G A 0.83 10 
Chr4_right_arm 3054 15612 A T 0.80 12 
Chr4_right_arm 3054 15613 A T 0.82 14 
Chr4_right_arm 3056 21488 A C 1.00 9 
Chr4_right_arm 3073 15163 G A 0.81 184 
Chr4_right_arm 3093 18090 C T 0.92 11 
Chr4_right_arm 3101 31011 C A 1.00 14 
Chr4_right_arm 3101 74492 T A 0.91 10 
Chr4_right_arm 3118 61253 C T 1.00 21 
Chr4_right_arm 3256 388360 T C 0.81 52 
Chr4_right_arm 3256 91244 T C 1.00 14 
Chr4_right_arm 3277 213456 C A 1.00 12 
Chr4_right_arm 3278 31224 G A 1.00 14 
Chr4_right_arm 3285 39 G T 0.93 25 
Chr5_left_arm 3550 16104 T C 0.82 41 
Chr5_left_arm 3558 149509 A G 0.83 99 
Chr5_left_arm 3597 37559 A C 0.81 13 
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Chromosome 
Scaffold 
Number 
Position 
within 
scaffold 
(bp) 
Base 
in 
142S 
Base 
in 
M1 
Proportion 
of 
concordance 
Number of 
concordant 
reads 
Chr5_left_arm 3605 14863 A C 1.00 14 
Chr5_left_arm 3650 138706 T A 0.83 5 
Chr5_left_arm 3650 138707 A T 1.00 5 
Chr5_left_arm 3650 57614 A G 0.84 70 
Chr5_left_arm 3722 14362 T A 1.00 14 
Chr5_right_arm 3849 3397 A G 1.00 12 
Chr5_right_arm 3862 8703 T G 1.00 7 
Chr5_right_arm 4039 35985 A G 0.82 84 
Chr5_right_arm 4041 5618 T G 0.91 30 
Chr5_right_arm 4058 13411 C T 1.00 10 
Chr5_right_arm 4059 184522 A G 1.00 11 
Chr5_right_arm 4059 189832 C A 1.00 24 
Chr5_right_arm 4147 36733 A T 1.00 10 
Chr5_right_arm 4209 81150 A C 0.93 315 
Chr5_right_arm 4209 81161 A G 0.94 317 
Chr5_right_arm 4216 385116 A C 0.92 11 
Chr5_right_arm 4226 578362 A G 0.82 40 
Chr5_right_arm 4228 123775 C T 1.00 14 
Chr5_right_arm 4229 357992 T A 0.94 15 
Table 7.1A: All SNPs identified in the M1 line 
Table showing the location of each SNP in M1 in terms of which chromosome and which 
arm of the chromosome they are located on. The table also gives which scaffold of the 
C24 genome they are located on and the SNPs exact position within that scaffold. The 
base in 142S and M1 is given and the proportion of concordance and number of 
concordant reads supporting the M1 mutation are given for each SNP. 
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Appendix 1.4 All left arm of chromosome one SNPs in M1 and exact position in annotated genome 
SNP 
position 
(bp) 
Mutation 
location 
TAIR ID 
Gene 
name 
Base 
change 
Proportion 
concordance 
in M1  
Mutation location and amino acid change 
272314 Exon AT1G01740 AT1G01740 G to A 0.87 (111) Exon 10 Codon 417: CAA (Glutamine) to UAA (Stop codon) 
288235 Intronic AT1G01790 KEA1 C to T 0.93 (99) Intron 10 
448847 Exon AT1G02280 TOC33 C to T 0.86 (127) Exon 6 Codon 264: GGA (Glycine) to AGA (Arginine) 
469888 Exon AT1G02350 AT1G02350 C to T 0.85 (97) Exon 1 Codon 25: UCC (Serine) to UCU (Serine) 
613895 Exon AT1G02810 AT1G02810 C to T 0.86 (113) Exon 1 Codon 38: UCC (Serine) to UUC (Phenylalanine) 
788675 Intergenic     C to T 0.93 (90) Intergenic, 1415bp upstream AT1G03230 
859201 Intron AT1G03445 BSU1 C to T 0.86 (96) Intron 2 
989786 Exon AT1G03890 AT1G03890 C to T 0.89 (89) Exon 2 Codon 145: UUC (Phenylalanine) to UUA (Leucine) 
1101701 Intergenic     C to T 0.89 (76) Intergenic, 2921bp upstream of AT1G04180 (YUC9) 
1180293 Intron AT1G04390 AT1G04390 C to T 0.91 (105) Intron 8 
1197642 Intergenic     C to T 0.89 (78) Intergenic, 475bp upstream AT1G04430 
1403045 3'UTR AT1G04945 AT1G04945 C to T 0.86 (96) 3' UTR 
1732989 Intergenic     C to T 0.83 (90) Intergenic 49bp upstream AT1G05790 
1864858 Exon AT1G06140 AT1G06140 C to T 0.83 (80) Exon 1 Codon 21: AAC (Asparagine) to AAU (Asparagine) 
1893527 Exon AT1G06190 AT1G06190 C to T 0.87 (109) Exon 1 Codon 49: GGG (Glycine) to GAG (Glutamic acid) 
1988596 Exon AT1G06490 GSLO7 C to T 0.87 (127) Exon 40 Codon 1884: CUC (Leucine) to CUU (Leucine) 
2076617 3'UTR AT1G06760 AT1G06760 C to T 0.88 (122) 3' UTR of AT1G06760 and AT1G06750 
2114176 5'UTR AT1G06890 AT1G06890 C to T 0.85 (112) 5' UTR 
2351992 Intergenic     C to T 0.87 (103) Intergenic 300bp downstream AT1G07630 (PLL5) 
2503774 Exon AT1G08060 MOM1 C to T 0.93 (126) Exon 11 Codon 1561: GCG (Alanine) to GCA (Alanine) 
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SNP 
position 
(bp) 
Mutation 
location TAIR ID 
Gene 
name 
Base 
change 
Proportion 
concordance 
in M1  Mutation location and amino acid change 
2543135 Exon AT1G08130 LIG1 C to T 0.90 (96) Exon 16 Codon 756:  GAA(Glutamic acid) to AAA(Lysine) 
2584446 Intron AT1G08230 AT1G08230 C to T 0.89 (96) Intron 4 
2908764 Exon AT1G09030 NF-YB4 C to T 0.90 (107) Exon 1 Codon 89: AAG (Lysine) to AAA (Lysine) 
2929529 Exon AT1G09080 BIP3 C to T 0.92 (119) Exon 6 Codon 589: ACG (Threonine) to ACA (Threonine) 
3130907 5' UTR AT1G09660 AT1G09660 C to T 0.86 (95) 5' UTR  
3753966 Exon AT1G11200 AT1G11200 C to T 0.91 (125) Exon 2 Codon 24: UCG (Serine) to UAG (Stop codon) 
3816744 Exon AT1G11340 AT1G11340 C to T 0.93 (132) Exon 1 Codon 226: GGA (Glycine) to GAA (Glutamic acid) 
4280595 Exon AT1G12610 DDF1 G to A 0.93 (82) Exon 1 Codon 80: UUG (Leucine) to UUA (Leucine) 
4316338 Intergenic 
  
C to T 0.94 (65) 
Intergenic between two pseudogenes, 1970bp upstream 
AT1G12672 
4564003 Exon AT1G13320 PP2AA3 C to T 0.94 (113) Exon 12 Codon 527: GUU (Valine) to AUU (Isoleucine) 
4798406 Exon AT1G14000 VIK C to T 0.95 (120) Exon 3 Codon 146: CCA (Proline) to UCA (Serine) 
4866043 Intron AT1G14240 AT1G14240 C to T 0.88 (82) Intron 3  
5218865 Exon AT1G15165 AT1G15165 C to T 0.96 (121) Exon 4 Codon 119: AGG (Arginine) to AAG (Lysine) 
5274409 Exon AT1G15330 AT1G15330 C to T 0.96 (126) Exon 1 Codon 14: AUC (Isoleucine) to AUU (Isoleucine) 
5326847 Exon AT1G15500 ATNTT2 C to T 0.96 (127) Exon 1 Codon 142: GCU (Alanine) to GUU (Valine) 
5360698 Intergenic     C to T 0.97 (91) Intergenic 1310bp upstream AT1G15570 (CYCA2;3) 
5419895 Exon AT1G15750 TPL C to T 0.98 (106) Exon 4 Codon 98: GUG (Valine) to AUG (Methionine) 
5469631 5'UTR AT1G15920 AT1G15920 C to T 0.99 (78) 5' UTR 
5575831 Intron AT1G16300 GAPCP-2 C to T 0.98 (105) Intron 6 
5613754 Exon AT1G16420 MC8 C to T 0.98 (120) Exon 1 Codon 26: GUC (Valine) to AUC (Isoleucine) 
5623557 Intron AT1G16470 PAB1 C to T 1.00 (138) Intron 4 
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SNP 
position 
(bp) 
Mutation 
location 
TAIR ID 
Gene 
name 
Base 
change 
Proportion 
concordance 
in M1 
Mutation location and amino acid change 
5677535 Exon AT1G16610 SR45 C to T 0.96 (103) 
Exon 6 Codon 195: GAU (Aspartic acid) to AAU 
(Asparagine) 
5701373 Intergenic     T to C 0.93 (14) Intergenic 1379bp upstream AT1G16680 
5701399 Intergenic     T to C 0.93 (14) Intergenic 1353bp upstream AT1G16680 
5701425 Intergenic     G to T 0.93 (14) Intergenic 1327bp upstream AT1G16680 
5781761 Intron AT1G16900 AT1G16900 A to C 0.83 (15) Intron 1  
5892010 Exon AT1G17230 AT1G17230 C to T 0.97 (99) Exon 1 Codon 212: AGC (Serine) to AGU (Serine) 
6324487 Intergenic     C to T 0.97 (86) Intergenic 667 bp upstream AT1G18370 (HIK) 
6393196 Intergenic     C to T 0.99 (92) Intergenic 2667bp upstream AT1G18580 (GAUT11) 
6595680 Exon AT1G19100 AT1G19100 C to T 0.97 (109) Exon 2 Codon 41: CAA (Glutamine) to UAA (Stop codon) 
6651377 Exon AT1G19250 FMO1 C to T 0.96 (126) Exon 4 Codon 360: GGG (Glycine) to GAG (Glutamic acid) 
6729457 Exon AT1G19440 KCS4 C to T 0.99 (134) Exon 1 Codon 113: UAC (Tyrosine) to UAU (Tyrosine) 
6736478 Intergenic     T to C 0.80 (133) Intergenic  1595bp upstream of AT1G19450 
6952070 Intron AT1G20060 AT1G20060 C to T 0.98 (112) Intron 16 
7280563 Exon AT1G20910 AT1G20910 C to T 0.98 (106) Exon 2 Codon 25: GAA (Glutamic acid) to AAA (Lysine) 
7445662 Exon AT1G21270 WAK2 C to T 0.93 (124) Exon 1 Codon 222: CCU (proline) to UCU (Serine) 
7963776 Intergenic     C to T 0.93 (76) Intergenic 265bp upstream AT1G22540 
8090097 Exon AT1G22870 AT1G22870 C to T 0.90 (112) Exon 2 Codon 176: CUC (Leucine) to CUU (Leucine) 
8107946 Exon AT1G22910 AT1G22910 C to T 0.95 (115) Exon 6 Codon 347: UGC (Cysteine) to UGU (Cysteine) 
8352560 3'UTR AT1G23550 SRO2 C to T 0.96 (111) 3'UTR 
8397784 Intron AT1G23730 BCA3 C to T 0.96 (87) Intron 8 
8403007 Exon AT1G23760 JP630 C to T 0.93 (81) Exon 2 Codon 243: GGC (Glycine) to GGU (Glycine) 
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SNP 
position 
(bp) 
Mutation 
location 
TAIR ID 
Gene 
name 
Base 
change 
Proportion 
concordance 
in M1 
Mutation location and amino acid change 
8450341 Intergenic     C to T 0.89 (104) Intergenic 725bp downstram AT1G23910 
9304860 Intergenic     C to T 1.00 (13) Intergenic 720gp upstream AT1G26850 
10047444 3'UTR AT1G28590 AT1G28590 A to G 1.00 (13) 3' UTR 
10922907 Intergenic     G to A 1.00 (13) Intergenic 1011bp downstream AT1G30780 
11050895 Intergenic     A to T 1.00 (14) Intergenic 165bp upstream AT1G30980 
13085698 Exon AT1G3552 ARF15 T to C 0.81 (189) Exon 2 Codon 19: AGA (Arginine) to GGA (Glycine)  
13477372 Intergenic     C to T 1.00 (8) Intergenic 4292bp downstream AT1G36078 
Table 7.2A: All homozygous SNPs on the left arm of chromosome one in M1 and their location in the Col genome 
Table showing the exact position of each SNP in bp on chromosome one and also shows whether this position is intergenic or genic. If the SNP is 
within a gene it also gives the gene name and where is the gene the mutation is (UTR, exon or intron). The base change from WT to mutant is also 
given as well as the proportion of reads that show concordance in this change, with the actual number with this change in brackets. 
SNP position (bp) Mutation location TAIR ID Function 
272314 Exon AT1G01740 Protein kinase containing tetratricopeptide repeat domain 
288235 Intronic AT1G01790 Potassium efflux antiporter, ion transporter 
448847 Exon AT1G02280 GTPase involved in chloroplast import machinary 
469888 Exon AT1G02350 Protoporphyrinogen oxidase 
Appendices 
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SNP position (bp) Mutation location TAIR ID Function 
613895 Exon AT1G02810 Plant inverstase/pectin methyltransferase inhibitor, inhibits cell wall modification 
788675 Intergenic   Eukaryotic aspartyl protease 
859201 Intron AT1G03445 Serine–threonine protein phosphatase, involved in response to brassinosteroid 
989786 Exon AT1G03890 RmlC-like cupins superfamily protein, involved in metabolism 
1101701 Intergenic   Reduction of NADPH to NADP 
1180293 Intron AT1G04390 BTB/POZ domain containing protein 
1197642 Intergenic   S-adenosyl-L-methionine-dependent methyltransferase, involved in protein trafficking 
1403045 3'UTR AT1G04945 HIT-type zince finger protein 
1732989 Intergenic   Lipase, lipid cleavage 
1864858 Exon AT1G06140 Pentatricopeptide repeat protein 
1893527 Exon AT1G06190 Rho termination factor, involved in transciption termination 
1988596 Exon AT1G06490 Callose Synthase, involved in creation of sieve elements in phloem 
2076617 3'UTR AT1G06760 Winged helix transciption factor 
2114176 5'UTR AT1G06890 Nodulin MtN21 /EamA-like transporter 
2351992 Intergenic   Protein phosphatase 
2503774 Exon AT1G08060 Transciptional silencing 
2543135 Exon AT1G08130 DNA ligase involved in DNA replication and base excision repair 
2584446 Intron AT1G08230 Transmembrane amino acid transporter 
2908764 Exon AT1G09030 Transcription factor 
2929529 Exon AT1G09080 ATP binding protein involved in protein in the ER in response to heat stress 
3130907 5' UTR AT1G09660 RNA binding KH domain containing protein 
3753966 Exon AT1G11200 Unknown function 
3816744 Exon AT1G11340 S-locus protein kinase, involved in pollen recognition 
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SNP position (bp) Mutation location TAIR ID Function 
4280595 Exon AT1G12610 DREB family transciption factor involved in flowering and growth 
4316338 Intergenic   Unknown function 
4564003 Exon AT1G13320 Part of regulatory subunit of protein phosphatase 2 
4798406 Exon AT1G14000 MAP Kinase involved in auxin signalling 
4866043 Intron AT1G14240 GDA1/CD39 nucleotide phosphatase 
5218865 Exon AT1G15165 
Zinc finger protein associated with a ubiquitin ligase complex which ubiquitinates 
proteins 
5274409 Exon AT1G15330 Cystathionine beta-synthase protein 
5326847 Exon AT1G15500 ADP antiporter transport protein found in chloroplasts 
5360698 Intergenic   A2-type cyclin involved in cell division control 
5419895 Exon AT1G15750 Transcription factor involved in repressing root development in aeriel tissues 
5469631 5'UTR AT1G15920 Polynucleotidyl transferace, related to ribonuclease H 
5575831 Intron AT1G16300 Encodes a chloroplast GAPDH protein 
5613754 Exon AT1G16420 
Metacaspase which promotes cell death in response to UV light, hydrogen peroxide and 
methyl violegen stress 
5623557 Intron AT1G16470 Proteasome subunit 
5677535 Exon AT1G16610 Involved in RdDM and spliceosome 
5701373 Intergenic   Protein chaperone 
5701399 Intergenic   Protein chaperone 
5701425 Intergenic   Protein chaperone 
5781761 Intron AT1G16900 Protein kinase in curculin-like lectin protein family 
5892010 Exon AT1G17230 Leucine rich protein kinase found in membrane 
6324487 Intergenic   Kinesin involved in cytokenesis in pollen 
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SNP position 
(bp) Mutation location TAIR ID Function 
6393196 Intergenic   Protein with galacturonosyltransferase activity. 
6595680 Exon AT1G19100 
Chloroplast envelope protein similar to histidine kinases, DNA gyrases and heat shock 
proteins 
6651377 Exon AT1G19250 Response to viral infection, promotes cell death 
6729457 Exon AT1G19440 3-ketoacyl-CoA synthase involved in fatty acid biosytnhesis 
6736478 Intergenic   Major facilitator protein involved in carbohydrate membrane transport 
6952070 Intron AT1G20060 ATP binding microtubule motor protein 
7280563 Exon AT1G20910 DNA binding proteins which contains ARID/BRIGHT domains 
7445662 Exon AT1G21270 Serine/threonine protein kinase involved in cell expansion  
7963776 Intergenic   Oligopeptide transport protein 
8090097 Exon AT1G22870 Serine/threonine protein kinase 
8107946 Exon AT1G22910 RNA binding protein 
8352560 3'UTR AT1G23550 ADP ribosylation of proteins 
8397784 Intron AT1G23730 Carbonate dehydratase 
8403007 Exon AT1G23760 Aromatic rich glycoprotein 
8450341 Intergenic   Polyketide cyclase/dehydrase and lipid transport protein 
9304860 Intergenic   S-adenosyl-L-methionine-dependent methyltransferase 
10047444 3'UTR AT1G28590 GDSL-like Lipase/Acylhydrolase 
10922907 Intergenic    F-box associated ubiquitination effector protein 
11050895 Intergenic   Transposable element from mutator like transposon family 
13085698 Exon AT1G3552 Auxin response transcription factor 
13477372 Intergenic   Unknown function 
Table 7.3A: Functions of genes that the SNPs on the left arm of chromosome one are within or closest to 
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Table showing the position of each SNP of chromosome one in bp and whether the SNP is genic or intergenic. For cases where the SNP is within a 
gene it also gives the name of that gene. The function of the gene the SNP is within or closest to is given for all SNPs. 
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Appendix 1.5 At1G19100 (MORC6) sequence differences between WT Col and WT C24 
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Figure 7.4A: SNP differences between WT Col and WT C24 for the At1G19100 (MORC6) gene 
DNA sequence alignment of WT Col and WT C24 for the At1G19100 (MORC6) gene. Intergenic DNA is highlighted in gold, the UTRs are highlighted in 
purple and the introns are highlighted in blue. The areas of black uppercase text are exons with the start codon highlighted in green and the stop 
codon highlighted in red. Base substitutions have been highlighted in black and the 5’ UTR single base deletion highlighted in yellow. There are fifteen 
base substitutions of which most are intronic (thirteen), one is in the 5’UTR and one is in the 2nd exon, but does not cause an amino acid change. 
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Appendix 1.6 MORC gene family and genome location 
Name Locus 
Chromsome 
number 
Chromsome 
arm 
Gene size 
(Kb) 
Number of 
exons 
Protein size 
(amino acids) 
MORC1 At4G36290 4 Right 3.75 18 635 
MORC2 At4G36280 4 Right 4.05 18 626 
MORC3 At4G36270 4 Right 4.22 18 486 
MORC4 At5G50780 5 Right 4.94 20 819 
MORC5 At5G13130 5 Left 3.9 18 706 
MORC6 At1G19100 1 Left 6.43 20 663 
MORC7 At4G24970 4 Right 4.44 19 707 
Table 7.4A: MORC gene family in Arabidopsis 
Table showing all MORC genes found in Arabidopsis and their location within the genome. The size of each gene, exon number and protein size is also 
given. 
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Figure 7.5A: Location of MORC genes in the Arabidopsis genome 
Diagram showing the location of MORC genes within the Arabidopsis genome. Each 
chromosome’s centromere is shown in blue and the MORC gene location is shown in 
red. 
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Appendix 1.7 Gene expression of Arabidopsis MORC genes 
in C24 and Columbia ecotypes 
 
Figure 7.6A: Developmental expression patterns of MORCs in Columbia and C24 
ecotypes 
Graphs showing mean expression levels of expression patterns of MORC genes for 
different developmental stages of Columbia (A) and C24 (B) taken from microarray data 
from Genevestigator. There is a key at the bottom of the figure showing which MORC 
corresponds to each coloured circle. Each circle on the graph represents the mean 
relative signal intensity. Low levels of gene expression are considered to be genes with a 
relative intensity among the 25% lowest intensities of all genes and medium levels of 
gene expression are considered to be those within the interquartile range (IQR) of 
relative intensity. The different developmental stages are represented as pictures and 
are from left to right, are: seedling, bolting plant and developed flower. The number of 
microarrays with probes for MORC genes at that developmental stage are shown below 
each developmental stage.  
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Appendix 1.8 Alignment of MORC proteins from Arabidopsis other Plantae and Metazoa 
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Figure 7.7A: Alignment of Plantae and Metazoa MORC proteins 
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Alignment of protein sequences from Plantae and Metazoa species for MORC proteins. There is also a bacterial MORC homolog from Myroides 
odoratimimus (Mo). The Plantae species are: Arabidopsis thaliana (At), Medicago truncatula (Mt), Populus trichocarpa (Pt), Vitis vinifera (Vv), Oryza 
sativa (Os), Zea mays (Zm), Physcomitrella patens (Pp) and Selaginella moellendorffii (Sm); and the Metazoa species are: Mus musculus (Mm), Homo 
Sapiens (Hs), Bos taurus (Bt), Xenopus tropicalis (Xt), Danio rerio (Dr), Caenorhabditis elegans (Ce) and Nematostella vectensis (Nv). For most species 
there are MORC paralogs in each species, bar M. Musculus, D. rerio and C. elegans which have only one MORC. Amino acid residues that are 
conserved are highlighted in blue, with the darkness of the blue indicating how conserved each residue is, dark blue are the most highly conserved 
while light blue are only conserved in a few species; amino acid residues that are not highlighted are not conserved between species. The amino acid 
sequence which codes for the GHKL ATPase domain is represented by a labelled black line underneath the relevant sections of the alignment. The 
GHKL domain begins at the start of the region identified by Pfam and SMART as the GHKL ATPase but ends beyond the region identified by these 
systems and instead ends after the fourth conserved motif of the GHKL ATPase domain. The four conserved motifs of GHKL ATPases are highlighted 
with boxes on the alignment: motif I is a green box, motif II is a red box, motif III is a purple box; and motif IV is a yellow box. 
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 Appendix 2 
Appendix 2.1 Confocal images of the M9 3rd leaf at 7 hpd and 13 hpd 13 dpg 
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Figure 7.8A: GFP expression in epidermal layers of 3rd leaves of 13 dpg plants at 7 hpd 
The 3rd leaves of 13 dpg seedlings were imaged under a confocal microscope to observe GFP expression. These images were taken at 7hpd. The upper 
and lower epidermis of each leaf was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP (cyan) 
and one for propidium iodide and chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP channel (ii) 
and propidium iodide and chlorophyll channel (iii) are shown. Leaves from the following plant lines were image: 142 (A and B), 142S (C and D) and M9 
(E and F). A scale bar is shown for each image in the propidium channel only image. Images are representative of the three leaves visualised. 
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Figure 7.9A: GFP expression in epidermal layers of 3rd leaves of 13 dpg plants at 13 hpd 
The 3rd leaves of 13 dpg seedlings were imaged under a confocal microscope to observe GFP expression. These images were taken at 13 hpd. The 
upper and lower epidermis of each leaf was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP 
(cyan) and one for propidium iodide and chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP 
channel (ii) and propidium iodide and chlorophyll channel (iii) are shown. Leaves from the following plant lines were image: 142 (A and B), 142S (C 
and D) and M9 (E, F and G). E and F show areas of the leaf where silencing is less (E) or more (F) prevalent. A scale bar is shown for each image in the 
propidium channel only image. Images are representative of the three leaves visualised.
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Appendix 2.2 Confocal images of the M1 3rd and 5th leaves at 7 hpd and 13 hpd 14 dpg 
 
Figure 7.10A: GFP expression in epidermal layers of 3rd leaves of 14 dpg plants at 7 hpd 
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The 3rd leaves of 14 dpg seedlings were imaged under a confocal microscope to observe GFP expression. These images were taken at 7 hpd. The upper 
and lower epidermis of each leaf was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP (cyan) 
and one for propidium iodide and chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP channel (ii) 
and propidium iodide and chlorophyll channel (iii) are shown. Leaves from the following plant lines were image: 142 (A and B), 142S (C and D) and 
M1(E and F). A scale bar is shown for each image in the propidium channel only image. Images are representative of the three leaves visualised. 
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Figure 7.11A: GFP expression in epidermal layers of 3rd leaves of 14 dpg plants at 13 hpd 
The 3rd leaves of 14 dpg seedlings were imaged under a confocal microscope to observe GFP expression. These images were taken at 13 hpd. The 
upper and lower epidermis of each leaf was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP 
(cyan) and one for propidium iodide and chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP 
channel (ii) and propidium iodide and chlorophyll channel (iii) are shown. Leaves from the following plant lines were image: 142 (A and B), 142S (C 
and D) and M1 (E, F and G). E and F show areas of the leaf where silencing is less (E) or more (F) prevalent. A scale bar is shown for each image in the 
propidium channel only image. Images are representative of the three leaves visualised. 
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Figure 7.12A: GFP expression in epidermal layers of 5th leaves of 14 dpg plants at 7 hpd 
The 5th leaves of 14 dpg seedlings were imaged under a confocal microscope to observe GFP expression. These images were taken at 7 hpd. The upper 
and lower epidermis of each leaf was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP (cyan) 
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and one for propidium iodide and chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP channel (ii) 
and propidium iodide and chlorophyll channel (iii) are shown. Leaves from the following plant lines were image: 142 (A and B), 142S (C and D) and M1 
(E and F). A scale bar is shown for each image in the propidium channel only image. Images are representative of the three leaves visualised. 
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Figure 7.13A: GFP expression in epidermal layers of 5th leaves of 14 dpg plants at 13 hp 
The 5th leaves of 14 dpg seedlings were imaged under a confocal microscope to observe GFP expression. These images were taken at 13 hpd. The 
upper and lower epidermis of each leaf was imaged. All images were taken at 20 time magnification. Two separate channels were used, one for GFP 
(cyan) and one for propidium iodide and chlorophyll (red). In all cases a combined image of both channels (i) and separate images of just the GFP 
channel (ii) and propidium iodide and chlorophyll channel (iii) are shown. Leaves from the following plant lines were image: 142 (A and B), 142S (C 
and D) and M1 (E, F and G). E and F show areas of the leaf where silencing is less (E) or more (F) prevalent. A scale bar is shown for each image in the 
propidium channel only image. Images are representative of the three leaves visualised.
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Appendix 2.3 Sorting GFP negative and positive protoplasts 
in M1 and M9 samples 
 
Figure 7.14A: GFP expression of the adaxial and abaxial side of M1 and M9 
leaves at 21 dpg 
Images of the adaxial and abaxial side of odd numbered leaves from lines 142 and 142S, 
taken under a fluorescence microscope at 21 dpg. Images A, B, C and D are of the 1st 
leaf, images E, F, G and H are of the 3rd leaf, images I, J, K and L are of the 5th leaf and 
images of M, N, O and P are of the 7th leaf. The first column (A, E, I and M) are image of 
the adaxial side of 142 leaves. The second column (B, F, J and N) are images of the 
adaxial side of 142S leaves. The third column (C, G, K and O) are image of the abaxial 
side of 142 leaves. The fourth column (D, H, L and P) are images of the abaxial side of 
142S leaves. A scale bar is shown at the bottom right of each image. 
Appendices 
 
400 
 
Appendix 2.4 Sorting GFP negative and positive protoplasts 
in M1 and M9 samples 
 
Figure 7.15A: Sorting GFP positive and negative protoplasts in M1 sample 
Graphs showing results of flow cytomtery analysis of the M1 protoplast sample. A: Dot 
plot of ssc against fsc. The values for the y axis and x axis are relative values of ssc and 
fsc respectively. The dots colour indicates how many events are found at this point. It 
ranges from red (low number events) to purple (high number events).The R1 box 
highlights the area of the graph where protoplasts are found. Anything below or to the 
left of the R1 box is likely to be cell debris, while anything above or to the right of the R1 
box is likely to be multiple protoplasts still attached to each other. The R1 box acts as a 
gate to the other 3 graphs, so only points found within the R1 box are shown on the 
other graphs. B: Dot plot of chlorophyll fluorescence intensity against GFP fluorescence 
intensity. Both axes give relative values of intensity for the two flurophores. The R2 box 
highlights the GFP positive protoplast population. The R3 box highlights the GFP 
negative protoplast population. This area of the graph has been blown up. C: Histogram 
of intensity of GFP fluorescence. D: Histogram of intensity of chlorophyll fluorescence. 
For both C and D the areas of the histograms corresponding to the GFP positive 
protoplasts is highlighted in green while the areas if the histograms corresponding to the 
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GFP negative protoplasts is highlighted in red. The x axes for both C and D are relative 
measurements of intensity. In D the GFP positive and negative protoplast populations 
overlap each other. 
 
Figure 7.16A: Sorting GFP positive and negative protoplasts in M9 sample 
Graphs showing results of flow cytomtery analysis of the M9 protoplast sample. A: Dot 
plot of ssc against fsc. The values for the y axis and x axis are relative values of ssc and 
fsc respectively. The dots colour indicates how many events are found at this point. It 
ranges from red (low number events) to purple (high number events).The R1 box 
highlights the area of the graph where protoplasts are found. Anything below or to the 
left of the R1 box is likely to be cell debris, while anything above or to the right of the R1 
box is likely to be multiple protoplasts still attached to each other. The R1 box acts as a 
gate to the other 3 graphs, so only points found within the R1 box are shown on the 
other graphs. B: Dot plot of chlorophyll fluorescence intensity against GFP fluorescence 
intensity. Both axes give relative values of intensity for the two flurophores. The R2 box 
highlights the GFP positive protoplast population. The R3 box highlights the GFP 
negative protoplast population. This area of the graph has been blown up. C: Histogram 
of intensity of GFP fluorescence. D: Histogram of intensity of chlorophyll fluorescence. 
For both C and D the areas of the histograms corresponding to the GFP positive 
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protoplasts is highlighted in green while the areas if the histograms corresponding to the 
GFP negative protoplasts is highlighted in red. The x axes for both C and D are relative 
measurements of intensity. In D the GFP positive and negative protoplast populations 
overlap each other. 
Appendix 3 
Appendix 3.1. Repeat of Solo LTR Southern blot 
 
Figure 7.17A: CHG methylation pattern of Solo LTR 
Southern blot looking at CG and CHG methylation of Solo LTR. DNA from 7 dpg and 21 
dpg plants of lines 142, 142S, M1, M9, rdr2-1 and rmd3 were used. The order of loading 
is given at the top of the blot. DNA was digested with MspI, which is sensitive to CG and 
CHG methylation. An image of the probed Southern blot and part of the SYBR safe 
stained gel used for blotting are shown. The stained gel indicates the amount of DNA for 
each sample used for the Southern blot. Two lanes have been removed from the images 
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of the blot and gel which is indicated by the white vertical line between the M9 21 dpg 
and rmd3 7 dpg samples. 
Appendix 3.2 Detection of Solo LTR siRNAs in floral tissue 
 
Figure 7.18A: Northern blot for detection of Solo LTR siRNAs 
Images of a northern blot probed with 32P-labelled probes for Solo LTR (top) and miR167 
(bottom). Floral RNA samples of lines 142, 142S, M1, M9 and rmd3 were used and the 
order of loading is given above the blots. For this blot the miR167 probe acts as a loading 
control. The rmd3 sample is a negative control as it is a mutant in nrpd1 and so should 
lack 24 nt siRNAs.  
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Appendix 3.3 Confirmation of normal distribution of LN and 
descriptive statistics for each line 
  Line  
Statistic C24 142 142S M1 M9 rmd1 
Kolmogorov-
Smirnova 
0.200 0.075 0.020 0.088 0.200 0.193 
Shapiro-Wilk 0.488 0.326 <0.001 0.067 0.303 0.675 
Table 7.5A: Table showing statistics testing normal distribution of LN data for 
each line tested 
Two statistical tests that both look at the normal distribution of the LN data for each 
line. The significance value for each line is given for both tests. For all lines, except 142S, 
both tests show there is no significant difference and so the data is normally distributed. 
For 142S both tests shows that 142S is not normally distributed.  
  Line  
Statistic C24 142 142S M1 M9 rmd1 
Mean 
61.02 
(0.642) 
62.30 
(0.636) 
62.96 
(0.895) 
67.76 
(0.799) 
59.17 
(0.696) 
55.25 
(0.681) 
Median 61.00 64.00 64.00 68.00 59.00 54.50 
Variance 56.85 42.52 96.11 84.22 60.99 57.46 
SD 7.54 6.52 9.80 9.18 7.81 7.58 
Min. 
Value 
38.00 46.00 37.00 49.00 41.00 34.00 
Max. 
Value 
78.00 83.00 115.00 96.00 80.00 76.00 
Range 40.00 37.00 78.00 47.00 39.00 42.00 
IQR 10.00 8.00 13.00 12.00 10.00 12.00 
Table 7.6A: Table of descriptive statistic for LN data from each line tested 
Table showing the following descriptive statistics for leaf number (LN) data for each line 
tested: mean, median, variance, standard deviation (SD), minimum value, maximum 
value, range and interquartile range (IQR). The lines tested were C24 WT, 142, 142S, M1, 
M9 and rmd1. For the mean the number in brackets is the standard error of each mean. 
There are no units for these statistics as the data is count data.  
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Appendix 3.4 Confirmation of normal distribution of 
rosette weight and descriptive statistics for each line 
 Line       
Statistic C24 142 142S M1 M9 rmd1 
Kolmogorov-Smirnova 0.200 0.200 0.200 0.200 0.200 0.200 
Shapiro-Wilk 0.079 0.060 0.78 0.982 0.561 0.735 
Table 7.7A: Table showing statistics testing normal distribution of rosette 
weight data for each line tested 
Two statistical tests that both look at the normal distribution of the rosette weight data 
for each line. The significance value for each line is given for both tests. For all lines both 
tests show there is no significant difference and so the data is normally distributed. 
  Line  
Statistic C24 142 142S M1 M9 rmd1 
Mean 
1.523 
(0.039) 
1.868 
(0.050) 
0.876 
(0.019) 
0.759 
(0.019) 
0.709 
(0.015) 
0.652 
(0.016) 
Median 1.470 1.870 0.890 0.750 0.710 0.670 
Variance 0.210 0.260 0.043 0.050 0.029 0.032 
SD 0.459 0.510 0.208 0.223 0.170 0.179 
Min. 
Value 
0.360 0.450 0.390 0.160 0.310 0.200 
Max. 
Value 
2.680 3.640 1.500 1.400 1.130 1.050 
Range 2.320 3.190 1.110 1.240 0.820 0.850 
IQR 0.540 0.570 0.280 0.290 0.230 0.220 
Table 7.8A: Table of descriptive statistic for rosette weight data from each line 
tested 
Table showing the following descriptive statistics for rosette weight data for each line 
tested: mean, median, variance, standard deviation (SD), minimum value, maximum 
value, range and interquartile range (IQR). The lines tested were C24 WT, 142, 142S, M1, 
M9 and rmd1. For the mean the number in brackets is the standard error of each mean. 
The units for all the statistics, bar the variance, are in grams (g) and for the variance the 
units is g2.
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Abbreviations 
A  Adenine 
aa  Amino acid 
AGO  Argonaute 
ANOVA Analysis of variance 
APS  Ammonium persulfate 
At  Arabidopsis thaliana (Thale Cress) 
AtMu1  Arabidopsis thaliana Mutator-like 1 
ATP  Adenosine triphosphate 
AtSN1  Arabidopsis thaliana SINE 1 
BLAST  Basic local alignment search tool  
bp  Base pair 
BSA  Bovine serum albumin 
Bt  Bos Taurus (Cattle) 
C  Cytosine 
CaCl2  Calcium di-chloride 
CaMV  Cauliflower mosaic virus 
CAPS  Cleaved amplified polymorphic sequences 
CDS  Coding sequence 
Ce  Caenorhabditis elegans (Nematode worm) 
Chr  Chromosome 
CHS  Chalcone synthase 
CLSY  Classy 
CMM  Conserved MOM1 motif 
CMT  Chromomethylase 
CNV  Copy number variant 
Col  Columbia 
CRH  Compromised recognition of TCV homolog 
CRT  Compromised recognition of TCV  
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CTAB  Cetyltrimethylammonium bromide 
CTP  Cytidine triphosphate 
dATP  Deoxyadenosine triphosphate 
DCL  Dicer like 
dCTP  Deoxygcytidine triphosphate 
DDM  Decrease in DNA methylation 
dGTP  Deoxyguanidine triphosphate 
dH2O  Deionised water 
DME  Demeter 
DML  Demeter-like 
DMS  Defective in meristem silencing 
DMSO  Dimethylsulfoxide 
DNA  Deoxyribonucleic acid 
dNTPs  Deoxyribonucleotide triphosphates 
dpg   Days post germination  
Dr  Danio rerio (Zebrafish) 
DRB  Double stranded RNA binding protein 
DRD  Defective in RNA-directed DNA methylation 
DRM  Domains rearranged methyltransferase 
ds  Double stranded 
DTF  DNA binding transcription factor 
DTT  Dithiothreitol 
dTTP  Deoxythymidine triphosphate 
EDC  1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
EDTA  Ethylenediaminetetraacetic acid 
ELISA  Enzyme-linked immunosorbent assay 
EMS  Ethyl ester methane sulfonic acid 
ER  Endoplasmic reticulum 
EtBr  Ethidium bromide 
FACT  Facilitates chromatin transcription/transaction) 
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FDM  Factor of DNA methylation 
FLC  Flowering time locus C 
fsc  Forward scatter 
FWA  Flowering wageningen 
FUBAR  Rude word for properly screwed 
G  Guanine 
g  Gram 
GFP  Green fluorescent protein 
GHKL  Gyrase, Hsp90, Histidine Kinase, MutL 
GTP  Guanidine triphosphate 
GW/WG Glycine tryptophan/tryptophan glycine 
H  Cytosine, adenine or thymine 
H1  Histone one 
H2  Histone two 
H3  Histone three 
H4  Histone four 
H2O  Water 
HCl  Hydrochloric acid 
HDA  Histone deacetylase  
HEN  HUA enhancer 
HMW  High molecular weight 
hpd  Hours post dawn 
Hs  Homo sapiens (Humans) 
HSP  Heat shock protein 
Hz   Hertz 
IDM  Increased DNA methylation 
IDN  Involved in de novo 
IDNL  Involved in de novo-like 
IDP  IDN paralog 
IGN  Intergenic loci 
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IGR  Intergenic region 
Indel  Insertion or deletion 
IQR  Interquartile range 
IR  Inverted repeat 
JMJ  Jumonji 
kb  Kilobase 
K  Lysine 
KCl  Potassium chloride 
KOH  Potassium hydroxide 
KTF  KOW domain-containing transcription factor 
l  Litre 
LB  Lysogeny broth 
LCR  Low-complexity region 
Ler  Landsberg erecta 
LHP  Like heterochromatin protein 
LMW  Low molecular weight 
LN  Leaf number 
LSD  Lysine specific demethylase (Chapter one) 
LSD  Least significant difference (Chapter five) 
LTR  Long terminal repeat 
M  Molar 
mA  Miliamps 
Max.  Maximum 
MBD  Methyl- CpG- binding domain 
MBq  Mega becquerels 
MDS  Multi-dimensional scaling 
MEA-ISR Medea-intergenic subtelomeric repeats 
MES  2-(N-Morpholino)ethanesulfonic acid 
MET  Methyltransferase 
mg  Milligram 
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Min  Minimum 
miRNA  Micro RNA 
ml  Millilitre 
Mm  Mus musculus  
mM  Millimolar 
mm  Millimetre 
Mo  Myroides odoratimimus (Bacteria species) 
MOM  Morpheus molecule 
MOPS  3-(N-morpholino)propanesulfonic acid 
MORC  Microrchidia 
mRNA  Messenger RNA 
MS  Murashige and Skoog  
Mt  Medicago truncatula (Barrel clover) 
MULE  Mutator-like element 
MZ  Metazoan 
N  Cytosine, guanine, adenine or thymine 
Na2HPO4 Di-sodium phosphate 
Na3CIT  Tri-sodium citrate 
NaAc  Sodium acetate 
NaCl  Sodium chloride 
NaH2PO4 Sodium di-hydrogen phosphate  
NaOH  Sodium hydroxide 
nat-siRNA Natural-antisense small interfering RNA 
NB  Nuclear bodies 
NERD  Needed for RDR2-independent DNA methylation 
ng  Nanogram 
NLS  Nuclear localisation signal 
nm  Nano metres 
NOS  Nopaline synthase 
NRPB  Nuclear RNA polymerase B (II) 
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NRPD  Nuclear RNA polymerase D (IV) 
NRPE  Nuclear RNA polymerase E (V) 
nt  Nucleotide 
Nv  Nematostella vectensis (Starlet sea anemone) 
Oz  Oryza sativa (Rice)  
p  Promoter 
32P  32Phosphorous 
PAZ  Piwi Argonaute Zwille 
PCR  Polymerase chain reaction 
PDS  Phytoene desaturase 
PEG  Polyethylene glycol 
PHB  Phabulosa 
PHV  Phavoluta 
Phyre  Protein homology/analogy recognition engine 
piRNA  PIWI RNA 
PIWI  P-element induced wimpy testis 
PL  Plantae 
PML  Promyelocytic leukemia 
PolIV  Nuclear RNA polymerase IV (D) 
PolV  Nuclear RNA polymerase V (E) 
Pp  Physcomitrella patens (Moss)  
Pt  Populus trichocarpa (Black Cottonwood) 
PTGS  Post-transcriptional gene silencing 
PVP  Polyvinylpyrrolidone 
rcf  Relative centrifugal force 
rDNA  Ribosomal RNA gene 
RdDM  RNA-directed DNA methylation 
RDM  RNA-directed DNA methylation 
RDR  Plant RNA-dependent RNA polymerase 
RING  Real interesting new gene 
Abbreviations 
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RISC  RNA-induced silencing complex 
RMD  RNA-directed DNA methylation defective 
RMR  Required to maintain repression 
RNA  Ribonucleic acid 
RNAi  RNA interference 
ROI  Region of interest 
ROS  Repressor of silencing 
rpm  Revolutions per mintue 
rRNA  Ribosomal RNA 
RT  Reverse transcriptase 
s  Seconds 
SAM  S-adenosyl methionine 
SD  Standard deviation 
SDC  Suppressor of drm2 and cmt3 
SDS  Sodium dodecyl sulfate 
SET  Suppressor of variegation 3-9, Enhancer of zeste and Trithorax 
SHH  Sawadee homeodomain homolog 
SINE  Short interspersed elements 
siRNA  Small interfering RNA 
Sm  Selaginella moellendorffii (Lycophyte) 
SMART Simple Modular Architecture Research Tool 
SMC  Structural maintenance of chromosomes 
SmcMORC Structural maintenance of chromosomes microrchidia 
SNP  Single nucleotide polymorphism 
SR  Serine/arginine rich 
SRA  SET and RING associated 
sRNA  Small RNA 
ss  Single stranded 
SSC  Saline-sodium citrate 
ssc  Side scatter 
Abbreviations 
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SSLP  Simple sequence length polymorphisms 
SSRP  Structure specific recognition protein 
SUP  Suppressor of ros1 
SUVH  SU(Var)3-9 homolog 
T  Thymine 
TAIR  The Arabidopsis information resource 
tasiRNA Trans-acting small interfering RNAs 
TBE  Tris borate EDTA 
TCV  Turnip crinkle virus 
TE  Transposable element 
te  Tris-EDTA 
TEMED Tris(hydroxymethyl)aminomethane 
TGS  Transcriptional gene silencing 
Tm  Primer melting temperature 
tRNA  Transfer RNA 
T-DNA  Transfer-DNA 
U  Uracil 
UBP  Ubiquitin protease 
UTP  Uridine triphosphate 
UTR  Untranslated region 
UV  Ultra violet 
V  Volts 
Vv  Vitis vinifera (Grape vine) 
WT  Wild type 
x g   Times gravity 
Xt  Xenopus tropicalis (West African Clawed Frog) 
Zm  Zea mays (Maize)  
α  Alpha 
β  Beta 
γ  Gamma 
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µg  Microgram 
µl  Microlitre 
°C  Degrees Celcius 
%  Percentage
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